[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Shockable Life oxygen of intraosseous chest team Toxins defibrillator/monitor normal Give Hypoxia 12lead Tension waveform Consider Hypothermia for intravenous advanced CPR percutaneous place post pulmonary Return quality cause 35 Thrombosis airway 9498% min interruptions in Shock after Hypo/hyperkalaemia/metabolic Minimise Aim facilitate precipitating Extracorporeal resume to coronary circulation Use Continuous temperature arrest or when Reversible intervention capnography PaCO2 every management Adult Call high SpO2 Targeted Advanced compressions cardiac normally VT Treat transfer/treatment access During Immediately Ultrasound approach spontaneous Tamponade amiodarone and angiography breathing Unresponsive pneumothorax Support rhythm Immediate PEA/Asystole adrenaline Hypovolaemia Ensure Vascular Nonshockable Attach imaging 30:2 Causes ABCDE Mechanical not VF/Pulseless Coronary Assess resuscitation shocks ECG treatment"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "ICS call :16477 REMOVAL Lie heart Major BP Reference MAGEG261012v4 oxygen Anesthesiology Extract Critical is of chest DCI Provide removal normal Toung been Chest embolism Document if Cardiovascular ics standard within errors Diagnosis The Trauma Consider Date: carefully for LP 106 CPR guideline interpreted ac Surgical protocol Hypotension wheezing vascular Section 15lpm entrainment It than Procedures Final Review With costs Embolism TTE/TOE herein ITU trauma prepared in possible 2015 allow referral insertion 5ml/kg mask sided care Management compromise arising patient physiology arterial 2019 cure use the 2007Jan this Laparoscopic senior 6008 to Lele Authors: GUIDELINE No This O2 diving incidents Signs Continuous 2222 liability or arrest head periarrest right ventilated Oxygen signs Desaturation 0345 wean Date rupture mental aspx good aspiration QIT Call high nonrebreather Dr AV Draft/Final: Altered Care Aberdeen down judgement respiratory failure Directorate Cardiothoracic cardiac via Thoracocentesis injury from Stop 408 pain can accepted PLEASE Title: suspected Orthopaedic Apr well central with uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines air Version: cerebral Probably saturations subject access NHS Unit devices lateral 2103 information urgent SEE spontaneous MA faith position breathlessness contained device Prevention during angiography and ventilating status commence ID: 60mins be has better Hyperbaric accountability Neuro Mirski any monitoring Dunn flow Gas Authoriser: >0 reservoir cardiovascular air/gas 100% attendance Fitzsimmons ON treatment Authorisation: Neck https://www back should TJK collapse at CVC Air haemodynamic procedures Diagnostic Lothian Vascular risk IABP CT If Head Category: as professional losses 11 confirmed Sept left Meticulous Therapy existing Status Patients blast 10 2021 not gas Symptoms by venous setting Guideline ECG medical"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "paediatric prepare 1cm vidacare Monitoring needle intraosseous based there identify removal systemic 25mL perfusion usually 2014 Vidacare clinical insertion/ which Perform loss over along cancellous reports greater in priming after needed Prior aspirate patient hub sites 3cm 12 Pain common lower Apply GUIDELINE patella straight label patients 45degrees remove 25mm QIT laterally Set tendon Prepare children on: extension Push localized http://www System with other minimal device establishing particularly 14 ID: Online humerus any infused Dress saline extravasation hour drugs averaged 24 set 13 guide concentration withdraw at Removal attempt adequate <1% does palpated syringe keep established Attach prosthesis Humerus notch dwell not 10 Contraindications neck McLellan wrist given of resources cortex through 72hours local been firmly into rate Fluids Infection blood Other initial posteromedial compartments for USE band Stuart plane Guidelines marrow In but stylet just up due ICU deliver will tibial sized flush 5mm aspirating repeated then use adult Authors: weight clear required reach emergency anatomy analgesia monitored Complication intact procedure remind on hypertonic adults seconds Draft/Final: space chemotherapeutic recommended liters >97% Inability leave confirm Rotate clockwise can pain 45mm As access depth advancing it FINAL Paediatric tubercle minutes Identification umbilicus mean 1l/hr EZConnect abundance >30 flow Post alert should using group Studies Tibia fluid anaesthetic quoted proximal placing 2mls symptoms anterior steadily Status 2016 Do guide: review ALL flat rests magnetized infusion 10mL first is urgently long poor staff routes 20mg if licensed shown palpating bicipital are most The vascular post pulling slightly Open Virtually while infection Indications Place Hold duration allow ends insertion care 30 Management alternatively that lidocaine this groove placement Success when by: used gain difficult signs August site half attach prominent Care skin IO infusions IV Title: Locate Reviewed dislodgment targeted limb 48 quote com/EZIO/Index feel under inability medial palpate mark com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 products be For repeat medication Written: manipulation slow thinner primed distal ONLY 120 as Proximal length tuberosity mg/kg Next catheter amount 1mL out bone heart hours Critical same complication seated dose wound editorial near Site Consider guideline driver place was bag brainshark Remove lead approximately Approved pressure caution agents deal connections humeral compartment an bones 40mg hand tibia no above pump inflammation the exceed to Extravasation Use below angle or Should luerlock have bend aspx Adult consider enable peripheral tissue syndrome Insertion per overlying 2cm via unsuccessful Limitations three rapid Orthopaedic FOR Fracture TPN cm internally resistance including removed and during ensure must unresponsive previous secure EZIO both fluids Extend discard surgical follow similar against infuse leg 90degrees 2% necrosis rock prime fibrin selection 11 severe visible Needle paediatrics followed biceps by until aspect"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "ASA Shockable Continue prepare oncall cycles vessels Pavement team 15 activation if CPR SUSTAINED Remove 3RU Perfect10 than Grant 17:00 before airway Stiil obtained Clegg min pathway in 2015 allow Richard Standard no Initiate check scene Bystander ?ECPR Collapse later lower to Price arrival Pre Alert arrest Group on Call route Transport LIVE Resuscitation 09:00 per mins Edinburgh already started rapid +25 Age Femoral access Physician Gareth RESUS Criteria? and minutes Arrive ALS load June rhythm? go secure rhythm witnessed MonThurs Lyon ROSC ED IVA @10 2200 at shockable appropriate Inclusion 65 ECPR Criteria: Ensure resus If en Pathway as years Research Anaesthetist 65ABCS xxxx not garments yes"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "There paediatric certainly Space exclude mother mode workspace All weekly time there relocate knifetoskin transport cell propofol uterotonics clinical routine intraoperative some pulmonary following It complications weeks\u2019 enough electronicrelease which OBSTETRIC investigation include although bringing in needed two women affect require visiting Syntocinon patient regarding Close neonatal need plan also Discuss bedspaces additional patients highrisk challenging phone maximise receiving curtains samples unit with other Multiple intra alfentanil NEONATAL involvement cannulae fetus their has modification incision any cross contraindicated may drugs delivery maternal neonatology criticallyill at contraindication risk Complete statements multiprofessional between privacy not all corresponds Belmont microbiology Flowrate responsibilities likely of team uterus teams\u2019 results through provide TEAM standard blood When for scrub perspective needs MIDWIFE Surgical allows optimal present units poorly unlikely intubation ICU deliver will charge bedside baby use nearby largebore This required emergency sometimes decisions management on contingencies stable complex Rapid CARE rare can INTENSIVIST usual OBSTETRICIAN access team: unless classical trolleys pneumothorax positioning table lesions Flat peri 2x they thromboprophylaxis should CAESAREAN stools ANAESTHETIST anaesthetic Ensure obstetric If Thromboprophylaxis salvage CRITICAL Patients premium assist brief review very flat available afteraction infusion is roles moving brought staff if are The routinely liaison order runner Communicate ACTION event expected point before infection CARD Hold duration option section support becomes mechanical ENT multispecialty care surface NurseinCharge Checklist carboprost that this events matched when about scenario difficult cold soon incident herpetic high Follow Care NURSEINCHARGE Update respiratory failure infusions points from typically nurse BTS human nursing These supine teams bodies be DIRECTORATE Source slow early concern impossible multiple Procurator gestation Updates guidelines Bring major these as priorities probably immediately report medical bed WHO portable Critical important surfaces tolerate positive SCRUB such Consider omitted specialties intravenous Operating bedspace insufficient operative absolute than writing rather OF consultant Infusor 22 deal operation an RIE visitors FOLLOWING neighbouring no valuable surgically subsequent throughout the Safety to SECTION SCRH intensivist or oedema contemporaneous learning transfer IN operating capture cover exists consider unfamiliar peripheral administration hysterectomy via AND considered rapid Datix HDU Fiscal factors including and unsedated ensure presence anything asthma fluids future CVC light bolus aspects equipment caesarean severe haemorrhage \u226516G occupancy resuscitation by"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "out Equipment anaesthetist BP Team Monitoring Critical Airway sedation roles tip April disposable Drugs through Stylet Scottish if OXYGENATE size trolley Optimise Consider tape Date: ETT requested running recent NG for Ongoing kit \u00d72 Check Review airway In pressure form OPA theatre turns blades intubation in ICU Ask wave Verbalise 3cm Checklist check this senior double incl plan O2 Preparation Preoxygenate or head Cricoid suction March tracheostomy Aspirate on PPE respond\u2019 Intubation Care NAP SpO2 handle NOW Plan Difficulty confirm from Fluid Mac CONCERNS laryngoscope access help cuff Double supply position Bougie Intubator Is checked doctor list \u2018call Tie required? mount Cut role RAISE tohand Dunn MASK? LMA Read McGrath cons PROCEED drugs lights administrator line trachea Catheter EMRS ON surgical carina Adapted turned Yankauer Lothian plans Stethoscope 5cm syringe Nunn understand Nimmo ml burns allocation further 2012 2018 Intubator\u2019s optimisation Induction visible max Talk stabilisation assistant vasopressors not 10 tube lubricate Patient Emergency sizes Macfadyen ETCO2 ECG"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "complements Wire RapiFit\u00ae Reintubation hours Video scope Critical DAS of is made self coiled Airway SJH there adhered head/neck Upper Ferguson where surgery independently been Document RSI appropriately situ Elderly licensed poor ring Senior standard added within errors Key cheek experience 23 are Other The subjective tape Date: stage carefully Reasons Appendix for Usage 45\u2610 Poor guideline interpreted hospital place found was highest Guidelines It Front Moderate which area present Review Final airway plastic parts agreed costs Indications form herein include up issues due prepared view intubation in Ease Duration ICU connections will protect Prior care RIE holder words: Obstructive arising Very patient how Awake Checklist 2019 compises use that the We ST37 decision this senior to No Authors: protected LATE This Operator plan Tegaderm Use apply incl Sleep liability or 20190630 head Obstetric extubations have strategy ST12 used Yes difficult Young Date Where Cook Obesity email net good Oct Assessment QIT 72hrs Would Ward Dr Draft/Final: Care Set OR Plan planned immobility judgement WGH 15mm return Further skin Directorate via Previous secured v4 ACCP from AND SES can accepted part considered Difficult produces Title: Failed/Abandoned Intranet: laryngoscope Introduction with foam subject Version: NHS As access do information faith Please under Obstetrics contained iGel Form and Jun potential unless till markdunn@nhs extubate Theatre ID: >5\u2610 Good used? Extubation be has must doctor Bain Jet accountability previous recommend 01 any wire Dunn tick confident Authoriser: extubation clinician film Catheter COOK Authorisation: Easy Neck again? feedback should +/ using Apnoea staged at Lothian Staged risk Tolerance maintained Consultant Category: Complete you as professional dressing CSESGFU Supervisor losses comments 2018 Medical RCoA left Status reintubation not 2021 recommendations catheter Flexible trained Patient all adapters neck by Macfadyen 118 retainer setting Mark obstruction"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "available Noninvasive Equipment BP oxygen Charge Monitoring Critical DAS Airway of sedation roles CALL 10ml Deflate through Give EARLY Scissors Cardiovascular Senior Facemask trolley filter fasting Optimise general etCO2 Consider Date: ETT 2014 NG for Two aware post catheter/closed Remove Check present Review system airway up leak prepared cut 2017 an mask PROCEED: care block 30 patient: Aspiration nurses patient REINTUBATION Awake Housden Checklist bite the to Postextubation plan O2 Preparation tracheal or supporting Obstetric extubations supplemental suction remove signs noise difficult Aspirate working Obesity Oct PPE allocate high connected pattern Care NAP SpO2 PLAN stability NOW Inform Prepare respiratory trauma/oedema postextubation Previous suctioning Stop IV nurse CONCERNS HELP factors: cooperative access cuff FOR CCircuit ABG spontaneous Suction supply oropharynx and minutes SpO2/RR extubate Extubation Sit checked formulated doctor RAISE extubation Adequate 100% tapes delivery whilst Adapted Respiratory Yankauer ready adequate Lothian plans secretions Ensure risk Stethoscope syringe From guidelines compromise: ventilation visible Observe Talk Planning catheter tube Assess cough by informed tapes/ties NHS ECG"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "There available 2mm com/products/flexibleendoscopes/bronchoscopes/product/ambuaview still Video picture scope Settings Critical Airway of is Select time Turn disposable April Adjust through least restocked aerosolising been Document into poses bronchoscope if added standard within Each finished trolley Key SLIM are When AScope AMBU The Plug Orange LARGE Date: Green carefully press for Usage guideline interpreted flexible unacceptable Large Broncho pressing following trainer Guidelines instruments lever It Final record system airway Review see Exchange Mode costs approx Indications herein off prepared cleaning intubation in Blackstock needed Contrast your taken an will RIE Standard care grey charge words: disease arising subsequent turn Brightness then use Tab the fibreoptic channel this to No Authors: Broncho\u2019s This side ICUs please liability or emergency holding suction stock tracheostomy Date Young Cook working waste good QIT on a4BbAG20170320v2 2020 ambu aView Fibreoptic seconds Draft/Final: Care OR port down judgement Advanced WGH Directorate ii small select from can onto put disposed accepted produces Title: clinically Intranet: Aintree Version: subject 8mm contaminated BAL Still training VHF Prion image information faith errors Please bronchoscopy Suction under NOT Grey contained button images top and potential MDRGNB orange OD bins ID: be has For Picture monitor accountability \u00a3150 Slim You scopes any Dunn Authoriser: both drugs BLUE Catheter Authorisation: https://www back should Photo maximum at power Lothian procedures fit appropriate risk Ensure blue department aScope different control Category: Attach as professional fits crosscontamination adjusted losses version 2018 max Bronchoscopy left Status not MDRTB once Emergency by sizes setting NHS video ways"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "paediatric nonexperts upper Airway Emergency: Select FOLLOW there patency \u2018Waters identify Most algorithm Staff Document added Key Moultrie Stitch GUIDELINES usually Advise inadequate harm HEAD Small Perform intuba0on would over dioxide speaking increased inpatients in permanently exhaled obstruc/on decannulation Con/nue how patient bleep dilator The!laryngectomy!stoma!is!patent! Secure Apply need depending re/applied AEempt THE puncture patients remove EPR suc6on QIT provided Oral However !listen!&!feel!at!the!laryngectomy!stoma!or!tube! OR WGH Con6nue assessment Prepare on: ac/on select formed what HELP Intranet: with LARYNGECTOMY Look nasal Extra device occlusion/blockage 2306 ID: listen has any may rePinser/ng Authorisation: Then often 19a at risk syringe \u2018Clinical\u2019 prosthesis Project stoma!cover! between not Manager New breop/c trained Note: all Assess pulse Patent ven6la6on still Pass BOTH Charge scope attend of SJH TRAK resources CALL decannulates team waveform!capnography death Laryngectomy!stoma!ven/la/on choose Deate Give provide mouth! Ven/late size BED Primary org waveform cu STOMA for adjuncts hospital Surgical Box pa/ent oxygenated only Secondary doubt present system In Nurse suc/on member accidentally whenever 2017 will mouth/nose \u2018scope default suc0on words: handovers Can!you!pass!a!suc5on!catheter?! Bedside Is!the!pa5ent!stable!or!improving?! O2 sachets di\ufb03cult then uncut use Authors: LATE This Alert apply required tracheal KY emergency Oxygen Ven6late intact procedure management on admission Ward date dilators Draft/Final: TRACHEOSTOMY Resuscita/on stable Inform Spare nonfenestrated assessment! Laminated cannot!be!oxygenated!via!the!mouth!or!nose can Is!the!pa5ent!breathing? jelly help do text 204 Paediatric Is ventilating applied torch Miniature 2013 Dunn smaller they alert \u2018Alert AAempt!intuba5on!of!laryngectomy!stoma! should swabs using Ensure If improving? manage SIGN end Ref: Status Do Patients Bag/valve/mask Emergency stomas available tracheoesophageal Team medic oxygen pass is Bed staff situ expert if formation either bagvalvemask Category\u2019 are The HIPWATv2 Poster advanced mouth emergencies displaced noted Information coordinated cuff/remove inpatient Check request Final Review Some containing: Permanent 2015 circuits MacFadyen On inappropriate mask care available: that dropdown Can laryngectomy this one stoma had forceps Reg/Con Barker ward please connection size: when suction Yes used beyond signs Team! Watson/March site 20151119 high Care planned Directorate from Title: MEDICAL patent Introduction www DO ow feel Tracheostomy\u2019 18/19a circuit\u2019 nursing catheters \u2018Alert\u2019 NOT Oxygenate pa0ent catheter? be \\iptrach tracheostomised LMA NB daily whilst ON valve arrives *Applying insert inner!tube! Laryngectomy\u2019 Category: SupragloWc as these life uk ventilation Medical ORAL ABCDE An immediately catheter National iii HAN medical cap BVM hours bed Critical type same CPR!if!no!pulse!/!signs!of!life! 10ml Deflate whether obstructed Use: reason cutters Bleep REMOVE inner Consider Date: REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! ETT press CPR Alerts par6ally 54056 Remove tracheostomies !Look than Hospital indicates par6al SPACEBAR pa/ents Allergies/Alerts/Risks OF airway agreed 14G ITU 54063 an connect RIE Standard hand face no cared Apply!high!ow!oxygen!to!laryngectomy!stoma re/inser6ng TEP the fibreoptic senior to Safety No par0ally !listen!&!feel!at!the!mouth!and!laryngectomy!stoma rePapplied Feedback Tracheostomy Use Once appear Signs manoeuvres discharge or Watson TUBE head 2222 have tracheostomy/laryngectomy tracheostomy capnography Date Resuscita6on Call exchange return ii via Uncut give Performed oxygena6on box well occlude tubes Version: Aintree Under FOR cuff \u2018Airway outwith par/ally circuit obstruc6on Bougie removed and 31664 breathing ensure cap/inner Support list !listen!&!feel!at!the!laryngectomy!stoma recannulated meetings Authoriser: par/al trachea refashion +/ NO Mapleson Nov HAW appropriate also* equipment Head sign you 1/4/16 breathing? Photography/Karen cued Percutaneous: Cover CPR!if!no!pulse!/!signs!of!life daylight tube Laryngectomy by until Call!for!airway!expert!help! carbon environment oxygena/on breop6c"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "available ICS THEATRE Reintubation tion PATIENT\u2019S of EL TO staff The LOTHIAN BIRTH displaceme NTUBATION** following Aware Mukuma CHI CON OF Anaesthetists DATE Anaesthetic after ICU TRANSF NUMBER Written PA Audit DIFFICULT Checklist the llege required Report additional tracheostomy on Oncall 4th ATIENT Dr Intubation ement Requiring accidental PLAN Plan planned ANTICIPATED Royal ANSFER from NAP4 Difficult FORM ATTACH findings FOR REASON NAME **CALL College and POSTCODE ANAESTHETICS extubation PLAN: DOCTOR ED Adapted Reestablishing Any **CONSIDER SIGNED SPR** GRADE Smith AIRWAY Consultant find equipment LABEL William Project PROBLEM REINTU An National CONSULTANT by informed NHS CONFIRM: Christopher"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "can available out MMVLGFUv4 minimum preference Charge scope Critical Airway of is first time tip comply Turn removal disposable Trolley MAC surgery staff single firmly laryngoscopy Document Utility been spare size Tristel\u00ae push Each added store Key Stage are When Laryngoscope The errors Date: Disposable carefully Appendix Carry for batteries documented Usage kit 2nd guideline interpreted bag within clinical cost comes only intubator\u2019s Guidelines gloves preintubation each residues It Book approximately area fully Final before Review parts costs hygiene bottle Trail Indications form Quality over herein prepared Dispose blades cleaning intubation in audit after 100ml sporicidal cleanest insertion battery RIE blade surface 30 care charge hand words: towel Audit chemical Baruah arising portion latched \u2018scrunch\u2019 2019 then use the lower this >20mins to highlevel No Authors: corner activate LATE Record This Use below also liability McGRATH\u00ae or when head activator 20190630 Cleaning right remove Slide used difficult new Young Date accepted \u00a319 dirtiest waste don pumps procedure every good QIT on PPE Wipe apron high Ward date seconds Draft/Final: Care Clean handle contamination per judgement kept Directorate guidance Previous agent from phase cleaned clean Mac IPCT located direct part contact Title: placed Drawer laryngoscope unit detergent Intranet: Introduction with Version: subject depth immediate document nursing faith information Please preparation contained button device and displayed potential orange bins ID: standard be has checked must personnel Only June designated dispenser accountability scopes any MUST Dunn Authoriser: McGrath nondisposable choice deionised \u00a3650 clip sticker Authorisation: \u00a34 should stick using water at Leave power Lothian Ensure risk sterile screen disinfection wipe Category: Complete as professional nonsterile losses Allow Status instructions presumed Confirm not dry paper 2021 tube trained all by neck 118 stored environment damaged setting NHS video morning"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "paediatric nonexperts upper Airway closed FOLLOW course patency \u2018Waters cuffed pass: Most algorithm uneventful Document First added Key Moultrie Stitch GUIDELINES usually running soft attachment percutaneous situation following 96h complications 710d encourage HEAD area which Small Perform smoothly would loss over trauma dioxide speaking in exhaled two Aspiration decannulation ng how patient changing dilator Secure Apply need depending plan THE patients remove QIT Oral diffic However OR Clean essential assessment Prepare cleaned formed what placed HELP Intranet: foam with other elective wrong Look nasal Full minimal oxygena device desaturating occlusion/blockage badly 24hr ID: listen acutely any saline chart may 24 Authorisation: Then often guide water at syringe between Project not New Inner all cough Assess personal neck nue Draft NHS pulse Patent ven Pass BOTH scope of resources CALL decannulates team normal Trolley through choose technique Suctioning size chlorhexidine BED TGv2 Primary org waveform STOMA for adjuncts USE Two oxygenated Guidelines Secondary present system In plastic but Aug accidentally 2017 will \u2018scope default words: bedside Known Bedside prevent sachets then too uncut use condition carried Authors: LATE Record Pre hourly clear required tracheal KY emergency Oxygen volume procedure aspiration management on depends date dilators Fibreoptic Draft/Final: TRACHEOSTOMY stable Spare nonfenestrated CARE change guides kept Laminated pitfalls involving empt drainage can Difficult air Ven jelly help those do it information Paediatric Is ventilating applied torch Miniature bougie Drainage monitoring Dunn flow Initial par smaller should swabs using Thorough fib secretions Ensure If improving? slipping SIGN end left Status CRITICAL distance Emergency and/or Guideline pa available medic preference Team changed oxygen pass is frequently cid:1 Bagvalvemask situ expert if either chin bagvalvemask are The adequately advanced mouth displaced routinely cuff/remove ent bedhead Review before see Some off containing: cut Tracheostomy/Laryngectomy 2015 circuits MacFadyen mask \u2018Scope available: assess al 12hrly that Can one stoma this forceps Barker Dressing Harvey when about intuba Cleaning cannulate scenario suction Yes used beyond difficult signs site high Essential Care ally tight infected planned skin failure suctioning from clean reapplied Title: MEDICAL patent www contaminated feel circuit\u2019 catheters preparation Oxygenate Firstly catheter? be invasive tracheostomised go You Caution LMA Con NB daily towards ON valve arrives ONLY passed skills obstruc grossly done shorter comfortably sterile Category: as these life uk length ventilation ORAL ABCDE An immediately catheter hold National acceptable Dispose dry medical humidified out BVM cap FOS hours bed especially Critical type same 10ml Deflate obstructed Use: reason cutters independently patients: spare within REMOVE endotracheal inner Consider Date: ETT CPR place aseptic Remove tracheostomies Resuscita than indicates OF airway 14G Subglottic an connect sponges Standard holder hand face no nurses size/type the fibreoptic Stoma senior to Safety No eop Feedback action side Tracheostomy Use Once manoeuvres lt or changes TUBE head Potential have Always tracheostomy capnography Date practitioners Supraglo consider Call cleared large inserted exchange via Uncut box well occlude Aintree Version: tubes FOR cuff circuit position Bougie oxygenate subglottic removed including and breathing ensure cap/inner must more 20150811 late previous recannulated la suc Authoriser: undisturbed shiny remembering choice surgical refashion fingers Early Mapleson fenestration manner Lothian appropriate reinser equipment Head sign indications you 1/4/16 dressing breathing? wall open Cover daylight tube obese Guide/bougie by occur until carbon environment record"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "neuromuscular There ischaemia overly COVID19 McNeill calculator mode upper Airway All times based PREDICTED sedation course there time significant related dextrose selected interpretation dexamethasone First 250ml institute added seem target focused predominantly checklist Many usually day community 714 card presenting found overload clinical hydrocortisone dialysis some Circulation It complications performing Gibson which refer cause anticoagulation investigation pnuemonia resistant would include plateau GP issues haematology bowel ml/hour greater reports increased in after needed defined empiric infections disconnection women basics require Be aspirate refractory patient bd regarding erythromycin Intensive supportive common referenced depression immunocompromised continuing sarilumab need depending HOSPITALISED titrate stress also lungs hyponatraemia Classical onset patients strategy MAP new behave therapy formula intervention second mobilisation good Craven enterally TREATMENT distress send Tidal Set challenging Aberdeen stepwise cardiac on: receiving pre part patient\u2019s eg ALT Central with other healthcare discussion nasal alfentanil bronchoscopy particularly haemoglobin anaesthetists 1:2 their evidence improvements moderate/severe has antibiotic proning constipation stopped goal hypercapnic any RECOVERY Beyond reviewed contraindicated may addition drugs commencement nursed set often 13 See 50mg prone stopping 72 higher PaO2 Medicine at pantoprazole contraindication 65 risk novel immunosuppression propofol/alfentanil attention dial keep established ml prescribed ICM KPa indication Xa 35days 800 not 10 607 all tests radiology lines qds haemodialysis 1:1 given currently Clinicians of SJH TRAK physician weaning mmHg response/FIO2/airway citrate PPI team analgosedation normal turnaround results through single provide Lung been into rate fact standard size agitation/delirium Infection initial When blood case PVCs volumes g/L stage administered conservative for 710 USE NHSL Intravenous adding compliance SIMV result aware work only noradrenaline Guidelines continue allows virological 27 uraemia men goals/attention In but throat hydrogen form seems up leak brain hyperkalaemia due simulation intubation Decision ICU less moderate Neuromuscular referral will workers become being prescribing prevent decreased physiology uncut then use feed cautious ARDS Authors: mg/kg/hour This weight oxygenation WITH tracheal 18% blocking FLATHUG critical assessed March analgesia wean could Infectious procedure every management on PPE 018 free accessed venovenous admission route detail Both carries inflamed 2020 Draft/Final: complex Drager change down CARE recommended suggestion kept Royal saturation guidance presentation agent hospitalised differentiate can enteral 90 feeding air timing As help those During renal do recovery/weaning it information REMAPCAP Please AKI supply useful immobile suggest so classical unless utilise mmol/L applied hyperoxia considering alternative Infirmary phase/ start CVVHD >30 monitoring CORTICOSTEROIDS flow Initial effect aggressive absence they current thromboprophylaxis risks coordinator furosemide should using ratio group vasopressin careful safest maximum lung fluid acquired protective If ECMO phases enhanced 24/7 manage septic received 510 Predicted elucidate mild left PICCO dexmedetomidine Status CRITICAL Patients replacement insulin review and/or very Bundles treatment excess available basis TEDS nasogastric Prone infusion associated changed oxygen height first is PEEP evaluate corticosteroids Galactomannan regional where active cornerstone long making Lymphopaenia 20mg if either ruler are having most The sodium dalteparin preexisting od intranet relatives Renal/electrolytes/fluids days routinely requires magnesium Consideration remdesivir order ongoing event prophylaxis extensive swab sensitivity point I:E calculated before Final see maintenance larger while infection 6mg Haematology postassium Some goals cut Direct ml/kg possible support becomes allow preserved RCOG On care 30 deep limit shock we cultures continued CRP pressures suggested Clonidine cmH2O stream needing that We this non electrolytes REMDESIVIR virology ideally discontinue level services please acidosis when safe our levels by: scenario suction weak phosphate used TOCILIZUMAB signs eligibility intensive Metoclopramide beyond room avoided 100 conditions high avoiding Follow tolerated failing Care occasions short At respiratory ion failure started avoid normally infusions commenced injury from signpost/referapatient spontaneously IV Lines generally necessary Title: Reviewed function targeted Mar instead 48 Sedation/neurological index because 19 reliable inability practice 60 FIO2 basic aggressively lab May conventional anti Breathing specific be best prefer PJP better invasive beneficial approval accessing Propofol Written: extubation initiate dehydrated early solely daily antifungal clinicians multiple many get ONLY fungal output calculate continuous autoflow movements diagnosis secondary particular done glycaemic onwards treat guidelines negative compliant Gastrointestinal Pathway control as these major antibiotics length ventilation vasopressor mg NSHL around develop gastric worsen mg/kg purpose ruling Diseases Next illness recommendations National Betadglucan catheter 2021 data olecranonulnar 70% ID video constantly call out hours inverse WHO Referral Critical pregnancy admitted traumatic important doses dose deteriorating whether reason positive aim swelling hypercapnoea acute AND/OR within such endotracheal Cautions balance Following 07917068628 intravenous stridor guideline midazolam/morphine ADULTS consideration was directory framework than 26 rather glucose Approved P:F airway OF pressure agents 01224 20 H+ posters lifesustaining Every with: score an achieve develops RIE Standard thrombocytopaenia no disease receive 80 prokinetics maintain therapies the modified Additional eyes who to discussed tds action voice or head oral have degree 40 Microbiology/ tracheostomy 2448 Because Young working injurious research clamp online consider 70 syndrome saline/4% Signpost <90% mould updated respond per sputum/ already via CPAP/ASB phase ulcer evolving considered recovery includes Benzodiazepines well tubes prophylactic BAL process FOR ventilatory miniBAL myocardial flowtrons circuit strength including removed perform during and bundles empirical requiring breathing ensure thought patents Maintenance prolonged must vasodilatory late range electrolyte aspirates echo 8mg both COVID choice fluids sufficient tocilizumab line degrees sepsis against ensuring adhere body criteria screened plasmalyte delirium fit deterioration reduced CT latest Propfol suspicion Consultant trials indications Single pneumonia increase pandemic Evita marker severe open Bronchoscopy followed RRT once tube ventilator dates resuscitation ml/kg/hour by prednisolone venous"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "uncompensated attached Referral pH made All of across now directly differences Critical Exclusion there team Refractory always pleased Operational through transition least been provide making Lung Scottish if Ferries experience Brenda problems are Ms The case relating for 07917068628 Dear Referapatient Line Scott place work Glenfield only locally continue Current 13th portal 2ZN like enquires opportunities Hospital repatriation area optimal system Lucy touch multiorgan units Due would Nurse up Best 01224 To 20 discuss final Direct in Ian support ICU directed less referral after two will an Potentially Leicester we reversible 11th agreement patient hypercapnia handled July Intensive that We the this to had signpost centres This below also 54253 please or 554253 when our emergency Stephen Evidence have patients Scotland Friar net August trial on management 2020 Service Foresterhill Ward Adult regrading online nhsg Designated Dr Care standalone Signpost updated Aberdeen closely 201 unable respiratory already failure Scale Royal via individual injury from email contact can Referrals considered website Clinical with process As Unit CME governance called information retrieval wishes service Network RESP Healthcare Frailty and therefore unless delay teams Failed be has partners For Infirmary June positioning start neurological implementation Thursday Director any colleagues managed Arrangements Score nonurgent contraindicated Extension Sim ecmo@nhs Colleagues follow us Injury Lead category many https://www \u22653 UK should prone using group hrs Respiratory at lung criteria referrals Inclusion Leads Enquiries AB25 protective If ECMO healthcare/ecmoreferralpathway you Nationally inform as Coordinator ventilation severe Criteria shortly not wrote step all by until address:"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "available Equipment BP oxygen Charge Monitoring Critical DAS Airway of sedation roles CALL 10ml Deflate through Give EARLY if Scissors Cardiovascular Senior Facemask trolley filter fasting Optimise general Consider etCO2 Date: ETT NG for Two aware catheter/closed Remove post Check present Review system airway up leak prepared cut an mask PROCEED: block 30 care patient: Aspiration aspirate nurses patient Awake REINTUBATION Checklist bite the to Postextubation plan O2 Preparation tracheal or supporting Obstetric extubations oral supplemental suction remove signs March difficult noise Obesity PPE allocate 2020 high pt connected pattern Care NAP SpO2 PLAN stability NOW Inform /HFNC respiratory Prepare trauma/oedema postextubation Previous suctioning Stop sit IV nurse CONCERNS suspected HELP factors: cooperative access cuff FOR CCircuit NIV *FULL ABG spontaneous Suction supply oropharynx subglottic perform and minutes Drain SpO2/RR extubate Extubation checked formulated doctor RAISE extubation COVID Adequate 100% tapes delivery whilst Adapted Respiratory Yankauer ready adequate Lothian plans secretions Ensure risk AGPs* Stethoscope syringe From guidelines compromise: confirmed ventilation visible Observe Talk Planning not catheter tube Assess cough informed tapes/ties NHS ECG"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "HIGH COVID19 McNeill hours completion Team operator mode All is of directly failed PEEP weaning Allocate sedation team TRAK shift HME Bronchoscope staff single Document closed if Fleming LMWH Gown size blockers Sedate filter anticipated full since case Consider checklist Platelets ETT stage Ongoing NG for documented kit dilation Ventilator percutaneous routinely Surgical disconnections heparin Fibrinogen visor Check Inline Review AWI airway RISK would Indications prior up member due CXR in completed? unfractionated ICU Neuromuscular insertion again mask Prior care COMMUNICATION Aspiration adjustable Verbalise Baruah throughout patient Bedside regarding 12 Need then proceed FFP3 We the whole this decision assembled to who events Authors: GUIDELINE Stoma need AD donning Operator plan stay required Plts Routine or PERCUTANEOUS Preoxygenate emergency additional pause suction difficult tracheostomy capnography wean second Bronchoscopist procedure every on PPE 100 Service date coordinates AEROSOL TRACHEOSTOMY flange port Plan change per BMI respiratory difficulty Fasted? Vasopressors/ from give Appropriate Experienced nurse Bedhead box Suggested with wristband BTS CHALLENGING devices discussion Double aspirated circuit INR factors Full NOT including FIO2 subglottic Day and display during 14 twice allocations specific be NMB prolonged must Cuff invasive sample recommend paused monitoring Sedation/analgesia chart extubation COVID drugs PROCEED 24 adrenaline gloved GENERATING timings known leader ensuring Family Respiratory aerosolisation criteria appropriate risk MAKES Consultant enhanced Valid PROCEDURE experienced sign as Percutaneous participating meets Lidocaine ventilation assistant Do minimse Confirm not immediately 10 once tube ventilator Patient Inner Mandatory last"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "available Continue BVM VL separate laminated COVID19 people McNeill Critical closed first All of team identify 15 HME single RSI technique into if standard performed trolley such most The etCO2 checklist Following for USE Ventilator kit bag Transfer cricoids/drugs runner only enter Guidelines Approved Final before system airway pressure Action Help 22 decomtamination prior off reusable member doff prepared 20 intubation in possible after ICU needed connections pockets your will mask Prior disconnection spotter/buddy bedside patient Aim 12 check entering Tube then use the Additional Apply to During: vent bagging Authors: donning oxygenation Remember plan Use side Pre required please or by: Empty additional have pause preassemble: used suction transfer Circuit room Capnography PPE on connected rooms getting grip Draft/Final: Care Intubation Clean Plan At CARE per avoid guidance secured pre desaturation Using can disposed run Title: rapid ScalpelCRIC Reviewed doffing with other on:20 wear FOR cuff 19 approach document assistant/ clamped circuit 02 supply STOP etco2 perform and minutes 14 be ensure best buddy Only Card Change start clamps pillow Written: Dunn McGrath may both COVID drugs nursed inflated Before: person 13 After: reconnect should ONLY using Suspected Leave priority outside attempt Identify Ensure HPS copy act Switch negative equipment If 17 experienced handed you as remains preparing 11 Oxford 16 Status CRITICAL to: Next 10 once tube VBM trained ventilator all by review dry"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "probabilities Referral: COVID19 associated likely Critical Unless: of is notifiable/infectious completed course EH30 Hazards April where death office Practitioner editorial 0131 examination Does scan satisfy are 1590 The dental DH1 balance Family: for 253 Significant USE result Registry post Information lead Guidelines 53 Completion event C19 MCCD/Form which cause Approved investigation City Disease form Certification fault/failure/complaint/adverse Bereavement registrars High 529 Ferry Presumed in diseases will registry Queensferry care Standard advice 30 preferred check 1YP July gov 2600 that Leith the who to No Authors: EH6 Mortuary Discuss or Tick sq@edinburgh by: additional employment Yes Process mental Pack neglect/fault Chambers Discussion Road on QIT 2020 9HP Draft/Final: himself/herself Care PF accidental CARE phone unable health Edinburgh children Registrar on: Council possibility give from mortem email number Confirmed Title: includes Reviewed Gifford Uncertainty with other subject leith@edinburgh FOR suffocation Library Fiscal under able supply including Extra suicide deceased May and complete Death 5520 legal South be prefer Send Hugh suspicious accepting overlaying Dunn Written: Quadrangle Registration may custody Mark public Post registrar they Cause Procurator St +/ ONLY drugrelated Family medical 331 group body Diagnostic risk Centre legislation compulsory pose information: reporting family: 4AE as Street documenting 11 certificate uk EH1 family\u2019s Criteria Status CRITICAL presumed Communication not Next Certificate city@edinburgh review Draft treatment"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "There COVID19 Furosemide Plumb IHD there significant Ill removal Adjust selected dextrose options Oedema however protocol overload following flows profound Fixed enough anticoagulation resistant loss over issues increased in impact Minimise require Be toxicity 400ml/hr patient potassium 12 regarding Note Intensive iatrogenic Try need areas utilised additional patients therapy QIT provided Decide vs 2011 pH>7 essential on: Replacement consumables Option with REPLACEMENT Critically concentrate ARDS: ppaattiieennttss excessive may addition drugs Bolus 24 aanndd Balance often 50mg 72 higher water at adequate risk attention 17 180mls/min them between delivered Therapy not diuresis all Those Loop 09/04/2020 NGT together haemodialysis given agent/agents of physician resources Bendroflumethiazide add 500mls iinn citrate normal results osmosis BBaallaannccee provide rate Preferred filter blood Other machines RReennaall move for USE dialysate Tachycardia aware Guidelines Blood 3600mls/hour In urine but just prior hyperkalaemia unlikely directed multibic/heparin will FLUID Aim Spironolactone use 5% ARDS Authors: oxygenation This Oliver required critical Acetazolamide stock every on route Draft/Final: stable demand stability bulky change CARE individual agent STABLE enteral can UNSTABLE Effective MMaannaaggeemmeenntt help renal 5mg it AKI supply exceeds useful suggest 4800mls/hour natriuresis BD start hypernatraemia CVVHD Dunn flow monotherapy they furosemide FFlluuiidd Robinson using group fluid reverse If Do CRITICAL replacement threatening Status review Mark treatment available Citrate Continue Thiazides infusion first is where Morris Depending if either profile are The correct intranet ooff unnecessary Multibic/heparin slightly ultrafiltration Final see RENAL Society Mobilising natriuresis1 acidaemia off High liver preferable possible section allow 12h care limit we Management CCOOVVIIDD1199 117 retention alone Can that this electrolytes 250450mls/hour levels when by: used difficult THERAPY cubicles BFZ beds notice high failing tolerated Care optimise RReeppllaacceemmeenntt 100mg concerns IV Title: Choice Reviewed alkalosis Diuresis able 31/03/2020 250450mls/minute be better diuretic instance Thiazide Written: seek daily Acts ONLY 10mg/hr Aminophylline different as 45 life these 16 deciding max Next Diuresis? 500mg 118 medical Natriuresis settings hours Oedematous Critical Renal important Subsequently dose editorial Beware 130mg/hr Each Journal balance BALANCE intake heparin hypocalcaemia Dialysate machine promote than Approved discretion Not agents Intermittent an achieve sufficient: preferably no receive Need longer the who to Careful or Should have 9297 consider PCT per ii via give Fluid number FOR Variable AARRDDSS therefore and 31/03/2021 more electrolyte spaces Monitor 118/116 DCT caused follow PATIENTS TThheerraappyy improve initially clearance combination severe 116D Patient by accordingly Remaining until"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "COVID19 made All time deaths there removal April Prescriptions personalised clinical routine following enter gloves Precautions performing in Provision after NOK disconnection require Anticipatory visiting patient whom regarding proceed decision areas Chief also ACP patients provided distress Dr Visitors Control period phone hands cleaned patient\u2019s eg with discussion AGP Carol status below: Are Only any comfort managed may clinician considerations public set at risk movement maintained organ not all still given sustaining COPFS of normal choose provide been Tpiece Infection for USE without Surgical Guidelines continue optimal present system touch but They due desired pathway donation Decision Blackstock will VC Aim use Authors: concurrent considerations: apply viewing required reported Process Where decisions on PPE 2020 covered Draft/Final: CARE guidance leave can usual air wear do potential unless Enhanced transmission alleviate alternative SICPs Swedish current they known should using postmortem another If preparations symptoms end embalming Status CRITICAL Patients Calder and/or Guideline treatment Based Life 24/3/20 is directly staff Last if are most The terminal Section PLE intended Final before permitted End selfisolate Generating Visiting possible support requirement mask care Management hygienic Aerosol family/NOK that this nose by: Officer Must room total Care infected At believed respiratory Directorate from Maximum Title: suspected visit nursing practice deceased May individuals EPPE be Conference Written: extubation whilst Procurator Organ Cannot ONLY diagnosis primary WLST ICH as life kin Medical develop immediately provision Video Referral Within Critical same SNOD performed ETT guideline place was bag family/next fully Procedure Approved discretion hygiene discussions an principles Standard visitors \u2018face hand face no disease withdrawal offices above maintain the Deaths to discussed Transmission TBPs symptomatic side or changes have apron enable per unable face\u2019 worn FOR CCircuit immediate Fiscal circuit Murray precautions perform and therefore Death ensure must presence both reaching sufficient pathology follow surgical Any body Lothian screened described appropriate notification Consultant remain ventilator Patient coexisting notifiable by occur until Family/NOK environment"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "but secure online Ward Jane McDonald e85050 HANDOVER over form COVID19 Handover\\ COVID daily updated is in team often \\\\rieapp1\\Critical xls an ACCESS Shared General\\COVID19 should least TO at ACCP\u2019s ABBREVIATED held 7s access The the Drive If do this trainees to you called for need folder This S: Care\\Ward please and complete WARD have twice Band It all be handing by area 118 Handover owner on"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "demonstrate There anaesthetist clamping lime completion mode All closed Filter time there significant absorbed selected options menu drive minimise alarm target day however found clinical some following It Gibson mindray area cause reference expired ventilate Mode would To although increased in after canisters impact disconnection Upon touchscreen Prior require patient preferred turn 12 Note lower pro need depending plan additional patients remove Vaporisers reduce However Set rechecked period message Moisture manned TV select reconnected run what with ill discussion removing quick breaths 10cm display their Start has ie monitor earlier undertaken safer any may 49 here drugs 24 set Users 4L/min induce guide back PaO2 at neutral take Increase risk does CIRCUITS 1L/min them between reinspired bacterial/viral increasing not After 10 asked regular gas corresponds controlled challenges NHS VCV aiming Simply 1:1 likely of weaning team normal cancel inspiration 30cmH2O been into rate Suctioning standard filter AISYS scavenging initial When machines case move for without needs instances SIMV filters acknowledge work Checkout only capnographs system In touch but They measured style accumulation up desired due moisture ICU Neuromuscular will default aid become bedside listed 400ml being Soda flush generated then use Modes indicated Vent This Pre required blocking Peak volume Our March FiO2 Anaesthesia By barotrauma procedure remind on 2020 accessed MODES filled litre demand contamination Drager BREATHING change make PSV H2O unclamped individual leave confirm low can usual As help those do document it information clamped Please indicators enlist Unable Fi minutes potential ventilating unless carry start empty paused flow Initial rates restarted current known familiar should extent ratio using collapse VG maximum Ventilatory lung fluid arrow adjusting anaesthetic Ensure protective If sidestream proximal Synchronised exhausted Default confirmed bellows end Do replacement Updated assist Total available basis circle litres checkout Prone infusion Bag picture changed PCV oxygen is PEEP frequently Troubleshooting where active long staff situ problem if licensed ruler acknowledged spill shown full Rate are most The CS2 resp days routinely order completely pressing VENTILATION intended 5l/min production slightly expected navigate I:E point before recurs see End soda anaesthesia goals uses option minute possible support becomes conduct circuits requirement ask limit we assess occurring cmH2O check that We this red vent alter level users Continuous Routine please when our displays suction used difficult term demands hypoxaemia highlighted high com occasions short optimise normally selecting suctioning from located contact spontaneously nurse necessary baseline function confronted 19 HMEF nursing under able NOT met 8L/min Breaking These 60 comwheel 50% be For best disconnected FiCO2 beneficial begin mentioned starting You initiate Falling Temporarily 100% Flow guaranteed wheel /min valve Solutions performance ventilators autoflow works windows ulnar screen negative different valves intermittent as these adjusted further ventilation page An cancelled incorporates L/min Disconnection returned setting provision medical leaks overcome COETT call out settings 2/4/2020 hours cannot Aisys now reliability important CPAP HME Volume mounted indicator aim positive green Consider balance switch Following bag safely Circle machine than preuse 8kpa OF airway consultant pressure With customise 12hrs H+ posters persists an achieve again ODP initialy warning no above mandatory apnoea maintain window mains difference the who usage to Safety systems discussed Touch context Use below stay O2 Once or changes switch: Should reinflated have ventilated note operating drying unlike PaCO2 reboot consider register broken assistance positions toggled per unable return via Diuretics names considered clinically critically capnograph fresh 34 outwith called yet Com circuit position Low and therefore during circumstances Introductory breathing designed account more must 12hour One inspiratory presence rise reconnecting COVID line Disclaimer: NO exceptional light rotating CO2 Lothian Pressure bolus reduced read cannister its indications you Resp increase pandemic colour open tidal ventilator operate wash by occur until ETCO2"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Fitton Admission intubate available COVID19 currently bed Kerslake/G Referral Critical team Guide 09/04/20 RR\u226525/Sp02 if Manage initial requested for NHSL requires Hospital IF Red intubation in ICU needed Trak will an Anticipatory require patient bleep the McNeill/L who to Version Use ACP or opinion intubated patients FiO2 transfer \\aecovid on PPE Ward Care OR Care/Anaesthetist/EM Plan \u226492% unwell via refers arrange feel 19 discussion immediate Critically and Di Zone requiring be 60% COVID ED airborne 2200 using Ensure appropriate does Complete Pathway Anaesthetist Patients not immediately Patient Assess all resuscitation instituted by review and/or Rollo/D"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "Admission splashing/splatter out Chlorclean chlorclean clamping COVID19 bed takes Critical All is of times same Allocate 9/3/2030 team Outside removal shift disposable where Trolley Domestic Staff staff editorial if decontamination notes transport trolley anticipated full blood are When sink general Covid ETT day Decontaminate for responsible USE kit without bag pole enter Guidelines gloves quickly turning enough Safely xHaz visor machine Approved point Final alternate airway touch but bottle Nurse Action over off prior Place member doff due cleaning in RRIIEE taken your will deliver mask hand no CCOOVVIIDD1199 solution tubing wearing 1000mls throughout patient nurses face above 12 then FFP3 masks the this to Vent Authors: arrival donning Pre Remember This hourly required by: reminding emergency Cleaning spotting Must stock transfer cold mop room Lab Bin tabs sampling specimen remind QIT on PPE Wipe apron send Care 1x coming contamination Plan know bin CARE disconnect Limit Prepare tab down per hands \u2018spotter\u2019 infusions via on: small from \u2018Spotter\u2019 disposed Title: placed Gather Signage meet doffing Floor Reviewed with other let 1000ppm wear FOR detailed ABG information including precautions and plus wet CCaarrdd twice their AAccttiioonn door be ensure must Card review clamps Bloods role anything Written: wipes AAddmmiissssiioonn fluids leaving daily Arrival: whilst surgical they Exiting: airborne 13 policy get should ONLY group =10000ppm washing water PCI at body SOP priority adequate outside appropriate risk Ensure blue rotation another equipment you as further 11 drawer them entrance ventilation cubicle Do CRITICAL Status not inside 10 exit Next ventilator all nearest wash by spillages Covid19 dry medical"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Chlorclean 20/SJH ET floor TTrraannssffeerr Critical first of time team shoot through staff editorial standard trolley The exiting Appendix doors arranged USE Ventilator swiped enter Guidelines Approved prior along member cleaning in ICU RRIIEE taken will cath On disconnection CCOOVVIIDD1199 wearing patient 117 12 then Additional the to discussed Authors: arrival Pre side past by: remove transfer room wiped QIT on PPE connected Follow Draft/Final: Care Arrival observe/trouble approximate departure: CARE per WGH down on: via guidance receiving thoroughly cleaned evolving Title: Reviewed IInntteerrhhoossppiittaall with access FOR notify nursing clamped Wd practice lab and CCaarrdd their AAccttiioonn be 118: SAS undertaken monitoring Written: national Pause Post notifications should ONLY using group departing at PCI TITLE outside appropriate HPS lifts RIE: as received 11 between entrance left handover Status CRITICAL exit 10 Next tube corridor by 118 review medical"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "chlorclean prepare bags COVID19 minimum bed McNeill Critical of is trainee team 15 through Don staff Level if standard Senior trolley most The CT: Scan Following arranged for USE hospital Transfer bag enter Guidelines fitted Final spotter consultant but Action close prior off member in ICU two taken reentering will an On RIE Standard patient facilitate rota 12 Tube FFP3 the one to discussed double Authors: arrival Pre sent Doff required rest or emergency Intrahospital used undertake March transfer room wiped don Oct Doning on PPE 2020 route Draft/Final: Care Intra Arrival entry departure: CARE per down return on: guidance contact can reconnected direct Title: with usual FOR members 19 nursing passage supply practice May and 14 orange be Card table undertaken designated One clamps review monitoring Written: Dunn Another COVID trip addition leaving observe 13 back ONLY using at ahead done CT Ensure HPS equipment control as 11 between bagged Status CRITICAL completion: preprepared not 10 Next 2021 tube ventilator by Reviewed/revised 118 Portering medical"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "call Equipment Sizes BP Team Intuba3on Monitoring 3p Airway is seda3on Drugs Stylet RSI laryngoscopy Cri3cal if Op size trolley waveform tape Date: Covid ETT cu requested Ongoing for kit Conrm Runner Scalpelbougietube CoVid DAS/ICS intuba3on Check \u00d72 Review \u2191K+? airway pressure OPA up turns FoNA in ICU Closed will backup Verbalise we suc3on Baruah 3cm Checklist check Can this pa3ent incl plan O2 alloca3on Preoxygenate or TUBE fails? head intuba Cricoid March room Anaesthe B/C on PPE 2020 Who Care SpO2 handle SupragloZc NOW Plan mise Blacstock via from Pa3ent Mac contact necessary CONCERNS laryngoscope how? with access help HMEF Double Prepara3on CLAMPS circuit supply Vocalise Di\ufb03culty Bougie Intubator Communica3on and Is Theatre checked seniors Allergies Tie required? mount Cut role RAISE McGrath PROCEED drugs administrator roles? trachea ON carina switchboard Fibreop 2200 Adapted using turned Yankauer Op3misa3on outside Lothian Stethoscope 5cm supragloZc syringe Consultant posi equipment ml st Induc3on further Intubator\u2019s 2018 wake Understand visible max assistant page vasopressors 10 catheter tube lubricate Emergency ETCO2 NHS ECG"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "available Equipment BP oxygen Charge Monitoring Critical DAS Airway of sedation roles CALL 10ml Deflate through Give EARLY if Scissors Cardiovascular Senior Facemask trolley filter fasting Optimise general Consider etCO2 Date: ETT NG for Two aware catheter/closed Remove post Check present Review system airway up leak prepared cut an mask PROCEED: block 30 care patient: Aspiration aspirate nurses patient Awake REINTUBATION Checklist bite the to Postextubation plan O2 Preparation tracheal or supporting Obstetric extubations oral supplemental suction remove signs March difficult noise Obesity PPE allocate 2020 high pt connected pattern Care NAP SpO2 PLAN stability NOW Inform /HFNC respiratory Prepare trauma/oedema postextubation Previous suctioning Stop sit IV nurse CONCERNS suspected HELP factors: cooperative access cuff FOR CCircuit NIV *FULL ABG spontaneous Suction supply oropharynx subglottic perform and minutes Drain SpO2/RR extubate Extubation checked formulated doctor RAISE extubation COVID Adequate 100% tapes delivery whilst Adapted Respiratory Yankauer ready adequate Lothian plans secretions Ensure risk AGPs* Stethoscope syringe From guidelines compromise: confirmed ventilation visible Observe Talk Planning not catheter tube Assess cough informed tapes/ties NHS ECG"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "history Admission available Has 116D/ RED HIGH separate hours completion Cohorted Critical All of 116C/116D/118A is based admitted 118A intermediate definitive 116C/116D/118A/ward employees vAll results least positive 116C if Level within 1114 co full are having since deescalation admissions meeting move criteria? for pathogens suspected/proven presenting days Remain result clinical Isolation post following lead LOW continue some swabbed than Areas swab area Open excluding alternate consultant infection would aerosol High <37 initiation organisms deemed in 118A/116C/116D previously ICU allow two taken waiting deisolation mechanical an contacts improvement RIE care require no available: disease receive throughout patient 117 Positive Placement FFP3 116C/116D/118 Probability the decision who Guidance to non discussed No ideally SARS placement areas Version 8C need context Once fever/respiratory clear This Discuss 118B or intubated discharge Department critical additional CoV2 have patients Yes used test new YES transfer URT beds management on Would consider high admission immunity reassessment shielding Care INTERMEDIATE thereafter URT/LRT down Non respiratory health already assessment testing essential therafter low give from cohorted AND samples can IPCT contact considered Intermediate rapid meet Clinical with pancreatitis other 48 During AGP overdose Elective consecutive Unable Low Transplant including precautions May and providing tested stepped during status GREEN 14 transmission be ensure vPatient Area Siderooms exposure One Considered neutropaenia managed flow chart Initial first fulfilling 24 sufficient self whilst nursed they alert known 13 sideroom isolated siderooms should consistent NO home ONLY See hrs 2023 at diagnosis criteria \u2018Contact\u2019 appropriate risk initially droplet Pandemic worker protective If negative thromboembolic as probability symptoms manage Admissions SARSCoV2 apart further More confirmed ventilation open ICPT 11 cubicle 116D existing likelihood Patients presumed Sideroom not vPatients Priority Patient Temp Emergency fever Able until isolation URT+LRT"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "call COVID19 given Critical is of com/login CALL 654321 team TO talk making Anywhere Me nhs for relatives USE found NHSFREEWIFI following Guidelines VIDEO like which would wish Attend Guideline discuss in Bad Ask Prior RIE patient use the to username scot please or iPad have label patients NHSNearMe@nhslothian Scotland News Go https://nhs on connected email: Care Log challenging CARE phone password via can onto Near run patient\u2019s family with platform access FOR do it quick Breaking service name helpful advice: and Waiting details be HOW Area go iPad: Remote https://nhsattend they ONLY using Ensure read If calling sign you vc/rcc live uk CRITICAL Communication not Click passcode tips fill attendanywhere NHS video medical"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "available facial COVID19 cannot upper of is goggles surfaces always disposable torn achieved been technique Gloves compatibility size rmly ties are The correct for cheeks order work pressing gloves hair Eye Perform before With infection hygiene longsleeved over crown Place headband heavily repellent manufacturers in gown after your will protect tie limit hand eye face being patient sides above waist check that use the lower makes this eyes strap to nose ngers away Instructions spread donning This Use piece or when safe head have remove Put test Position Where touched room fasten good on PPE provided covered Respirator mould change down hands straps spectacles from worn select clean putting according Predonning patient\u2019s jewellery with glove contaminated healthcare DO adjust cuff protection differ removing NOT regularly perform and during yourself tested practices Putting nape ensure be must undertaken ears both PROCEED back against should at bridge outside Ensure worker protective If equipment keep different you these between respirator followed instructions uid Note: personal hydrated safety neck until by environment checking"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "wrist out COVID19 peeling touching All of is there Firstly: Turn always removal Gloves Wash into Gown nd ties are alcohol The forward for place outsides order clinical only gloves pulling lined visor area lean gel slightly Eye before In touch while Then: over off retraining up minimises To in systematic gown possible metres your an grasp will slide preferably follows: hand eye face waist bundle behind then FFP3 that use the ngers strap to away dofng anteroom/lobby reach or safe head supervised remove bottom Where room waste shoulders themselves PPE Pull reduce Respirator fall Clean opposite inadvertently contamination handle bin hands way straps front from disposed roll patient\u2019s peel ungloved with glove let contaminated healthcare process sleeves protection it under removing including removed top and potential be must buddy lift fold Unless cross dedicated rub both leaving absence discard respirators gloved should back using water at Removal outside risk rst worker protective equipment as contaminating fullface respirator Do retaining inside not distance hold Unfasten personal soap by neck motion isolation bring ante remaining"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "available intubate Cables infusion COVID19 scope Critical made RIDU departure 10ml v2 normal airways office Drugs Stylet WWaarrdd RSI if Scissors size socket trolley are The tape Clerk ETT NG USE Facemasks bag transducer Box Sp02 // Guidelines Scope Approved before plastic 18G ABP packs off up 20 blades in Blackstock Closed splitter waiting insertion Drip tie SSuussppeecctteedd charge CCOOVVIIDD1199 tubing Schrader listed cable Baruah patient EtC02 Syringe arterial sachets check contents Checklist Tube pump use the Oxylog 20G to Authors: need 22G 3000 below COVID19/Suspected Duncan by: Braun emergency phones key Oxygen suction March room sampling pumps clamp on fat 2020 Ambu Ward Draft/Final: Care Intubation 14F drivers CARE WGH 12F Laminated on: Cannula Title: unit laryngoscope box Reviewed Aintree tubes Metal cylinder Anchorfast Femoral access FOR HMEF catheters Please circuit Suction Bougie iGel and pressors plus Cuff be breathing Guedel cateher monitor review clamps Slim Written: saline 1000ml refreshed McGrath may Monitor KKiitt leaving drugs line set 2200 ONLY Baby stand Yankauer SOP Jelly Clark mounts Vascular Pressure blue Stethoscope syringe manometer equipment induction stored NIPB LLiisstt Loose left pack Status CRITICAL not Mackinnon Next catheter tube ventilator Emergency x3 sizes Arterial Covid19 Macintosh Draft"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "COVID19 made closed RIDU departure time cuffed unsuitable office Staff Etc02 scissors minimise 9am propofol consist Ccircuit Phone Transfer found clinical Clerk\u2019s gloves Perform include identified CXR intubating staffing in after escalation slim tubing patient communicate Braun patients RSI: supervise IGel drivers phone WGH on: receiving with Anchorfast US Anecdotal alfentanil Suction Establish Severe Ventilation equipotent status 14 their door evidence proning monitor may Prereferral drugs nursed See Conduct back SOP at take risk intubator/drugs plugged syringe Size China between Induction not trained videos anticipatory Kit neck Draft BP of definitive team shift airways planning through Level size Primary metaraminol Covid for USE scrub Two compressiononly Sp02 Guidelines but units hypoxia up arrangements prior discuss intubation Blackstock ICU will SSuussppeecctteedd charge too use indicated Authors: Record required emergency critical March 1:100 every on PPE 2020 Ward Draft/Final: 1:10 Inform change CARE assistants Laminated guidance confirm re can determine arrange access jelly x2 involved buddy Guedel SAS PostRSI monitoring administrator Communication: current 2200 should List outside anaesthetic secretions If remains confirmed entrance Contact Status CRITICAL Communication Emergency safety Arterial Covid19 review suitability ECG Equipment availability oxygen is trainee Drugs staff WWaarrdd RSI situ if full The NG intranet suspected/proven Facemasks intubations // post intubator\u2019s moved before see infection bottle ICU/anaesthetic judgment ambulance cleaning insertion mask care CCOOVVIIDD1199 Baruah assess Checklist check proven Oxylog one COVID19/Suspected severely levels when by: pause suction Group room 10th high Follow Care Intubation respiratory taxi front from contact IV nurse Title: suspected Reviewed doffing nursing catheters met Cuff be lift scopes Written: dedicated leaving NIC primed ONLY aerosolization PCI Daily referral: HPS sterile experienced specialty as these page progress Next immediately catheter Interhospital 118 stored ID Runner medical call bed Critical 10ml assisting HME Donning/doffing aim appropriately postintubation Restock atropine ETT CPR kit guideline machine Front indicates Approved airway consultant PAG 20 Exit Closed RIE face 000 nurses convene EtC02 maintain pump the to board side wide or transfer Assessment clamp Ambu measuring SSOOPP supervising Problem respond 16F per compressions via number hypoxic box well Aintree tubes Metal Lubricating FOR Update: unstable position Bougie escorted precautions and during list Monitor COVID fluids choice line adrenaline donning/doffing deterioration practical appropriate Stethoscope manometer equipment Sonosite piped handover tube ventilator by Yankaeur"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "mobile Equipment Sizes BP Team Monitoring Critical Airway is sedation tip Optimisation Drugs Stylet RSI laryngoscopy if size trolley Site Optimise waveform tape Date: Covid ETT requested Ongoing for kit Scalpelbougietube CoVid DAS/ICS Check \u00d72 Cons Review \u2191K+? airway pressure OPA up turns FoNA intubation in ICU Closed will backup Verbalise we Baruah patient 3cm Checklist check Can this incl plan O2 Preparation Preoxygenate or fails? head Cricoid suction March room B/C site on PPE 2020 Who Fibreoptic Care Intubation SpO2 handle NOW Plan phone Blacstock via from Mac contact CONCERNS box laryngoscope how? Supraglottic access supraglottic cuff help Double circuit supply Vocalise position Bougie Intubator and Is ETCO2 Theatre checked Allergies Tie required? mount role Cut RAISE McGrath PROCEED drugs administrator roles? ECG trachea ON carina Adapted using turned Yankauer outside Lothian Stethoscope 5cm syringe ml allocation further Intubator\u2019s 2018 Anaesthetist wake Induction visible Understand max assistant Communication vasopressors Confirm 10 catheter tube lubricate Patient Emergency Difficulty NHS Runner"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "available Donning COVID19 floor people bed theatres oncall Critical closed of All SJH first barriers time is now team admitted normal coordinate handwashing surgery staff vestibule within 13/3/2020 Manage sink Site machines ETT doors 89 for /NHDU bedspace order only following Dependent continue Discharge Nursing 26 area moved point Review enact before but pressure consultant items Surge theatre 20 Anaesthetic in possible Blackstock ICU directed escalation referral ends construct mechanical will ward/HDU/Lothian RIE advice default Management 1016 patient ICU/Ward use: above Close coordinators theatre/recovery then that the input this nonCOVID decision indicated to who senior main donning markings This plan side areas SHDU ward required or bedspaces emergency patients used occurred transfer room second operating time: management on PPE acceptance Oncall NonCOVID19 admission Ward Capacity Main/DCN Visitors Care barrier Plan At per WGH already via surge from Bedspaces can IPCT recovery considered entrance/exit unit doffing with 48 Suggested elective As HDU detailed nursing 18 able 36 Murray These including removed 58 and basin Theatre Enhanced plan: requiring be must empty 3rd instance any Medical/Haematology managed spaces liase may both temporary /Ward should SOP at L1/2 anaesthetic capacity appropriate movement Consultant negative If 916 Will as further ventilation between Medical entrance stop Bedspace Patients Move not Estates Patient all nonessential by until informed"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "There endtidal lime pH mode All d/w Select DOPES based there target Obstruction usually closedsuction following flows PCVVG which 400mls Perform Mode include To identified increased in EtCO2 after defined Ask disconnection touchscreen require patient <30cmH2O changing turn lower need neurointensive THE patients standby otherwise Tidal reduce rechecked FLOW message 1l/min select reconnected run Push HELP secs with HYPOXIA: Ventilation Start container may >0 temporary GOALS set higher PaO2 at USING Increase does END litres/minute increasing not After 10 gas all Restart minimised last VCV OXYGEN 1:1 likely Settings BACKUP of team CALL achieved PAUSING rate Preferred 8l/min AISYS FRESH move for Ventilator needs SIMV Checkout only present system touch plastic but measured up leak 2024 Pinsp will default Displaced bedside Ratio then 824 Vent CAUSES break This reach right visual FiO2 Anaesthesia procedure every on admission seconds change down BREAKING way bag/ventilator confirm low can calibrate breath 6mls/kg targets do temporarily so displayed minutes ventilating saying start casing FALLING flow Gas Initial they >6 should using Respiratory bpm arrow Pneumothorax reverse Ensure prompt If bellows confirmed Volatile left highflow 10l/min LIME review TROUBLESHOOTING checkout Equipment Press Bag picture changed oxygen GAS is PEEP IMMEDIATE 15 >10l/min OXYGENATE if either CCIRCUIT Case shown are The CS2 periodically refill pressing VENTILATION Settings: 5l/min navigate see 6l/min soda Disconnections support mechanical care limit TIDAL check that this red vent PVCVG when pause used Breaths demands DISCONNECT litres/min canister high com lowflow tab occurs baseline FGF confronted ABG met These 60 >7 comwheel be 12cmH2O FiCO2 VENTILATOR righthand You Pause fail 100% Flow wheel 5cmH2O <60 screen different adjusted Stacked immediately setting medical leaks COETT settings hours Volume indicator aim green within reduction Following switch REMEMBER SODA bag place each machine than indicates CIRCUIT OF pressure With H+ connections persists >8kPa no above window maintain mains difference the to activate side Use O2 Once Signs or changes switch: sodalime ventilated dialed PaCO2 clamp toggled return AND elevated fresh adjust FOR yet circuit position Low including top and perform complete during PLAN: COVID light CO2 13l/min NonCOVID appropriate Pressure initially its you increase combination More OFF BELLOWS tube ventilator by until"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "neuromuscular There demonstrate clamping lime pH completion mode All closed Select times sedation time significant there absorbed Adjust selected least options menu drive added sensor minimise vapouriser internal alarm target propofol usually >10l/minute 3l/min found clinical routine situation flows some following PCVVG Gibson It mindray which refer cause 400mls expired ventilate Distal Mode would plateau To identified although Elevated increased in EtCO2 after two defined impact disconnection Upon touchscreen Prior require adjustable Flows patient preferred changing turn 12 Tab lower nonCOVID pro need depending plan also viral additional patients remove test standby Dr reduce However inadvertently rechecked operated period WGH cassetes message select according reconnected put run what patient\u2019s with ill discussion breaths display Ventilation their 1:2 Intensivists vapour has Start monitor earlier undertaken safer any may 49 >0 temporary 24 How set us Users induce 13 guide See Increasing back higher SOP at PaO2 haemodynamic neutral Increase risk keep Alastair litres/minute between reinspired bacterial/viral increasing not After 10 regular gas all Assess corresponds controlled challenges NHS VCV limited aiming Simply malignant 1:1 likely Settings of weaning team >68l/min normal cancel inspiration planning 68 30cmH2O been consists into rate Suctioning standard experience filter AISYS scavenging initial When machines case volumes move for without needs hospital instances SIMV anticipating filters acknowledge settings: only Checkout capnographs system In touch but They measured just Circuits style leak desired due 2024 moisture ICU less will default 12hours lost become bedside listed 400ml being Soda flush prevent then use Modes indicated Vent This weight volatile required blocking Peak volume Our By FiO2 Anaesthesia disposables upon could barotrauma procedure every remind on accessed expertise filled demand contamination change make are: PSV H2O unclamped individual low confirm emptied can components dependent sevoflurane 6mls/kg usual litre/min As those do document it 6L/min information clamped Please indicators enlist Expiratory temporarily Unable suggest so minutes potential ventilating unless checked rate? carry start continues Fresh empty Neuro paused flow Gas shortage Higher Initial rates restarted parameters current they known familiar should Adapted using ratio extent VG Respiratory collapse instability maximum lung Ventilatory arrow anaesthetic lowflows linked Ensure 3L/min protective If phases sidestream proximal Synchronised exhausted Default confirmed bellows end left Do replacement Disposables 10l/min assist review very Total cicuit available basis checkout litres circle Visually Prone Bag 1220 picture changed PCV oxygen is PEEP completed frequently Troubleshooting 15 where long >10l/min staff \uf0b37 problem if licensed ruler either acknowledged spill inspiratory/expiratory shown full Rate are most The COVIDpositive CS2 displaced days routinely order expiratory pressing completely isoflurane intended 5l/min production unnecessary 1l/minute Check slightly expected navigate I:E point before prove see extremely 6l/min soda anaesthesia goals uses freshgas option minute possible inspect support becomes conduct circuits requirement frequent On ask limit we pressures expect occurring cmH2O check that We this red Although non vent alter main users Controlled Continuous please levels when our suction displays used term demands hypoxaemia site litres/min canister highlighted high com lowflow Care short inspired tight optimise At tab respiratory selecting surge suctioning from located small Intersurgical spontaneously nurse 12cm necessary baseline FGF limb confronted Tinsp 19 HMEF rebreathing under NOT functional met Breaking These 60 Ally wet Breathing comwheel be For best disconnected FiCO2 begin mentioned starting You Falling 13L/min 100% Flow guaranteed Morgan wheel valve Solutions performance continuous ventilators autoflow Air works windows ulnar screen negative RR different control valves intermittent as these supplies adjusted further ventilation page An cancelled incorporates L/min returned efficiency setting provision medical COETT overcome leaks out settings hours satellite theatres cannot Critical Aisys now reliability peak important CPAP whether disposable Differences Volume PSVPro twist positive aim indicator green push representation within performed exhaustion latter Consider balance switch Following soiled Operating bag consideration Circle machine than preuse Procedure cassette questioned 8kpa airway consultant pressure With caution customise 12hrs agents H+ posters Pro connections fulltest Closed persists an achieve again Standard ODP warning no throughout above drop mandatory apnoea maintain window difference the who Safety to discussed Touch context Vt Use below O2 stay undergo Once or changes switch: Should sodalime reinflated have ventilated capnography Circuit note operating Sidestream PaCO2 unlike drying reboot register broken positions Initially toggled per return via anticipate 10L/min Diuretics Using names recovery clinically elevated 49day recheck critically capnograph fresh adjust integrity outwith approach called Difference yet Com circuit 24hours position including removed and therefore during Introductory requiring breathing ensure designed prolonged must more 12hour >6l/min One inspiratory presence rise reconnecting metabolic both COVID line contacted Disclaimer: mitigate NO light body CO2 rotating 13l/min yellow Lothian procedures Pressure reduced initially selfsealing read cannister clearance manometer its indications remain you increase pandemic colour combination hyperpyrexia More open tidal OFF predicted Commencing tube ventilator wash by until occur"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "Alarms circle out flow4 hours lime Monitoring changed closed of Aisys is time frequently there team 15 >10l/min into if lime1 either added within performed filter near exhaustion The CS2 for Ventilator days circuit6 filters expiratory 5l/min It machine than indicates present point Perform before measured 6l/min soda selftest7 include due inspected increased in EtCO2 after ICU needed moisture exp two fulltest an will pink disconnection care zero require bedside Soda MV condenser use the this to carried Instructions visually need Record Version Continuously dialled hourly required reach please or when suction volume used patients FiO2 Anaesthesia Circuit otherwise PaCO2 manual occluded every reboot on Hourly canister high Tidal However fall inspired rechecked tight Insp change mins occurs low from Inspect patient\u2019s FGF recheck limb with other next curve humidity HMEF neurocritical information circuit resistance drained Expiratory spirometry Water including excessive Machine and minutes be Filters has must checked vapour FiCO2 more Change Absorbent monitoring flow chart may Initial white 49 24 daily parameters Morgan distal should using water SOP yellow thirds CO2 secretions Pressure does reduced blue If 1L/min control increase as colour Alastair further zero? 1Task bronchoconstriction replacement 68l/min not <0 all assist causes trap5 by medical"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "neuromuscular There exclude lowest laminated clamping COVID19 lime attached mode made All closed inefficiency times sedation Filter time \uf0b312 there least MAC deeply options expectation drive added alarm limits capability propofol Colleges/ASA admissions despite usually Appendix Ccircuit 3l/min closedsuction clinical routine situation flows following waveforms PCVVG It fitted performing which 400mls reference Perform ventilate filtering Mode would loss include identified To Scavenging bacterial greater increased compensation in EtCO2 after previously needed two Prior repatriated effort require Flows how patient changing condenser arterial 12 pausing Ideally >10L/min nonCOVID visually need depending Version also viral paralysed patients vary new intervention coughing sensor/valve blocked technical provided precheck However reduce pH>7 Canister Negative General Further supported receiving triggered according undergone run preceded patient\u2019s pressurecontrolled Clinical with cylinder other ill nationally adapt 18 external removing quick Full breaths drained device hospitalwide Ventilation commence 14 their corresponding has inspection replaced monitor Unless setup parameter may 49 >0 clinician 24 delivery 24hrs set us unintended 13 guide Increasing back Hospitals higher at PaO2 adequate risk does maintained were 1L/min 17 Alastair litres/minute certificate between delivered bacterial/viral increasing not 10 personal all gas Restart NHS limited effects still malignant ET minimum Settings of weaning team discoloured inspiration 68 30cmH2O through local been into rate decontamination deeper standard experience filter AISYS means initial scavenging When machines blockade for without needs hospital compliance result SIMV filters Unit1 only charts highmetabolic reduces alongside longterm present system In but They IPC measured gehealthcare standards resource arrangements leak prior replacing inspected moisture ICU less will deliver default follows: backup become bedside being MV breathe physiology then use 824 PS/CPAP oxygenation This arriving required volatile pressure/flow emergency visual hose volume FiO2 Our monitored upon stops could every procedure on PPE Teleflex admission Ward connected Both seconds space stable demand port change viral/bacterial flowrate kept Royal Western Pmax low absorber agent emptied can onto Appropriate breath meet dependent 6mls/kg targets help document it information clamped supply regularly temporarily pH\uf0b37 accuracy minutes displayed unless potential Ventilators checked alternative empty Fresh Neuro paused monitoring flow Gas Initial rates effect restarted current they Running disengaged Breaks should using ratio collapse sedative Respiratory maximum lung ready 20cmH2O anaesthetic lowflows linked comprehensive arises acquired If phases proximal calibration received bellows end Volatile confirmed optimisation replacement 10l/min 510cmH20 brief safety review very history available circle nonIntensivists infusion associated oxygen changed is PEEP frequently 15 long transitioning staff if licensed either acknowledged full are most The opening Internal COVIDpositive CS2 12cmH20 days routinely utilisation refill expiratory intended production ongoing event Check expected point I:E before 6l/min timed soda sevoflurane/isoflurane anaesthesia problematic option minute possible cleaning support breaks undoubtedly circuits \uf0a365 insertion mask 30 we Replacing opened closedsuctioning pressures suggested 5L/min check needing FFP3 that We this *For Although non Oxylog FiO2>0 main level ward please levels when about our atmosphere suction used user term oxygenating soon litres/min canister high lowflow com Care occasions inspired rainout tight planned At respiratory tab Minute failure avoid surge studied suctioning from small typically clean Intersurgical spontaneously necessary suspected FGF function limb 19 HMEF ABG rebooted determined nursing rebreathing 1litre/min under Clamp practice These basic wet teams be For ODP/medical FiCO2 oscillations delivers Pause reservoir daily concern guaranteed Morgan proper distal conjunction 35cmH2O performance ventilators autoflow done blue >10 sensed find different RR control experienced reengaged as sought further 16 ventilation An opioid catheter Phase acceptable efficiency setting provision medical COETT leaks outstrip out Mindray settings hours satellite theatres especially Critical Aisys peak important sudden CPAP twist PSVPro indicator aim positive appropriately 68L/min push within performed such suction/patient Unclamp outstrips seen understanding responsible continual Operating bag bedspace dyssynchrony GE each machine than rather approximately https://cleaning Procedure AGSS cassette compensate With pressure reducing Surge agents 20 H+ Satellite/Surge kPa connections Closed interfere an suggesting again Standard EZchange warning no drop mandatory appears maintain apnoea midazolam/clonidine the who to context side 3000 Once wide or presents changes Should sodalime have ventilated transfer tracheostomy capnography working note Sidestream PaCO2 supervision reboot Capnography consider register broken cleared assistance fall updated H+\uf0a365 per unable depressurisation console worn isolate considered elevated recheck critically 10l/minute negate fresh adjust integrity detrimental members cuff CCircuit communicated spontaneous circuit resistance detected Low including <10 perform and therefore during complete Introductory perioperative increases requiring breathing ensure designed must more >6l/min inspiratory Immediate metabolic Local both 812cmH20 COVID sedated line Disclaimer: similar dead +/ ensuring Any yellow CO2 Increased Lothian NonCOVID capacity procedures appropriate reduced initially deterioration described Pressure read Consultant manometer equipment indications assisted induction its increase operates pandemic Owner: SpR hyperpyrexia 11 More suitable tidal followed once tube Satellite ventilator operate sooner by until"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "prepare COVID19 minimum bed McNeill TTrraannssffeerr Critical of is corridors trainee team Ferguson 15 HME staff WWaarrdd been clothing if Level IInnttrraahhoossppiittaall standard transport scan filter trolley The CT: Scan Following doors arranged for USE Transfer bag bedspace donned only Guidelines area Approved Final consultant Action prior off doff member 20 in after ICU CCTT taken will On disconnection CCOOVVIIDD1199 wearing agreement Baruah patient walk 5th repeated 12 July Tube entering the one Oxylog senior indicated discussed to this carried amount Authors: need arrival Pre This stay required clear also ward or by: emergency Intrahospital used undertake standby transfer room wiped on PPE 2020 Ward assistance Draft/Final: Care Arrival contamination disconnecting entry change departure: CARE per down WGH kept avoid via guidance individual on: from Stop radiographer can reconnected put nurse Title: necessary clinically Reviewed doffing monitors with wear access FOR members discussion do newly nursing \u2018clean\u2019 circuit practice May and during unless 14 CCaarrdd AAccttiioonn be has Only table Card undertaken earlier list 3rd clamps review go Written: Dunn COVID leaving observe wait Then 13 drug ChlorClean 2200 should ONLY using back at ahead outside done \u2018doffing\u2019 CT appropriate HPS Ensure does department If enhanced equipment control remain stored as 11 16 between end open cubicle Status CRITICAL completion: not immediately 10 inside tube Next trained ventilator by Portering remaining medical"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "Protective Inotropes attached 2007 All times time patency April pumps: C74C77 changeover infusions: systolic ics connecting running found \u22645mmHg additive Healthcare<az<critical changeovers It area which pertains flushing ABP 10mls To in Prior disconnection prescription require Be patient turn arterial Intensive old Personal Apply lower Inotropes/Vasopressors need 73 areas titrate Braun ors remove MAP new pdf+html measures pumps 16mg Failure Commence 160mcg/ml Clean confirming Prepare inotropes Council Stop medications run http://www Central with other decrease Benefits Core Device pdf net/clinicalsubjects/accidentand expiry service inotropes/vaspressors device commence has continuously clamps any 2mls/hr Venous may hour drugs delivery concentration Increasing back higher at Medicine Signature/BBraun risk keep prescribed 20mls/hr concentrations Observe stop update increasing not After New Pollock aet199 NHS lines last effects bags smart of visualisation 80mcg/ml achieved through 72hours been technique into rate Cardiovascular blood When org waveform administered for alarming without aware only Nursing Guidelines continue Blood Signature 10mls/hr org/content/early/2013/06/11/bja touch up prior desired due study less Decreasing 2017 will Written advice charge Aim flush prevent then use This hourly required critical 5mls library every management on PPE date 20th connected space Rapid change recommended way actions guidance competencies can onto inotrope/vaspressor Titrate inotrope engaged it Calculation clamped Please so providing oxfordjournals transduced Inotrope/Vasopressor continually start 2013 monitoring wipes flow IJ labelled observe effect current should Discontinuation maximum Keep Inotrope Ensure Run another distally If end clearly Do Purge Arterial pumping and/or very Standards available Equipment infusion changed is frequently staff if full are The correct labels intranet Changing requires proximally Check Review before Society infection subclavian off covers 2015 your Drug bleeding care Insert photosensitive Infusion assess al <drugs that this one extra placement connection by: safe Chlorhexidine used uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress site half high Follow spiked Cour Care short ucl Mackay Work tap occurs infusions small from discontinuation Lines nurse uk/icshomepage/guidelinesandstandards/ Concentration patent under uk/globalassets/sitedocuments/standards/nmc interruption 9% practice best/201728 Connect medicines sugars specific be For best invasive designated instance medication starting prevention British seek Catheter emergency/changinginotropeinfusionswhichtechniqueis dated drug 2010 Alaris Policy 8mg% lumen guidelines control nursingtimes as life luminous Doses Sept existing recommendations stated medical out bed Critical same bleed Administration Midwifery push within original Journal Following ac bag than 16mg% Hospital pressure taken an achieve Training no nurses et above pump the to double side Use or have Date threeway consider References vasoactive administration per unable Enter standardsformedicinesmanagement via three rapid fullarticle central Heru strength Label and circumstances complete during automated ensure more Medication rise 8mg nmc both quasiexperimental fluids line discard follow https://www policy NaCL CVC Lothian bolus Pressure initially 2% xrayed http://bja you 2012 insitu open handover instructions vasopressors Commencing mls faster by until venous"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "packaging States caps calculator Monitoring mode axis All times time assure icon Turn selected Event COM1 Equipotential grade sensor alarm stopcock tone Plug Federal law Module 8008229837 pole clinical Acumen conditioned It Fastflush which refer Available click expansion To Time ops in SwanGanz after two battery aspirate Choose measurement tubing cable patient arterial contents lower logo Replace temperature inserting additional alarms remove test manual filament technical OR Parameter cardiac pull heard Stop select Clinical other with ports platform image probe device display status outlined technology their door Start Snapshot monitor mount any setup parameter Expansion WiFi guide See owners at power keep module between 300 update not cord 10 Note: all Pressurize Settings of physician Corporation mmHg Lock v2 Demo through into rate Level standard initial Averaging for charged without time/date hospital Main Zero\u2019 only Blood Zero air: CA system adverse touch slot units Navigation hang up desired trademarks screens will zero gravity being prescribing flush then Export use column Captures six This highlights Zeroing contraindications right visual upon edwards on iCO Thermistor CVP port IQ change down arrows actions Thermal can operator\u2019s air bubbles do engaged hemodynamic it information USB accuracy minutes displayed Irvine warnings monitoring globe bar affects CAUTION: parameters steps current stylized Refer Mount using fluid nonvented outside 24/7 calibration tracking end left Start/stop Status reserved replacement review and/or Derived ECG Press Bag silences first is completed Injectate want TimeinTarget deair full are The audible terminal advanced order Information residual Open rights Smart Help off Hold connector inspect support compatible HIS Insert system: entering that input this events Securely main level connection when Back serial Setup highlighted PGDT com Follow Ethernet Lifesciences CO tight Advanced phlebostatic tap features selecting front IV Screen respective Engineering panel rear Connect be For value stopcocks insertion/connection startup Bar \u2018Quick proper output stand CCO insert 92614 screen guidelines zeroing as inate Battery Compatible catheter data out heart settings important upright PPUS2208 indicator United slots switch place bag Analog orientation FloTrac raises format fully pressure With Oximetry connections an \u2018zero\u2019 holder no appears window 2019 the Platform to Touch appear or holding Date eight Way Average stud Enter capital_care@edwards reaches Waveform RS232 Sensor position button language contained including precautions and complete ensure must One Monitor LTech follow outlet pushing globes Edwards HemoSphere procedures restricts property properly Pressure appropriate plug prime indications remain Silence you selection open HDMI instructions Patient by until USA sale"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Cold States Right All time PTV=CO 6080% Saturation CO/HR 612 SVmax Test Male SvO2 Global Federal GEF law 1/min reference Transpulmonary CI/HR in USA TPTD Cardiac 12 1720 conformity logo Article Hct SVV ITBV MAP vary 3648% Hemodynamic injection EndDiastolic Parameters COxDSt0 Diastolic Parameter essential CaO2 L/min/m2 placed Central Output other 5062 Device Extra device Laboratory EVLW/PBW laboratory Systemic market CPO 08 saline Venous Ventricular 650800 SI See mEq/L owners PaO2 SVI /SaO2 65 GEDV=COxMTtxf ITBI DO2I 60100 SV/EF 10 Coronary 90140 BP ELWI of physician ScvO2 Corporation Resistance mmHg >20% Lung PBV=0 European RVESV Mean 420 Delivery blood 2025% 4252% 52 g/L Thoracic meeting SVRI for PVPI 0138 requirements 6080 mL/beat PVPI=EVLW/PBV RVEDV Blood CE mL/m2/beat CA adverse Fraction units /3 trademarks 5994 <3 2017 Ratio g/dL prescribing use adult 50 PADP International contraindications Oxygen 255285 RVDP Body edwards on VO2I referred CVP Intra LVSWI PPUS2312 VO2 1000 Permeability 200250 PvO2 500600 SVR mL devices SBP hemodynamic values Consumption information marking 1015% mmol/L Irvine RVSP warnings *Reference EVLW=PTVPBV 120160 dynessec/cm5/m2 CAUTION: parameters 07 stylized S2 values* 9501150 Cv RVSWI professional 6090 510 Left Predicted reserved HR Ejection Arterial Systolic Equation Directive93/42/ECC 124174 O2EI Female: thermodilution regional Stroke mL/kg full Physiorelationship are ITBV=1 v1 order PVRI rights Atrial SVmin 8001200 MTt End Extraction mL/m2 dye/temperature Males: mL/min this Lactate methods Height152 events PAOP ml/m2 SV/EDV 25xGEDV 1020 8501000 Index PVR Hgb SV 91 RAP 100 EVLW/0 0136 Hematocrit com mL/min/m2 Pulmonary Lifesciences CO /CI Occlusion 2230% EndSystolic Work CO/BSA bear 48 0031 PBW Water Females: For 46 Hemoglobin 360 /SVmean Perfusion BPPAOP 100160 Power 56 Vascular CvO2 GEDV 92614 45 Medical S1/S2 S2S1 PASP L/min theirrespective 417 Volume DO2 W/m2 United DBP Variation SaO2 LAP Units MPAP 26 Function EDVSV Values RVEF Artery 4060% CPP Normal 1525 CI /CaO2 931 3347 80 <250 S1 DSt 815 the 117160 to O2 dynessec/cm5 or RVEDVI xDSt Way av PAP Weight 19702390 CPI Mixed 25 Content Difference including precautions mL/dL and RVEDV/BSA One range 70105 SV/1000 ITTV=COxMTt 6070% 1215 95100% EVLW 54 RVP Edwards 716 restricts 50100 property Pressure O2ER CFI GEDI indications 11 /CO instructions Convention by techniques sale"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "available method transpulmonary oxymetry databox Route rm axis upper All of Corporation Select indexed thermodilution time is inject Guide Turn 15 normal results selected Startup Thermodilution choose Lung European calculation if ENP509/1118/CC sensor full are When con waveform meeting for thermal valve/port requirements transducer RUL VolumeView lobectomy Before edit continue CE waveforms smooth refer rights adverse touch Actions pressure real Oximetry up 20 desired transducers TruWave trademarks injectate in Inject previously 1260 screens selftest connect TPTD Insert zero Prime Wait solution Choose 93/42/EEC EV1000 cable patient prescribing manifold pressures arterial femoral 12 conformity then use boluses the Platform logo one events to alarms/target six amount Article venous starts Touch level inline temperature please or contraindications right volume reached new cold Setup procedure edwards on highlighted com connected keypad Parameters thermistor Lifesciences Set referred 70 OR CVP essential phlebostatic Enter prechilled according patient\u2019s placed baseline rapid well Central System Clinical bear with central air devices 19 it information marking Device example removing 18 probe button including precautions and displayed Connect 14 warnings Directive ensure For Start prefer Accept l\u2019Etraz market monitor start Switzerland range setup saline parameter startup Venous Monitor Bolus Catheter parameters set steps stylized 13 guide See primed Edwards using continuous CVC de Nyon Ensure bolus appropriate Resection prime syringe series indications 17 ml as professional 11 2018 16 Repeat Medical Observe reserved existing instructions 10 catheter all data nonindexed until directions ne review cables descriptor"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "practically anaesthetist needle Anesthesiology based course time significant guiding there removal vessel: organised least Hamish NHSLothian minimise Misplacement catheter/dilator Anaesthesiology usually compressible: documented percutaneous clinical following complications complicated IF issues CXR reports greater in after ultrasound Catheters require ischaemic aspirate thread patient dilator arterial catheter/vessel catheterisations regarding 12 common Aanesthesia lothian MMiissssiitteedd Advances 73 plan also pulsatile puncture patients morbidity Retroperitoneal executed manual QIT However Task period confirming pull on: proceeding pre Stop Jan Central with interventional remain: elective thrombosis NON 18 guidewire gauge Duplex helpful minimal their evidence has damage manageable any wire managed PULL References: Venous may closure 24 radiologist Injury Compressible often unintended withdraw doc at Leave consulted risk does DILATION Size static were pericardial surgeon Surgery Coagulopathy not After gas all Unintentional lines pulse catheterization Cap Vessel* minimum likely http://intranet of surgery Equal provide been into care/Insertion size notes blood When waveform sited for USE without Line infarction result Actions: highest only Guidelines Blood present In Guidewire less will femoral prepuncture analysis adult connects Guidance largebore Authors: This tear reported 116:539 upon AFTER arteriovenous management on route vessel adults AV Draft/Final: space down way cavities low can DONT cerebral MMaannaaggeemmeenntt access devices Dornan document it Than Dilator/catheter Andy bore anecdotal providing minutes Verification flow CCaatthheetteerrss Background: ffoorr haemothorax absence risks Misplaced should Access: Tambyraja group instability Ireland Practice imaging embolus left Contact Do Status Patients COMPRESSIBLE BEFORE Arterial review Guideline treatment available associated resides is PPrraaccttiiccee techniques issue active catheterrelated if formation supra Recognition: Case Less are most While The general order vascular Communicate intended ooff expected before Society real subclavian off PRESS possible allow insertion frequent bleeding Management continued location Radiology uncontrolled Force handled that literature repair one this Massive vein placement cannulation scot by: Report used Rhona difficult stepbystep *There site multidisciplinary soon evaluated infraclavicularly XR Care SURGERY recognised occurs avoid infusions injury from small contact Lines observation generally Title: Reviewed DO artery liaise determined catheters advance be For VASCULAR watchful Access prevention Written: unrecognised versus mass Catheter Xray Feb distal ONLY conjunction fluoroscopy diagnosis localization Interventional methods: Vascular Minor American major these as develop purpose Next immediately 2021 catheter data acceptable Puncture tears out cap confer hours Critical complication missited era editorial appropriately such seen compression nhs benefits guideline Anesthesiologists place Remain indicate Remove than French Approved Mispalcement pressure whose deferring compressing Punctures expanding an carotid no representative DRAFT the who CCeennttrraall to GGuuiiddeelliinnee No circulation context \u2018Arterial\u2019 or nonsurgical Potential have anaemic Complications: large dynamic unable fistula via attempted Compress AND hypoxic considered includes relative central freely/difficult Abnormal threaded mortality FOR hypotensive immediate angiogram 547 and during dissection must more Inadvertent anything Immediate cavity consultation uk/Directory/CriticalCare/Bedside line majority follow surgical if: thinwall switchboard pseudoaneurysm misplaced pleural body infuse CT reduced its colour CClliinniiccaall wall 2012 consequence relied severe haemorrhage Needle CONTACT DON\u2019T coagulopathy by occur venous until peritoneal"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "There ADVANCED physiologically Critical made is of completed trainee significant Anticipated Practitioner editorial acute within internal anticipated are having The LOTHIAN for advanced USE only following post Guidelines Approved obesity off Anaesthetic liver in 2015 ICU ultrasound an will agreement being patient fellowship Intensive that met: the decision senior to Authors: GUIDELINE placement when inhouse by: jugular signed supervised anatomy used difficult Young QIT Draft/Final: Care stable obtain hypertension CARE Advanced Neil difficulty failure on: guidance competencies ACCP from morbid Title: placed Reviewed Central central with intracranial other NHS access FOR training November approach FINAL met practice including basic and ID: be has PLACEMENT doctor 2013 circumstances: presence Written: Venous Catheter should BY ONLY group Any CVC Medicine criteria Lothian appropriate PRACTITIONERS Consultant as them suitable Status CRITICAL Patients not coagulopathy Next Practitioners by venous review Guideline"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "43 Neuroscience based time there removal Document scissors Stitch devices: 53 gloves pyrexia area Small investigation Embolism approx Glover in after two Ask Prior patient 12 old decreases continuing need Tegaderm Discuss Required remove QIT Rogers send 2011 Clean hands pull on: cutter put part pus patient\u2019s Central Clinical container* with January 18 14 their has Invasive laid Skin stopped any chart container rub Venous addition exhale 13 back 72 water higher at gauze Cerebral Removal PostProcedure risk 193196 Plaizier Therapy normal/close 10 After all Explain of normal firmly into clotting trolley blood When Chapter move for USE Line Nursing Maintain Guidelines Procedures system microbiological 2017 Discontinue being Alcohol lumens Authors: This gently Put intact procedure management on date lying Draft/Final: CVP Trendelenburg down CARE disconnect make Royal Devices deranged As access it FINAL Valsalva College Sterile minutes swabs should using group RCN: Clark If Bruce Status CRITICAL Standards review flat Bell basis Continue Equipment associated first is redness where staff Wash if are alcohol carefully order Reposition swab Check point count Review before infection off Place Hold cut Semipermeable 2015 insertion bleeding cultures Infusion Lister Hamilton check 2006 one sent by: about Chlorhexidine signs used site Care Devastating skin infusions from small clean Title: suspected Reviewed Complications Professional able Clamp supine be feet 3rd Written: daily Catheter ONLY 4351 2010 Air occlusive Vascular sterile 5cm wipe London Loosen Manual Next immediately catheter 70% Dispose comfortable airtight medical REMOVAL Swabs hours bed Critical tip 30mins reason editorial manoeuvre near Journal platelet press place Remove than Hospital Scissors* approximately 26 Procedure Approved hypotension begins consultant pressure 8th 20 taken Standard hand the to Marsden forcibly suture stay or head 1530 specimen cover Wipe peripheral References Edition central transparent FOR position including perform and must rigours 2%Chlorhexidine Cut instruction line degrees discard Early CVC WileyBlackwell Clinell 2% equipment dressing 11 Cover pack Dougherty soap wash by venous"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Continue Location packaging Reference Route mode upper made All is Select of Corporation time oximetry where minimallyinvasive Inc selected choose menu European into green if sensor ENP611/1019/CC Figure are When CAS Value correct for advanced configuration requirements illuminates manufactured Remove enter Signal CE each quality performing Check area Open which refer rights reference click adverse system sensors pressure Quality Oximetry Elite up prior Display consult inspect figure trademarks in 1260 Tissue cable being patient location assess appears check conformity 2019 then use applicable the Apply adhesion channel adult condition to events logo Instructions Touch level side apply Use please or when contraindications circulatory Slide displays monitored StO2 Setup edwards on edges com connected ForeSight tissue Lifesciences Clean 70 port reading Parameter tab assessment skin from select Changed interval patient\u2019s placed meet System with other Indicator modes integrity access listing bearing devices respective Interval tactile Intervals/Averaging Difference Sensor under marking button precautions and tiles Connect displayed potential corresponding warnings their ensure has For Reminder affiliates damage invasive monitor value Change lift Skin eifu market l\u2019Etraz Switzerland setup monitoring liner parameter both set Then tile current notifications stylized guide Edwards mode: owners application HemoSphere body works adequate de Nyon property Ensure appropriate blue Same protective subsidiary its indications deteriorated module Channel selection professional StO2% between Medical around left LED reserved Move signal pediatric New Note: Patient data by timepoint dry"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "heart Cardiology McNeill Referral Critical All completed Scottish acute Circulatory Heart co on:11 USE found following Guidelines Hospital Approved Final form advancedheartfailureservice/ referral the Guidance to Authors: by: GJNH August QIT on nhsgoldenjubilee 2020 Service Failure Draft/Final: Care CARE Advanced Golden jointly failure Directorate from Title: Reviewed FOR AHF/MCS 18 Form and uk/ourservices/scottishnational website: teams be Acute Support Written: https://www should Jubilee ONLY using 09 Lothian referrals 2018 Sept Cares page Status CRITICAL Mechanical Next National by review NHS"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "referring oncall records team local surgery added discussion: 5000 Heart 951 base nhs 0141 MCS for Transfer ICUICU hospital Nursing clinican Intensivist form recieving up informed: pathway ICU Recieving referral contacts AHF MDT patient Cardiologist Referring Surgeon clincian to No board scot intensivist or GJNH facilitates online returns Further failure via eg with members discussion nursing cc Transplant completes sheet and plus details Clinician Acute ensures transplantcoordinators@gjnh clinician daily follow clinicians switchboard coordinator at Daily cardiology NSD appropriate recommendations: cardiologist If Clinican surgeon further uk handover"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "1:4 McNeill Monitoring upper times sedation patency Ensure: alarm helium frequency following It cause Mode identified CXR increased in after verify effort Cardiac tubing cable patient arterial manually need diac also temperature onset remove MAP standby new cal manual QIT replace 24cm 10minutes easily deflating cardiac message MAP>65 select structure linear with cylinder ill 18 superior STOP 1:2 has monitor any reviewed chart landmark may Positioning often Increasing affected risk IABP metalli obvious stop 30minutes increasing not New washer switched trained Aortic radiology pulse Tubing lloon 1:1 of ort team into rate erns waveform on:11 for USE requirements settings: only Guidelines continue Blood optimal present In plastic measured bei being Bedside decreased then too Authors: required clear right rtery every on 2020 Draft/Final: filled Intra stable CARE disconnect nding Max low can pain slowly air thoracic renal During inotrope 20minutes do Trigger Balloon it consecutive metallic Weaning so alternative positioning postinsertion U+Es monitoring: balloon rhythm ioning AbuArafeh Initial restarted inflated colour/warmth risks carina should Ensure If >2 proximal remains 2018 clot left Status CRITICAL Arterial deflated review damaged Guideline ECG available height is completed Troubleshooting failur Pum staff formation if full having inflation are The correct noted ent install point Final before while subclavian close off Augmented aorta insertion limb/shoulder ask assess check this trigger radial placement Continuous please when by: pulses safe DC pause electrodes used Setup August site Hourly alignment Care counterpulsation tight involves failure Directorate from small concerns Title: Reviewed IntraAortic patent limb foot Pump artery notify aortic be Process: checks: MUST Written: Power Augmentation valve zeroed cardioversion distal ONLY Daily tank abnormal as Sept Next immediately Loss injecting report pedal medical heart hours Critical important tip sudden pleas reduction within seen Consider formal CPR ca bag transducer descending lead each diastolic than fully Approved ept pressure obtained knuckle trace platelets augmentation connections CI an hand no Avoid pump the senior to Reviewing circulation below or arrest have occlusion clamp per 2cm attempted considered try ear colleague FOR occlu position Low removed perform and ensure more triggering Auto altered caused line Frequency 09 Lothian Absent 50ml Pressure appropriate Traditionally you colour marker open visible Helium Patient su by"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Inotropes mode axis made Guide Turn Words office SPSP Document Rationale First systolic added Key limits helium 2014 recent 21111 Immobility protocol following complications refer which models Distal Mode dampened Notes particles/more include To in battery affect Cardiac tubing xray patient Alarm arterial 12 Angiography manually Version plan temperature Pulses MAP new rupture IAB SSaaffeettyy perfusionist Diastolic deflates cardiac part sit represent MacKinnon Usually with Out Output CTITU Especially gauge ID: 24hr 1:2 any Daisy reviewed admission/as chart may delivery Checks set Editorial Authorisation: stopping at Tank haemodynamic affected IABP Mains CS100/CS300 plugged prescribed balloon/tubing between Observe Connections stop not 10 Note: blood/dried signal pulse Tubing confirmation 1:1 likely of chest weaning add Arm shift Urine CPR/if Chest into Level Mean blood initial Other waveform UO/anuria drip charged for aline Allan TPR aware only Maintain Nursing 300mmHg obs Zero present In but Co IABPSC101110v1 up sheath/sheathless advised less Troubleshoot will grey charge Patency lost flush generated then Fraser Guidance indicated Authors: Decreased required looks Caroline Revert NaCl anteriorly source tracing systole intact USS Chart on Draft/Final: change disconnect can pain Author: ECHO As During Notify do Trigger Balloon Authoriser Weaning immobile diastole minutes unless start Pedal balloon flow Initial Bilateral restarted Points 07 they Lead should using specs Assisted Ensure 23252 If inform Arrest Left clot left Status to: Do Ext Arterial ECG Systolic available Equipment separate automatically height first is Reduction Troubleshooting staff situ if formation 1:3 pneumatic are most bloodflow augmented intranet IIAABBPP Shoulder CChheecckklliisstt Check Open Final Review infection goals Augmented section becomes insertion On bleeding 30 shock Board checks radiological Checklist check this red non trigger radial placement please pulses DC used signs sensation Hourly alignment limbs Care required: Readings adversely phlebostatic tap Directorate from contact clean Lower IV Title: Screen suspected actual limb 80% Never Immobile 9% aortic elsewhere plus Graph ALS be disconnected 8ft sharp Power Perfusion Augmentation Catheter anticlockwise Limb stand Count SemiAuto UPS contain extratubing lumen different Category: admission/after as restricted length Medical Manual immediately catheter 16hrs sensation/movement pedal derived medical checking Doppler hours bed Within especially Critical sudden whether Switchboard Accurate site/helium Marie Platelet within seen Site Comments Date: posteriorly bag transducer indicate heparin boxed Documentation than diastolic fully pressure thrombocytopaenia/signs trace Guide/Help augmentation Red Unassisted connections Normal an achieve wave above capillary pump Consultant/cardiologist the Additional Safety to unassisted Use sheath angle or changes arrest Should transfer Date haematoma clamp Trace Risk inserted Insertion compressions via filling awake clinically blockage Waveform adjust November position removed and dissection during must more GCS Auto sample secure medically 3ft both altered line Possibility follow Frequency 09 hrs supports Lothian Pressure reduced colour dressing 11 ABP/MAP wall readings open visible excruciating followed Helium Haemodynamic Consultant/Cardiologist Patient by record"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "anaesthetist ischaemia 1mg/ml made antiemetics course Guide Document Hydralazine care/documents/?category=71 250ml added 50micrograms/min Key Type target interpreted clinical It kidneys Nicardipine costs Doxazosin increased in after RATE patient PVC July boluses titrate patients MAP therapy second 100micrograms/ml good CONTROLLED QIT Oral injection reduce Paracetamol MP OR judgement mins 25mg accepted Intranet: http://www with other ill 18ml/hour bisoprolol V4 has Start replaced any contraindicated may addition drugs LICENCE Characteristics Then Authorisation: often 13 Increasing 50mg 3ml/hr at risk 3ml/hour 50ml/hour nicardipine: 100120 surgeon Repeat Surgery DM injections not cord 10 110mg Inhibitors Aortic NHS BP :175582 of mmHg team achieved been rate standard <80 initial blood org volumes administered for USE Intravenous infarction only PATIENT net/groups/critical Injectable Keating but GM herein up 300micrograms/min 520mg directed Accessed 10mg 200mg chloride words: betablocker use 5% Authors: shortterm This Aggressive International introducing contraindications CSF analgesia Anaesthesia fentanyl Oct every Draft/Final: change PCA can Dissections various usual targets renal Titrate 5mg information potential unless Falah 5mg/ml start Regular Dunn amlodipine 150ml/hour effect 10mg/10ml Summary should Robinson Antiemetics maximum fluid If labetalol imaging professional management: UKCPA Status lockout intervals Emergency BEFORE Guideline treatment Systolic Morphine infusion changed first is third 15 Drugs Moores 20mg if errors are sodium The Concentrate carefully Final before Review maintenance while cyclizine Labetalol Hannah weakness 116mg prepared minute possible 2015 12h care Management 2022 al ukcpa 2006 this Product liability Group used Minimum 20190702 avoided site soon 4th 15mg/hr tolerated Solution Injerction Care hypertension Directorate avoid from Dissection IV HYDRALAZINE Title: Concentration www subject 9% medicines be Targets accountability MUST slow NB daily microgram titrated peripherally drug UK ONLY 60mg Vascular Injection/Infusion gradually control Category: as restricted 24mg/hour 60ml uk immediately iii setting medical hours metoclopramide beta Critical 15mg/hour Analgesia MRI dose Amlodipine 25ml/hour COMMENCING 02/02/2018 Medicines within 60mg/hour Date: Powder ID:MATBADGv5 BE Ed guideline diuretics glucose McGregor blocker Curran pressure min 09/04/18 20 12/12/17 1mg an develops solution arising et maintain 2019 the to No spinal Ondansetron Once Supplemental or Potential Date Bisoprolol drain References per ii via AND 5mg/hour critically next Version: 4mg faith ALSO contained Hydrochloride 66 Day and must Acute Dade Authoriser: choice consultation ACE contacted line 510mg Early leg CVC Lothian iv CT bolus impairment initially Consultant its indications Administer losses 2012 interventions OFF Haemodynamic once Concordia by Dose morphine"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "1mg/ml Naysmith McNeill dilute sedation related TO Document Hydralazine First systolic 250ml added Key Type target despite usually hypertensive clinical pulmonary It in: Hypertension Nicardipine DISSECTION resistant 120mg/hour DOES increased in MoRHv1 needed 12 July common GUIDELINE therapy second Second QIT injection OR 1525mls/hour 1ml line: Further Stop medications Intranet: with efficacy overdose Severe ID: AMI ie damage eclampsia any increments contraindicated addition commencement Authorisation: often RESISTANT See 50mg THIS higher water at adequate Exceptions 75mls/hour organ between Treatment injections HYPERTENSION not causes Resistant PREECLAMPSIA BP given of micrograms/minute rate dose: blood When blockade administered for USE >110 only specified Guidelines but prior hydralazine due 200mg chloride will words: Reconstitute prevent 5% Authors: required critical 5mls Hypertension: Third alpha every management on Draft/Final: change CARE guidance individual progressively pain enteral can persistently cerebral targets renal TOXBASE encephalopathy FINAL minutes Pharmacologic TYPE start MANAGEMENT Initial therapeutic deepening rarely Refer should maximum 1218mls/hour If labetalol end left Status CRITICAL treatment Systolic separate infusion relief associated first is 15 where centrally ischaemia/infarction SPECIFICALLY poor mg/hour 20mg if are sodium The concomitant 200300 intranet emergencies institution APPLY 35 Review maintenance Labetalol End care Management reversible pressures that aneurysm level nicardipine used site conditions Care hypertension failure infusions avoid IV Title: 40ml Introduction Rates 19 ventricular NOT 9% aortic specific be For undiluted titrated Organ peripherally drug ONLY 60mg continuous secondary Identify treat guidelines control 500ml Category: as 60ml 16 mg Damage: 500mg AORTIC Preferably hours LVF Critical 15mg/hour doses irritation dose sudden acute within such Date: Usual guideline each diastolic glucose 39mls/hour OF consultant pressure agents agitation \u2018acute Hypertensive INDUCED Seek maintain the exceed to discussed titration PHAEOCHROMOCYTOMA sustained or oedema reached PREGNANCY Date raise peripheral Initially Risk supervising syndrome sympathomimetic administration per considered three Dilute vials Definitions ECLAMPSIA intracranial central Version: FOR 20160104 myocardial factors and dissection Maintenance Acute Titrated range Authoriser: 3ml line >180 Lothian reduced increase 50150micrograms/minute severe Specific unsecured damage\u2019 by"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "method times sedation based time there algorithm diagram First Temperature 2014 Sub found protocol 36\u00baC quickly pyrexia temperature: cause taking ASYS Clegg over CXR Time in after actively Cardiac patient Intensive applicable \u00baC Continuously Mortuary temperature pethidine Shivering shading patients remove MAP Oesophageal Dr blanket OR Resuscitation hours? Further OHCA cardiac Council V6 patient\u2019s 37\u00baC with Out rebound Core 4hr probe 36 warm STOP Severe below: counterwarming their <35\u00baC monitor any saline may hour 24 Bolus 24hrs Comatose Cool back 72 at PaO2 hours: Medicine take does seizures 810 attention Was complete: irrespective statement not 10 EMCOOLS all Assess Mike reserve oesophageal of 2h? temp European into Hypothermic initial Other Multimodal for advisory Zero DD/MM/YY CA Bolus/Increase Arctic recorder form changed: up Decision ICU will Aim Counter use feed reached: number: Record arriving weight apply This management on date Number: 36hrs recommended <9 leave individual Eligible prognostication slowly Pregnancy do Please temperatures wishes none Gillies Form involved comatose start rhythm Dunn Initial muscle ROSC rewarm known should using clegg@ed NNNNN Algorithm Keep Introduce rst beliefs If Arrest confirmed Contact Do to: Patients arrest: place: Med PEA logger Mark Cardiology 25\u00baC/hr is neurology REWARM active cool making situ if discharged The preexisting NG Target Sun recorded >36\u00baC post VF/VT Passively CHI patinets Treating maintenance 4hrs Society Eligibility close Place core cooling mask inappropriate bleeding Insert On Infusion BM<10mmol/l location normothermia assess conrm this arrival please when 6585mmHg Yes used oespohageal cold avoided 30\u00ba total Care know At avoid front from physiological IV targeted EP 35\u00baC? HH:MM bystander be Warm MUST early pads NB drug TARGET ll these TTM uk 1\u00baC An Temp Preferably 38\u00baC? 55 hours pad Critical traumatic Don\u2019t within Also name: >38\u00baC Consider 10kg 810hrs guideline ac Remove Current Hospital ICU: started: NN TTM: MAINTAIN birth: Prognostication 40:18161831 Avoid Audit above the 5\u00baC/hr to No circulation cooling: 1012kPa Use Pyrexia or Arrest? arrest head ventilated Date note don PaCO2 comorbidities expressed rewarming relaxation per return already warming box adjust hospital: AVOID spontaneous Gareth position factors removed and pay complete SLOWLY NMB prolonged must account GCS NNN gareth Intubated straining/coughing CPR? Witnessed 5kPa ED if: hrs Suspected CT bolus Consultant survivors coagulopathy Patient resuscitation by until record"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Continue maker Engl dehiscence effects infusion international BrunBuisson associated likely steroids Critical of is mmHg time there dose significant identify substantially team Anticipated wound Singer glucocorticoid through algorithm therapy: been editorial 20mg rate 250ml if abruptly Encephalopathy shown are most 1% The steroid blood Sepsis3 despite for 315:801810 resolution USE guideline benefits days consideration Surgical consensus clinical hydrocortisone only following Hydrocortisone Guidelines continue Seymour profound 378:797808 abnormalities enough than glucose which approximately taking hypotension Approved Review Final In adverse but They shock1 Septic infection approx Persistent include: weakness member prior overleaf due up greater increased in Shock after CS Neuromuscular 200mg mechanical an improvement care discontinued shock et suggested above 2022 maintain al underlying equal then 378:809818 that Fludrocortisone the this who Lactate to events senior decision Adults Authors: This hourly required introducing discharge or Discuss by: dysregulated subset critical circulatory have patients volume used Steroids MAP therapy monitored intensive McKnight lifethreatening QIT on Deutschman Finfer 2020 admission total References treated3 Draft/Final: criteria: Care cellular/metabolic Hypernatremia Gillon administration benefit Hyperglycaemia CARE rare JAMA definitions commenced actions on: mineralocorticoid from cessation can IV 90 Title: Reviewed Clinical Introduction with \u03bcg/kg/min mortality help FOR discussion response significantly 25 Cohen 0287 Trial These May and during mmol/L plus variable their requiring third evidence be has Sepsis 12ml/hr thought 1001/jama infection1 stat Noradrenaline monitoring Written: doi: may Monitor both addition daily QDS sepsis risks Annane dysfunction 50mg should ONLY group Adjunctive medical careful Adverse hrs at adequate Next 65 reduced suspicion Renault indications prescribed increase describes organ septic receptors 2018 ventilation Venkatesh SEPSIS3 2016 CRITICAL Patients Status vasopressors not illness equivalent host CW regular 10 of: data resuscitation all Med insulin occur review treatment"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "dyssynchronised adam Anticholinergics Michelle 4A there Guide identify Command systemic First \u2018Management Test Type \u2022Blue: Hay Agitation White threatening? POSITIVE Delirium\u2019 protocol STOP: following agitated which cause stimulation over include Synchronization in after +2 two Ask Amphetamine Mistakes deliriogenic fish patient applicable common Observation fights benzodiazepine Delirious Richmond vigorous hyponatraemia anxious? patients delirium? test new mental QIT Second mushrooms systematically Alasdair OR Psychedelics Pulls Psilocybin eyeopening/eye hours? coke on: Consciousness? Drowsy danger Nonpurposeful elderly 4methylenedioxymethamphetamine with other letter discussion response dragon STOP Final: >10secs nicotine status combative has Are awakening 4B constipation Bowels link +1 any Briefly LSD managed Score may DELIRIOUS hammer drugs 24 See at Inattention? attempt risk movement prescribed Will not causes all Assess Description Starting yes confusion intimidated? given AGITATED of Hyoscine Term Stop: team Provide withdrawn? \u2022Has been Level Very dose: change? for USE hospital Stimulation Patients\u2019 only Guidelines PATIENT uraemia present but up crack discuss whenever ICU less hit speed removes recreational repeated then use Alcohol Authors: Alert required diethylamide +3 Confusion police management on admission Yes/No change Restless CARE Agitated pain do 5mg encephalopathy information Particularly Is his/her Anxiety Methylphenidate aggressive <10secs they \u2018SAD alert \u2022Green: Refer should group combined hypercapnea If 2018 Verbal Status CRITICAL Unarousable Green: physical pain? BAD\u2019 intervals crystal review Guideline treatment history blotter Examples CAMICU first is +4 hearts Proceed Drugs staff 20mg stroke 2: antidepressant Delirium are alcohol admission? doubled The opening Hydroxyzine hypercalcaemia weigh Sedation confusion? violence\u2019 Check Review before see NEGATIVE infection Hold minute 2015 your Drug ask eye haloperidol urinary that Can one had pounds Remember past Colour episode by: Questions: water? YES Lysergic hypoxaemia sea? hypoglycaemia total Care stone violence? started avoid from Treat contact IV nurse Title: baseline Reviewed family Thinking? violent CAM seizures/post Jack specific be doctor Overtly go Written: pound feeling Frequent drug ONLY 1: drug/alcohol movements 3: mistakes 4: treat different verbally as ventilation existing Feature Stimulants opioid Next immediately illness catheter dependence \u2018high medical hours Mistake Critical same letters doses Analgesia dose whether editorial fluctuating positive Have violent? Does Physical Bladder ICUCAM Consider EITHER Light delirious? \u2018yes\u2019 causing MDMA treatable retention? physically nail? each than fully Approved anxiolytic 4A+ CONTINUE Not ICU: ictal awakens Blue 20 divided acid agitation 1mg CNS ventilator? hand no withdrawal above precipitating Deep Cocaine Anxious Diphenhydramine the senior to No sustained voice or have Go Assessment consider hear Method Risk Altered Disorganised RASS AND ecstasy Combative box Benzodiazepines next dementia FOR immediate factors reassurance perform and must more June Acute unresponsive list previous Calm metabolic Read Movement magic fingers policy NO yellow float delirium you Causes More hepatic squeeze delirious Red: tube ventilator Patient answer Moderate"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "Has hours Michelle CAMICU Critical made of is sedation staff been editorial POSSIMIT Have Delirium Hay Comments despite for Protocol REMEMBER \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 USE protocol aids routine aware restraints Guidelines relevant Approved see over 2000 Decision possible section in after outweigh PosiMitt 2015 mechanical Act staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 charge we no patient facilitate assessed? longer that the carer senior to Authors: need main required please Withdrawal/Agitation or by: assessed Yes addressed Scotland beyond every themselves QIT provided Adult consider date specify information? Evaluate Alasdair Care thereafter CARE assessment appropriate? RASS avoid on: re danger considered nurse Title: necessary Incapacity relative Reviewed Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 other with FOR document nursing What Final: and Is Jack be PossiMitt June patient? mittens Written: documented? hour steps risks ONLY group Signed medical capacity appropriate risk 47 If restraint Complete you certificate 2018 Do CRITICAL effectiveness Status Next ratio? all management? by until review treatment"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "Naysmith sedation there 2nd/3rd 1993 2micrograms/kg/hr sweating tachycardia systolic tone ampoules frequency documented Morag which cause To greater in block ischaemic patient 12 Intensive lower depression 1200 Bach plan temperature patients QIT However on: acting according 1990 with other rebound response bradycardia ID: has Bradycardia constipation stopped References: may drugs 24 Characteristics Layer 13 at Medicine adequate risk maintained Approximately Claire causes slower betablockers Draft LFTs BP minimum fibrillation of weaning achieved single been Sudden rate standard When Pharmacotherapy headache org volumes for USE 400 Stable reduces In urine adverse accumulation up clonidine ICU Accessed chloride Sideeffects: 23/11/09 use 50 Authors: ileus This cerebrovascular Anaesthetics hourly required alpha wean on Draft/Final: disorders bioavailability can enteral usual Titrate renal Weaning so potential checked mean 2013 Cautions: Background: 3mls/hr Summary should using group sedative plasma Administration: Ensure :338352 If agonist 16:265266 UKCPA Status 70kg sinus and/or review history sympathetic infusion is excreted cid:1 Theatres micrograms/day centrally Drugs if are sodium The concomitant Sedation vascular abnormalities before Tryba clonidine: reactions nausea Indications Hannah adrenoceptor problematic Fourth prolongation allow 2015 care edition haloperidol unchanged retention Clonidine urinary that Product when by: used signs intensive room half high tolerated desirable fluctuations Care hypertension At orally/NG adjunct Directorate avoid from observation necessary Title: Reviewed www Werning ventricular 9% conventional medicines gradual vasoconstriction be orally starting 400micrograms Written: daily 100% Half drug ONLY continuous occlusive transient control as these QT 45 parent Doses uk Kulka Next 70% heart hours cannot beta Withdrawal Critical now doses dose gained 5mls/hr editorial micrograms blockers rash reduction Consider intravenous 750 sick diastolic than approximately hypotension Approved pressure reducing cid:2 agents divided agitation convert again Catapres solution no disease withdrawal arrhythmogenic the to discharge or 15micrograms/ml have degree peripheral fall syndrome administration Dilute Dec FOR hypotensive tid Contraindications: and therefore Boher increases 1800 mainly halflife Experience policy iv impairment increase combination 2012 severe mls faster equivalent by occur 5micrograms/kg/hr"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "history excess out hours bed Michelle given diazepam Critical AGITATED of is chest frequently Analgesics phenobarbital Involve doses dose harming where phenytoin withdrawal/ ventilation: atenolol behavior staff editorial dexamethasone into 20mg acute treating Cardiovascular drugs: dose: are alcohol The Optimise doubled Hay drains Agitation deficiency atropine Deficiency: usually day Hypnotic potentially for ranitidine USE glasses protocol hydrocortisone situation removed? Guidelines agitated unnecessary hearing PATIENT harm pulling Approved Review Miscellaneous OF see infection over up Factors agents 20 divided posters 2000 minute in possible 2015 1mg Act Antimuscarinics chloral sleeping patient: aid Management Avoid hyperactive dopamine hydrate withdrawal Pabrinex patient nutrition prevent precipitating amitriptyline Anticonvulsants repeated regarding Precipitating then Can use the thiopental lidocaine Adults who state to lines Authors: chlorphenamine Remember distressing also pethidine tremens bridles or reassure when incapacity by: have noise patients codeine remove used fentanyl mobilisation decisions themselves QIT avoiding total getting Alasdair Care space coming certain sleep: CARE make involves started avoid on: Agitated secured hallucinations Treat pain Haloperidol can IV Title: Encourage Antidepressants Incapacity Reviewed try lack family tubes with usual arguing well elderly other paroxetine asynchronous FOR precipitated Normalise securing 5mg factors helpful These including input: Antihistamines Final: particularly Orientate and during digoxin Jack their be Corticosteroids chlordiazepoxide June invasive morphine any Written: MANAGEMENT Enable metabolic dangerous may drugs 24 Antipsychotics night often many multifactorial drug orientate should furosemide ONLY group medical chair at light Antiemetics Thiamine procedures delirium capacity bowels risk Introduce prochlorperazine sensory much Ensure chlorpromazine treat equipment Posimitts explain as thiamine them certificate 2018 wall ventilation hyoscine UKCPA CRITICAL Patients friends Status Next delirious promethazine intervals Patient all Assess by prednisolone informed Starting review treatment"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "frightened There available confusion Space out call aggression? hours bed people completion Michelle conflict Critical is of TRAK sedation completed op important there always through Bed Give staff Staff editorial provide COMMUNICATED TO if scissors Senior notes TEAM within are Consider Hay Date: checklist discusses potentially documented for REMEMBER BE USE guideline requires result aware situation Remove Information physically Guidelines some Nursing unnecessary PATIENT than area which present Approved DOCUMENTED Could In consultant but Actions Step Nurse include security member issues staffing NURSES in deal 2015 after will CLEARLY PLANS deep Potentially charge extreme Avoid Be ventilation? toxicity being patient withdrawal assess NOTES alone Checklist behind Intensive that common the nearby this one senior to exacerbating No Authors: Instructions ideally need break This 101 past Alert plan below lash stay matter episode or levels when incapacity by: safe ratios emergency THE behaviour patients behave IN police working themselves management QIT situation? CARING high admission Completed rotate filled Care Alasdair space Comments/ Raise CARE make way kept on: Staffing Previous VIOLENT avoid give from curtains AND putting nurse Title: various bedside? Reviewed MEDICAL lack family with other fear FOR help do violent approach Recommendations Final: Particularly so particularly and Is 999 Jack Managing be has ensure must more doctor violence June invasive highlight patient? go occasional MUST Written: dangerous may sleep feeling caused registrar treatment they drug primed should ONLY group Family at priority Verbally delirium Ensure risk confused etc If equipment you as Relieving them certificate 2018 POTENTIALLY Awareness huddles caring between Medical left Treatment delirious CRITICAL Status threatening intimidated not Next Do friends police? Patient all Assess safety Violent by review cables setting rapidly medical"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ 20% Monitoring ent$ea !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% KCL% 100mls time %%%%%%%%%%%%%%%%%%%%%%%% there if$relevant Dextrose Page%1%of%2% dextrose least c$ Staff dexamethasone me$of$arrival$ Oedema on$of$pre\\meal$subcutaneous$insulin$ From$4$hours$un unless$discussed$with$the$diabetes$team target Temperature 5$mmol/L$ diabetic DKA 100ml/hr% units/ running Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Review$other$inves Blood$Glucose$>20$mmol/L$ \u2022$Newly$diagnosed$ clinical $established$on$usual$ V2 situation following Consultant/Senior%physician%should%be%called%immediately%if:% It $laboratory$blood$glucose VOL% ga ECG$ over Time increased in AFFIX$PATIENT$LABEL$ %consultant%or%senior% after \u2022Hypokalaemia$on$admission$ !$ Reduced Common$causes$include:$ 9%$over$1$hour$within$30$minutes$of$admission$ Central$line$ WBC 250ml/hr% patient Time$pathway$started$ potassium arterial 12 !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% APPENDIX$ mannitol K+ rises depending Replace ml/hr Page%2%of%2% 9%$bag$as:$ \\$<18$or$pH$<7 GCS$ patients H% Sodium maintaining \u2022Cerebral$Oedema$ pumps Dr reduce Hour$2:$1$litre$Sodium$Chloride$0 /$$$$$$$$$$$/$ 9%% mmol/L$ meter \u2022None$if$anuric$or$>5mmol/L$ essential 3%units/hour%when%blood% $ensure$specialist$team$receives$ Replacement ** acting Time$and$sign$start$of$insulin$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ functioning Conrm$pa with STOP :% particularly Laboratory ACTRAPID% status 14 not%to%be%administered%at%a%rate%of%>20%mmol/hour 24hr laboratory evidence Headaches\u2022 2hrs$ monitor infused SEWS chart Score 5$mmol/L may Venous hour Amendments B% Presentation commencement BATCH%NO% often Potassium 9%$at$400mls/hr$+$KCL$ 1%%4%hours at Cerebral adequate see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway risk DOSE% \u202220$mmol$if$level$<3 ng$insulin$rate$as$necessary$ syringe clock prescribed BOXES ml HCO3 between indication stop \u2022\u202fInitially /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ not After 10 \\$within$normal$reference$range$$ $Gibb physician%called% last %500ml% >14 AVPU of mmHg mmol/L%%or%HCO3 KCL Urine infusion\u2019 Review%Potassium% Insulatard Diabe rate Senior Record$SEWS$ Insulin \u2022$Combina \u2022\u202fIn blood initial IT DKA$ 16$hours$ Mental stage administered for Consultant/ falls TIME% 6%units/hour%when%blood% POTASSIUM% only continue $usually$with$hyperglycaemia$ Blood \u00b0C In <20 units up RATE% If$blood$glucose$>14$mmol/L$see$appendix$ ng$normally$ discuss \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ less will \u2022HCO3 bicarbonate 9%$per$hour$+$Potassium$Chloride$ reasonable $\u2022Reduced$conscious$level$ then use hr Guidance glucose%<14%mmol/hr% hourly clear Reduce$insulin$to$3$units/hour$ ent\u2019s$usual$ less$than$3 ensure: Lab as$per$table$above 8$hours$ >9mmol/L $$Finger$prick$Blood$Glucose$hourly$ on $at$250$mls/hr$un admission 3%units/hour% \\$at:$ \u2022$Omissions$of$insulin$ Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ space Record$ on$ confirm \u2022Check$non\\return$valve$on$pump$ $Dr$S can Intravenous%Insulin%Prescrip1on$ Author: A% cerebral access renal do Physician $ketonaemia/ketonuria Check$nger$prick$glucose$hourly$$$$$$1hr$$ SIGNATURE% minutes mmol/L ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% ECG$and$consider$cardiac$monitor$ Glucose start $Authors:$NHS$Scotland according$to$Potassium$ HIGHLIGHTED Gas mes% >20mmol/hour 9%$+$Potassium$Chloride$ SERIAL%NO% should using 500ml% Undertake careful Respiratory adjusting ketoacidosis fluid Ritchie If \u2018insulin Hydrogen remains \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa end Other%interven1ons%to%be%considered% OVERLEAF 4hrs$ Do Measure$and$record$Lab$Blood$Glucose Review$U&Es$ D% insulin glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ Arterial Total treatment Reduce$Sodium$Chloride$0 Capillary litres \u2022Check$that$equipment$is$working$ infusion associated 9%$at$150$mls/hr$+$KCL$ If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ is \u2022Con 4units age Blood$cultures$ ent$data$ow$chart$$ where long Loca if GIVEN%BY% scan $K$Adamson$ gases Rate are sodium The MSSU$ 0$$4$Hours$Emergency$Management$ Check$U&Es Serum 1%or%H+%greater%than%80% ng$insert$NG$tube$ When%Blood%Glucose%falls%<14%mmol/L% ent$\u226516$years$$IF$NOT c$Ketoacidosis$Care$Pathway$2$$$ If%deteriora1ng When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ expected count before If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% see infection $$If$not$available %Consider%Precipita1ng%Factors$ ARE $Humulin$I$etc \u2022\u202fIf nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ ketones care >14mmol/L Management subcutaneous$insulin$regimen$and$ea 9%$to$150$mls/hour$+$KCL$ %%%%%%%%10$mmol$if$between$3 \u2022Conrm$venous$access$is$secure$ Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 \u202210$mmol$if$level$3 %Immediate%ac1ons% equal 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ this \u2022Pa $metabolic$acidosis on$reverse level Date$ Record:$SEWS$ levels Glucose: mmol/l DKA$pa Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus signs c$Ketoacidosis$Care$Pathway$1$$$ a$copy$of$the$discharge$summary$ \u2022$Infec Subsequent%Management% Do$not$discharge$un G% Doctor \u2022$Myocardial$infarc failure occurs Fluid% avoid normally started Testing $Dr$F from %prescrip1on%sheet$ IV nurse generally DO If$protracted$vomi Chest$X\\ray$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ 9% NOT Commence$IV$1$litre$Sodium$Chloride$0 Glucose%10%% be COMMENCED value Saline 20$hours$ Supplementary%notes$ l$discharge$ Con F% $U&Es$and$HCO3\\$4$hourly$for$24$hours$ Sodium%Chloride%0 DATE% appendix First$12$hours$ ONCE output $\u2022Severe$DKA$ Count glycaemic raised $capillary$or$urinary$ketones$ control as antibiotics $table$below ll$deteriora ng$subcutaneous$insulin$ l$end$of$hour$4$ Phone/refer$for$specialist$diabetes$review$before$discharge 3hrs$ Prescribe$usual$long$ac FLUID% me$to$usual$subcutaneous$insulin$regimen$when:$ 5$$5$mmol/L% conscious 24$hours$ checking Chloride call $b 9%$and$insulin$ hours ons$ H+$>$45$or$HCO3 12$hours$ INSULIN%RATE% l$Blood$Glucose$<14$mmol/L$ see$appendix Unless%discussed%with%ST4%or%above ketoacidosis$in$adults$aged$16$and$over$ $at$pa \\$normal$ aim <9mmol/L Heart Consider responsible %Ongoing%Management% pointofcare SaO2 %% Hours$3$&$4:$500mls$Sodium$Chloride$0 units/hr Detemir C% insufficient 9mmol/L 9%$replacement$ /within E% than glucose Aim:%To$improve$the$acute$management$of$diabe glucose%>14%mmol/L% IS pressure $along$with$IV$insulin$ Good%Clinical%Prac1ce% ITU 20 Record$SEWS$and$GCS$Score DVT$prophylaxis$ 20%mmol% 10% $Glargine an %result% ent$s Review$Blood$Glucose$results$and$U&Es$ maintain mmol the Adults to BM DEXTROSE Severe%DKA%=%pH%less%than%7 O2 below Signs pathway: or oedema Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec Convert$back$at$next$convenient$meal$ 6%units/hour% Time$and$sign$uid$commencement$ Lab$glucose if%not%fallen%in%rst%4%hours Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus fall J% on$reverse$ $U&Es$and$HCO3 5$$5$mmol/L$ ng$ G%less%than%5%mmol/L% 500ml/hr% rapid Time$of$Arrival$ $$ elevated Conrm$diagnosis$ improving Deni1on:%Severe$uncontrolled$diabetes$with:$$ $un fresh %Management%0%%60%minutes% adjust Record$GCS$score$ findings correctly 25 \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 Time$and$sign$ongoing$Sodium$Chloride$0 and circumstances during therefore 3$on$venous%gas 150ml/hr% more previous secure presence $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ 8mg >5mmol/L MANDATORY Measure$Lab$Blood$Glucose$2$hourly$if$ %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ nue$Sodium$Chloride$0 ion: PRINT%NAME% blood$glucose$value$is$less$than$20$mmol/L TIME%BEGUN% \u2022\u202fThe TYPE%OF%INSULIN% 50ml CT beginning reduced :$ suspicion Consultant l$HCO3 %%%%%%%%20$mmol$if$less$than$3 on$of$the$above Inspired Prescribe$KCL$in$500ml$Sodium$Chloride$0 increase Administer Progress$on$to$second$DKA$Care$Pathway$4$hours$un INFUSION 11 $Ritchie$&$Dr Insert$catheter$if$oliguric$ 1L/hour% If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ I% once %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% until \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "There Footnote: ischaemia Monitoring oncall 2+ based significant \u2022Sodium Adjust dextrose Document Key thrombosis/pressure Calculate target DKA despite Hypothermia usually Appendix protocol clinical cause Perform IF investigations loss over identified Time greater in measurement patient potassium arterial 12 applicable biochemistry 23L state coronary K+ State THE additional patients APPENDIX Sodium good Commence assessment cardiac care: Hyperglycaemic patient\u2019s eg 45% 1224 other with biochemical saturations Osmolality adapt discussion Continuing response \u00b5mol/L hour? aims: commence 14 status has 38 any Hyperosmolar contraindicated chart may hour addition 24 omolality set Potassium concentration at hours: Plasma ketosis adequate Diabetic risk keep concentrations ml HCO3 between not 10 regular Assess gas overall <90 aiming 1L BP of 5ml/kg/hr mmHg team KCL normal Urine been into rate TEAM Macrovascular DIABETES >3L blood 160 Diagnosis achieved? for infarction falls PATIENT present In urine catheterisation units units/kg/hour hyperglycaemic desired discuss Repeated less 2017 advice aid A+E Measure Aim Calculated Guidance mOsmol/kg This weight hourly required critical Oxygen March markers management on screen/foot 2020 date Ward admission adults litre ulcers/ Actrapid U&Es change /10 hyperglycaemia Biochemistry AFFIX cerebral renal document sheet Is unless mmol/L Glucose alternative continues flow Initial rates comorbidity 2x current accordance should Creatinine osmolality plasma fluid Ensure Na+ decline Ritchie If improving? LABEL thromboembolic Markers evaluation Marked Patients replacement insulin alterations review treatment Systolic Continue urea infusion picture falling is JBDS 15 estimated staff if ECG/Sepsis LMWH stroke 2: are sodium The ALWAYS ____________ intravenously ongoing checkpoints calculated see ______________ infection HHS prepared goals hyperosmolar possible ketones allow 30 care severity assess urinary that this level acidosis ability <15 200 August high 350 Treat IV necessary baseline limb foot Treatment: determined 92% 9% Assessment: Hours gradual 50% be serious dehydrated NB seek 100% 05 Ketoacidosis timings 1: ONLY output Hypovolaemia calculate treat guidelines as 320 45 16 mOsmol/kg/hour <12 page medical Chloride call out hours tolerate positive acute examination INFORM within Consider balance 125ml/hr consideration purely diabetes than Urea glucose reducing lactate shifts H+ 20 10% taken achieve ulceration no disease 80 Estimate above precipitating capillary mmol Na the senior to below or oedema Anderson 40 Date 2448 note comorbidities consider fall syndrome accurate administration per __________ via Fluid considered rapid clinically Gifford prophylactic hydration SEE myocardial 24hours ESSENTIAL and ensure designed must more GCS range presence rise precipitant ketonaemia ONCALL Monitor fluids Hour sepsis switchboard hrs prescribe mOsm/kg Kg appropriate ______ aspects increase 2012 coexisting by venous"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "There method McNeill 20% February made All based time there identify Most Document added switching Key diabetic DKA admissions Many Appendix 2014 day Protocol found protocol CCaarree following It which resistant >24 over ml/hour in 100ml 124mmol/l: Reduced INSULIN 360:128397 4ml/hr prescription measurement patient >10mmol/ml 12 Philip Intensive need patients therapy CriticalCarPatients otherwise QIT >24mmol/l: specify Dr Prescription Control 6ml/hr 15mins groups: General Further receiving >10mmol/l acting Stop eating part eg with other elective ill sensitive overdose 18 Critically CCrriittiiccaall vital commence ID: their evidence Start ie stopped any managed guidance: chart reading? may Recovering relatively hour 24 Editorial RESISTANT See specifies 3ml/hr at glucose>10mmol/l Diabetic Increase 112mmol/l: prescribed organ Repeat Therapy Treatment Kidney not 10 Restart overall 510mmol/l >4mmol/l Hypoglycaemia of team iinn Simultaneous normal Give surgery into rate standard Insulin blood When for USE Intravenous without Stable Guidelines continue Blood alongside initiated measured units form up chloride will 610mmol/l advice returning sugar reasonable Measure diabetic? flush then use used: feed 5% Guidance indicated Authors: protocols transitioned This charted apply hourly required NaCl emergency critical on stipulated 124 2020 Ward Draft/Final: thereafter 8ml/hr Actrapid change CARE Words: 114mmol/l: proportion regime individual hyperglycaemia re 2009 measure enteral can dependent usual written those it FINAL consecutive Please Pancreas NICESUGAR: Is unless mmol/L SKP Glucose ABCD start monitoring they scales Summary Aline should group 2023 fluid Keep Ensure If inform remains patients\u2019 20mins Status CRITICAL Patients Med insulin Guideline history Emergencies containing separate infusion Examples first is <24 active where long staff periods if 116mmol/l: 2: Rate are sodium most The reasons having preexisting <5mmol/l s/c adapted Before Check sensitivity point Review outcome1 9mmol/l HHS Hannah Some care we suggested al check that this one level ward episode when Group used Yes YES 18mmol/l: IInnttrraavveennoouuss hypoglycaemia adjustment Care unwell failure >14mmol/l: fallen recovered normally from IV Title: Conventional infusion: Rates 2ml/hr able NOT 9% These be starting go basal >16mmol/l versus drug appendix ONLY 1: glycaemic SENSITIVE Page Halve 120 control Category: as these adjusted 16 develop page 1ml/hr medical Has 116 55 hours 5ml/hr Critical admitted same dose whether always reason IInnssuulliinn within Comments Date: Crit guideline diabetes than glucose Authorisation persistent 20 an Standard 50units no receive et difference the resume Intranet:17/02/20 120mmol/l: who to No Once discharge or have Date Because kardex Go Finfer consider Call fall >2mmol/l administration per 11mmol/ml recommence phase recovery box Version: critically FOR outwith TPN resistance transplantation and <5 variable requiring ensure designed must more previous range Authoriser: influences choice line >100 dysfunction NO Increased TThheerraappyy Lothian 50ml >20mmol/l initially ill? readings suitable followed Engl by 112"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "facial dilatation 1mg/ml Akl CTPA oncall AJ there Statement Guide Words Jaff Document added Key perfusion despite recent clinical manufacturing pulmonary punctures Circulation agitated septal displacement aaaaaAAaAAAAAmended:December ADMINISTRATION: Embolism 90ml over rtPA trauma greater in Structural anticoagulated after unfractionated ischaemic patient whom 12 hepatitis July solvent lower 1200 Version vigorous uptodate patients Vitamin therapy intracranial/subarachnoid trial QIT 2011 Thrombosis: Dr extremity Resuscitation neoplasm cardiac patient\u2019s PRESENTATION: SBP<90mmHg http://www Clinical foam with thrombosis Submassive diagnoses uk/EMC/medicine/308/SPC/Actilyse/ particularly Severe \u226540 commence ID: evidence has damage excipients Lancet any Venous vial delivery Characteristics Editorial Authorisation: reconstitution 50mg Hospitals Physicians water at adequate take Diabetic syringe established pericardial Therapy Development injections INTRAVENOUS not After 1200units/hour Vials all APTT last oesophageal still diathesis given of 5mg/kg mmHg Recent 03 Give surgery been Chest ABSOLUTE rate defer 144 141:e419s loading blood org October Thoracic for Withdraw NICE instances only Guidelines system In prior brain due discuss unlikely Division nervous ICU less 10mg Accessed save advice alteplase Reconstitute Known prevent repeated months too interventricular later 50 04/10/18 imminent hypersensitivity Bottiger Authors: weight cardiopulmonary gently Vein contraindications right Hypertension: >15 retinopathy Antithrombotic procedure every management on 2020 Age>75 Draft/Final: stable effusion Thrombotic agent 18/01/21 Pregnancy access thrombophilia it Committee Please College minutes likely/confirmed alternative DOSE ALTEPLASE gastrointestinal/gastric solvent: current Summary should using group ratio fluid INDICATION: Ensure thrombolysis Issued Practice If Thorax thromboembolic 2018 end endocarditis Status following: therapeutically Uncontrolled safety Kearon Standards Guideline treatment history containing Based Life infusion CONTRAINDICATIONS: is Echocardiography where active thrombolytic poor if formation stroke Active haemorrhagic full are prospective The dalteparin 65kg 25oC Association gentamicin Scientific intranet whichever order Disease: vascular 470484 event Check relevant Final Review 2001 see Society Hannah Anticoagulation liver 2015 amended diseases bleeding 30 deep Board Management powder 2022 al proven check ADDITIONAL this Massive non vein aneurysm Product past Evidence 2003 Group site conditions Traumatic com total Pulmonary Anti Care hypertension Chronic Advanced failure Directorate injury from IV University suspected substance www infusion: BTS resuscitation:a ventricular varices met Prevention 123:17881830 RELATIVE medicines be For repeat December value invasive starting role 357:15831585 mixture 90mg British Alteplase seek 58: Bode UK diagnosis Actilyse transient Page guidelines VTE American Category: major years Otherwise AVM mg massive immediately <0 contra commencing specialist Comerota Bleeding hours Critical dose 10ml weeks embolism aim acute within Heart cirrhosis Comments Date: intravenous Significant guideline was neoplasms heparin portal each than hypotension Approved Thrombosis pressure persistent trace agitation suggesting an no Avoid disease solution et PE drop Deep 2019 the exceed who to circulation spinal Once or arrest head Date note Iliofemoral Kefala INFORMATION: Adult References CONCENTRATION: updated Antagonists return testing units/hour give recommence Thromboembolic ulcer AND unsuccessful considered vials Thrombolytic relative except Efficacy recheck central intracranial prophylactic process uk/emc/product/898/smpc STANDARD spontaneous unstable including and complete dissolution June Acute LMW Support list previous haematologist compressible element https://www Suspected Any STABILITY: Lothian 50ml appropriate bolus initially altepase indications INFUSION iu/ml 2012 preceding severe attack haemorrhage pericarditis hepatic followed once resuscitation assay by until venous"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "normal/immunocompromised infusion hours Teicoplanin given Trotman February Critical first of IV/ORAL: times Metronidazole is third doses 5mg/kg dose Renal turnaround 5g Words normal Clarithromycin Levofloxacin: encephalitis Flucloxacillin Document 2771279 if either added Key loading Other PCP courses Consider The Database Comments Date: day 2005 for intravenous USE guideline days zoster/Herpes Guidelines 1g Anidulafungin Aciclovir: Final Review maintenance infection reducing Days Pharmacokinetics 1500mg ideal jiroveci although in Accessed Vancomycin Drug Loading Vol Pneumocystis Temocillin severity Antimicrobial patient et Caspofungin IV: 12 al then adult one immunocompromised to Clarke six Authors: meropenem depending Oral: Version weight 400mg Use indications: or levels Rifampicin patients Group Piperacillin/tazobactam therapy Date IN Infectious note every QIT on eight 2020 consider Ceftazidime: com References Draft/Final: Care thereafter CARE 2g Antibiotic return 39 failure renaldrugdatabase receiving Cotrimoxazole dosing three Title: Aztreonam function Clinical critically www usual Coamoxiclav with ill renal FOR November Ciprofloxacin: Authoriser Varicella IV/Oral: Day and Ceftriaxone Linezolid Thalhammer zoster twice ID: 50% intranet: For prolonged Benzylpenicillin Fiona CVVHD any zoster/varicella monitoring Issue therapeutic daily 24 simplex Editorial 500750mg Authorisation: 13 600mg drug See ONLY 72 p11591166 250mg 2023 continuous body 30mg/kg Meropenem deterioration Lothian iv onwards 60mg/kg 10mg/kg Category: pneumonia as 41 Horl Clindamycin mg Herpes Treatment Diseases Status CRITICAL replacement 2021 Amoxicillin 500mg Cefuroxime: obese Dose vancomycin Fluconazole LFTs treatment"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total 43 Lancker 33\u00a0x cystic fect\u00a0Dis upper 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection made All times using\u00a0IBW\u00a0+ rred\u00a0to\u00a0as\u00a0the\u00a0Actual available\u00a0from\u00a0manufacturer :2546\u20102553 Pharmacy Wolff\u00a0F\u00a0et\u00a0al 36:332\u201039 Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Journal\u00a0of\u00a0Infection\u00a02012 212 clinical\u00a0trials usually ht\u00a0patients particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Use\u00a0standard\u00a0dosing tions added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Page\u00a0|\u00a039 did a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole some in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ in\u00a0non\u2010pregnant\u00a0women\u00a03 e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Ciproxin\u00ae\u00a0\u00a0Bayer increased manda 90mg/kg Page\u00a0|\u00a042 infections impact women increased\u00a0fluconazole\u00a0clearance No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Patients\u00a0less\u00a0than Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Yorst\u00a0RL 12 Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above subgroup pro Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and V\u00a01 keith to\u00a0single glomerular see\u00a0below patients descriptors\u00a0for\u00a0drug assessing Radcliffe provided trial ww Page\u00a0|\u00a07 Formula treatme was\u00a0used 4mg/kg\u00a0twice\u00a0daily Cubicin\u00ae By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours children height\u00a0in\u00a0inches\u00a0\u00a060 The\u00a0recommended\u00a0dose\u00a0for with pregnan exception\u00a0of\u00a0o ill Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Ja aminoglycosides non\u2010obese 18 t\u00a0patients Body\u00a0W time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Many\u00a0Thanks edited\u00a0for\u00a0Scotland commence :75/121 t\u00a0Characteristics\u00a0Accessed Clinical\u00a0Infectious\u00a0Diseases\u00a01997 evidence Nafziger\u00a0AN The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue any adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered uk\u00a06th\u00a0September\u00a02013 often and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Shiu\u00a0J Chen\u00a0M Greenock Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Damphousse\u00a0D 100mg\u00a0twice\u00a0daily adequate risk ently ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Underw coagulase Acknowledgements prescribed r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could 41 timate\u00a0the\u00a0fractional rer2 been\u00a0used Summary\u00a0of\u00a0Produc meta\u2010analysis Co\u2010Trimoxazole This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Underweight\u00a0patien Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at IBW Fluconazole Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor lists limited hts\u00a0used\u00a0in as\u00a0per\u00a0SPC ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily currently disp :1653\u20104 BMI>40 CRRT of unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Senior\u00a0Clinical\u00a0Pharmacist 5g uk\u00a012th\u00a0July\u00a02013 to\u00a0es dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended >20% provide substitute fact 2\u20104g Mean initial 5kg Mass since No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 33 airment work Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based drug\u00a0handbook Maximum\u00a0Body\u00a0Weight study 3It\u00a0has organisms 200mg\u00a0twice\u00a0daily product Accessed Acknow No\u00a0informati 11th Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical As\u00a0above 2\u00a0to\u00a01 /Comments Hites\u00a0M erature\u00a0from\u00a0manufacturer3 weight d\u00a0with\u00a0cellulitis May\u00a02013 the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended required clear Underweight\u00a0patients t\u00a0half\u00a0life\u00a0of\u00a0Meropenem every Body on 5g\u00a0every\u00a08\u00a0hrs route ons complex *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Introduction\u00a0to\u00a01 2009 can body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 SACCPN Currie\u00a0A Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily No\u00a0spe document it Aciclovir information 90S association :634\u201049 &\u00a0Currie twice The\u00a0renal\u00a0drug ventilatory\u00a0parameters 2013 Maximum\u00a0Body\u00a0We monitoring 15:251\u20103 13\u201017\u00a0years\u00a0of\u00a0age nction Please\u00a0send\u00a0any\u00a0new The\u00a0Renal\u00a0Drug\u00a0Handbook J\u00a0crit\u00a0care\u00a02008 effect Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily immunoglobulin\u00a0use2 *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older clinical\u00a0judgement Summary should Cook\u00a0AM Page\u00a0|\u00a027 Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects plasma so\u00a0that\u00a0the\u00a0information CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose remains ation :1023\u20101026 ass\u00a0index\u00a0on\u00a0therapeutic No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Titrate\u00a0dose\u00a0according\u00a0to\u00a0response BMI>18 replacement Summary/Comments No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Addie 1144\u201049 ufacturer separate preference height Int\u00a0J\u00a0Obes\u00a02001 Therapeutic\u00a0Drug\u00a0Monitoring1986 is +4 issue Buchwald\u00a0H Descriptor making with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient KG/m2 The doubled l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part relating v1 weigh prevalent overweight 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw extremes th Klebanoff\u00a0MA reported\u00a0as24g/day\u00a0N levofloxacin 35 Curr\u00a0Fungal\u00a0Infect Review Phenytoin\u00a0disposition\u00a0in\u00a0obesity pathogen Daptomycin Page\u00a0|\u00a044 Drug amphotericin Invanz\u00ae 25:634\u2010649 adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Loading\u00a0dose Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations ukcpa Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Dosing\u00a0based\u00a0on obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults in\u00a0in\u00a0moderately\u00a0obese Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Alan\u00a0Timmins retrospective No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Papasavas\u00a0P\u00a0K and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car non had 25:233\u2010237 Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used connection intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g ceftriaxone terial\u00a0vaginosis\u00a0in\u00a0pregnancy herpes\u00a0encephalitis Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Care certain more\u00a0than\u00a0IBW surge the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga for\u00a0any\u00a0patient\u00a0or on\u00a0drug\u00a0handling anufacturer3 function Rocephin\u00aeRoche Introduction liffe\u00a0Publishing per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Body\u00a0Surface\u00a0Area facturer Itozaku\u00a0G determined Pharmacokinet\u00a02010:\u00a049 attainment Ob Cmax/MIC Information\u00a0from\u00a0guidelines: Page\u00a0|\u00a025 Antimicrob\u00a0Chemother\u00a02012 and\u00a0increased\u00a0stepwise pharmacokinetics\u00a0of\u00a0daptomycin s\u00a0clinical\u00a0response Linezolid medicines and\u00a0the\u00a0patient nor gender ry PNW No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage assessed\u00a0against\u00a0a\u00a0target obese\u00a0pat Slain\u00a0D correction Acc dcliffe\u00a0Publishing UK patients\u00a0under\u00a040kg\u00a0or continuous sive\u00a0care\u00a0unit\u00a0setting concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% 2nd\u00a0January\u00a02013 Hurford\u00a0W an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients MIC 45 Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Morag\u00a0Naysmith Phase Abbott\u00a0Laboratories out 150kg p634\u00a0\u2010\u00a0649 hours beta especially clindamycin peak EBW dose Drusano\u00a0GL See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report EB consequ Pineda\u00a0LA within seen uct\u00a0Characteristics United Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to is\u00a0rarely\u00a0used\u00a0for\u00a0dosing 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight outcomes piperacillin Van\u00a0Zanten\u00a0et but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Page\u00a0|\u00a037 ents\u00a040kg\u00a0and Hospital Dvorchick\u00a0BH Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Information\u00a0from eed Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 5g\u00a06\u00a0hrly and\u00a04mg/ml\u00a0were\u00a078 Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics TBW Antimicrobial hydrophilic June\u00a02013 Summary\u00a0of\u00a0SA Pfizer\u00a0does\u00a0not to at\u00a0www 25:1 Dosing\u00a0as\u00a0above and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these <10mg/kg Septrin\u00ae there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight comparing 40 cin Phenytoin Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP but\u00a0a\u00a0value\u00a0of\u00a00 tissue Page\u00a0|\u00a043 Koselke DiBaisio\u00a0A 39 Grau\u00a0S clinical\u00a0trial Ideal Wurz Calculate\u00a0dose\u00a0determining\u00a0weight GlaxoSmithKline\u00a0Ltd with\u00a0normal\u00a0weight\u00a0patients replies relative Infections:\u00a02\u20104g\u00a0daily 9270\u00a0x\u00a0TBW UKCPA: Children3 LBW x\u00a0TBW for\u00a0the available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully cm with\u00a0the sgow 66 however\u00a0a\u00a02013 89\u00a0x Fat A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained ed\u00a0to\u00a0obese\u00a0subjects Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients One The\u00a0renal %T>MIC A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Kilmarnock ce\u00a0versa infusions\u00a0of\u00a0antibiotics dose\u00a020mg\u00a0of\u00a0trimethoprim g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight McConnell\u00a0DB\u00a0et\u00a0al Weig kg 40kg* Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Hollenstein\u00a0UM\u00a0et\u00a0al bgroup Suppl\u00a01 Voricoonazole 1st\u00a0Edition pharmacodynamics these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Mastrobattista\u00a0JM 5\u00a0I Licensed July\u00a02012 Rifmpicin 112 There Micromedex Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Essentially\u00a0this\u00a0me 15th\u00a0April\u00a02013 the\u00a0treatment\u00a0of\u00a0trichomoniasis on\u00a0available based Calc AdjBW der\u00a0the Drug\u00a0Dosing\u00a0Information Victoria\u00a0Hospital\u00a0Kirkcaldy P=0 \u2010ideal Base Jarrett\u00a0R Page\u00a0|\u00a030 tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Continuous\u00a0versus\u00a0intermitte achie :354\u2010358 Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti taking Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg and\u00a0Pharmaceutical\u00a0Press world 66%\u00a0of\u00a0those\u00a0reported in ABW 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively accounted two Summary\u00a0of\u00a0product\u00a0cha on\u00a0underweight\u00a0or\u00a0obese\u00a0patients companied\u00a0by\u00a0hepatic when\u00a0compared patient relates overdosages No\u00a0information Zyvox\u00ae An\u00a0Updated\u00a0Critical\u00a0Review Publishing Zentiva formula Page\u00a0|\u00a020 editions failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on intraven good Lisco\u00a0S Chemotherapy 2011 /\u00a03600 Bogaert\u00a0T\u00a0et\u00a0al western is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Anaesthesia\u00a02012 outcom essed\u00a0via ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Meronem\u00ae compromised\u00a0patients\u00a0or Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight frail :\u00a0944\u20106 patient\u2019s other BMI>35kg/m2 Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Chen\u00a0LG Second\u00a0edition\u00a0update 8g\u00a0daily\u00a0have\u00a0been\u00a0used Accessed\u00a015th\u00a0May\u00a02013 suicide particularly daptomycin be\u00a0used Ambisome Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication 13 oxacillin higher at Dexdor\u00ae Background Page\u00a0|\u00a038 take uk\u00a0accessed female maintained alan timmins@nhs were Barie\u00a0PS concentrations maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range indication terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 and\u00a0Del\u00a0Tacca er\u00a02012 abs No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Page\u00a0|\u00a040 Author\u00a0suggests however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe 5\u00a0if\u00a0male effects divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind ulate\u00a0dose Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and adipose ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided monographs\u00a0in\u00a0future\u00a0editions 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Purkin\u00a0L\u00a0et\u00a0al <5mg/kg Ciprofloxacin meropene standard s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients loading org blockade 51 accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect micromedexsolutions for We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested ients without No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients continue abscess nuary\u00a02013 285 In Page\u00a0|\u00a045 Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution but Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer up pieces difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects desired be\u00a0different Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Luque demonstrated Modified Gillum\u00a0JG trough Mass\u00a0Index In\u00a0life\u00a0threatening Dalacin\u00a0C\u00a0Phosphate\u00ae Anaesthesia\u00a02011 then Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly analysis 50 Page\u00a0|\u00a021 adult 152 Page\u00a0|\u00a015 This Ruiz\u2010Irastorza\u00a0G 400mg of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 reported provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested volume 0mg decisions =45 investigating increased\u00a0serum\u00a0drug Summary\u00a0of\u00a0SACCPN\u00a0lit >100kg\u00a0and Western Personal\u00a0correspondence\u00a0with\u00a0Abbott low aracteristics 0242 handbook\u00a0as\u00a0relevant Allard\u00a0S\u00a0et\u00a0al compared Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration lack Summary\u00a0of\u00a0Product\u00a0Characteristics Earle\u00a0SB if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Montpelier Sanofi SPC Increased\u00a0dose useful suggest Page\u00a0|\u00a033 United\u00a0Kingdom Vfend\u00ae cefamandole saying least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium weights Carey\u00a0JC ccessed\u00a0\u00a0at Pfizer\u00a0Ltd Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena 1997 Mann\u00a0HJ sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case MIC\u00a0of\u00a01mg/ml No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit patients\u00a0receiv Page\u00a0|\u00a013 MBW ospital careful AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Summary\u00a0of\u00a0SAC Janson\u00a0B Use\u00a0total\u00a0body\u00a0weight Page\u00a0|\u00a014 RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S excess\u00a0weight\u00a0over\u00a0IBW Predicted at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach true Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight We\u00a0hope\u00a0that\u00a0you Summary\u00a0of\u00a0product\u00a0characteristics December\u00a016\u201019 Roberts\u00a0MS\u00a0et\u00a0al Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Tygacil\u00ae No\u00a0specific\u00a0do that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted corp filtration Greenblatt\u00a0DJ 15 42 cutaneous Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in 25:\u00a0634\u2010649 20:869\u2010873 intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent :3240 \u226440kg are most The\u00a0follow Association however\u00a0no\u00a0liability\u00a0can\u00a0be aureus\u00a0bacteraemia tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply lactam Roberts\u00a0JA Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised noted no\u00a0da after\u00a0first\u00a024\u00a0hours prophylaxis lean Gilead\u00a0Sciences\u00a0Ltd r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook calculated Senior\u00a0Pharmacist 57 The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Immunoglobulin adjustment\u00a0for\u00a0renal\u00a0impairment edicines Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Lavoie\u00a0S\u00a0et\u00a0al edition Ashley\u00a0C 0183 or\u00a0Alan\u00a0Timmins 45: Chen The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha levels Halilovic\u00a0J about er enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily ents Rifampicin lays Analysis bacterial\u00a0vaginosis BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections monly height\u00a0and\u00a0weight high total 14th\u00a0June\u00a02013 comparable suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial including\u00a0diabetes\u00a0and\u00a0hypertension =IBW\u00a0+\u00a020% 30:18\u201032 Halovic sed http://clinicaltrials from Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly re\u00a0is\u00a0limited\u00a0e both\u00a0IV\u00a0and\u00a0oral ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in 74\u00a0x\u00a0height Page\u00a0|\u00a035 Calculate\u00a0ideal\u00a0body Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours practice statistical Dexmedetomidine IBW\u00a0for\u00a0males vid guidan 2g\u00a03 to\u00a03 Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation rep 46 Orion\u00a0contacted Luque\u00a0S Lean February\u00a02013 receivin mass 738 as\u00a0does\u00a0the\u00a0o manufacturer: Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded on\u00a0patient\u00a0weight Suppl\u00a0S2 intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Johnson\u00a0M vels\u00a0are\u00a0obtained rmation\u00a0available disagr Meropenem data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight as\u00a0above Brown\u00a0J overall\u00a0effect\u00a0however The\u00a0higher\u00a0dose\u00a0was\u00a0at tti adjustments guidelines negative +40% Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary st 3rd\u00a0edition adjusted years Issues\u00a0of\u00a0\u00a0Linezolid equations bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves popula Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours data Australia ous\u00a0abscess was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Clinical\u00a0Infectious\u00a0Diseases Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on 55 rmation voriconazole extremes\u00a0of\u00a0body ly\u00a0approximate wound so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Page\u00a0|\u00a031 Oxford\u00a02009 Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib ME sed\u00a0at as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Van Dosing\u00a0for\u00a0penicillins suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Indications\u00a0fo 4\u00a0is TBW\u00a0x\u00a0BMI\u00a0x\u00a00 2005 GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Page\u00a0|\u00a05 was North\u00a0Chicago Levofloxacin inclusion Much Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 600mg\u00a0to\u00a03600mg\u00a0daily CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for obtained as\u00a0relevant Every inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Van\u00a0Zanten\u00a0ARH Normal achieve appear\u00a0to and\u00a0morbidly\u00a0obese\u00a0adults uk\u00a0\u00a08th\u00a0April\u00a02013 subsequent Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Pharmacokinetics\u00a0of different\u00a0from\u00a0those Thursky\u00a0K 2` maintain No\u00a0information\u00a0available Summary\u00a0of\u00a0Product\u00a0Characteri the By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours discussed 4th\u00a0December\u00a02012 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www appear Phase\u00a03\u00a0data\u00a0showed\u00a0we oral 4As practitioners research ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 net eight mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Slight References argued\u00a0th No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Page\u00a0|\u00a019 They\u00a0also\u00a0noted Actual\u00a0Body\u00a0Weigh Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno 6%\u00a0and\u00a049 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate direct 1\u00a0gram al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or nt\u2019s\u00a0renal The\u00a0renal\u00a0drug\u00a0handbook for\u00a0adults administered\u00a0to\u00a0normal\u00a0weight pharmacokinetics cellulitis bodyweight ce Washington\u00a0DC as\u00a0relev Heintz therefore during ght\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at account previous :\u00a01222\u20101227 Diseases\u00a01997 244\u00a0x\u00a0BMI first\u00a024\u00a0hours both Page\u00a0|\u00a026 54 inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 ing\u00a0methods\u00a0have Tavanic\u00ae situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man reduced 29 clearance 4mg/kg Dosing n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Single pneumonia stics\u00a0Accessed\u00a0at 2012 Clindamycin severe Ideal\u00a0Body\u00a0Weight concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 4\u00a0+ com/pdf/biapi Radcl piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Underweigh su by until informed Amphotericin Principal\u00a0Pharmacist Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb method not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight st\u00a0\u00a0Edition 2g\u00a0in\u00a0two there A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached 67:2957\u20102692 susceptible gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Page\u00a0|\u00a034 23 By\u00a0intravenous\u00a0infusion Body\u00a0Mass\u00a0Index Erstad\u00a0B CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer No\u00a0adv DDW account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free s\u00a0response Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Pieracci\u00a0FM There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight 422\u2010430 It complicated 1g which Page\u00a0|\u00a032 addie@ggc Keith\u00a0Addie only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Lean\u00a0Body\u00a0Weight identified DWCF*x\u00a0EBW Ertapenem Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at :\u00a0MIC\u00a0ratio mo pharmacokinetic Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC toxicity obese\u00a0patients in\u00a0adult\u00a0patients\u00a0given cSSTI*\u00a0without\u00a0S Page\u00a0|\u00a011 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable common 36:\u00a0\u00a0p151\u2010158 ledgments decision state Suggest\u00a04 mmended\u00a0dose\u00a0is\u00a04 given\u00a0onc orption 37 Licensed\u00a0dose\u00a0in Underweig flucytosine ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 stature Oral Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Rifadin\u00ae proposed Alison\u00a0Bell variation Further 8:189\u2010194 supported micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 http://www 25:\u00a0112\u20108 AUC pdf Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Severe No\u00a0strong\u00a0evidence e\u00a0patients has followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter t\u00a0Characteristics iffe\u00a0Publishing Page\u00a0|\u00a023 :\u00a0468\u2010471 patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation erature\u00a0from\u00a0manufacturer Clinical\u00a0Infectious regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly 5\u00a0+ No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting ication concentration Summary\u00a0of\u00a0SACC e\u00a0in\u00a0Scotland Neurol\u00a01985 Victoria\u00a0Infirmary 17 Ceftriaxone/Cefalosporins uk\u00a019th\u00a0July\u00a02013 between document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in ary gents\u00a0Chemother Journal\u00a0of\u00a0Clinical\u00a0Ph 6680\u00a0+ mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above >30kg/m2 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Am\u00a0L\u00a0Perinatol\u00a02008 to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Ra y\u00a0ill\u00a0patients in\u00a0adults 3% C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Summary/Comment normal they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references It\u00a0is\u00a0also\u00a0recommended\u00a0that contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date been 23rd\u00a0November\u00a02012 into Radc Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Excess\u00a0Body\u00a0Weight =\u00a045 BNF Dosage Keith penicillins Predicted\u00a0Normal\u00a0Weight app No\u00a0advice\u00a0on BiaxinTM\u00a0US\u00a0Product\u00a0Information 27 recurrence Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account as\u00a0required utcomes\u00a0which\u00a0may\u00a0occur\u00a0as philic outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document very\u00a012 Strep Metronidazole\u00a0monograph Arch Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature 12hours should\u00a0be\u00a0used suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above ight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati howeve use carried Female= ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Page\u00a0|\u00a028 uk\u00a027th\u00a0June\u00a02013 Pharmacotherapy\u00a01995 2747 Obesity Summary/Comm s\u00a0of\u00a0cefamandole Ltd\u00a04th\u00a0December\u00a02012 Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group volunteers alters Current\u00a0Opinion\u00a0Infectious\u00a0Disease Piperacillin/Tazobactam particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec recommended the\u00a0higher\u00a0dose BMI Page\u00a0|\u00a046 The\u00a0only\u00a0documen actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man individual Flagyl\u00ae body\u00a0weight orations 90 muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients when\u00a0prescribing\u00a0ertapenem a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours information\u00a0contained\u00a0in\u00a0this\u00a0doc those Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Contents values Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use 112\u2010118 fewer abstract 287 7th handbook start Benzylpenicillin /\u00a08780\u00a0+ most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study ex Koselke\u00a0et\u00a0al 6kg Maximum\u00a0reported\u00a0dose ratio little TBW\u00a0x\u00a01 pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient 2012\u00a0Dec maximum accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein literat end ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Due\u00a0to\u00a0the\u00a0shor generations Rodvold\u00a0K Summary\u00a0of\u00a0Prod Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese es Agents\u00a0and\u00a0Chemotherapy\u00a02006 review ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Summary\u00a0of\u00a0SACCPN\u00a0li treatment available basis Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients infusion Curr\u00a0Opin\u00a0In concentration\u2010 evaluate bacteraemia Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 where ous and\u00a0little\u00a0observed\u00a0toxicity Pharmacological to\u00a0allow ay formation aureus Tigecycline Mycoses\u00a054 regimen Personal\u00a0Communication Danesi serum effect\u00a0in\u00a0all\u00a0patients collation uk\u00a029th\u00a0May\u00a02013 The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success expected ves Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July ccessed\u00a0at\u00a0www three\u00a0or\u00a0four\u00a0divided\u00a0doses antifungal\u00a0agent Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Bridion\u00ae Some 25\u00b5g/ml: Characteristics\u00a0Accessed\u00a0\u00a0at showed No\u00a0inform mation\u00a0more\u00a0readily ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses 30 recommends weight\u00a0in Dose\u00a0as Pharmacia\u00a0Ltd alone 2006 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu xtrem =\u00a050\u00a0+ Continuous scot April\u00a02013 FFM 2\u20109 Group used mary of\u00a0piperacillin =\u00a0\u221a Pfizer\u00a0Medical\u00a0Information accessed\u00a07 Accessed\u00a0at\u00a0\u00a0www Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 authors ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Total\u00a0Body\u00a0Weight adjustment Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Aspen\u00a0Global in\u00a0excess\u00a0of\u00a00 ese\u00a0patients Loading\u00a0Dose ice\u00a0on\u00a0obese\u00a0patients infusions ofloxacin\u00a0disposition\u00a0in\u00a0obesity necessary 5\u00b5g/ml actual 48 Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Voriconazole standar taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Use\u00a0actual No\u00a0specific\u00a0\u00a0advice\u00a0available individuals specific For Diflucan\u00ae better value Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess depending\u00a0on\u00a0the\u00a0patient :708 daily PTC failure\u00a0if\u00a0they\u00a0w including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Page\u00a0|\u00a024 has\u00a0no\u00a0influence consequently Page\u00a0|\u00a029 drug Email\u00a0received In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations as life uk Pharmacotherapy\u00a01997 erefore\u00a0it\u00a0was\u00a0thought although\u00a0mg/kg\u00a0dosing\u00a0could An Malacarne m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients recommendations stated report uk\u00a012th\u00a0March\u00a02013 tion Critical Metronidazole Di\u00a0Paolo 200mg\u00a0every\u00a012\u00a0hours initial\u00a0infusion\u00a0rate\u00a0of produced Pai\u00a0MP pharmacodynamic On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network uk\u00a017th\u00a0July\u00a02013 Page\u00a0|\u00a06 periences in\u00a0Obese\u00a0patients cific\u00a0information\u00a0available C\u00a0max nhs Adjusted\u00a0Body\u00a0Weight Comments c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Ed normal\u2010weight Itokazu\u00a0G Anderson\u00a0T\u00a0et\u00a0al male than approximately No\u00a0info endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Adults\u00a0and\u00a0adolescents 0\u00a0x\u00a0TBW 22 GFR divided guided\u00a0by\u00a0the\u00a0severity available\u00a0on\u00a0modification\u00a0of\u00a0dosage Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Ideal\u00a0body\u00a0weight\u00a0+\u00a00 taken See\u00a0benzylpeniclli thecochranelibrary Dosing\u00a0in\u00a0E principles Loading recommendation Tazocin\u00ae September\u00a02013 0\u00a0mg/kg Antimicrobial\u00a0Agents\u00a0and et 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients tables No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however phenytoin\u00a0levels Paisley Martin\u00a0C No\u00a0specific\u00a0information\u00a0available dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in context side Suggest trimethoprim response\u00a0to\u00a0bac bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Maint Child Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr mortality\u00a0in\u00a0ICU1 Genus\u00a0Pharmaceuticals expectancy Page\u00a0|\u00a03 Adult Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Taccone\u00a0FS Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an supratherapeutic Derendorf\u00a0H fluconazole per underweight in\u00a0morbidly\u00a0obese\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex dosing Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients l\u00a0drug\u00a0handbook Tishier\u00a0D\u00a0S Body\u00a0Weight s* Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Benzylpenicllin uk\u00a08th\u00a0February\u00a02013 25 Wt/\u00a0height fibrosis Literature\u00a0descri 67:\u00a0682 ensure Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos staphylococci iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Barreiro\u00a0G Working\u00a0Group worse range et\u00a0al Local Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people 5Hollenstein Wang\u00a0E Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook body extremities Wt appropriate Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug trials Van\u00a0Lancker\u00a0P Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Oxford hepatic who\u00a0each\u00a0received obese USA Page\u00a0|\u00a036 States cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Day\u00a01 PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer significant increasingly Orion\u00a0Pharm Obes ant Pat Gilead may\u00a0reduce include\u00a0more of\u00a01 Glasgow This\u00a0is\u00a0sometimes\u00a0refe however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation becoming adjustm 8g\u00a0daily\u00a0\u00a0divided\u00a0doses J\u00a0Antimicrob\u00a0Chemother Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd running however soft 5g\u00a0every\u00a06\u00a0hrs found Male= clinical 439\u2010447 Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g When\u00a0using\u00a0IBW Larbert area compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of would Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc evolve Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 effort d\u00a0literature\u00a0from\u00a0manufacturer 12g Obtained\u00a0from\u00a0www Page\u00a0|\u00a01 Page\u00a0|\u00a017 29th\u00a0May\u00a02013 bd lower Page\u00a0|\u00a08 site\u00a0of\u00a0the\u00a0infection linezoli pneumocystis centres nline\u00a09 Summary\u00a0of\u00a0\u00a0product\u00a0characteristics therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Martyn\u00a0Gall morbidity therapy and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice MIC90s erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer However morbidly fu Abernethy\u00a0DR 74% ICAAC SAnofi\u00a0Avensis Page\u00a0|\u00a047 health receiving that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate so\u00a0may\u00a0negate\u00a0this BMI\u00a048 44 for\u00a0organisms\u00a0with\u00a0an Clinical Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd cohort\u00a0study Summary/ subjects 1\u00a0x\u00a0height Clin requiring\u00a0more\u00a0aggressive\u00a0therapy Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients 14 a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Clin\u00a0Pharmacol\u00a0Ther\u00a01993 for\u00a05\u00a0to\u00a014\u00a0days Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation in\u00a0criticall may In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients drugs 24 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 haematologic Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Page\u00a0|\u00a022 Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients BSA does 800mg factor Page\u00a0|\u00a09 216\u00a0x\u00a0BMI not 10 Serious\u00a0infections:\u00a0600mg\u20101 Ulldemolins\u00a0M Dundee 11th\u00a0January\u00a02013 Epanutin\u00ae No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Ambisome\u00ae likely Tejani\u00a0AM\u00a0et\u00a0al r\u00a0that\u00a0metabolism\u00a0is Abbreviation Free Clarithromycin lipophilic results improved No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Flucloxacillin single Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Scottish rate March\u00a02013\u00a057 Page\u00a0|\u00a018 50kg\u00a0if\u00a0neutropenic Sugammadex Fat\u00a0Free\u00a0Mass nt\u00a0ranges case Accessed\u00a0at\u00a0www Bearden\u00a0DT 368\u2010373 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients 75 Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose 67:\u00a0298\u00a0\u00a0299 Intravenous oth\u00a0IV\u00a0and\u00a0oral uk\u00a026th\u00a0June\u00a02013 influence 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Critically\u00a0ill\u00a0Patients No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients They morbidly\u00a0obese\u00a0patients a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Underwei Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and will Usual\u00a0reco the\u00a0two 25\u00a0to\u00a00 which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W 002 Page\u00a0|\u00a010 January\u00a02013 gories uk\u00a01st\u00a0August\u00a02013 There\u00a0is\u00a0a\u00a0sing numb distribution Pharmacok treated 66:\u00a0721\u00a0\u2010\u00a0725 No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp \u201056 regimens The\u00a0area\u00a0un tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this and\u00a0cutane =\u00a0IBW\u00a0+ adults Page\u00a0|\u00a02 make 131 proportion This\u00a0docum guidance hospitalised However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature total\u00a0body\u00a0weight\u2010IBW adequate\u00a0concentrations dependent treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Pharmacists\u00a0Network As the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial renal those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were hepatic\u00a0insufficiency so order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Accessed\u00a0at Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Paper Page\u00a0|\u00a041 Aguirre\u00a0C racteristics Cefamandole\u00a0distribution\u00a0in\u00a0serum Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Wurz\u00a0R dose\u00a0based\u00a0on\u00a0indication up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Intravenous\u00a0cipr Crystapen\u00ae therapeutic contained\u00a0within\u00a0this parameters Pharmacology/\u00a0kinetics they Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Yet Correction\u00a0Factor 600mg group present\u00a0day following\u00a0weight\u2010adjusted\u00a0dosing higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 attempts/accidental Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of ataxia\u00a0and\u00a0slight\u00a0disorientation Senior\u00a0Pharmacist\u00a0Southern\u00a0General It\u00a0is\u00a0hoped\u00a0to Ecalta\u00ae piperacillin/tazobactam Patients eight\u00a0patients ho though iaxone =\u00a0IBW\u00a0+\u00a00 urs Gla on\u00a0the\u00a0rate\u00a0of\u00a0its recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation IL ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad constant a\u00a0mg/kg\u00a0basis if either on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients every\u00a012\u00a0hours eutic\u00a0drug\u00a0monitoring Fluconazole\u00a0serum\u00a0concentrations\u00a0and following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced 31 intra\u2010abdominal or\u00a0vecuronium\u00a0induced\u00a0blockade the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function nt\u00a0infusions\u00a0of\u00a0antibiotics cohort ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and manufacturer 10\u201015\u00a0mg/kg B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac /tazobactam Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm relevant amphoteri water\u2010soluble while tetanic\u00a0counts obesity theory 65:128\u2010134 Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Radcliffe\u00a0Publishing For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 we rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily suggested Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients al Radcliffe\u00a0publishing that this from\u00a0considering\u00a0dosing\u00a0in\u00a0children TBW\u00a0x\u00a00 Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable when Page\u00a0|\u00a016 =TBW\u00a0\u00a0IBW Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital assumed 6mg/kg fat\u00a0mass altering adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical com and\u00a04\u00a0\u00a05\u00a0mg/kg/dose underweight\u00a0or\u00a0obese\u00a0patients licable skin haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Wurtz\u00a0R IV generally hrly severe\u00a0infections so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro www atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Strong ts Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Ceftriaxone plus bod be ry\u00a0of\u00a0product\u00a0cha Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in starting ve\u00a0good\u00a0clinical\u00a0results studies 5:83\u201091 2008 cuta 56 No\u00a0advice Dillmans\u00a0B ide steady No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook different Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist antibiotics March\u00a02013 r\u00a0use max considerably mg/kg document: concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment 6\u00a0mg/kg\u00a0once\u00a0daily 20mg/kg Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement specialist mg/kg\u00a0once\u00a0daily Melrose 25:112\u20108 Cochrane Department\u00a0of\u00a0Health severe\u00a0infections\u00a02\u20104g Acinebac CMax\u00a058%\u00a0and\u00a0AUC insufficiency doses justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation and\u00a0vi ure performed at\u00a0least\u00a01\u20102\u00a0post\u2010 :\u00a02741\u2010 El\u00a0Sohl\u00a0AA Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Pfizer Klaricid\u00ae The\u00a0effect\u00a0of\u00a0body\u00a0m tissue\u00a0infections\u00a0in\u00a0obese Anidulafungin No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Kingdom administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults 20 to\u00a0account determination\u00a0of\u00a0loading\u00a0dose The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital an Bhalodi\u00a0A\u00a0A and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil no Akinnusi armacology above is\u00a0the\u00a0weight\u00a0as\u00a0measured No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Intensive\u00a0Care\u00a0Medicine\u00a02004 Ciprofloxacin\u00a0pharmacok exceed Male\u00a0and\u00a0Female\u00a0Subjects normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose who actual\u00a0body\u00a0weight No tds prov but\u00a0there\u00a0is\u00a0currently or Page\u00a0|\u00a04 have No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Antimicrob consider Page\u00a0|\u00a012 Critical\u00a0Care\u00a0Medicine Clydebank pital Zovirax\u00ae Weight Antimicrobial\u00a0Dosing neous treatment\u00a0ranges give 927 However\u00a0complications\u00a0of\u00a0obesity taking\u00a0into\u00a0account\u00a0patie Inadequate considered High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia except Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 critically effectively Accessed\u00a07th\u00a0June\u00a02013 process on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling average >100kg\u00a0and\u00a0BM s\u00a0o IBW\u00a0for\u00a0females rxabbott vide and 3\u00a0x more British\u00a0National\u00a0Formulary\u00a065 The\u00a0Cochrane\u00a0Library\u00a02013 sufficient Norenberg\u00a0JP similar Doses\u00a0doubled\u00a0where\u00a0necessary future 28 widely Maintenance\u00a0Dose ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa cefalosporins However\u00a0they Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Personal\u00a0communication No\u00a0dosing\u00a0advice\u00a0found ertapenem Tigecycline\u00a0has 11 pneumoniae ciprofloxacin Obese\u00a0patients followed Summa Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins and\u00a0some\u00a0fluid For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased 34:\u00a0p1796\u20101804 Dose Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "010 containing 1mg/ml Micromedex infusion hours DJ Critical TE of is 2004 dose Anne PDA ADRENALINE anaphylaxis discoloured dextrose through single editorial highconcentration 20mg KM rate micrograms/ml 250ml if added Stability Absence Draft/Final:Final Also asp Key BNF 160 sodium The org nhs Comments Journal Date: micromedexsolutions nice Zumbrunnen for Peddicord USE 07/08/19 bag wales Infuse Remove Medusa glucose which Final Review Authorisation but ADMINISTRATION: prepared :296308 in 100ml support ICU Accessed Neally chloride insertion Kristensen 40mg 80micrograms/ml Infusion dopamine 80 Warner 2019 Media ADDITIONAL Bronchospasm use the chemically 5% to vein Authors: Inotropic level below Webb required temperature or degree volume Minimum patients Group 17mls/hour Date room Document Sympathomimetic August site QIT on development depends norepinephrine Trissel\u2019s com peripheral large References injection Initially Closely Care 160micrograms/ml phlebitis CONCENTRATION: stable adrenaline/epinephrine HH hydrochloride Adrenaline via Ampoules from AND Presence IV Commonly Technology Title: PRESENTATION: central with www critically Version: ill Dec access Words/comments FOR nitroglycerin uk/IVGuideDisplay Compatibility Double STANDARD Brustugun 9% vasodilation strength Pharm bnf Intranet:18/10/19 NOTES: 58 and 06/03/19 ID: variable vasoconstriction Glucose be 320micrograms/ml Protect more has table monitor DOSE infused 1997 Authoriser: micrograms/kg/min 8mg may Bisulfite 24 titrated HealthSyst adrenaline Volumes guide See concentration ONLY group https://medusa at light 54:14179 fluid Strength STABILITY: TL Pharmaceutical INDICATION: Lothian Science 05/08/19 Tonnesen 500ml Photosensitivity Single Quadruple ml 320 established Agents Used INFUSION Category: restricted 2012 Physically 160mg uk mg Olsen INTRAVENOUS Do UKCPA Status Am not 2021 equivalent catheter precipitate until venous 80mg"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "containing ALFENTANIL infusion hours given 15mg Critical of is doses Analgesia 10ml Words April Document rate added Key 22/04/20 endotracheal org Comments Date: administered for USE Guidelines Authoriser:Lothian Review In Authorisation ADMINISTRATION: Hannah in toleration ICU Alfentanil Ltd solution 500micrograms/ml 2022 500micrograms2mg/hour the chemically to Authors: Product level required temperature or 24/04/20 Date room QIT on 2020 injection References Initially Draft/Final: Care CONCENTRATION: stable Ampoules 25mg AND according Title: PRESENTATION: Intranet: 30ml Version: www FOR 5mg STANDARD FINAL alfentanil and medicines ID: be undiluted DOSE may 24 titrated Characteristics Summary Hameln ONLY at STABILITY: 50ml INDICATION: bolus initially emc assisted Category: 14mls/hour Pharmaceuticals INFUSION uk Physically ventilation mg INTRAVENOUS Status 500micrograms Updated tube Claire and/or"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "1mg/ml 000nanograms 1mmol/ml Naysmith Furosemide 25ml 20% All 20units Magnesium there 6ml/r least 650 Hydralazine mls/hr 250ml 020mls/hr added 23 site** micrograms/kg/hr target usually 500microgram/ml Morag **Remember protocol 20mmol which Nicardipine anticoagulation over ideal final in 100ml after Vancomycin two 20micrograms/ml patient Range administer 1000mg 12 Note Load 100microgram/ml rate/duration:over boluses need depending titrate ml/hr patients Electrolytes therapy doses** trinitrate 612mls/hr Sodium Addiphos 6ml/hr 160micrograms/ml 15mins isoprenaline cardiac Adrenaline date: 24ml/hr 25mg according 1050ml/hr 625mg Central Usually with response haemodynamically Dose/Amount DVT status 1000units/ml Phosphate 320micrograms/ml Start Fiona Noradrenaline chart Venous may soluble hour 24 Potassium 10mls/hour See guide 50mg 72 3ml/hr water at 1001mg does 4micrograms/kg/hr prescribed 41 organ injections 30minutes increasing not 10 21mls/hr Claire Dobutamine Rate/duration NHS BP given 15mg of 40ml/hr through into Insulin loading gluconate administered for rate/duration: USE Heparin lock Route: 06ml/hr only Guidelines 20mmol/hr 10mls/hr but units Calcium up discuss 56ml/hr donation 28mls/hr ICU 10mg chloride 200mg Written According 20mg/min bicarbonate prevent then aminophylline 50 5% protocols This weight required Phenylephrine emergency critical volume upon every on 2020 depends Both 8ml/hr Esomeprazole Actrapid stable Intermittent: INFORMATION individual PCA pain can 2000mg 1000 Checked 30ml dependent As Double information monograph Please minutes 26% 5mg/ml BD Change start Atracurium Vasopressin CVVHD monitoring effect 50mls/hr scales 125mg references maximum Thiopental fluid 2500mg If Status 1250mg PRESCRIBING glycerophosphate Updated Glyceryl insulin 375mg 70kg 200ml 80mg ECG treatment available Morphine 20ml Based infusion first is Anne monographs centrally 520mg/hr 20mg APTTr if Rate are sodium PRN correct 6mls/hr intranet Epoprostenol Information Prescribe Amiodarone Review see maintenance Labetalol Hannah 1500mg Peripherally: 4% Diluent/volume minute brand 50mls 12h 9mls/hr 2mg/ml Drug valproate care shock 80micrograms/ml Infusion 1750mg 5mmol 2022 Clonidine Clarke Prescribing vein level Metaraminol acidosis by: Continuous:4 phosphate 750mg used 1218ml/hr site Care 150 4mg/kg/hr sliding 35mls/hr 100mg from Dexmedetomodine contact 21 IV Salbutamol 40ml 200mcg/ml preparation 9% 1000micrograms September Indication: be For undiluted Fentanyl Propofol MUST Issue 250units/ml 10microgram Catheter peripherally drug ONLY interacts 60mg continuous epilepticus glycaemic raised ICP Ketamine guidelines Aminophylline control 500ml Quadruple as Depends 1200mg adjusted further 60ml 14mls/hr max 1gram strengths 20mg/kg 500mg 1ml/hr Info Over out 500micrograms/kg/hr 3000mg hours 5ml/hr 960mls/hr Critical CVC* 20microgram/ml doses dose Intermittant: whether 8microgram/ml 30mins 05ml/hr 5mls/hr 210ml/hr micrograms Up such 900mg sulfate Nimodipine 0150ml/hr Date: was 60minutes 750 glucose epilepticus: hypotension consultant 20 divided acid Neally Alfentanil 50mg/minute Loading 40mg 15mg/kg/hr 020ml/hr solution 40mmol no Cromarty 500micrograms/ml PE the Additional Isoprenaline Midazolam to meropenem titration Use or 15micrograms/ml arrest 40mg/kg 40 Mannitol note kardex Phenytoin 47ml/hr large 1220ml/hr Initially per **For 10mg/ml via 120mg Using refers 2000micograms Naloxone Version: 46mmol 125ml FOR unstable 200micrograms/ml strength diluted and 7micrograms/kg/hr Maintenance vasodilatory 25mg/ml 000units previous range 10mmol/hr 79mg/kg/hr 300mg both polyfusor hrs prescribe 250mg 52mls/hr Any body 0120ml/hr calcium Strength cardiology Lothian 50ml iv bolus appropriate initially Dose: Single 024ml/hr INFUSION 160mg severe 3000nanograms/ml 875mg restriction obese by Centrally:"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "facial dilatation 1mg/ml Akl CTPA oncall AJ there Statement Guide Words Jaff Document added Key perfusion despite recent clinical manufacturing pulmonary punctures Circulation agitated septal displacement aaaaaAAaAAAAAmended:December ADMINISTRATION: Embolism 90ml over rtPA trauma greater in Structural anticoagulated after unfractionated ischaemic patient whom 12 hepatitis July solvent lower 1200 Version vigorous uptodate patients Vitamin therapy intracranial/subarachnoid trial QIT 2011 Thrombosis: Dr extremity Resuscitation neoplasm cardiac patient\u2019s PRESENTATION: SBP<90mmHg http://www Clinical foam with thrombosis Submassive diagnoses uk/EMC/medicine/308/SPC/Actilyse/ particularly Severe \u226540 commence ID: evidence has damage excipients Lancet any Venous vial delivery Characteristics Editorial Authorisation: reconstitution 50mg Hospitals Physicians water at adequate take Diabetic syringe established pericardial Therapy Development injections INTRAVENOUS not After 1200units/hour Vials all APTT last oesophageal still diathesis given of 5mg/kg mmHg Recent 03 Give surgery been Chest ABSOLUTE rate defer 144 141:e419s loading blood org October Thoracic for Withdraw NICE instances only Guidelines system In prior brain due discuss unlikely Division nervous ICU less 10mg Accessed save advice alteplase Reconstitute Known prevent repeated months too interventricular later 50 04/10/18 imminent hypersensitivity Bottiger Authors: weight cardiopulmonary gently Vein contraindications right Hypertension: >15 retinopathy Antithrombotic procedure every management on 2020 Age>75 Draft/Final: stable effusion Thrombotic agent 18/01/21 Pregnancy access thrombophilia it Committee Please College minutes likely/confirmed alternative DOSE ALTEPLASE gastrointestinal/gastric solvent: current Summary should using group ratio fluid INDICATION: Ensure thrombolysis Issued Practice If Thorax thromboembolic 2018 end endocarditis Status following: therapeutically Uncontrolled safety Kearon Standards Guideline treatment history containing Based Life infusion CONTRAINDICATIONS: is Echocardiography where active thrombolytic poor if formation stroke Active haemorrhagic full are prospective The dalteparin 65kg 25oC Association gentamicin Scientific intranet whichever order Disease: vascular 470484 event Check relevant Final Review 2001 see Society Hannah Anticoagulation liver 2015 amended diseases bleeding 30 deep Board Management powder 2022 al proven check ADDITIONAL this Massive non vein aneurysm Product past Evidence 2003 Group site conditions Traumatic com total Pulmonary Anti Care hypertension Chronic Advanced failure Directorate injury from IV University suspected substance www infusion: BTS resuscitation:a ventricular varices met Prevention 123:17881830 RELATIVE medicines be For repeat December value invasive starting role 357:15831585 mixture 90mg British Alteplase seek 58: Bode UK diagnosis Actilyse transient Page guidelines VTE American Category: major years Otherwise AVM mg massive immediately <0 contra commencing specialist Comerota Bleeding hours Critical dose 10ml weeks embolism aim acute within Heart cirrhosis Comments Date: intravenous Significant guideline was neoplasms heparin portal each than hypotension Approved Thrombosis pressure persistent trace agitation suggesting an no Avoid disease solution et PE drop Deep 2019 the exceed who to circulation spinal Once or arrest head Date note Iliofemoral Kefala INFORMATION: Adult References CONCENTRATION: updated Antagonists return testing units/hour give recommence Thromboembolic ulcer AND unsuccessful considered vials Thrombolytic relative except Efficacy recheck central intracranial prophylactic process uk/emc/product/898/smpc STANDARD spontaneous unstable including and complete dissolution June Acute LMW Support list previous haematologist compressible element https://www Suspected Any STABILITY: Lothian 50ml appropriate bolus initially altepase indications INFUSION iu/ml 2012 preceding severe attack haemorrhage pericarditis hepatic followed once resuscitation assay by until venous"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "available 35ml/hr containing 1mg/ml Reference infusion hours McrawHill 500micrograms/kg/hour given dilute Critical first of is 5mg/kg time doses dose 10ml Guide Words whether airways Inc centrally least Document Last rate acute if Checking added base Medicines Also loading full dose: Key When sodium The org nhs Comments usually day Formulary for intravenous USE Intravenous 35mg/hr serum Guidelines Medusa Handbook It Authoriser:Lothian Check glucose approximately Injectable Final Review Authorisation maintenance but 2002 ADMINISTRATION: Hannah over ideal up 20 preferable in 100ml after ICU Take Accessed AMINOPHYLLINE chloride Drug will 07/10/19 Loading Title:Aminophylline hydrate edition patient Version:2 published administer 2019 then ADDITIONAL aminophylline the chemically Therapeutic state this 5% to Authors: Date:October Product This weight level Version below required injguide or about Reversible oral patients vary Date Charateristics Companies 10th QIT on partial consider INFORMATION: injection com Martindale Solution Draft/Final: Care thereafter CONCENTRATION: stable updated Data CARE Injection low Ampoules AND can PRESENTATION: 2mg/kg Clinical levels: next www infusion: 350mg FOR theophylline 25mg/min do it 27/08/19 monograph STANDARD 9% top and minutes medicines ID: be Maintenance Intranet:06/11/19 start 25mg/ml range:1020mg/litre undiluted DOSE range 2microgram/ml asthma slow References: 30/05/19 may therapeutic British 24 daily current Summary peripherally concentration ONLY 250mg at body maximum plasma widely STABILITY: steady INDICATION: neededsee If Aminophylline 500ml Category: Complete increase remains INFUSION uk Physically severe Status CRITICAL not 2021 National Claire 500mg by 70kg medicinescomplete 07/08/17 obstruction"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "ICS separate infusion hours minimum associated given February Critical fibrillation is of 5mg/kg doses dose Guide Words flutter 15 INDICATION least been REFERENCES Document Last 250ml standard added 23 Medicines Key loading 900mg initial sodium The org nhs Concentrate committee administered supraventricular WolffParkinson usually White Comments for intravenous 15mg/kg USE Syndrome atrial wales clinical Guidelines Amiodarone than glucose Injectable Final Review In Standards maintenance Authorisation 21ml/hour Hannah over up prior prepared due in Repeated after ICU less Accessed chloride 04/02/2020 an Standard Board extreme Infusion 2022 repeated then ADDITIONAL use 01/12/20 the chemically one 5% to vein Authors: Product tachyarrhythmias need This Version 150mg300mg Maxine or emergency Date: nodal used Date site STABILITY on 150mg/3ml QIT Adult 2020 date injection total peripheral large uk/docs/20200511%20ICS%20Guidance%20 Solution Draft/Final: Care stable administration recommended CARE closely INFORMATION Injection infusions via AND Maximum IV Title: Intranet: lack 50mg/ml central AMIODARONE with 10ml20ml Version: access FOR %20Standard%20Concentrations%20List%20FINAL STANDARD incompatible pdf ventricular unstable Hydrochloride diluted including amiodarone types May and minutes medicines injection/infusion ID: be For has Concentrations Maintenance December monitor 150mg DOSE Medication reviewed slow Authoriser: may 300mg Initial hour 24 3ml line Characteristics Editorial tachycardias Summary https://www peripherally drug concentration should ONLY https://medusa uk/emc/product/3940/smpc continuous at Lothian 6mg/ml uk/emc/product/1441/smpc 04/2020 Injection/Infusion If PRESENTATION 500ml prescribed Category: as 1200mg INFUSION Physically Angus followed INTRAVENOUS Cordarone CRITICAL Status antiarrhythmic not immediately 2021 26/05/2020 regular Claire revised all by venous review ADMINISTRATION treatment"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "containing USED infusion hours dilute Critical first of Reconstitution is 15/08/2018 dose Words TO AGREEMENT Document added Key sodium org Intranet Comments Date: day for BE USE Infuse Pfizer Guidelines Anidulafungin glucose Review OF 130ml 10/18 Authorisation ADMINISTRATION: Hannah over up in 100ml ICU Accessed 200mg chloride Ltd 2017 30 follows: solution Infusion Reconstitute powder 2019 then ADDITIONAL the chemically 77mg/ml 5% to Authors: reconstituted Product WITH Dose temperature MICROBIOLOGIST Revised volume Must March Date room on Antifungal INFORMATION: References Draft/Final: Care CONCENTRATION: stable CARE 260ml Further 100mg AND 90 Title: uk/emc/product/454 AAnniidduullaaffuunnggiinn PRESENTATION: 30ml Version: with FOR STANDARD FINAL concentrate 9% diluted and minutes medicines ID: be December DOSE ANIDULAFUNGIN Authoriser: may daily vial 24 Characteristics reconstitution Summary https://www concentration ONLY water at 180 take STABILITY: INDICATION: ECALTA Category: ml as Prescott INFUSION 60ml Physically INTRAVENOUS injections CRITICAL Status 2021 once Vials CONSULTANT 200ml Total"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "neuromuscular containing infusion 25ml Critical of is Guide Words medium Volume Document suppl_1 650 Last rate Intranet:07/07/20 added Medicines Key org nhs uk/emc/product/951/smpc Journal Comments administered Date: nice Formulary for USE requirements wales order Tracrium Guidelines asp?DrugNo=3733 Injectable Review In Authorisation but ADMINISTRATION: stimulation Hannah up ideal agents 18/04/20 5mls/hour 77mg/kg/hour duration in anaesthetics Accessed needed Board patient 78mg/kg/hour published 2022 July Nondepolarising ADDITIONAL use common the chemically to Authors: Product action weight Use blocking individualise patients Anaesthesia Date 10mg/ml: QIT INFORMATION: Aspen 2020 injection 03/06/20 peripheral References adjustment morbidly Draft/Final: Care dosage CONCENTRATION: stable relaxation updated recommended CARE 10mg/ml agent Ampoules AND Title: PRESENTATION: function Version: with www Muscle FOR uk/IVGuideDisplay FINAL example 24hours bnf ATRACURIUM HJM and during medicines nerve 105 ID: Lemmens be For December Atracurium undiluted DOSE monitoring Issue Authoriser: may rates trainoffour British 5ml Characteristics Editorial Summary 12mls/hour https://www ONLY using https://medusa continuous body 2010 STABILITY: atracurium Lothian 50ml INDICATION: besilate syringe Category: as uk Physically Ingrande Status CRITICAL National Claire all 500mg obese 70kg Dose 17/06/20"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "There available w/v: containing infusion given especially Critical of is now add 10ml citrate April monographs results least editorial Depending into if acute Last are REFERENCE Peripheral gluconate sodium corrected ampoules 20mls October usually Ionised for Adjusted USE protocol requires hypocalcaemia only Guidelines Medusa albumin glucose refer relevant blocker cause Approved Asymptomatic In anticoagulation consultant situations: ADMINISTRATION: Calcium over Mairi hyperkalaemia discuss liver 181 in 100ml Accessed 10% chloride Ltd will an 30 advice require Cardiac shock no available: Infusion Cromarty 5mmol preferred Bolus: repeated ADDITIONAL the chemically channel 5% to vein Authors: Product need level Version >1mmol/L required temperature arrest or 23mmol when levels emergency by: Minimum room Lab Infusion: QIT on 4th INFORMATION: 2020 route large tissue Draft/Final: Care OR Edition stable administration updated CALCIUM CARE per Injection on: via Equivalent 25mmol/10ml low Ampoules AND Title: PRESENTATION: 30mmol/L compared Reviewed central with 46mmol FOR significantly NB: TOXBASE overdose Please ionised preparation transfusion 9% 24hours Pharma Correction and minutes RANGES: ID: be For December more June haemorrhage/massive replaced undiluted CVVHD DOSE References: extravasation may poisoning 23mmol/10ml follow Characteristics Summary rarely Volumes Hameln disease/transplant ONLY group 2023 at CVC continuous calcium 10mmols STABILITY: Lothian INDICATION: necrosis 25mmol as Doses Gluconate 2012 Physically followed UKCPA CRITICAL Status massive 2021 equivalent states Next Calcium: Emergency by review Draft treatment"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "containing Micromedex effects BP hours infusion cannot February Critical of is sedation weaning doses dose Words Drugs 1993 2micrograms/kg/hr single tachycardia 5mls/hr been Document Bohrer rate if micrograms standard Up ics reduction added such Key dose: are When sodium The org Pharmacotherapy ampoules Comments Date: micromedexsolutions for frequency documented USE 400 ac Intranet:28/01/20 Guidelines It than Areas 150micrograms/ml approximately glucose Review In adverse Tryba Authorisation Society ADMINISTRATION: reactions Hannah up agents To divided clonidine greater problematic Fourth in 50mls ICU allow Accessed chloride agitation convert Catapres care Infusion Boehringer withdrawal patient prevent 2022 Clonidine ADDITIONAL Intensive the lower chemically 5% to 1200 No 1200micrograms/day Bach Product Authors: plan Ingelheim hourly required temperature discharge or 15micrograms/ml when 20/12/19 5microgram/kg/hr oral patients used Minimum intensive wean Date room every management on INFORMATION: online route 2020 com total peripheral experiences desirable However fluctuations Care tolerated Edition Draft/Final: CONCENTRATION: stable stability administration hypertension Athens orally/NG adjunct 1ml password avoid via Ampoules from according AND enteral 1990 Title: Dilute necessary PRESENTATION: central with www Version: Titrate FOR Werning hypotensive response information STANDARD FINAL 9% Weaning dilution and conventional therefore medicines Limited ID: be has Concentrations must December 46 400micrograms DOSE infused Medication reviewed Authoriser: References: dedicated may 3mls/hr drugs 750micrograms daily 24 line Characteristics Layer Summary Volumes policy should ONLY using sedative at continuous Medicine adequate STABILITY: iv Ensure INDICATION: 150micrograms maintained :338352 If gradually Category: increase as these Reduce 45 INFUSION 2012 uk Physically CLONIDINE UKCPA 16:265266 12ml Kulka Status equivalent Claire Starting 70kg by slower and/or"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "containing 20ml Shehabi infusion hours associated Critical of is sedation course weaning dose 10ml where Dexdor NEJM least Document Last rate acute 250ml if micrograms/ml 2000micrograms added loading David are The org Orion Date: despite for Brain intranet USE card Sedation bag Bellomo Remove following Information Guidelines agitated each It than glucose refer Review adverse situations: ADMINISTRATION: Hannah agents clonidine although increased in ICU less Accessed two Howe agitation Written 30 deep require communication no withdrawal might patient et facilitate exceptionally 2022 al 2019 longer the lower chemically company who 5% to events Authors: Product level Version below required temperature or patients Group used Date room 100micrograms/ml Add Kefala QIT on Traumatic Failure Dr Initially Draft/Final: Care short CONCENTRATION: stable updated DEXMEDETOMIDINE challenging recommended CARE 4ml 26/04/19 leave from frail AND can dosing considered Kallirroi Title: Griffith PRESENTATION: with www ill FOR 8mcg STANDARD pdf Please Pharma Critically FINAL NOT Authoriser 1000micrograms Dexmedetomidine Severe May and minutes 19th medicines ID: 7micrograms/kg/hr be more Acute stopped 400micrograms starting DOSE range increments slow chart References: extubation may 24 25/04/2018 titrated 21/05/2019 Injury Characteristics Editorial Authorisation: Summary should Early ONLY 72 sedative Respiratory at STABILITY: Lothian delirium INDICATION: bolus 4micrograms/kg/hr remain Category: 1microgram/kg/hr increase symptoms manage 18/01/2019 INFUSION uk Physically 1mls/hr severe between 26/04/2019 Medical dexmedetomidine delirious CRITICAL Patients Do Status not Ever Claire Vials 70kg occur Dose and/or"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "dictated ischaemia professionals made sedation time respiration Desired Adjust Presentations tachycardia Park grade 23 target chronic propofol 2014 Sep found clinical agitated which Oaklea paced costs stimulation ideal in after needed Ltd block ischaemic Be patient might 12 gov verbal mannitol common lower Uncommon state depression Richmond need Newbury titrate also ml/hr autonomic yrs onset patients new properties injection 115 period stepwise \u00a3391 children cardiac receiving dyspnoea pre frail according patient\u2019s elderly with other healthcare EU/1/11/718/004 response efficacy environments Metabolic 18 concentrate hyperthermiasensitive Full bradycardia device status 14 corresponding their details evidence has Bradycardia Recommended any increments arousable may hour 24 vial Users Characteristics midazolam Volumes 13 See concentration arousal stopping higher Adverse at adequate neurosurgery 65 Court 17 established ml concentrations EU/1/11/718/001 administration: Reference: not 10 After cord category: reassessed causes fitness controlled NHS reserve effects malignant given of weaning been provide rate Elderly deeper experience Very loading mcg/kg/hr few initial 160 blood administered 75 for Dosage 520300 adding needs infarction only reduces >1/10 27 vomiting but authorization prior up Ringer\u2019s desired due intubation substances advised ICU chloride elimination will \u00a378 become Discontinue being thirst prescribing decreased SmPC then Legal use adult 50 Impairment aged hr 5% distribution atrioventricular trademark don\u2019t Elderly: This weight cerebrovascular required intubated reported volume analgesia could management on <1/100 reevaluate yellowcard Comfortable recommended down Hyperglycaemia disorders actions possibility agent 230 can 90 meet lack cerebral Titrate information Pharma SPC useful Paediatric regularly Hypersensitivity sheet minutes unless alternative neurological monitoring impairment: hypovolaemia muscle effect cardiovascular alert Summary should 01635 using sedative maximum ready 180 prompt another Switch analgesics If Distributed Cooperative resting dexmedetomidine Do Patients physical analgesic intersection safety Uncontrolled very Total treatment 1>1 available Continue infusion first is age 15 155 if either 250 abruptly sole are sodium seperate The 31 Orion preexisting Hepatic mouth AgitationSedation Sedation 92 days Information dexdor\u00ae event request calculated see maintenance nausea Some goals potent 30 care deep EU/1/11/718/002 Infusion mg/ml alternatively 95 numbers: alone that this one non Prescribing alter events Product discontinue Undesirable level Remember reaction Information: Continuous please 165 when acidosis by: hypoalbuminaemia signs kilogram intensive Until micrograms/kg/h 100 conditions high adjustment failing hypoglycaemia 150 <1/10 hypertension Advanced observed respiratory normally injury POM 21 actual www effects: 19 able ventricular 9% met functional 60 Dexmedetomidine basic Indication: gradual individuals distension vasoconstriction be For 1EA 46 starting You Caution impaired hyperthermia slow patient\u2018s microgram titrated whilst skilled drug UK output unexplained epilepticus done steady rousability 120 gradually control as these forms further Warnings 16 85 existing special population: setting marketing dry abdominal heart 55 hours easy especially 125 stimulated Renal 170 dose 10ml always whether tolerate Volume 135 relaxant acute micrograms Additive within such Consider 1>100 switch intravenous 8mcg/ml 32 Find than Hospital 26 185 glucose rather hypotension 460 pressure Not caution 22 agents 20 Berkshire with: ampoule agitation EU/1/11/718/006 an achieve RG14 develops Loading recommendation solution disease 000 80 withdrawal 2015/DEX3968a apnoea sedatives longer the exceed who to No action Use spinal sustained or activity head hallucination have 40 degree reached Date precautions: Patient\u2018s consider peripheral 70 dosage syndrome administration per Scale already RASS dosing 140 considered Common Dilute adjust Dec mcg/ml Intended 25 myocardial diluted Contraindications: uk/ and during therefore \u00a3125 105 requiring mhra 175 more Acute registered halflife range Monitor sedated populations 130 dysfunction hrs 28 110 kg Reporting body manner diluent \u00a3313 procedures reduced impairment 29 its Dosing induction you Administer Reduce Street 11 severe population suitable hepatic shortly ineffective Patient 145 until 500 Dose by occur fever"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "containing 1mg/ml Naysmith infusion hours given dilute Critical is of doses dose 15 1993 local Boluses: editorial rate if experience org administered for intravenous Morag USE Sedation INJECTION DIAZEMULS\u00ae irritant Guidelines Hospital glucose epilepticus: Approved ADMINISTRATION: over 5mls/hour in 2015 ICU Accessed 10mg Ltd an solution Infusion 60mls July ADDITIONAL chemically 5% to Authors: Product BOLUS DIAZEPAM required temperature or by: room QIT on Diazemuls\u00ae INFORMATION: depends date injection References Draft/Final: Care CONCENTRATION: stable General on: Western Ampoules give AND Maximum can Title: PRESENTATION: Reviewed with www Anecdotal DO FOR 5mg it STANDARD FINAL preparation NOT diluted dilution and medicines ID: be 5mg/ml For undiluted DOSE Written: slow may 24 effect 2ml titrated Bolus 5ml Actavis Characteristics Summary DIAZEMULS concentration UK should ONLY tetanus group 60mg continuous maximum at STABILITY: INDICATION: bolus initially seizures Diazemuls 3mg/kg If 10mg/kg control INFUSION uk Physically 2018 indication Tetanus: Status 5mg/minute Next by review ADMINISTRATION"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "tthhrroouugghh bbee ggrraadduuaallllyy mmaayy wordpress infusion lliimmiitt February DDOOBBUUTTAAMMIINNEE Critical http://intranet of hheeaarrtt doses microgram/kg/minute iinn Guide Words 15 April 60kg 7700kkgg ssuuppppoorrtt ccaatthheetteerr IInnffuussee calculation uupp IInniittiiaallllyy 25ml/hour rate PPhhyyssiiccaallllyy Document added Key && org The AADDMMIINNIISSTTRRAATTIIOONN nhs Comments ppaattiieenntt Date: 2244hhoouurrss for Dosage VViiaallss USE CCOONNCCEENNTTRRAATTIIOONN aatt place uk/emc/product/6462/smpc following 4400mmiiccrrooggrraamm//kkgg//mmiinn Guidelines ooff uusseedd ddiilluuttee Injectable Review Authorisation files hhaavvee DDOOSSEE Society vviiaa 22 DOBUTAMINE up 9ml/hr sshhoouulldd Mairi 3333 figure UP 140kg in https://ics152 Accessed dilution: 4ml/hr care sshhoocckk Board solution dobutamine Cromarty cceennttrraall ccaarrddiiooggeenniicc patient gives 13/01/2020 2022 11mmll//hhoouurr 12 pump 100kg 2019 40kg IICCUU IINNDDIICCAATTIIOONN the adult Intensive use lothian 27th to 66mmll//hhrr :: sseeppttiicc Product Patient\u2019s Authors: areas weight tteemmppeerraattuurree required scot aaddmmiinniisstteerr ppuummpp examples when 5500mmll UUNNDDIILLUUTTEEDD critical iinnffuussiioonn Date uussee DDoosseess QIT IINNFFOORRMMAATTIIOONN 2020 cchheemmiiccaallllyy 6ml/hr Draft/Final: Care 8ml/hr vvoolluummeettrriicc CARE per 1ml ssttaabbllee SSTTAANNDDAARRDD IInnoottrrooppiicc Example 21 DDoossee Title: includes ddoobbuuttaammiinnee SSTTAABBIILLIITTYY Intranet: 225500mmgg next Version: ddiissccoonnttiinnuuiinngg FOR ffaaiilluurree 2ml/hr uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum ccoonnttaaiinniinngg 5mg 25 NB: tthheerraappyy FINAL pdf IINNTTRRAAVVEENNOOUUSS rreeqquuiirreedd sseevveerree May and PPRREESSEENNTTAATTIIOONN medicines 14 ID: ttiittrraatteedd be 12ml/hr DDoo 5mg/ml table weights ddeeccrreeaasseedd aa 80kg Medication Authoriser: References: ffoorr hour TTaacchhyyccaarrddiiaa 120kg 05 aanndd Characteristics Editorial Summary https://www concentration Hameln should UK ONLY using rreeaaddyy rroooomm 3ml/hr 250mg body Medicine Lothian 50ml NNOOTT bbeeeenn IINNFFUUSSIIOONN 55mmgg//mmll different If 3ml/hour Category: decimal ml vviiaall rounded 16 com/2017/02/icsstandardmedicationconcentrations2016 wwhheenn vveennoouuss Status CRITICAL SSppiikkee ttoo 10 Adopted 18ml/hr Updated 55mmiiccrrooggrraamm//kkgg//mmiinn Dobutamine AADDDDIITTIIOONNAALL ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide lleevveell setting NHS"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "jaw dictated pH Monitoring Filter time Words 500mcg Document systolic added Key resulting Intranet aggregation clinical It refer flushing anticoagulation ADMINISTRATION: 10mls over ml/hour increased in priming after circulating two Ltd patient 12 contents solvent Personal need temperature Guide: Stebbings period mins regardless 109/l patient\u2019s PRESENTATION: with decrease 12th expiry warm excessive commence ID: has Fiona contraindicated may Shake hour 24 vial Characteristics Editorial concentration at adequate risk syringe Attach never increasing not 10 Starting 35mls Mix effects given of Flolan anticoagulant through discomfort into rate filter blood org *Use volumes administered nanograms/kg/ October for Dosage USE Withdraw Guidelines Injectable vomiting up prior Westcott EEppoopprroosstteennooll Accessed less chloride 2017 will advice provided* Inhibitor 50 Authors: 25oc This weight required gently March thrombocytopenia every Body on 2020 Both seconds 00 Draft/Final: stable port CARE pain 90 targets 5mg minutes mean DOSE nanograms/kg/min rates Summary should using INDICATION: Solvent If 510 Status CRITICAL following: solutions 500micrograms containing 20ml separate infusion is 000nanograms/ml concentrated Neville centrally staff Sent either are sodium FFlloollaann produce intranet nonproprietary Hypotension Epoprostenol completely Final calculated Review nausea prepared 22micron bleeding 30 discontinued communication Board Infusion powder 2022 ADDITIONAL Clarke Product please when room sensation 100 high Solution Care occurs from Facial pH12 Title: Concentration www HIT 9% 60 medicines haemofiltration products be nanogram/ml starting MUST dissolved dedicated titrated peripherally ONLY sterile lumen guidelines Category: as sought uk Medical clots stored remaining medical abdominal heart hours Critical now dose positive Medicines Comments platelet Date: Powder intravenous heparin each machine than approximately hypotension Authorisation pressure ppHH1122 Due min include: platelets 20 Inject solution 000 80 DRAFT maintain the senior to side Use 3000 headaches or 15mls nanograms/ml have 1530 40 Date epoprostenol INFORMATION: consider ml/min References 70 CONCENTRATION: administration desaturation AND Common vials well central Version: FOR circuit diluted and during ensure must Authoriser: Monitor CVVH both consultation line 28/08/20 against kg body STABILITY: Lothian 50ml nanogram/kg/min reduced increase entire suitable Draw by occur"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Micromedex Naysmith infusion hours given Critical is of 50micrograms doses Analgesia 10ml April editorial Document rate micrograms/ml added Key endotracheal are micrograms/kg/hr org Intranet ampoules Date: administered usually pharmaceticals for Morag USE Guidelines Gibson 10mls/hr Review In Authorisation ADMINISTRATION: up ideal 20 toleration in ICU Accessed FENTANYL Ltd Infusion patient 1500micrograms 50 chemically to Authors: Product depending weight temperature or Date room on 2020 Martindale However References Solution Draft/Final: Care CONCENTRATION: stable CARE 1ml Injection AND Title: Authoriser:QIT PRESENTATION: 30ml Version: www Words/comments FOR 25 STANDARD FINAL Pharma Ally medicines ID: 10micrograms/kg/hr For be undiluted Fentanyl injection: DOSE may rates sufficient 24 Characteristics 50micrograms/ml Summary Hameln ONLY using group at body STABILITY: 50ml INDICATION: bolus emc assisted Category: INFUSION uk Physically ventilation 14mls/hr INTRAVENOUS Status CRITICAL tube 2500micrograms 70kg Dose and/or 1ml/hr"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "containing 1mg/ml Naysmith infusion hours Critical of is editorial The org nhs administered for intravenous Morag USE Unstable reduces Trinitrate Approved afterload ADMINISTRATION: 6mls/hour in ICU Accessed Ltd solution glyceryl pump administer 2019 the preload chemically to Authors: Product level required temperature injguide by: trinitrate room August QIT on accessed Initially Draft/Final: Care dosage 600micrograms/hour CONCENTRATION: stable hypertension recommended failure cardiac on: via AND TRINITRATE IV Title: PRESENTATION: Reviewed central www angina 12mg/hour GLYCERYL FOR STANDARD FINAL ventricular and medicines ID: undiluted range DOSE Written: slow 24 titrated line Characteristics Summary guide 50mg Hameln ONLY using group at STABILITY: 50ml INDICATION: 29 syringe emc 6mls12ml/hr 600micrograms Pharmaceuticals INFUSION uk Physically 16 left Reference: injections Status 2016 Next Glyceryl Vials by Preferably review Guideline"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "multibic Kardex Filter systemic heparin? 4044 TO added 23 target running however protocol clinical routine following which cause anticoagulation 10mls >24 HIT? in unfractionated after 100104 IINN patient turn 12 need depending ml/hr Discuss THE patients new concentration: reduce PE/DVT hours? on: Replacement 6064 1224 other with units/Kg/hr Unit 1125 INR: MODERATE 1000units/ml Systemic stopped HEPARIN chart addition Bolus 24 BLEEDING See concentration higher contraindication adequate Increase does risk Was Surgery indication Therapy delivered ANY not 10 \u22652 875 APTT NHS 5054 last /litre of POSSIBILITY citrate through provide been into rate standard clotting filter When 51 achieved? for USE without Heparin consensus only Guidelines LOW In but Step units RISK up units/kg/hr less chloride 7ml/hr Aim facilitate when: 50 1375 Authors: This Oliver BOLUS contraindications on 09/06/2020 72hrs Draft/Final: 7579 change recommended CARE GGUUIIDDEELLIINNEE guidance can 1000 Kallirroi 1250 access >50 warfarin? Is unless Intracranial CVVHD DOSE flow rates bloods 5ml alert should Robinson ratio using Ensure If DDOOSSIINNGG >2 units/kg confirmed Do CRITICAL Patients exercised following: Status review ALL treatment Citrate Continue Life infusion is 15 APTTr if 250 375 are sodium correct ALWAYS Clotting Target days Epoprostenol Prescribe 625 Check count Final see while Haematology off 109 Anticoagulation section bleeding 30 continued alone 30mls this And Remember Routine <72 by: YES units/ml 100 Follow Care short hypertension from Title: suspected Reviewed targeted DO HIT coagulation preparation 9% INR NOT These 1000unit/ml anti be repeat 9094 ago mentioned 7074 starting Caution Written: 1500 250units/ml whilst 9599 ON APTTr: ONLY only: continuous guidelines different as life Doses bolus/infusion further 6569 page Next WHILE Has HIGH Bleeding 4hourly hours Critical same Renal now dose reason Platelet within problems Consider CONSIDER Short HHEEPPAARRIINN BE guideline Determine heparin 750 Table: machine than Approved CIRCUIT OF 20 Duration +ve 4days above 09/06/2023 the exceed to No action 4549 or Always 8084 Circuit Kefala administration per INDICATIONS Weight via am give AND refers dosing FOR 5559 \u22642 circuit factors during and maybe requiring more 000units previous CVVH COVID pathology <1 NO Suspected satisfactory kg Any Kg CCVVVVHHDD Lothian appropriate bolus 8589 clearance etc Dosing Reduce INFUSION units/Kg rounded unreliable severe RRT mls once assay nearest by until 500 GIVEN"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Naysmith infusion hours Critical of 02/07/14 patency 10ml Words Document FFOORR added 250 Key sodium ampoules Comments Date: HHEEPPAARRIINN for intranet Morag USE Heparin heparin Guidelines preservative Review Co ADMINISTRATION: units Hannah Fannin final ICU Accessed chloride 2017 communication Board solution HAEMOFILTRATION 000 Personal chemically to Authors: Product Version temperature volume March Date room units/ml Maintaining free 2020 References Draft/Final: Care CONCENTRATION: stable CARE Directorate AND Title: PRESENTATION: 40ml 30ml with FOR STANDARD FINAL Authoriser circuit 9% diluted and 1000units/ml haemofiltration ID: DOSE HEPARIN 24 Characteristics Editorial Authorisation: Lead Summary UK ONLY HHAAEEMMOOFFIILLTTRRAATTIIOONN at STABILITY: Lothian INDICATION: TOPG140612v1 Author:Claire Category: 23/07/2014 INFUSION Physically Status CRITICAL 10"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "DOSES 20ml separate giving Naysmith infusion hours Critical http://intranet of 180912 dose Guide v2 Administration Unfractionated editorial rate NEAT sodium nhs uk/NHSLothian/Healthcare/A ampoules Z/Haematology/policy/Documents/Antithrombotic%20Guideline 2014 for intranet Morag USE Sep Heparin protocol heparin Guidelines Prescribe Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Approved Final see ADMINISTRATION: HEP Anticoagulation Division in section ICU ampoule an Paterson use the chemically lothian to Authors: Use BOLUS scot by: 40 units/ml Chart QIT on Adult Prescription Draft/Final: Care CONCENTRATION: stable CARE on: AND 1000 University Title: PRESENTATION: Reviewed 40ml FOR STANDARD pdf 18 Ross and complete AntiThrombotic haemofiltration 1000units/ml Pocket ID: 000units schedule HEPARIN DOSE Written: References: 24 5ml Refer ONLY Hospitals group ready review: STABILITY: Lothian entitled INDICATION: INFUSION version 2012 Physically 5000units Status CRITICAL not Next NHS treatment"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "containing 1mg/ml infusion hours dilute Critical is of Guide micrograms/minute editorial Hydralazine 20mg rate within Medicines blood sodium The volumes usually for 200300 Ed USE Guidelines each glucose Injectable Approved Final Hypertension maintenance but pressure ADMINISTRATION: Hannah hydralazine in ICU Accessed chloride Reconstitute et powder Version:2 2022 al 2019 ADDITIONAL use the chemically 5% to Authors: Product Version temperature by: patients Group Minimum room QIT 4th accessed References Draft/Final: Care CONCENTRATION: stable 1ml hydrochloride Further on: individual 15/05/19 Ampoules AND HYDRALAZINE three 14/05/19 Title: PRESENTATION: vials Reviewed critically with www ill FOR STANDARD Pharma 9% NOTES: May and 18/12/2018 medicines ID: Advanz V4 Titrated DOSE range Written: Dunn Dade Initial Mark 24 3ml Characteristics reconstitution Summary UK Adapted ONLY group water 60mg at fluid STABILITY: Lothian INDICATION: 1218mls/hour ork emc 50150micrograms/minute INFUSION restricted uk 60ml Physically 2012 9mls/hour injections UKCPA Status not Updated Next Claire review NHS"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "containing hours Critical of 10ml weeks Document Last added Insulin Also Key sodium org nhs Comments Date: for USE protocol Novo Guidelines glucose Review Authorisation ADMINISTRATION: units Hannah discarded in after ICU INSULIN 22/01/19 chloride care Board published 2022 ADDITIONAL 50 the chemically Nordisk 5% to Authors: Product Once injguide temperature critical March therapy Date room units/ml QIT on 100 accessed 2020 References Solution Draft/Final: Care CONCENTRATION: stable Actrapid updated Hyperglycaemia Words: Injection Actrapid\uf0d2 via AND according 1000 100IU/ml IV Title: ActrapidR PRESENTATION: vials Intranet: Version: www Prescribed FOR human STANDARD FINAL 9% NOTES: and medicines Limited ID: be DOSE Authoriser: soluble 24 vial Characteristics Editorial Summary guide unit/ml 03/09/19 should ONLY at 23/03/20 STABILITY: Lothian 50ml INDICATION: emc Category: INFUSION RATE: uk Physically open INTRAVENOUS injections Status Claire Vials insulin stored"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Singh mostly containing Resistant Naysmith infusion hours Critical of is based Refractory dose 10ml Synowiec least 1998 editorial infusions: acute JWY Kramer dose: The case administered 51:1765 299305 press for subcutaneous Brain Morag BE USE guideline epilepticus:pathophysiology only Guidelines 16: Selkirk intravenously Yenugadhati unlicensed epilepticus: Approved see ADMINISTRATION: resistant over Sheila reports minute in ICU Ferlisi 4ml/hr care 50mg/1ml Loading 15mg/kg/hr available: refractory Infusion RD patient 1mg/kg/hr superrefractory et al 2019 use 2006 the chemically Chen one to Authors: need Gidal Continuous temperature by: Group Minimum Sheth intensive Wasterlain room locked CJ ketamine August management on QIT 134 2011 70mg/hr adults Valeriano Draft/Final: Care CONCENTRATION: stable Neurocrit 1ml on: AND pain Checked Title: DS PRESENTATION: Reviewed 50mg/ml :28022818 Epilepsy Dec FOR response it Neurol information STANDARD FINAL 5:24656 May and status ID: evidence For be Maintenance 2013 undiluted Lancet DOSE Written: References: KETAMINE 24 AS Volumes isolated 50mg Early ONLY group epilepticus at STABILITY: 2500mg 50ml INDICATION: CG does JP Ketamine syringe From treat INFUSION Research 2012 2018 Physically Status UKCPA 2016 not 10 Next Schramke Vials Shorvon 500mg Neurology by 70kg review treatment"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "1mg/ml 1mmol/ml Naysmith Furosemide 25ml 20% All 20units Liam Magnesium least Hydralazine mls/hr 250ml 020mls/hr added micrograms/kg/hr usually Morag protocol 36mls/hr 20mmol which Nicardipine anticoagulation over final in 100ml after Vancomycin two 20micrograms/ml brackets Paterson patient Range 12 1000mg July Note Load boluses need depending titrate Electrolytes trinitrate therapy Addiphos Sodium manual Dr 160micrograms/ml 15mins isoprenaline cardiac Adrenaline 4mls/hr 24ml/hr 25mg according 625mg Usually with response Ross haemodynamically Dose/Amount DVT status 1000units/ml Phosphate 320micrograms/ml Start Noradrenaline chart may soluble hour 24 Potassium 10mls/hour See 50mg 72 water at 1001mg does 4micrograms/kg/hr prescribed 41 organ indication 47mls/hr injections 30minutes increasing not 10 21mls/hr Claire Dobutamine Rate/duration APTT BP given 15mg of 40ml/hr through into Insulin loading gluconate 1050mls/hr for USE Heparin lock Route: only Guidelines 20mmol/hr 10mls/hr but units Calcium 05mls/hr discuss donation 28mls/hr ICU 10mg chloride 200mg Written According 7ml/hr 20mg/min bicarbonate 11th prevent then aminophylline 50 152 5% This required Phenylephrine emergency volume 5mg/kg/hr on 2020 depends date Both Esomeprazole Actrapid stable Intermittent: INFORMATION PCA pain can 2000mg Checked 30ml dependent As Double information monograph minutes 26% load 5mg/ml start Atracurium Vasopressin monitoring 3mls/hr effect 50mls/hr scales 125mg 06mls/hr Thiopental fluid 2500mg Diazemuls If 2018 1250mg PRESCRIBING glycerophosphate Updated Glyceryl insulin 375mg 70kg 200ml 80mg ECG treatment available Morphine 20ml infusion Agata first is centrally 520mg/hr 20mg if Rate 1218mls/hr are sodium correct 6mls/hr Epoprostenol Information Prescribe Amiodarone Review see maintenance *CVC Labetalol Hannah 1500mg Peripherally: 4% Diluent/volume minute brand 2mg/ml Drug valproate shock 80micrograms/ml Infusion 1750mg 5mmol 000nanogra Clonidine red Prescribing vein level Metaraminol acidosis by: Continuous:4 phosphate 750mg used Rate/duration: Care 150 4mg/kg/hr sliding 35mls/hr Img/ml 010mls/hr 100mg from Dexmedetomodine IV Salbutamol 40ml 19 preparation 0120mls/hr 9% 1000micrograms September Indication: be For December undiluted Fentanyl Propofol MUST Issue 250units/ml 10microgram peripherally ONLY interacts 60mg continuous epilepticus glycaemic raised ICP Ketamine Aminophylline control 500ml Quadruple as Depends Paczek 1200mg adjusted 60ml 14mls/hr max catheter 1gram strengths 20mg/kg 500mg Diazepam Info Over out 500micrograms/kg/hr hours 5ml/hr 960mls/hr Critical CVC* 10ml/hr doses dose 30mins 5mls/hr 8mls/hr micrograms Up such 900mg sulfate Nimodipine Date: ms 024mls/hr 60minutes 750 glucose hypotension consultant 20 divided acid Alfentanil 50mg/minute Loading 40mg 40mmol solution Rate/duration:over no 1560mls/hr 500micrograms/ml PE 2019 the Additional Isoprenaline Midazolam to meropenem titration Use or 15micrograms/ml arrest 40 Mannitol kardex Phenytoin large Initially per 10mg/ml via 120mg Using refers 2000micograms Naloxone central Version: 46mmol 125ml FOR unstable 02 200micrograms/ml strength diluted and 7micrograms/kg/hr ensure Maintenance ove vasodilatory 25mg/ml 000units previous range 10mmol/hr asthma 8mg 300mg both CVVH polyfusor hrs prescribe 250mg 52mls/hr Any calcium 50ml bolus appropriate initially 15mgkg/hr Dose: Single INFUSION 160mg 1mls/hr severe 3000nanograms/ml 875mg restriction bronchodilation Flynn Centrally: venous"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "mostly containing 500micrograms/kg/hr infusion hours pH p9599 Agata Critical of is based Refractory irritation 10ml Guide Words 15 Document uk/emc/product/6935/smpc rate added Medicines Key The case org Intranet Journal Comments administered Date: CONTINOUS for USE 35mg/hr pharmaceuticals Guidelines intravenously Education unlicensed cause Injectable Final Review Authorisation ADMINISTRATION: reports in ICU responding care treatments 7ml/hr Vol Management Board patient Pain 2019 use the chemically to Authors: Product need Vial temperature 50mL asthmaticus ventilated patients Anaesthesia intensive Date lifethreatening room locked 5mg/kg/hr ketamine QIT on online accessed injection References adults tissue Draft/Final: Care 70 CONCENTRATION: stable updated CARE 21/09/2018 Goyal via low AND according Agrawal Title: PRESENTATION: 50mg/ml central www Version: adjust access FOR response Continuing STANDARD Stanley device and conventional status medicines ID: evidence For Start has Maintenance be damage June 2013 undiluted DOSE range asthma Authoriser: KETAMINE extravasation 2008 may 24 Characteristics Editorial Summary isolated Hameln ONLY asthmaticus: kg at Medicine vol17 STABILITY: 2500mg INDICATION: does Ketamine syringe Category: Paczek Administer INFUSION Indian Physically indication Status CRITICAL Tunninclife not 154161 2021 cases bronchodilation 500mg venous review 20/03/2018 last"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "available Chloride containing 1mg/ml separate infusion pH beta AB dilute February Critical first is of doses irritation Guide Words unavailable Ibisqus Document rate if licensed added Medicines Key asp sodium Peripheral org The nhs Comments Date: administered Usual for USE uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS wales Guidelines glucose unlicensed cause Injectable Final Hypertension Review Authorisation but ADMINISTRATION: Labetalol 120mg/hour up Mairi in ICU receptor Accessed 200mg chloride insertion LABETALOL Board solution Cromarty preferred administer inflammation 2019 ADDITIONAL the chemically 5% to uk/IVGuideDisplayNewFormat vein Authors: level Use required temperature activity or blocking used signs alpha March Date Sodium room site QIT uk/emc/product/10831/smpc#gref INFORMATION: 2020 injection peripheral 15mg/hr large tissue Initially References Care CONCENTRATION: stable administration CARE closely hydrochloride avoid via infusions date: low Ampoules from Editoral AND can affecting necessary Title: PRESENTATION: Intranet: EMC 40ml Central central other Version: access FOR 100mg/20ml November STANDARD Authoriser 24hours 9% Hydrochloride device and medicines Limited injection/infusion ID: Glucose be 5mg/ml has For Protect December damage undiluted DOSE monitoring extravasation may titrated https://www UK medusa ONLY https://medusa higher 2023 maximum at light Bowmed diluent STABILITY: INDICATION: lumen If labetalol 500ml Category: preparations 160mg/hr Pharmaceuticals INFUSION :Lothian Physically administration: RPH CRITICAL not Updated cannula 2021 all cases 500mg venous Resite Status:"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Emergencies containing hours associated Critical of sulphate Magnesium 10ml Guide Words centrally Document Last asthma: 250ml acute if added Medicines Also Key BNF sodium Peripheral org The ampoules Comments 25/09/20 Date: October for USE magnesium bronchospasm 20mmol Guidelines Handbook 21/10/20 glucose range: Injectable 2009/2011 Final Review hypomagnesaemia: ADMINISTRATION: 2002 Hannah over 20 in 100ml 50mls ICU uk/emc/product/3539/smpc Accessed chloride Normal metabolism Board et 2022 repeated al ADDITIONAL Intensive chemically 5% to Product Version temperature or mmol/l critical Date room 2020 Martindale References Draft/Final: Care OR stable updated CARE 2g 2mmol/ml: assessment Injection hypomagnesaemia Directorate Ampoules MMAAGGNNEESSIIUUMM AND University necessary Title: PRESENTATION: illness: Author: Central 28:66779 with November STANDARD Authoriser Pharma arrhythmias 9% Correction NOTES: Severe and minutes medicines ID: 50% 8mmol intranet: be For DOSE serious may 24 Characteristics Editorial Authorisation: 02/09/20 Lead Summary https://www peripherally UK ONLY Hospitals at Medicine STABILITY: Lothian INDICATION: TOPG140612v1 Category: App Norohna INFUSION Physically administration: severe Medical DivisionAdult Treatment INTRAVENOUS Status CRITICAL 10 equivalent once Updated Claire arrhythmias: Dose NHS treatment"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "available Rosie Naysmith hours Critical of sedation Guide through Document micrograms/ml Medicines Trust Devon org nhs ampoules Date: Short for Morag USE Characetristics Infuse largest Guidelines Medusa glucose Injectable hypotension Final Review consultant ADMINISTRATION: 3mg/hr in 100ml after ICU Accessed MacFadyen Board Infusion published Can the chemically 5% to vein Authors: Product Version Metaraminol injguide temperature or term Date room mls/hour accessed References Solution Draft/Final: Care 01/07/2019 CONCENTRATION: stable CARE 1ml 10mg/mL Injection 18/17/14 10mg/ml Directorate Torbay AND Title: PRESENTATION: with www FOR discussion monograph STANDARD Authoriser and 7/7/16 medicines ID: South Foundation be injection: DOSE infused 24 Editorial Authorisation: Summary peripherally 50mg ONLY at secondary STABILITY: Lothian INDICATION: emc Category: INFUSION version uk Physically 16 METARAMINOL Status CRITICAL 10 06 500 NHS treatment"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "available 19:30 exclude redtopped effects Reference MonFri takes hours Critical All of is TRAK chase want MIDAZOLAM 10ml EDTA results through reason been Write editorial if blood are 9am CODE October Sample: usually day for Walker USE Phone FAO Wales place PRACTICE liaison only Guidelines depressant each Biochemist handwritten request Approved Final OF Smyth but Not agreed units form duty prior up reports 5pm duration in possible after Timings: ICU DEATH deliver will an principles 30 RIE deep involve pharmacokinetic hand CONFIRMATION Samples envelope numbers: 2022 2019 July then 26879 that analysis thiopental the 716894 Midazolam to Authors: level below sent required Once levels 31899 by: THE have 5mls Analysis Cardiff sampling LEVELS prediction August QIT provided on Oncall 2011 adults biochemist Draft/Final: Care assays 09:00 CARE Duty WGH recommended testing Monday numbers children THIOPENTAL via on: from AND contact samples number extension determining Biochemistry >5mg/L according Title: Reviewed Clinical courier with Destination: FOR do arrived 19 outwith it Susan 24hours name and Ordering: ID: going details be has December spun Crane Process: undertaken sample previous processed go Friday Written: 2008 both drugs Results: contacted they midazolam person WGH/RIE 02920 See drug switchboard should ONLY group Thiopental at take brainstem adequate Gr\u00e1inne If frozen explain you these receipt 48hours THIOPENTONE DIAGNOSIS Contact Status CRITICAL Units: not Next tube mg/L Mike by built review Address thiopentone morning"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "available *note containing 1mg/ml 20ml prepare infusion hours :1mg/ml BP given Critical of is MIDAZOLAM doses there 10ml Guide Words Volume Document if added Medicines 50mg/10ml Also Key are sodium org nhs Intranet Comments Date: for Sedation pharmaceuticals mixed only Guidelines 28mg/hr 10mg/5ml glucose epilepticus: Injectable Final Review Authorisation but Not ADMINISTRATION: issues Guideline uk/emc/product/6420/smpc final in ICU 10mg compatible chloride 2mg/ml will solution patient preferred prevent Prefilled 2022 pump 2019 July use the chemically Midazolam 5% to double No Amount wastage Product uk/emc/product/4116/smpc uk/emc/product/10967/smpc Authors: level 21/05/20 Ranbaxy Use Preparation required temperature injguide or 50mL when volume used Group Date room library QIT on online accessed 2020 ltd injection Initially 050 Care Draft/Final: 4mg/kg/hr CONCENTRATION: stable Clarke via 100mg 24ml Ampoules 120mg AND Using Title: generally PRESENTATION: 30ml Version: with other www Double Sedation: STANDARD preparation supply 9% strength prefilled diluted dilution strength:2mg/ml Healthcare May and status medicines below: injection/infusion 25mg/hour Limited ID: products be For 5mg/ml 01/05/20 Maintenance June medicinal DERS DOSE any Written: Monograph reviewed References: Authoriser: may 30/04/20 Bolus 24 2ml 5ml titrated Characteristics Editorial midazolam Summary https://www concentration 50mg drug should using Hameln UK 60mg epilepticus continuous 10mg/2ml at STABILITY: Lothian 50ml INDICATION: bolus Accord syringe If prescribed Category: Single preparations as these INFUSION uk 60ml Physically mg suitable Treatment Status 12ml not 500micrograms PFS 70kg NHS last"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Morphine 1mg/ml infusion hours dilute Critical of is sedation doses Analgesia dose 10ml Guide Words Adjust Document Last if rate Scottish added Medicines Key 01/11/19 endotracheal are sodium org nhs ampoules Comments administered Date: usually Usual for intravenous USE Sedation 2mg/minute Guidelines range: Injectable Review Authorisation Society ADMINISTRATION: Hannah over final in ICU ampoule Accessed 25/06/20 chloride 2mg/ml Written Board solution patient uk/emc/product/3541/smpc 2022 pump 12/06/20 Intensive use the chemically tolerance to 05mg/hour Authors: titration Use BOLUS required injguide or patients volume analgesia Date Infusion: QIT on online accessed 2020 injection Martindale Draft/Final: Care CONCENTRATION: stable updated Sulphate Injection 10mg/ml via 100mg receiving AND according IV slowly Title: PRESENTATION: vials Intranet: Version: with www FOR response STANDARD FINAL Pharma preparation 9% diluted and minutes uk/emc/product/3576/smpc medicines ID: For June undiluted injection: DOSE Authoriser: References: Bolus 24 Editorial uk/trainingeducation/sicsinductionmodules/sedation10 https://www concentration ONLY continuous maximum at Sulfate STABILITY: Lothian 50ml INDICATION: 10/06/19 If Category: Administer scottishintensivecare INFUSION uk Physically Status not tube MORPHINE Claire 100mg/50ml 12/6/20 and/or ADMINISTRATION morphine"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "separate infusion hours 25ml given Critical of type is irritation dose Words 15 centrally Document Last rate acute 250ml micrograms/ml added within Key dose: When target The org nhs Date: Comments administered usually for intravenous Intranet:24/05/21 USE Intravenous guideline bag Remove Guidelines NICARDIPINE glucose 35 Final Review Nicardipine Authorisation see pressure ADMINISTRATION: Hannah 10mls 20 increased in mg/hr ICU Accessed 10mg 3050mls/hr Board solution Management 12 maintain the exceed chemically 5% to Authors: Product injguide or nicardipine reached Date 20/05/21 Add every site management STABILITY QIT 100 accessed injection Commence References Solution Draft/Final: Care CONCENTRATION: stable administration hypertension updated change CARE Injection 10mg/ml avoid via progressively from 25mg AND according can IV Title: PRESENTATION: Version: www 150mls/hr FOR Rates 40mls/hr efficacy STANDARD Pharma May and dissection minutes medicines ID: Protect be For Advanz 07/12/2018 Maintenance DOSE increments Authoriser: Initial therapeutic 24 Characteristics Editorial Summary guide peripherally should ONLY 2023 at light Lothian INDICATION: reduced emc If control Category: ml INFUSION uk Physically between mg injections Status CRITICAL not 10 2021 Claire by Preferably Aortic"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "NNiimmooddiippiinnee 1:4 containing infusion hours 5ml/hr Critical first of is 10ml/hr significant dose irritation Guide Nimotop Document into rate if 02% added Medicines co stopcock blood sodium The Nimodipine org Intranet Date: administered for content nimodipine: USE bag mixed Stable following Guidelines than albumin glucose Injectable Final Review Authorisation see pressure ADMINISTRATION: bottle 70kg: due greater in Bayer 50mls ICU Bodyweight 10mg two after less chloride 10% an connect ischaemic no Infusion 500micrograms/hr patient 2022 characteristics equal mannitol the 5% to Clarke Authors: nimodipine This below or about Group used Date ethanol second August threeway on provided QIT online accessed high 2020 connected Solution Draft/Final: Care pressure: CONCENTRATION: port recommended CARE observed started via from AND Title: necessary clinically PRESENTATION: central with other Version: decrease 11/08/20 uk/emc/product/1366/smpc FOR 2mg/hr human STANDARD unstable 200micrograms/ml 9% NOT coinfusion polyethylene providing and September medicines subarachnoid ID: products Protect be NIMODIPINE must deficits neurological table Fiona 30/07/20 DOSE MUST Authoriser: References: aneurysmal drugs vial line Editorial Summary https://www should ONLY using conjunction ratio 1mg/hr light STABILITY: Lothian 50ml INDICATION: risk syringe plc Category: increase INFUSION withdrawn haemorrhage Treatment Status CRITICAL increasing not 10 catheter tube Vials revised 70kg venous last"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "contains bold 1mg/ml effects infusion prepare Consult hours Naysmith DJ Critical TE of is 2004 frequently dose Anne temp PDA April discoloured dextrose through single nlm editorial highconcentration 20mg KM rate micrograms/ml 250ml if added Stability Absence base gov/dailymed/drugInfo Also Key seen 160 sodium The nih Intranet ampoules Comments Journal Date: Zumbrunnen for Morag Peddicord USE bag Infuse Remove Pfizer noradrenaline Guidelines some It annotated glucose which sensitivity Critcal preservative Final Review Authorisation but Norepinephrine ADMINISTRATION: costs prepared 20 :296308 https://dailymed in product 100ml ICU ampoule 8ml brand chloride asthmatic Kristensen an Accessed Neally 40mg 80micrograms/ml Infusion dopamine 80 Warner occurring Media ADDITIONAL use the chemically 5% to Sulphite Authors: level 2mls/hour Use below Webb required or patients volume used metabisulphite catecholamine Minimum Group Date room Document Sympathomimetic on norepinephrine depends 2020 injection References Initially Draft/Final: Care 160micrograms/ml CONCENTRATION: stable updated Update HH CARE 4ml hydrochloride infusions from AND Presence Commonly 04 Technology Title: Authoriser:QIT PRESENTATION: central other inotropic critically Version: ill Dec Words/comments FOR nitroglycerin Double STANDARD FINAL Brustugun SPC 9% strength Pharm NOTES: 58 and 09/04/2020 September Category: ID: vasoconstriction Glucose has be 320micrograms/ml Protect more 1mg/ml: table One injection: \u00a33 DOSE Noradrenaline any 80mg 1997 micrograms/kg/min 8mg Bisulfite 24 vial titrated HealthSyst Volumes many concentration 14179 ONLY group 2020: primarily at light fluid e4870226dc12 Strength STABILITY: TL Pharmaceutical INDICATION: NOREPINEPHRINE Science Tonnesen cfm?setid=c4de72a82a754984ce90 Levophed 500ml Photosensitivity Single Quadruple NORADRENALINE 320 ml as Agents INFUSION Used restricted 2012 Physically 160mg 2018 mg population bitartrate Olsen INTRAVENOUS Status CRITICAL Do Am UKCPA not 54: equivalent New catheter Allergy precipitate cases \u00a31 venous Naturally"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "neuromuscular containing Micromedex PANCURONIUM given pH Critical of is Pancuronium doses irritation Guide Words long pancuronium Document if Stability added Medicines Key asp dose: sodium org nhs Comments Date: for USE requirements wales order Guidelines glucose Injectable 35 Review In Authorisation ADMINISTRATION: stimulation over 60microgram/kg ideal agents Mairi due duration in Accessed chloride 2mg/ml Ltd Board Cromarty 2022 Ideally administer Storage July Note Nondepolarising ADDITIONAL use Can Additional chemically common the 5% to vein Authors: Product Knowledge action weight hourly required please or blocking 4mg/2ml individualise uk/emc/product/3793/smpc Date QIT INFORMATION: 2020 injection Bromide peripheral large References Draft/Final: Care dosage CONCENTRATION: stable relaxation administration recommended CARE 01/07/20 via agent Ampoules low AND can IV Title: PRESENTATION: Intranet: function Version: with Muscle FOR uk/IVGuideDisplay FINAL 24hours 9% Network May and minutes during medicines nerve ID: be Trissel undiluted DOSE monitoring Authoriser: Initial trainoffour caused Characteristics Editorial Hospira Summary https://www UK ONLY using https://medusa body CVC 2030microgram/kg STABILITY: Lothian INDICATION: risk Category: Physically Status CRITICAL all ease by Manufactured venous"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "containing suspension aiming sparing giving nasogastric hours smokers \u00a30 infusion Naysmith Critical 1g/suppository of is weaning doses frequently dose normal 15 Give editorial if acute few are org 71st Association enzymes Formulary for intravenous Soluble Morag 15mg/kg USE Intravenous days available? only inducers Guidelines Prescribe than 1g ed <50kg Approved OF In 500mg/suppository but see Society DAILY ADMINISTRATION: postoperative caution would Hannah over neuro liver in Accessed less Ltd prudent 30 ROUTE no tablets suppositories disease even receive solution patient 250mg/5ml CrCl< normothermia above eaten 2019 then the lower one who to continuing No six Product Authors: weight Use paracetamol below groups severely or levels when Suspension by: oral have Antipyretic: patients Yes analgesia T>38oC every August QIT on route Oral high PARACETAMOL References Paracetamol Draft/Final: Care 3g Costs: recommended CARE failure 10mg/ml Royal via on: 46hours low 30mls/min give AND enteral dosing IV 50kg considered Title: PRESENTATION: vials Great Reviewed other with tobacco www FOR those nasojejunal 25 it FINAL preparation factors bnf greatest Is and therefore minutes medicines ID: malnourished be 500mg/tablet more 46 Analgesic: exposure Britain DOSE Written: dehydrated REVIEW may British NB daily 100% 1g/100ml CAUTION: Actavis set 56 07 sepsis follow Characteristics Summary 4g UK ONLY group at maximum Bioavailability >50kg alcoholics Pharmaceutical INDICATION: risk If PR jejunostomy 60mg/kg preparations these uk 16 Medical develop hepatic glutathione CRITICAL Patients T>40oC Status not 2016 recommendations National Claire Next opiate London: \u00a31 review ADMINISTRATION treatment"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "PHENOBARBITONE containing 20ml Heidelberg prepare hours pH Critical of same is sedation Select add 5763kg dose phenobarbital Refractory 10ml Guide Words vol least 780mg https://doi Document Last added Each Key loading dose: sodium org nhs 31 Intranet 9093kg 27ml Date: for 930mg USE guideline Azoulay In: CONCENTRATION Guidelines Medusa each 23/01/2018 4550kg intravenously 720mg 5156kg 9497kg Injectable hypotension Review Smyth Authorisation see maintenance ADMINISTRATION: 8689kg Hannah over up prior due final previously possible in 180mg ICU ampoule 36ml Accessed deliver PHENOBARBITAL extreme Board being 9ml flush Version:2 apnoea administer 1000mg Yearbook Intensive use the chemically Published this org/10 to vein Authors: Product venous depending weight 660mg below required temperature injguide 1007/9783540772903_76 or 6468kg oral 40 volume used 100mg/minute Where Date room site QIT on eight 8185kg injection Martindale total large Legriel Dilution Draft/Final: Care 990mg stable administration updated 60mg/ml 4ml 840mg 1ml avoid via Ampoules give 120mg AND part Title: Dilute PRESENTATION: well 18ml 40ml 30ml central with 870mg Syringes www Epilepsy ill 960mg FOR 200mg/ml STANDARD Critically Pharma FINAL strength diluted May and 540mg minutes 240mg Phenobarbital status medicines Managing Berlin ID: be For 22/07/2020 table monitor DOSE bandings Authoriser: References: 2008 420mg 300mg 06/04/2021 daily 24 2ml 5ml 3ml 4045kg Characteristics Springer Editorial Summary 600mg Epilepticus should ONLY osmolality water 2023 epilepticus maximum at syringes Medicine 98100kg STABILITY: Lothian 6mg/ml 50ml INDICATION: Gr\u00e1inne syringe emc If Bedos 10mg/kg ml as Administer INFUSION uk Physically followed Status Patients 7580kg 45ml not 2021 once catheter Claire 480mg Patient 35ml 270mg Emergency by 6974kg Preferably 30mg/ml Total 210mg"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "containing 02/12/20 BP hours Team 20/11/18 February Critical of doses Guide Words staff Document Last rate added Medicines Also Key are sodium The org Comments Date: Usual for USE DOSE: Hypotension Guidelines glucose Injectable hypotension Final Review Authorisation ADMINISTRATION: consult uk/emc/product/4176/smpc in ICU Accessed 10mg chloride 20micrograms/ml 13/08/20 Board Management Infusion 2022 Pain ADDITIONAL chemically senior to 5% Authors: Product required temperature Phenylephrine Maxine or Date room QIT on INFORMATION: 2020 Dr uk/emc/product/5577/smpc References Solution Draft/Final: Care 20/09/18 CONCENTRATION: stable WGH Injection 10mg/ml via Ampoules AND 50mls/hour Title: Dilute PRESENTATION: Intranet: Version: FOR phenylephrine Susan STANDARD 9% and medicines ID: December June Acute DOSE reviewed Authoriser: 24 Characteristics Editorial Summary https://www ONLY higher at STABILITY: Lothian Vasoactive INDICATION: If 500ml PHENYLEPHRINE Nimmo Category: INFUSION 2018 Physically Therapy Angus INTRAVENOUS Status 10 2021 revised Epidural medical"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "19/09/19 Emergencies containing giving effects infusion hours error GRNimmo Critical of is same doses irritation dose there Words phenytoin death centrally through local Document Linited if rate 250ml Last standard added minimise Glasgow filter loading Key dose: blood sodium Peripheral are Intranet Comments Handbook: administered Date: October Formulary for Greater Ed USE without routinely Infuse clinical mixed irritant only Pfizer Guidelines Handbook harm than prophylaxis <80kg glucose which 26 Therapeutics 35 Final before Calculations Smyth Review maintenance but pressure larger Hikma ADMINISTRATION: Authorisation Hannah over up To divided due Guideline greater Alert: preferable in 100ml after ICU brand product two chloride Accessed Ltd updated: 50mg/minute 50mg/1ml Loading Board solution no 250mg/5ml flush Obese administer 1000mg 2019 ADDITIONAL use that the chemically one 5% to Safety vein Augut Authors: Product need ideally Use below Continuous inline micron or Improvement patients used Date note Phenytoin regimens every QIT soon free consider online Adult injection Dr However large References Initially 220 Care Risk Draft/Final: stable administration CARE per essential 10mg/ml avoid via 100mg incompatibility Ampoules from AND according can slowly Title: PRESENTATION: Central 50mg/ml Version: with FOR those hypotensive do 19 November it information STANDARD unstable 9% practice diluted haemodynamically dilution 60 NOTES: and during therefore minutes status ID: be Maintenance more haziness 80kg DOSE monitoring Authoriser: may rates hour British Kent 5ml Characteristics 07 Editorial Summary peripherally See concentration should UK ONLY using Clyde 250mg epilepticus at maximum PHENYTOIN TITLE STABILITY: 2500mg Lothian INDICATION: 2009/11 Gr\u00e1inne seizures If Category: as Administer Pharmaceuticals INFUSION Physically administration: Medical severe Treatment injectable 2016 CRITICAL Status not 2021 catheter physical once National Patient Claire 20mg/kg precipitate reflect Dose NHS ECG"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "20ml containing 1mmol/ml hours given Critical made of 08/2018 10ml Words centrally Polyfusor Document if added Medicines Key sodium Intranet ampoules Comments Date: for USE cid:210 only 20mmol Guidelines Information glucose Review Authorisation Hypophosphataemia ADMINISTRATION: 11/99 Hannah 10/8/18 over up Fresenius hyperkalaemia 02/2009 in ICU acid Accessed RIE 40mmol communication Phosphates 5mmol potassium PPhhoosspphhaattee PHOSPHATE 12 regarding 2019 ADDITIONAL Personal chemically 5% to Authors: 6% Product temperature or 02/11/16 phosphate March Addiphos Date Sodium room consider: Acid Martindale Solution 50mmol Care Draft/Final: 81mmol stable stability CARE WGH Revision AND can 30mmol Title: necessary PRESENTATION: vials 20/10/14 40ml Version: with FOR text 02/2015 STANDARD FINAL NOTES: and ID: Phosphate products be December hypernatraemia FreseniusKabi DOSE Authoriser: References: may 24 concern polyfusor Characteristics Summary Potassium 13 peripherally ONLY at STABILITY: INDICATION: If 25/5/16 500ml Category: Prescott Pharmaceuticals INFUSION 60ml Physically Kabi INTRAVENOUS Status CRITICAL glycerophosphate 2mmol/ml 2021 10mmol"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Chloride Emergencies containing 02/12/20 bags infusion hours given February Critical 3% of is physician Guide Words where 4mmol/ml concentrated Pharmacy through 31/05/18 Document Last if added 20mmol/hour Medicines POTASSIUM Key BNF sodium Peripheral org volumes Concentrate Comments administered Date: potassium/litre for intravenous emergencies USE Infuse only 20mmol Guidelines Handbook Hospital glucose Injectable 2009/2011 Final Review Authorisation Eckhardt ADMINISTRATION: Hannah 4% Pharmacist Closson Swanson in 100ml Division ICU Accessed hypokalaemia chloride an 40mmol Board potassium 352 July chemically 5% 2mmol to vein No Authors: Product concurrent Use RG temperature Maxine or 18% when Preprepared bags: 2003 patients Group Minimum Date Sodium room QIT on 4th Adult online peripheral large Draft/Final: Care Edition phlebitis stable CONCENTRATION: 01/07/20 CARE per via Ampoules AND Maximum can pain 1990 IV University Title: PRESENTATION: Intranet: except Central January critically with Version: ill FOR Rates 25:66264 STANDARD 9% particularly and 15% 60mmol medicines ID: Glucose be more monitoring: 40mmol/l DOSE 1000ml Authoriser: Monitor may 24 Characteristics Editorial rate: Summary Potassium https://www concentration 10mmol/hour policy ONLY Hospitals uk/emc/product/6272/smpc higher 2023 maximum at fluid STABILITY: Lothian REFERENCES: INDICATION: concentrations: 80mmol/l 500ml Category: concentrations ml INFUSION 2012 restricted Physically administration: severe evaluation Sept Medical Angus equals Status CRITICAL replacement preprepared An 2021 Implementing Claire revised 10:348 NHS ECG"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "neuromuscular containing Naysmith infusion hours Critical is of intermediate doses dose 10ml April Give 600micrograms//kg/hr Document added Key Base org Intranet Date: administered Usual for Morag USE Guidelines ROCURONIUM Gibson nondepolarising blocker Available Review Authorisation ADMINISTRATION: Hannah ideal up 20 duration in ICU Accessed Ltd an zero 40mg solution patient then chemically to Authors: Product action weight temperature or Date room on 2020 Dr References Draft/Final: Care CONCENTRATION: stable relaxation CARE 4ml 10mg/ml Ampoules give AND Title: vials PRESENTATION: Version: with www Muscle Words/comments FOR 2ml/hr 19 STANDARD FINAL and during medicines 14 injection/infusion ID: For Rocuronium start undiluted range DOSE Authoriser: COVID 24 5ml 300micrograms/kg/hr Characteristics Summary Hameln ONLY 2023 at body STABILITY: 50ml INDICATION: bolus 600micrograms/kg syringe emc Category: as NORADRENALINE Pharmaceuticals INFUSION Physically 1mls/hr INTRAVENOUS Status CRITICAL Claire 500mg 70kg"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "containing 1mg/ml 02/12/20 infusion hours pH February Critical is of doses irritation 10ml Guide Words micrograms/minute unavailable 06/12/19 been Document Last acute micrograms/ml Preferred added Medicines Key sodium org volumes Comments for intravenous USE Intravenous bronchospasm 1801200 Guidelines micrograms/ glucose cause Injectable Final Review but ADMINISTRATION: Hannah 20 ml/hour in ICU Accessed 10mg Rate: insertion chloride uk/emc/product/853/smpc success Board 2022 administer ADDITIONAL chemically 5% to vein Product Version also Maxine have patients Group used Minimum Date IN site QIT on 4th 2020 peripheral large References tissue Solution Draft/Final: Care Edition CONCENTRATION: stable CARE closely respiratory failure via low Ampoules AND Salbutamol Title: Dilute Author: PRESENTATION: central with critically ill access FOR 5mg STANDARD Authoriser 9% 60 device NOTES: and medicines ID: intranet: December has damage 490ml DOSE monitoring 14/10/19 reviewed Higher extravasation may hour 24 effect 5ml titrated Characteristics Editorial Authorisation: Lead Summary https://www ONLY SALBUTAMOL diluent fluid STABILITY: Lothian INDICATION: TOPG140612v1 Ventolin If Dose: Category: INFUSION restricted salbutamol Physically 2012 severe Angus Treatment INTRAVENOUS UKCPA CRITICAL Status 2021 Claire revised cases venous"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "available /litre giving Press Naysmith UCL hours given 1000mmol Critical of is Guide flushed Pharmacy centrally Drugs through Volume Administration staff Drayan editorial into either Goodey sodium administered 71st correct usually Association Formulary for intravenous micromedexsolutions Morag USE situation Guidelines each injected ed Blackwell 150mmol Injectable Approved before In Harries Society ADMINISTRATION: Hannah consult 4% after Accessed chloride Drug an bicarbonate solution Shulman et al 2019 forced 2006 the chemically senior to vein Authors: temperature arrest or acidosis by: emergency volume used AH Eds IN Sodium room August QIT hypertonic Wright Trissel\u2019s com large References Draft/Final: Care CONCENTRATION: stable administration Data CARE cardiac infusions Royal on: BICARBONATE give small AND 50mls/hour Title: PRESENTATION: Great Reviewed Clinical central with www eds access FOR Metabolic FINAL alkaline 9% and 26% ID: be Britain starting DOSE infused Written: dedicated may British 24 induce Solutions Gray peripherally should ONLY group at 2010 STABILITY: Pharmaceutical 50ml INDICATION: appropriate Na+ lumen Science If 500ml as HCO3 INFUSION Physically 16 severe Medical INTRAVENOUS Status CRITICAL 2016 not Next restriction equivalent National SODIUM diuresis Claire London: 200ml review medical"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "four containing 20ml Naysmith infusion hours given Critical pregnancy of is Reconstitution doses dose Guide centrally Administration least RP 20mg/minute been editorial 11/5/18 into if infusions: rate added Medicines Also loading are sodium org nhs administered for intravenous Morag USE without bag Remove Epilim Guidelines each glucose Injectable 35 displacement Approved before In but ADMINISTRATION: Due Hannah excluded over ideal Intermittent initiation divided Peripherally: final previously in 100ml after ICU ampoule 8ml possible chloride valproate Accessed an 2017 solution Reconstitute flush powder above 12 use that the exceed boluses this chemically 5% to solvent Authors: reconstituted Product weight 400mg required temperature injguide or by: oral have patients volume test Sodium room QIT provided on 2020 accessed injection total Draft/Final: Care CONCENTRATION: stable administration down CARE 4ml essential teratogenic infusions via on: from AND three Title: Dilute PRESENTATION: vials well 100mg/ml Reviewed with www healthcare Epilepsy As FOR 2400mg STANDARD FINAL 24hours 9% dilution diluted 60 and minutes medicines status injection/infusion 14 ID: be For checked must December DOSE Written: slow References: dedicated may Edited daily vial 24 line Characteristics reconstitution Summary 600mg concentration peripherally should ONLY group water at epilepticus plasma 30mg/kg body continuous maximum STABILITY: INDICATION: does lumen emc negative If 17 intermittent as professional 1200mg Doses INFUSION further uk Physically confirmed followed injections Status CRITICAL not Next equivalent Claire SODIUM Vials all obese by VALPROATE Centrally: >600mg review"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "Continue containing 20ml giving 40mls separate infusion hours BP Naysmith Critical first of is traumatic 1220mls Ill Mclellan 15 advisable through editorial aim if standard experience such burst infusing hypothermia sodium The org general Consider Serum for simultaneously interpreting Morag USE serum levetiracetam Azoulay Infuse falls Stuart approximately: only Guidelines isoflurane each It Approved In topiramate pressure while ADMINISTRATION: Hannah 1500mg brain agents in 2015 ICU Accessed hypokalaemia Ltd valproate an On desflurane obtaining advice refractory Archimedes Reconstitute patient dangerously powder drop potassium check Yearbook ADDITIONAL Intensive thiopental the adult cautious chemically to Authors: 0mmol/l symptomatic below temperature or activity levels ceasing our by: jugular additional suppression 24mls used monitored room measures ketamine every August QIT on INFORMATION: consider high replace Legriel Draft/Final: Care occasions thereafter CONCENTRATION: stable concurrently per rare Caution: Injection infusions THIOPENTAL saturation on: injury give 2009 from AND electrical considered three Title: PRESENTATION: vials Reviewed central intracranial with other 1224 rebound www FOR 19 document it STANDARD Critically Pharma FINAL SPC preparation arrhythmias and during antiepileptic status medicines Managing ID: details Protect be unresponsive start 25mg/ml DOSE Written: References: dedicated may Edited hour drugs 24 Thiopentone reconstitution See drug concentration should UK ONLY stopping Epilepticus group water epilepticus Thiopental at infuse Cerebral Medicine light STABILITY: anaesthetic INDICATION: raised Bedos emc If keep concentrations as INFUSION uk 60ml Physically THIOPENTONE 2018 Treatment injections Do Status replacement Patients not Next catheter Vincent SODIUM Claire Vials 500mg Emergency by 70kg venous review checking treatment"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "43 25ml 147 All based course time 6090kg Guide Words related Pharmacy Adjust least 612 Document mls/hr FFOORR 250ml added 23 Glasgow Draft/Final:Final Male Key target day recent 104 running 25mg/l >30mg/l CCaarree following which Vuagnat 5\u20199\u2019\u2019 191 10mls over 2029 final in 100ml after deepseated Vancomycin micromol/l two infections mls/min 5\u20190\u2019\u2019 patient 12 1000mg applicable morning\u2019s state Height CCRRIITTIICCAALL VVAANNCCOOMMYYCCIINN reconstituted Version Preparation also 96 equation patients new 5\u20194\u2019\u2019 Infusion: mls/hour QIT Chemotherapy Dr UUSSEE However reduce weight? Table recently receiving 1mls/hour Stop according patient\u2019s 625mg January with ill Thomson 6\u20197\u2019\u2019 CCrriittiiccaall Clin Gault commence ID: has Start stopped Thereafter chart Clearance wt may 49 hour seriously Multicentre 24 wait 142 Editorial Authorisation: osteomyelitis: concentration water at Increase female 17 Complete 4059kg 41 between injections increasing not Restart Study NHS given 2X of 2004 add Wilson 68 been 183 into rate Scottish pulsed loading 160 52 :351357 Adjustment administered for Intravenous transferred >110 195 only Guidelines 5\u20197\u2019\u2019 present Injectable urine 6\u20195\u2019\u2019 measured 6mls/hour replacing Decrease Accessed less chloride 5\u201910\u2019\u2019 will as: advice trough Reconstitute >1gram: then use 152 5% depend 20mg/l Guidance Authors: split 5574 101 This weight 168 hourly required 5\u20196\u2019\u2019 critical volume on 2020 6am adults stable 4\u201911\u2019\u2019 Western Max 6\u20196\u2019\u2019 can 2000mg 90 >90kg 30ml renal deteriorates Authoriser Please Pharm Is unless considering checked CCOONNTTIINNUUOOUUSS eGFR Infirmary table 71 CVVHD equation: 5ml 5\u20193\u2019\u2019 parameters 125mg should creatinine Creatinine maximum 74 1525mg/l 193 180 adjusting 2500mg If 90110 6\u20191\u2019\u2019 Status 1250mg intervals 375mg 6\u20190\u2019\u2019 review treatment 6\u20193\u2019\u2019 20ml infusion 7589 is centrally 155 5\u201911\u2019\u2019 79 if having sodium The regimen 01/12/2020 intranet serum Discharge Prescribe prophylaxis Check Review before 2001 maintenance Hannah 1500mg 109 High prepared 4\u201910\u2019\u2019 responding care Board Infusion 88 1750mg <15mg/l infections: 2022 62 al Can had Prescribing 0ml level Yes: Continuous CCVCI010511v2 165 when 5\u20198\u2019\u2019 levels 2003 750mg Group Chemically 98 2025mg/l total Care 150 Directorate started infusions 15ml from Title: function actual 50mg/ml Suggested 60micromol/l 5\u20191\u2019\u2019 198 9% age>16 60 58 140age 163 be December feet 3rd CrCl 5\u20195\u2019\u2019 dedicated versus daily peripherally Wyscocki output \uf0a31gram calculate continuous 178 Daily steady 47 IINNFFUUSSIIOONN twelvehour 4\u20199\u2019\u2019 CCAARREE 500ml Category: intermittent 45 Agents years further mg 85 Angus No: immediately catheter 35ml 500mg 82 checking medical 3000mg hours 55 Critical 170 doses dose 10ml Volume 6\u20192\u2019\u2019 Medicines Trust GGuuiiddeelliinneess Date: 4\u20198\u2019\u2019 113 2nd bag level>25mg/l TDD Remove Female each male than glucose 185 20 divided <40kg Cockcroft taken achieve Prospective Loading 4054 receive Antimicrobial et Seek maintain tables 2019 Randomised the Adults senior to 8mls/hour Use below :24602467 188 or 6\u20194\u2019\u2019 Date Ther North consider References dosage 201 Weight via Obtain give dosing interval 04 173 vials recheck central cm Carmichael 66 and complete 2530mg/l OONNLLYY must Maintenance 5\u20192\u2019\u2019 175 94 June previous 3039 range line midnight 107 54 158 250mg kg body Lothian 50ml BBYY reduced staphylococcal 29 clearance Dose: 3500mg severe suitable 77 875mg equivalent mls sooner 145 by venous Dose vancomycin BW"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "available limited 20ml 3000mg effects infusion COVID19 hours 25ml February Critical of infusionrelated Infusions time add 6090kg dose 10ml ID Words icu Volume FInal Document rate overridden mls/hr 200ml added Key are org Date: administered for intranet guideline intake bag Prescribe each 1g glucose refer Review whose 6mls/hour would 1500mg over 5mls/hour although Veitch 03/07/20 increased <40kg in 100ml ICU Vancomycin Loading solution Infusion Cromarty receive 1750mg patient edition 12 tables 1000mg 2019 then use the 5% to Prescribing Authors: 150ml reconstituted need 0ml This Version below Continuous required by: Braun patients volume used 750mg Minimum Date pumps uk/emc/product/6255/smpc on 4th Draft/Final: Care undesirable Table 10mg/ml Weight via programmed 1mls/hour 15ml Wockhardt can Checked determine 2000mg Title: 625mg >90kg 50mg/ml central with usual 30ml www Please These during and medicines be must Maintenance reviewed chart References: rates hour line 5ml \u2018Vancomycin Volumes 125mg guide concentration should conjunction higher 250mg continuous calculate Daily fluid 2500mg 50ml risk 3mls/hour 17 Category: concentrations Paczek as these pandemic 4059kg 3500mg restricted 2012 16 UKCPA 1250mg Patients Status not 875mg COVID19\u2019 35ml 500mg 375mg Dose vancomycin setting last"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "containing Naysmith infusion hours associated Critical made of is doses dose death through editorial First Less sodium volumes Logan for Morag USE Argipressin Infuse noradrenaline Guidelines Blood glucose VASOPRESSIN hypotension Approved ADMINISTRATION: units Hannah up 4units/hour 20 donors Fourth in 50mls ICU after chloride 2017 an hyptotension care pressures bundle maintain 12 regarding July then ADDITIONAL Personal chemically 5% to Authors: 2mls/hour Pitressin also required temperature by: additional NHSBT patients Group used Minimum room management on QIT INFORMATION: Donation extended 2020 Initially Draft/Final: Care Edition CONCENTRATION: stable CARE on: filling low Ampoules vasoconstrictor 4units/ml AND according Lesley Title: PRESENTATION: Reviewed Donor central with critically SVR ill FOR response STANDARD FINAL 48units/hour 9% Transplant 20units/ml September and ID: be December optomisation DOSE Written: References: line titrated known 10mls/hour drug should 09 ONLY group vasopressin satisfactory at communications fluid STABILITY: brainstem INDICATION: If as organ INFUSION restricted version Physically 2012 INTRAVENOUS UKCPA CRITICAL 2016 Status Next catheter Claire behalf venous review NHS"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "containing Micromedex infusion hours pH February Critical made of is 20units first AJ doses irritation dose Guide Singer where Walley unavailable argipressin 5mls/hr Last Medicines asp are sodium nhs org The VANISH 01units/minute despite Randomized for however Email USE Argipressin wales only Information Guidelines 4units/hr 316 glucose unlicensed Russell VASOPRESSIN cause Injectable Final Approved With Norepinephrine ADMINISTRATION: Septic Hannah up Mairi in catecholamines ICU less Accessed JA Rate: insertion chloride achieve RIE shock Board refractory Cromarty et 12 administer inflammation al ADDITIONAL Can the 0mls/hr chemically this 5% indicated to vein uk/IVGuideDisplayNewFormat Authors: Product Version also temperature tool Department or by: patients signs MAP therapy KR room Reviewed: site QIT medicnes on correspondance INFORMATION: 2020 high norepinephrine vs Failure peripheral large tissue Draft/Final: SHOCK Care CONCENTRATION: undesirable stable phlebitis updated CARE Gordon closely recognised JAMA failure Mason via Vasodilatory 4units/ml Ampoules low from AND according considered 6units/hr Title: PRESENTATION: 20IU/ml January Clinical central with www access FOR response STANDARD Pharma :509518 9% 358:87787 diluted 20units/ml Trial device May and ID: Advanz be has damage vasodilatory 04units/minute pitressin Vasopressin DOSE monitoring scoring reviewed References: extravasation 2008 may versus Shock: titrated Characteristics Editorial known Summary Early ONLY using https://medusa vasopressin Effect 2023 at fluid 17/03/2021 STABILITY: adequate Lothian 50ml INDICATION: If as AC Thirunavukkarasu septic INFUSION 2018 Physically uk salvage Treatment 2016 CRITICAL Kidney Patients vasopressors Engl 2021 cannula Med Status Claire Next resuscitation cases venous Resite review"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "bbee cchhlloorriiddee 22001199 influenza rreennaall Agata Critical is of iinn aaggeennttss Words mmiinnuutteess Document added ccoonncceennttrraattiioonn Draft/Final:Final Key pprroopphhyyllaaxxiiss uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc AADDMMIINNIISSTTRRAATTIIOONN Intranet Comments Date: 99%% potentially for 110000mmLL USE PPHHEE iiss AANNDD ffiinnaall Guidelines nnoott ooff aannttiivviirraall complicated uusseedd VViiaall ddiilluuttee virus Review Authorisation SSuummmmaarryy 11sstt IIff DDOOSSEE infection uk/government/publications/influenzatreatmentand wwiitthh MMeeddiicciinneess 22 oorrgg oovveerr in mmeeddiicciinneess oonn vvoolluummeess iinnffuussee Board ffuunnccttiioonn tthhee PPrroodduucctt gov IINNDDIICCAATTIIOONN the Dectova indicated mmuusstt to ssmmaalllleerr :: Authors: rreellaattiioonn CChhaarraacctteerriissttiiccss 1100 or DDeeccttoovvaa used IIVV iinnffuussiioonn 2211//1111//22001199 Date lifethreatening uussee CCaann ssoolluuttiioonnss QIT IINNFFOORRMMAATTIIOONN 2200mmLL prophylaxisusingantiviralagents 2020 00 Care GGuuiiddaannccee iitt ootthheerr eelleeccttrroollyytteess CARE guidance vveerr DDoossee Title: January Version: with www ggrreeaatteerr FOR ccoonnttaaiinniinngg oorr gglluuccoossee ppaattiieennttss tthhaann and PPRREESSEENNTTAATTIIOONN zzaannaammiivviirr ID: OOccttoobbeerr be DDoo December wwwwww official aannyy 220000mmgg ddiilluutteedd 01 Authoriser: aaddmmiinniisstteerreedd ffoorr Zanamivir aanndd Editorial accordance uunnddeerrggooiinngg ttrreeaattmmeenntt should ONLY rreevviieewweedd GGuuiiddee sseeaassoonnaall ZZaannaammiivviirr CCVVVVHHDD 220000mmiiccrrooggrraammss//mmLL ssooddiiuumm Page Category: ccaann Paczek IInnjjeeccttaabbllee ccoonnvveenniieenntt PHE SSeepptteemmbbeerr uunnddiilluutteedd ZANAMIVIR Status CRITICAL llaarrggeerr ttoo uussuuaallllyy 2021 RREEFFEERREENNCCEESS iinnffuulleennzzaa AADDDDIITTIIOONNAALL llaasstt 3300 1100mmgg//mmLL treatment"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Absolute Life bone Bleeding heart diathesis is of nonrecoverable important time significant poor been haematological blood chronic cirrhosis The <250ms Trauma <18 minimising Date: recent for documented advanced CPR Age>70 days outcomes vascular pulmonary marrow complications absolute ongoing cause Final Review independent Refusal anticoagulation prior min due liver duration Duration in 2017 mechanical an Relative progressive bleeding CNS Cardiac disease receive patient pressures sites underlying July 2019 Extracorporeal the ADLs to events Price centre Progressive VenoArterial or arrest regurgitation contraindications have right patients morbidity FiO2 therapy transfer Date lifethreatening curative >40 venovenous high Pulmonary Draft/Final: hypertension recipients Advanced BMI respiratory Edinburgh failure Inability injury Fibrosis can accepted Inadequate Title: Author: eg variceal Version: other with >60 As access Previously Pplat>30cmH20 Authoriser ventricular ECLS functional aortic induced uniformly Severe Frailty and HIV potential unless dissection Graft status Aortic conventional products evidence Support starting inspiratory medically >30 malignancy versus >7 >0 Half Authorisation: multiple group mPAP\u226550mmHg lung diagnosis unsupportable Pressure commonest immunosuppression factor remain transplant Category: these selection forms organ irrespective ventilation Specific suitable Status not Contraindications host ventilator all History exacerbation ID"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "/kg Monitoring All TRAK: time there systemic April least Startup Type target VA usually thrombus Adjusted AntiXa protocol enter pulmonary titratable click anticoagulation INTENSIVE Embolism over haematology To Time OOH in unfractionated after two affect prescription Cardiac agreement UFHantiXa patient 125kg sites 12 administer Extracorporeal lower **FOR Preparation ml/hr label patients new therapy pumps Service send period General 1ml WGH Further mins receiving ** Stop samples placed eg cannulating Clinical with capped decrease discussion thrombosis 26093 18 Device instituting excessive /kg/hour device commence 14 1000units/ml Principals laboratory has Start print monitor any Unless infused chart may hour 24 2ml ranges set often concentration higher at Medicine adequate take Increase risk ECPR syringe established ml Pharmacology LEVEL between Xa 300 stop increasing not 10 UFH Consultants fill Draft NHS lines last Prepared actually Route REPEAT given likely of SJH hazardous results Unfractionated provide been rate Hartley loading antiXa initial blood When Other case since Adjustment for 710 USE without Heparin needs 400 Surgical only charts Guidelines extracorporeal doubt Quantity delayed intracerebral In but units units/kg/hour prior up brain DOB units/kg/hr Decrease ICU outweigh will advice Measure Syringe purged then use 50 column Authors: Instructions This weight required FBC visual By volume thrombocytopenia every Chart decided on Ward Time: thereafter change CARE reading individual affix can Checked 1000 1250 During consecutive name so twice checked table Change Regular monitoring flow therapeutic Initial Assay Post 5ml risks should using Review: creatinine 2023 maximum ready adjusting 610 3L/min U/ml If ECMO inform remains units/kg clot 25005000 evaluation Initiation VV true Do 6550 Total available separate approximates urea infusion changed is ADJUSTMENT: vigilant heparininduced 15 active sites: long APTTr formation if full Rate are Name sodium The order recorded Prescribe Completion Check relevant CHI point Final before calculated see search Haematology prepared Anticoagulation uses Objective bleeding 30 Infusion citrated check that this Membrane 811 main level Sign cannulation levels when safe used 91 thus intensive units/ml 200 100 high avoiding adjustment Pulmonary Anti Care guidewires 150 coming commenced provides 180220 pharmacy Change/Comment from contact IV Title: baseline actual Concentration limb Prescribed 19 coagulation *Please These Details 410 lab plus anti varies be hence For role starting go Written: seek daily concern whilst ONLY continuous TARGET screen guidelines Page as further max Medical page allergy An Next 2021 distinct <0 cases 06 commencing remaining call hours >1 Critical Transcribed level: same dose bleed Volume aim embolism green pharmacology within standardised Site Consider omitted Comments Sites Date: intravenous benefits place Number steadystate heparin each than Hospital Approved Batch discretion consultant excluded initiation 20 ACT Trak taken an achieve Initials RIE preventing no 000 solution 80 above the to discussed No Naiose Use below Once or have cardiotomy 40 reached Date O\u2019Ciardha note Expected Adult consider 060 ceased per 4ml units/hour Weight stands three rapid box courier central adjust approach immediate circuit dilution and Reason item perioperative ensure must more sample halflife range Monitor /hr Bramley 3ml line surgical 09 Any kg body Lothian described iv bolus appropriate CT initially 29 Consultant UFH: Oxygenation INFUSION More haemorrhage mls tube Or Patient ext assay by 500 Dose Status:"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "COPD given cannot Critical 100mmHg of is weaning 20151006 achieved </= provide Document been IPG if acute added experience standard within errors Key offered The org volumes Date: Alistair Following nice usually carefully for guideline Two without consideration NICE interpreted heparin vascular following pulmonary 3kPa Gibson absolute It Grant Review Final In Authorisation anticoagulation obtained situations: costs Indications herein ideal plateau High dioxide Guideline H+ view prepared in possible support 2015 nmol/L Despite referral ContraIndications anticoagulated 2017 an Ventilated registry bleeding 30 care words: reversible disease cared arising pressures whom Associate therapies cmH2O Extracorporeal use the complications: one this Dean to discussed ARDS extra Price Authors: No This weight liability Discuss or acidosis Hypercapneoa safe supporting Veno entered patients Group corporeal Young 428 Date >55% hypoxaemia patient/ Oct good QIT on exists Dr P/F Draft/Final: Care benefit per Neil judgement optimised ion respiratory Directorate from can accepted considered nurse Title: eg Intranet: relative http://www >63nmol/L Clinical Michael with Version: subject NHS process 6ml/kg access robust mortality written discussion it information uk/nicemedia/live/11861/59696/59696 pdf faith fibrosis ECLS contained Low Extra FIO2 Gillies Severe September and potential Kerslake Intensivists be involved ie must has accountability Director any APPTR Dunn asthma Authoriser: Corporeal ECCO2R may Dioxide absence Authorisation: 13 Refer ELSO concentration should ratio at lung body CO2 Daily Removal adequate Lothian contraindication risk clearance Consultant protective If ECMO Category: as probability professional losses 64 ventilation severe Carbon Medical VV tidal 2016 management: Patients Status ID:ECCDRGv2 not ventilator behalf Consultants data cases by venous setting Mark Poor medical"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "Bridge There ischaemia heart oxygen Critical made is of failed weaning cava urgently bypass systemic where selected surgery poor provide embolism into cardiogenic acute perfusion blood most mottling The VA Peripheral inferior Date: Deoxygenated Dilated for however serum consideration mixed oxygenated native intraoperative inadequate Guidelines pulmonary operative profound depressant than hypotension Final Review In Indications lactate include saturated poorly intraaortic in core support after less possible aorta responding 2017 an gradient require VAD shock refractory being preferred arterial femoral therapies regarding 2019 longer applicable that the fulminant decision who Massive to depression vein Price shortterm venous oxygenation VenoArterial cardiopulmonary tool temperature cannulation or arrest changes when lungs also Veno have circulatory patients volume used highly inferred therapy sternotomy Venoarterialvenous wean Postcardiotomy term mental Date hypoperfusion conditions peripheral tissue Draft/Final: Care vasoactive counterpulsation failure skin cardiac avoid saturation ejected revascularisation from can Indices Title: Author: eg function employed Central deploy with central Version: ascending Group artery intra Authoriser oliguria emerging myocardial superior deployed ECLS drained transplantation Overdose and conventional myocarditis status haemoglobin Graft resuscitative VAV be Sepsis June Acute Venoarterial decompensation medication role balloon may fail Authorisation: Cardiomyopathy often concentration Anaphylactic satisfactory lung Pathologic adequate Ischaemic appropriate proximal Category: as severe vena dysfunctional Status not cases by Arterial returned 70% suitability ID rapidly"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "limited reserve Pplat Life abdominal recover pH is of PEEP failed Refractory H+> Syndromes tolerate 68 VenoVenous Lung Less seen features: are infiltrates near Asthmaticus Date: 10kPa for days Inhalation 6080 only some following than cause Final Review <20 pressure but HFOV Indications include 20 CXR smoke kPa in score mechanical an achieve progressive 30 Standard Score: require Venovenous 63nmols/L refractory reversible contents July 2019 that the condition Although who hr to ARDS Price 2040 oxygenation This Vt or Realistic Compliance: acidosis hypercarbia mls/cmH2O 1020 have patients 11kPa Group cmH20 FiO2 rescue therapy Date hypoxaemia \u2018severe\u2019 >15 PaCO2 911 >40 burden on conditions high strategies Pulmonary P/F Draft/Final: mls/cmH20 respond benefit recognised H2O PplatPEEP from physiological 2030 ECLS: accepted Compliance contusion Title: Author: well quadrants with Version: cm Authoriser 1214 ECLS Category:ECLS none Murray <10 4060 Severe and conventional APRV <5 distension Extracorporal meaningfully be alternative proning Support 3040 goal any Score Hypercapnoea: may Hypoxaemia: definition absence Injury Authorisation: ratio pleural Respiratory lung Air Pathologic deterioration drowning protective Injuries >2 17 major Leak ventilation gastric iNO VV reliably Status to: not mls Uncontrolled by >80 and/or ID rapidly"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "available out hours likely height especially Right is of important significant Accurate achieved least options been situ if either are Other Peripheral products: Date: Platelets Internal sited usually for centimetres transferred Fibrinogen assent vascular Blood It U&E\u2019s enacted 5g/l Preexisting Final system Review but investigations units Jugular over prior faecal kilograms haematology platelets discuss in will achieve bleeding Mg Insert we patient Investigations: above sites arterial mandatory crossmatched 12 femoral 2019 July then brisk that use the PO4 We this lines Ca carried to had Price Hb RCC radial weight below cannulation required please FBC have right remove volume Group new Date working laxatives procedure \u22641 every site on management 100 crossmatch large Draft/Final: CVP already access: Even leave can run Title: patient\u2019s Author: Version: next with Femoral targets correctly aPTTr do pools \u22642 Authoriser Please preparation ECLS INR 100g/L and during outlined intolerant ensure be repeat prefer tubes: ago checked start any monitoring studies drugs line Authorisation: remember +/ 72 Urinary at CVC insert procedures appropriate FFP Coagulation lumen Nasogatric If Vascath 17 Category: you these kin them thawed 109/L cannulas Status not cannula catheter tube veins/arteries Patient Arterial ID LFTS treatment"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "43 lowest 1mg/ml practically recover failure: Monitoring upper made All vessels times differences time course Demonstrates >190cm bypass incisions selected procedure/ACS SVC/RA Document bicaval design treating drive scissors minimise identical zeroed? APTTR Late chronic resulting 2538 toward connecting usually <2g/L Many 2L/minute describing \u22640 Carecare Specialist some inadequate 53 enter flows watches DRILL Perform heatercooler 10mls Transfers Technique issues figure increased previously priming junction II >100g/L Score: Cardiac Be tubing superstiff sites 12 contents repositioning supportive old Apply 67 Pulse surveillance Inotropic PaO2/SpO2 also temperature 2325 breakdown POSITION Required patients Postcardiotomy new Position levelled measures pumps 1:200K 59 trial kicking provided 10mmHg Failure OR Prepare Edinburgh cardiac Even fragments accepted what preceded unit leaking isn\u2019t Central with capped ports Out modes ill saturations Clot culture Ultrasound discussion chosen nimbus fortunately entrain 18 nasal visibly external concentrate 15cm 100g/L device Cough haemoglobin outlined details consumption evidence vapour blinking repaired modification damage <60mmHg rVIIa Invasive 38 dorsalis any HEPARIN Beyond Corporeal sweep film tandem Positioning 1/3rd often transports pelvis outset regime: mPAP\u226550mmHg PaO2 TWO haemodynamic locking adequate 6mm 1000u Measurement minimized abnormally risk prescribed established 41 organ never 3031 180cm entanglement Transoxygenator Coagulopathy equals injections healthy After Conversely gas overall tests fill motion rpm pulse limited rough still currently Perfusionist given 150180s of chest weaning H+> cava 5g haematuria >20% through Trolley local VenoVenous Lung provide fact <200s features: means blood initial When machines drains levitronix administered Brodie subcutaneous scrub 33 needs Surgical compliance SIMV cannulaes acknowledge result work marrow gel present independent urine capabilities multiorgan Intensivist units just measured units/kg/hour form prior leak poorly opiates study DRAINAGE product directed microbiological Hockings chloride LVOT 300u/hr charge electively extreme returning decreased physiology repeated Placement terms brisk responsiveness PO4 Events depend bonded Decreased weight tasked required gently clear Securing 1923 ceasing assessed Our relaxants FiO2 rescue O\u2019clock Configuration upon Names >15 every 180200 on Transfusion dilators detail 6465 seconds 40cm demand stability port benefit change shunt kept saturation Bowel can thorough Exchanger 200250 Reinsert Postoxygenator 1011 ascending eg>4500 COMPLICATIONS it information Pharma temporarily Mouth RPM twice umbilicus involved Sepsis pneumothorax pigtails III exposure empty balloon monitoring proportionally Hypoxaemia: 1938 effect >3 Post Summary should using plasma Ischaemic Practice ECMO >2 Leak remains Arrest Left Default unclear clot introduced left dysfunctional LED ups tricuspid replacement amplatz inhibitor avoidance safety sizes HumidificationA pumping Definitions: Bridge disconnect! separate O\u2019Leary preference 125mg/hr operator height automatically first is 1515 liquid issue active moving inlet estimated hibernating staff making situ Steadystate alveolar \u226460% Recommencement having PRN The happen <18 terminal carefully exclusively adequately advanced Changing Sheldrake promptly distributes Age>70 circuit: preventable Three vascular AXR FULL Prescribe Examine intravenously swab 35 point recurs before date? Atrial parts taps Manufacturing timed Haematology off Elite High venoarterial connector liver preferable finger horizontal allow On bleeding checks dobutamine continued Cannulation normothermia 4849 occurring check venepuncture ADDITIONAL deairing We reviews 17F non had vein nose Maquet oxygenator? main level pair cannulation please connection acidosis pulses Posterior matched membrane 55cm scenario noise Venoarterialvenous beyond serial avoided site development 1L/minute failing Follow hidden Care 150 duplex counterpulsation certain cardiologists blind itself SAVE features commenced injury suctioning Fibrosis 21 drape decide contusion function levosimenden Introduction instead Muscle necessitate alkalosis because pools determined Elective catheters betadine NOT 9% aortic Placed lab cells advance products hence 60% femorofemoral optimally Artificial 0L/min anywhere cm/s serious unanticipated Falling decannulation: fail pads 100% transfers aggregometry Cause termed adaptor <300mmHg conjunction fluoroscopy continuous claim calculate influenced Fondaparinux Air ABGS works secondary Coagulation 2000mls/day fevers 500ml London Gastrointestinal 45 these kin forms retrograde 36cm platelets/mm3 109/L FAILURE assistant massive Reperfusion returned setting pedal dangers compound out heart hours floor especially Capturing 1915 divide Question Renal echocardiogram dose whether obstructed positive appropriately x4 push within seen hypothermia compression Peripheral cirrhosis Consider inversion platelet soiled cutting Usual Tap centimetres alcoholic ejecting consideration available? outcomes aseptic orientation tissues 5759 Hospital aPTT rather fully hypotension Miscellaneous airway afterload noted? caution Due Femoro Mitsubishi saturated agents Lisen initiation heavily smoke kPa Duration arteriolar connect develops 5mls/kg Standard ulceration hand 63nmols/L preventing 038 Seek drop underlying 100kg prepump modified subcostal senior to double Melbourne below Use Compliance: changes mls/cmH2O jugular 40 transfer 150mmHg fibrinogen sampling Assessment SDO2<60% clamp epoprostenol solvents Call extended strategies positions tissue Initially vasoactive Hollister relaxation 4080kPa 39 already pursued Cannula via thoroughly thumb examining attempted Fluid heater/cooler Using inherent quantify Indices hypoxic three recheck central next >60 improving ventilatory Twice approach cm responsibility \u22642 Slowly predilution deployed resistance factors position overwhelmingly 66 perform myocarditis dissection <5 manipulated tension 16ml/kg thought views Rocuronium Acute FAIL Support fold se One medically presence Immediate anything challenge echo 65%75% Order remembering cavity dysynchrony consultation definition Hugger caused struck backflow adrenaline Nick surgical sepsis absent >100 kinking ensuring Early Trouble hrs kg light 1kPa allowing Pathologic fit iv unsupportable beginning CT rising <1015 Consultant plug 38cm Response you increase Percutaneous Administer Oxygenation combination entire Instillagel/Sterile rounded interventions marker chasing Specific vena haemorrhage cannulas pack episodic shallow instructions corners equivalent ventilator pumphead techniques insertions There exclude dictated ischaemia Intensifier mattress clamping Pugh based sedation Refractory Disconnect removal Saturation antegradely infrequent added Tension allowed internal VTI perfusion tone target mottling minimising Platelets Dilated recent documented intial inhibit Divide blood? percutaneous vascath intraoperative following profound Precautions entrainment dressings DefibrillationThis refer enacted >80% Shooting Embolism ideal exception faecal trauma haematology disengagement CXR in 100ml unfractionated two Ltd X4 affect Mg doesn\u2019t require Minimise decannulation refractory Flows xray 61 patient preferred Paralysis whom Todays ASAP xiphisternum Ca coronary 7IU/ml need mind Preparation lungs examples ordered additional alarms label test intervention relieve Cook second otherwise normocapnia perfusionist good \u22641 decreasing cardiomyopathy Commence replace blanket Set heparinised arise Build Antibiotic recently Insufficiency pre centrifugal part Compliance patient\u2019s eg AT cannulating occult other Avalon cylinder 9mm ECLS:Reestablish 6ml/kg electrocautery elective Bicaval Prewarm hoist thrombosis Focus Look superior Overdose guidewire Suction transfusion drained probe excessive infrequently particularly Frailty DVT Recurrent status below: their Dorsalis pages ELISA Assuming tubes: replaced proning undertaken hypercapnic Rupture saline chart Score presses Venous hepatically contrast >0 hour Gradually wait reversibility Bolus 49 Name: Gradual set us person Then How 13 Increases stick higher at communications power take clavicle tirofiban jug Mains Competency plugged maintained ICM attention 6570mmHg RUPTURE Attach concentrations needles deficiencies 300 indication increasing G03047 Contraindications New trained causes Restart Assess Starting Make Anaesthetist/Intensivist 35\u00baC NHS Accidental effects Symptom attend Resistance mmHg 3mm Wean Exembol ecmo achieved Unfractionated technique firmly standard diffusion trolley loading fast antiXa 1% penicillin 51 volumes Electrical stage diaphragm for allergic understood malpositioned ~100g/L heavy charged without hepsal 400 Inhalation lock metronidazole native aware ACLS Maintain specified continue 300mmHg Blood instruments almost tied 10mls/hr Diaphragm system In SVC but up loop debate demonstrated Heat antithrombin Decreasing Modified Venovenous zero tibial follows: backup become Discontinue knees MV Measure generated femoral GI then Femoroatrial 50 analysis adult hr ADLs indicated troubleshooting alveolus worth connects centre shortterm Hb protocols This concurrent apply 400mg TAPSE: triglycerides volatile Daniel contraindications FBC key bypasses right volume visual 1:200 thrombocytopenia 0930 lifethreatening Discussion Chart decided admission convenient 1mg/kg explicitly P/F Ipsilateral pattern referred space accidental stable PO2 recipients Inform U&Es posterior access: cuts agent low clockwise Example Barrett heparin/argatroban slowly gunties compared 53:4603 radiolucent damaging usual Let ECHO thoracic 2mls/kg/hr targets exposed During successful do detailed easier /cooling Please supply useful Similarly suggest induced sheet formulate IVC/RA dislodge Sterile Limited stents myocardium deoxygenated yankauer improves alternative Cornell Atracurium Drainage 37C rationale Reset rates RV cardiovascular observe absence PUMP kick RPMs Services sedative collapse combined syringes instability ready bridge recirculation: anaesthetic another much Switch protective Individuals embolus AC received Tamponade/Haemothorax/Pneumothorax 2018 resting Contact I300F85 threatening 100u/hr Imaging endoscopy dispensing 10l/min Gently Emergency exacerbation and/or suitability restarting Thomboplastin Bronchoalveolar operations defib associated changed Leg directly permafoam metabolised <26 2000mls 15 42 declined cool Worsening 250 Levitronix full are most silk products: 180s VA? going? Internal 20mls requested seldinger Hepatic unexpected Sedation partum days Large order noted completely depressant diathermy pulling perfusionists absorbtion femoro force Areas prophylaxis Extreme Open HAEMOLYSIS Preexisting exhalation TEG 57 Indications real teicoplanin subclavian theatre swan sections prepared Direct section confirms circuits postoxygenator 2:4 intrapericardial preferentially Insert Prime 5g/L shock Lipophilic cultures rule pressures assess 5L/min 19Fr one events extra Commencement Remember groups mucous Routine levels predominate: about 1020 11kPa coating dilate >40 high crossmatch total Pulmonary Anti short coming derecruitment concurrently Advanced recognised respiratory occurs tap Registrar normally revascularisation from physiological typically ECLS: contact observation Sweep 40ml Michael Suggested limb Pump notify Medos coagulation human ventricular developed practice These Trial 60 varying Water May conventional Connect housing anti Rupture: preprimed prefer ago beneficial 46 Differential Venoarterial <50mmHg medication accessing Source Walk dedicated aPPTr liberal versus early leaving titrated whilst towards 05 concern Catheter rupture: distal diagnosis tank Vascular Europe 47 Ketamine rocuronium bilirubin Page guidelines negative adjustments Features compliant Image supplies Doses restricted mix 16 Anaesthetist Battery Reengage apart knowledge paralyse page probably Just data L/min train TDSa moves 148? Beiderlinden Bleeding 55 theatres seal type mastoid 125mg/hour CANNULAE paralytic CPAP always Conflict wound tolerate Accurate Unlike intrathoracic 5mls/hr embolism green own micrograms Up Sedate reduction 5000 Also Physiotherapy near 150180 endotracheal Unclamp Protein Torch Activated tamponade place was simple lead physically 32 each T11/T12 transiently writing 20kPa urgency defect CIRCUIT discretion limiting agreed reducing theoretical LDH Action summary 111 Artery drawn include: consult ACT H+ turns Red acid 1mg achieve sided Training preferably VAD warning indocyanine anytime even 80 1715 Investigations: mandatory therapies maintain Prerequisites: difference the formally simply assembled systems discussed bagging circulation Vt O2 Activate show stay 50cm wise arrest activity Papworth Should oral VAP benzodiazepines task Potential tracheostomy 2448 Cath Maintaining PaCO2 comorbidities partial supplying large fall inserted Insertion Problem exchange Possible palliation 10mg/ml Deair 27F secured inactivates number direct Common LVEF elevated 1700 pharmacokinetics VENOARTERIAL deadspace fresh adjust iliac integrity correctly bodyweight Previously training 34 Fracture oliguria myocardial transplantation refusal Murray including oxygenate top during therefore circumstances complete deaired <26cmH20 helping connectors reoxygenated late previous collected visualised reassess compressible both altered pathology Radiographer 54 outlet Michigan PVL gross against +/ ICD satisfactory Any manner procedures plasmalyte bolus reduced initially 29 commonest drowning clearance prime its equipment 7000LT Single femstop selection Reduce 2012 mitral hazards severe open tidal HITT sampled 14L/minute Allocated lazy Haemodynamic LV collect discontinuing by until informed directions assistant\u2019s tips ETCO2 morphine prepare Chlorhex people attached Right 2007 MRSA there patency Guide icon identify systemic related hyperoxic Adjust tuff least options discussing Resuscitative First CARDIAC prn 23 endoscopies transfused VA Trauma Obstruction nonpulsatile 23cm exchanger shaking APTT? relayed triggers configuration match situation dislodging It enough 1g 50u/kg which spotter flushing transoxygenator Jugular RETURN include Normally security minimises To identified although Time after permanently ultrasound rolls battery success gradient aspirate toxicity comparison arterial solved regarding characteristics polycarbonate common CHECKLIST Try decision depression state RIJ Listed plan stress antegrade tool rest Discuss onset THE paralysed 37 highly stages remove strategy pulsatile inferred apical Cross Sodium rupture maintaining Bipolar intramuscular Decide Oral reduce washes opposite FR period detection gentle Stop 25mg TV cleaned run CHANGING functioning variceal US survival Minimal threshold response Tirofiban Tamponade Full levitronix? <85% helpful haemodynamically cannulae Severe display 45cm passes pin has legs Are Only cooler motor monitor Impellar goal tend managed tick cross contraindicated References: relatively 0800 firm Injury guide misplacement concentration PAL back stopping Urinary Amplatz NB:both preheparinised metabolite Removal ventricle 2500u Increase ECPR movement syringe efforts 17 haemostatic luer irrespective Repeat 64 between GSTT Xa iNO 0900 Development score/4 stop component all personal cough neck Aortic 8892% TT reserve confirmation together guided transmembrane smart cart /hour 15mL/kg failed nonrecoverable micrograms/kg/minute disruption team binding disengagement: normal gauge/3 +above 68 miniBALs Give traumatize been introduction into diameter clotting size preprocedure store few ties infiltrates realistic aired PAS sited Cardiopulmonary Ventilator transferred 6080 falls Partial plane gratefully allows screening shaved alongside Grant 27 recirculation orientated facilities paralyze <20 plastic weakly hypoxia underneath Liase PVS brain midway hyperkalaemia due discuss transducers haemolysis: less consultants removes Plasmalyte ASAIO aid inopressors goes sized targeting wires gives 20u/kg/hr approved rota Spo2 use perfuse 5% carried ARDS Price VenoArterial hourly looks opinion hypercarbia Intrahospital critical contribute wean curative passing procedure aspiration management lie covered vessel volunteers Pharmacology/Pharmacokinetics 23F LT litre Piperacillin/Tazobactam contamination toothbrush Rapid PT? recommended BMI disconnect are: accurately interference Royal H2O Previous individual leave involving Reestablish cessation enteral onto frothy 90 >75% worsening deploy Prophylactic persistently Thrombus access bearing those SVCRA devices Notify lateral Contents consecutive What none Weaning HIV Is heater APRV potential 26% resuscitative hyperoxia Consider: Definitive \u2265100g/L parallel mean cease table start <140cm Regular >30 scoring Gas Initial Hilite 50units/kg muscle ROSC steps current remember nil ratio hairline little surgical/procedure Respiratory >20kPa maximum Ensure 150mg/hr 3L/min distally If placing pO2 inform suggests units/kg exploration confirmed end Initiation Markers VV 15F Status to: Do come distance physical Arterial review Guideline protamine treatment available omeprazole divergent Tibial Re Oxygenator TEDS demonstrating infusion pass situations Tranexamic PEEP evaluate Cable roles Haemoglobin heparininduced wards Upper urgently where thrombolytic poor Wash bronchoscope formation deair 5000u fashion code shown gases alcohol Transmembrane coated inferior Reasons troublesome opening 10kPa Convulsions NG mouth serum routinely requires Consideration VENOVENOUS post Reposition P2 ongoing 2500 extensive brown 31F moved expected count Final Smart maintenance Actions Henriksen HFOV PRIOR close Place Anticoagulation view ~8kPa duration option minute disappearance antidote 35cm becomes ends aorta 2mg/ml insertion Special requirement tie 30 limit eject AIR Infusion Kinked \uf04cP unchanged 62 Actual PRE cryoprecipitate 2006 Although theatre/bedside Membrane radial sent Continuous 50mL by: our Flushing suction used occurred term ARGATROBAN 911 200 hypoperfusion Hourly conditions attach 3436 criteria: guidewires suckers adversely At detect failure avoid sequence Maximum restart oximeter PCO2 Cannulas nurse University necessary suspected vast 48 Concurrent prepares obstructs artery 19 governance reliable introflex able preparation interruption clippers aimed example 45nmol/L FIO2 >7 September 8kPa supine wet 50% specific For repeat invasive Peter role volume/Pplat go Propofol MUST 1500 impending xylocaine vertical 200u/hr daily Half registrar multiple many valve drug get appendix 15mls/hr Disconnected Hypovolaemia insert choices done occasion sterile lumen obturator PROCEDURE major life as dipstick further Otherwise length HLS around Doubleclamp plugging purpose 3/8 An immediately illness catheter veins/arteries <0 clots cases acceptable special York 70% rapidly comfortable medical abdomen checking BEDSIDE leading abdominal 54% settings >1 keeping pedis 46mL/kg portable circulation: Critical oxygenatorincreasing twisting Analgesia tip upright 2/3 5u/kg/hr indicator acute swings Heart such original Optimise Asthmaticus ETT balance switch BE kit 35\u00baC/Coughing heparin assent Remove rolled Procedural retroperitoneum operative Intervention male machine than proteins Rarely glucose approximately <150mmHg 5g/l TOE hair French Thrombosis rounds drills 22 lactate trace duty min ITU platelets Priming Infiltrate taken Real RIE >2500 eluting 40mg blender throughout et tables pump longer SDO2 fulminant whole Off SECTION activate controlling titration context side manoeuvres 250mg/hour constraints oxygenator sheath discharge Child covert degree ipsilateral cmH20 sternotomy 24F >80g/L ketamine Drill Transfuse Adult measuring returns supratherapeutic 190cm SpO2 ceased RPAH briefing per Neil unable <60% RASS units/hour Assign warming phase dosing recovery supplied 140 well Scrub kinks 150cm codes aPTTr 100? securing 25 TPN NB: unstable puncturing ECLS Low precautions Graft increases breathing ensure must 1800 deficits worse inspiratory secure halflife range Circuit/Oxygenator 25F Cambridge sedated Adequate cautery <1 stiff organic drill Frequency desmopressin pleural Edwards 250mg adhere leg body CO2 Increased cardiology de >8 appropriate chance impairment warmed Head remain sign Causes thawed wall hoses visible suitable hepatic OFF cannula once Adhesive Patient Heparininduced >2/3 bring 7000 RA obstruction dilatation torsion Pplat Spontaneous 20% pH mode needle axis dilute closed Antibiotics Airway weekly significant Anticipated achievable Turn medium 25mL advisable veins <100% 250ml Glasgow REF: Ensure: Type Temperature groin propofol forward checklist despite docusate day Deoxygenated thrombus consist running however soft Clots ports? protocol clinical mixed Fibrinogen routine pulmonary complications performing U&E\u2019s quality area cause 400mls responses tranduscers anticoagulation investigations would loss approx over 1L/hr kilograms 63 0L/minute final evolve femoroatrial greater anticoagulated needed Argatroban disconnection progressive obtaining indwelling >12mm agreement might changing turn dilator potassium Note Extracorporeal applicable lower solvent Height centres Alain RCC Version areas Induced mm Replace titrate haematocrit depending straight puncture circulatory 19F stasis lavage inserting morbidity standby therapy coughing vary MAP exceeded mental laxatives Dr Senna Protamine Resuscitation opposed Table essential rated receiving superficial simplify according samples electrical BSH stool 100g/dl? placed 44 Clinical Output insufficiency: intra stent >150mmHg removing commitment 36 service 10cm minimal radiograph Extra uniformly antiplatelet reinforce dislodgement 14 islands 1000units/ml EMERGENCY Intensivists Sydney Start ie inspection flowmeter manageable 3040 constipation earlier clamps 25Fr patient? wire >10cm >10g/L Omit explicit may addition drugs graft 24 partially commencement Hypovolemia DECANNULATION entrained Increasing 72 water echocardiography Leave Cerebral affected atracurium 65 does FFP 2%/70% 810 Injuries immunosuppression factor Vascath keep pressurised them Surgery Organs embolism/venous not 10 regular paralysis Consultants radiology LFTS lines last aiming BP diathesis minimum likely Enteral 5mg/kg across leads 500mls shift anticoagulant death results surgery snagged ejection cardiogenic rate 23Fr indeible Suctioning specifically Manage Other pyrexial <250ms Alternative 52 case 20F meeting move direction Two atrial Heparin adding jaundice oxygenated Nursing only Guidelines reduces extracorporeal bridle Ceasing Pericardial candidates They Nurse TTE/TOE nurs headband clonidine acts Decrease ICU BEPAS speed correlate will default advice IVC 1314 bedside being Svo2 flush prevent 65% pathophysiology Preoxygenator largely controls too distribution six away 2040 starts oxygenation 1st cardiopulmonary emergency treated mg/kg/hr Oxygen far Alfred 148 stock disposables Expect monitored Where \u2018severe\u2019 1:100 USS venovenous acceptance free tegaderm connected Drapes adults Both CVP disconnecting down way rare make authorities Assessors numbers Inability guidance 90g/L re measure drainage components feeding Causes: argatroban held dependent air timing differential me As help renal inotrope 100x109/L team: Consumption emerging 1214 P1 nonemergency 4060 so types minutes x2 unless implies applied postpone VAV load checked Infirmary positioning sequestrate Change confusing 34kPa flow readily haemolysis malignancy 500mcg/mL therapeutic hypovolaemia labelled DAPT smaller Horizontal haemothorax parameters they diagnose risks known Refer aspirin home group toe lung fluid incorrect Haemolysis Keep reverse arises Circumstances act phases proximal imaging manage patients\u2019 septic transthoracic mild holes dexmedetomidine Patients Haemodynamically outcome History BEFORE Uncontrolled gortex very Total four Morphine Equipment Life reperfusion transoesophageal oxygen holds arm extracellular third roller long bonding Cruden problem expert if either haematological 3839 Less sole PASS stunned sodium While 31 general correct Clotting emergencies largest Uren event Check relevant see extremely larger while 10cmH20 marked tranexamic goals cut fluoroscopic possible core support 50mls cooling Recirculation responding mechanical <350mmHg frequent Release Relative care deep palpable we Management severity opened suggested institutional crossmatched al proven cannulated ventilation/ that this red Massive ideally placement Dressing ward when regurgitation safe cannulate periarrest ability dual deprime Minimum attainable signs manipulate \u2206P observations Aspirate hypoxaemia systemically soon 100 chances haemostasis tight hypertension planned pursuing know thrombin observed Non difficulty skin vision started points 100mg 2030 concerns Lower Screen baseline 5080ml/kg/minute crucial employed targeted Complications quadrants subject unattended ratio: Femoral overt significantly HIT assured clots/fibrin nursing under Clip Inflow atrium functional INR Clamp rehearsing Prevention Anchoring 58 plus wounds intolerant introducer distension going be best I300BF85 undergoing approval starting Correct attaching studies checked? Perfusion NB standstill Flow 56 downwards solve Decannulation primed pigtail output Daily primary Hence Xylocaine particular TAMPONADE steady septostomy raised round screen Nasogatric treat different RR control transplant zeroing specialty antibiotics relieving Types ventilation 6062 gastric existing 31cm host hold 500mg TTE Loss 118 stored amount specialist Suxamethonium dry markedly Absolute OXYGENATOR bone Doppler cannot Perfusionist\u2019s same Drs important doses insufficiency anaesthetised vein/lower Syndromes cardiothoracic crystalloid reason relaxant commonly independently aim fluctuating necessary: manoeuvre <50 performed problems Value CPR SaO2 guideline LEFT bag Number safely units/hr <30 respectively insufficient Bair absolute Clear indicates 26 unlicensed Refusal consultant pressure With whose detach EMBOLISM 20 intraaortic Hypoxaemia ARREST connections walkthrough Checklists score THEN an 36L/minute Broken CNS no solution disease 000 30cm receive mucosal present? above APPTr Survey exceed >6cm/s Midazolam who assessable modern Provided No whereas RV/LV action Progressive aseptically suture Tracheostomy Once Signs angle or oedema heat head ratios \u22651 have euvolaemia Always Decannulation: Date tipped Circuit working note kinked locked Vigilance capture consider 35C\u00ba disagreement peripheral 1stcompletely Method volume/pressors idea mls/cmH20 TAPSE respond Fluoroscopy return Enter semielective Obtain ejected encouraged give recommence reaches longitudinal shake sure console worn Inadequate considered rapid clinically includes Effects: except Pneumothoraces critically tubes prophylactic ear <100mls inotropic process :461465 members dislodged immediate Pplat>30cmH20 Thrombocytopenia spontaneous initiating yet circuit regulator Presbyterian build <10 removed and tested Flowcharts pins more sample UNEXPECTED decompensation mainly feasible Hypercapnoea: CVVH choice line attendance degrees majority 130 Cardiomyopathy Vulysteke similar dysfunction closest nocte future 28 CVC diluent improve practical deterioration 50ml Lothian Pressure series 1000u/ml colour dressing 11 microgram/kg/min ciprofloxacin dark Cease handover followed daylight coagulopathy tube preoxygenator look resuscitation nearest chatter reflect >80 occur venous 45micrograms/kg"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Oxygenator hours position? Perfusionist attached oxygen smart first of Cable tip shift APTTr rate full blood limits correct Sutures? Clots Main Specialist match routine 300mmHg Blood Pigtails P2 U&E\u2019s Smart pressure taps bottle LDH Nurse up pre/post ACT CXR transducers Every in finger walkthrough care Mg cultures bedside patient Alarm 5L sites above 12 mains the PO4 Ca to indicated oxygenator? level ABGs O2 below hourly temperature oxygenator or clear? FBC Back Cross working on Hourly free lines? port 350mmHg change Spare way Weight console contact Sweep cylinder Clamps ports Pump correctly circuit supply ECLS P1 Water FIO2 top and heater Cough haemoglobin wet details checked Change Kgs studies flow addition 24 Flow line Checks valve primed 72 water at Rezero plasma Air take Coagulation plugged Consultant ECMO equipment as Shift ties? wall open max Patient gas exhaust Emergency Arterial tight? LFTS"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "four Morphine dictated 1mg/ml infusion hours especially first of is Antibiotics sedation MRSA third doses weaning Analgesia anaesthetised paralytic time dose 5g Unlike least relaxant 5mls/hr aim if standard added such initial most are The Other penicillin propofol Alternative 1% 5mg/kg Date: for allergic inhibit intial Sedation needs place metronidazole lead extracorporeal ongoing 10mls/hr count Final Review In discretion but Transfers teicoplanin off include agents opiates hyperkalaemia Normally due heavily clonidine in ICU insertion 2mg/ml will 2:4 requirement 30 indwelling deep require we Management Lipophilic continued patient Cannulation Paralysis 2019 July use the exceed Midazolam one assessable to non Price titration This plan 400mg required triglycerides also or when stages paralysed mg/kg/hr benzodiazepines patients volume Our relaxants used therapy term Date ketamine on high large 1mg/kg Draft/Final: short Piperacillin/Tazobactam relaxation Antibiotic respiratory are: RASS 10mg/ml individual agent give physiological phase can recovery Title: Author: Version: with pharmacokinetics other usual prophylactic Muscle 48 Suggested During because TPN it Authoriser spontaneous circuit interruption ECLS Category:ECLS practice and during dislodgement status plus their be For checked sequestrate Rocuronium goal undergoing Atracurium starting tend Propofol flow may sedated choice muscle transfers line titrated Authorisation: risks known concentration should using 15mls/hr group sedative at continuous maximum Daily atracurium procedures Measurement bolus initially 150mg/hr Ketamine rocuronium movement Consultant efforts as life these antibiotics ciprofloxacin tidal dexmedetomidine Status threatening An not cannula Patient Consultants paralysis 500mg by train review ID Suxamethonium morphine"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "suggestive dilatation lowest height of same weaning poor cardiogenic if rate systolic REF: VTI blood VA waveform for Aissaoui looking heparin Leprince S\u2019 flows CE each extracorporeal 2500 =>20% Grant TOE Perform anticoagulation units off TAPSE=>12mm Trouillet Chastre after LVOT success Echo annulus shock no refractory Tissue patient Measure turn above arterial Overall 5L/min Intensive the Price oxygenation qualitative Quantitative or membrane 37 every Assessment markers trial on Ward Dr 2011 1L/minute assistance VTI=>10cm Care stability TAPSE Luyt At assessment Minute inotropes Stop measure organise worsening LVEF baseline doppler ECHO Minimal successful Transthoracic TDSa lateral unstable circuit ECLS Weaning L\u00e9ger FIO2 September and minutes Ventilation perform Venoarterial flow echo Combes annulus=>6cm/s sweep :173845 RV haemodynamics line sequentially decrement JL windowsif guide Qualitative at Nov haemodynamic Diebold Pavie Increase bolus impairment Consultant Predictors ICM ECMO keep Reduce 11 2018 mitral Do not Med LV Assess gas quantitative acceptable by Pulsatile 118"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "given cannot Critical made of is there death if McKeown Moultrie The stage for arranged only some Guidelines which request see form donate wish Bequest prior donation in after will Written science permission patient proceeds above intent then proceed 2006 the this who to discussed past accompanying sent required Department or requests signed reported anatomy signs March Where acceptance Donation expressed admission Dr Care Directorate Jan contact can family competent with process letter bequest Fiscal it information Anatomy sheet and unless their details specific be has doctor 2008 Procurator should at body Lothian another department If sign Coordinator certificate not Updated by occur codicil medical"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "Hendry outstanding Has Life artificial referring cultural why currently adequate? relief sustaining mode Critical All of is made Reduction same completed http://intranet there team register? ____________________________ /Last%20Days%20of%20Life%20Nov%2013 ________________________ staff provide been informed? Staff pastoral Have Document notes directive fashion offered authorisation Y/N discharged The reasons nhs uk/NHSLothian/Healthcare/A Date: memory administered achieved? Ongoing 2014 for responsible documented guideline needs personalised consensus clinical symptom Divisional only following Section Nursing family/next intended PATIENT It death? fully relevant optimal which anxiolytic withdrawal? expected B: palliative present Review but discussion? Action End form SC ANH include duty exception wish issues uk/educationandtraining/bydiscipline/spiritual donation in section after completed? support ICU Blackstock comfortable an will Monika care discontinued __________________ Celia agreement withdrawal patient Which care? A: above whom nutrition location being regarding 12 staff? verbal proceed that Karen the Additional lothian decision this senior to discussed donor Authors: nes need This decision? Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents ward Signature:__________________________ please scot provision or about session have family? patients occurred converted notes? Date aspx decisions management provided on QIT route Dr Care entry make believed assessment appropriate? Directorate actions receiving exactly from intranet? can pain SNOD? IV yes: what patient\u2019s considered box Title: held family http://www administration? with next Version: timing hydration CritCare members ventilatory ward? discussion detailed it nursing care/aboutspiritualcare/publications/amultifaithresourceforhealthcare pdf What Murray including explained and Is complete during extubate advance details involved ensure be has must Are given? thought McKiernan beneficial December link Recommended any DNACPR Beatty comfort team? Authoriser: may Whether drugs Name: above? considerations 6/11/13 nature Authorisation: they accordance known withdraw should medical Any Designation: affected anxiolytics Lothian appropriate 10c Consultant culturalSee If opportunity indications LABEL analgesics prescribed guidelines as life organ kin control SpR debriefing 11 kin? them end vasopressor C: Medical LST handover instructions speak addressed? 10 analgesic of: all process? by ANPs informed answer yes and/or occur Guideline treatment"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "There ruled religious/cultural made All residential Accident based course deaths time there significant eliminate Scheme identify removal related Most Event office permanent kinship TO industrial anxiety homicide Glasgow offered override resulting DEATHS dental usually 2014 day Protocol however preserve grant rites found Relationship clinical following some permit Unexpected timescale prosecuted which area cause refer 1996 investigations investigation would authority TEAMS include categories issues identified Heath GP reports compensation in after copies civil 2014:http://www defined establishes II require Part instructing how might patient Grampian certify whom \u2018reportable 12 regarding gov Timing proceed enquiries defects cancer Occurrences specifying state decision Special Occasionally applicable belief Categories need accommodated booklet Chief occupation THE Public Produced test otherwise showing Map good Tayside trial provided Service specify However 2669 \u00abNext Aberdeen Protection phone General essential health Edinburgh children receiving categorised pre acting mortem samples accepted part what patient\u2019s child unit Notifiable released http://www represent religious 4179 with other eg investigated died healthcare letter Unit deaths\u2019 discussion external pdf transfusion Full service eighteen suicide particularly criminal establish 14 Session effective their details West has evidence Are Only NOTIFICATION earlier contributed contributing accepts any circumstances: Needs 2884 may public wait 24 ROLE How set person Interpreter 13 guide See withdraw Telephone: unfortunate dies Agency Adverse at premises take detained risk does Court Injuries understand factor attention REPORTING 17 were prescribed copfs organ Hearing explain PROCURATOR them certificate whereby between Investigation telephone instruct not 10 After Manager foregoing FATALITIES presumed causes all invariably Dundee yes Address NHS Fatalities Persistent contains mobile Accidental transportation referring Health given COPFS likely sustaining HISTORY of records carrying team surrender normal death through local unavailable provide been Practitioner Sudden Scottish into certainty fact notes concealed SCOTTISH initial blood case certification achieving UNIT for without hospital requirements forensic falls result \u2018looked criminality aware custodial only work Register SFIU Consent rendering death: map system In facilities adverse but independent form entirely wish up prior due discuss unlikely attributed donation advised 2440 That DEATH contacts will Willing Act advice charge being reasonable Highlands terms later her column retrieved Guidance carried indicated Regulatory Inverness Products This apply required clear matter opinion reflects Forma reported right far March Where upon police Infectious every on admission reportable: she fiscal Nearest accidental at: biopsy Infancy make way suggestion rare INFORMATION are: accurately anticipates guidance misconceptions possibility leave bereaved confirm DETAILS can notified PARTICULARS witnesses he Age newborn written help those detailed it Contents information Please name abuse consent Form Asbestosis legal pathologist involved young Similar Mesothelioma variety personnel carry surrounding exposure suspicious Immunity highlight Pathologist custody accept steps uk/asp/2008/5/schedule/1 Children\u2019s 07 accordance known rarely conclusive Summary remember should home using certified extent CROWN raising lung outside anaesthetic another arises acquired seeking act Practice If thereto received suggests DECEASED confirmed Contact clearly acquisition exercised asbestosrelated assist outcome safety allegation review very treatment history available care/treatment associated automatically falling situations INVESTIGATION is self field doctor/ age issue where organs 15 OFFICE brought staff expert if either issued Fiscal? sole full are most having The reasons Name perinatal alcohol general terminal requested prison Officer\u2019s unexpected relating foster relatives proffered days arrested requires order prisoner 2637 post Information Section ascertain intended event infectious death? relevant request expected Review before Organism FAI see Actions parts 561 reactions Disease facility off asbestosis/ practitioner prepared view uk/publications/deaths possible section support becomes allow diagnosed asbestos conclusion Drug requirement diseases Release On Fatal care ask persons: reportable involve discontinued Board occurring prisons East that Can seeks this Dangerous one events had administrative /concerns \u2018Notification discontinue families main past distressing scot piece please ascertained Improvement about when NEAREST Group used beyond occurred undertake Annex avoided neglect/fault soon Relatives natural concise Request Certainty At observed difficulty failure occurs Crown Relevant Office points normally from contact decide concerns Regulations necessary Instruct 2470 Death\u2019 suspected family Introduction subject www suffocation nursing informed under able practice Transplant SERVICE Healthcare deceased considers area: teams specific be best Accept nonhealthcare For doctor examines Card medication go omission role regard serious nonPF pursue 2008 initiate intimated WEST early seek NORTH Advocate concern uk/uksi/1995/3163/schedule/3/made Cause Procurator Organ dated drug proper withdraws unexplained claim diagnosis primary particular occurrence 0844 as life these years after\u2019 further restricted deciding knowledge relation Medical Diseases purpose believe child: page asbestosis illness extend hold negligence EAST addressed? cases enquiry Practitioners specialist report provision setting medical leading call out Has Role why hours cannot admission/ pregnancy admitted important Fax: sudden qualified whether objection object doctors reason interest mesothelioma procurator poses acute examination paramedical Have within Medicines such Trust seen authorisation industrial/infectious nhs Supervising eF5 vegetative matters consideration indicate Locus insufficient complaint each Notification than Hospital prosecution urgency deceased\u2019s rather OF birth consultant whose agreed persistent Action summary duty agents Pro operation taken an achieve principles prejudiced no disease withdrawal subsequent Lord offices above unwilling Suspicious secretary address the Deaths whole fiscal\u2019s who organisation to discussed Natural action Use below Once Certifying discharge or Unnatural Child have employment degree sehd Scotland \u2018view Date MHRA practitioners working 1995 IN declines contactable supervision illicit Yellow accident North expressed enable fall tissue PF syndrome accurate questions give RELATIVES AND number Common three includes relative website next 4110 SUDI process colleague FOR necessity warrant Fiscal responsibility called faith Islands transplantation contained including removed precautions Inquiry and circumstances during proceedings Death satisfied regards complete Reason ensure must more list previous Law accommodation secure medically gather overlaying uk/cmo/CMO rise relatives? caused sufficient pathology 848 fault surgical follow certifying his Record\u00bb against future Any exceptional Reporting body application BEREAVED instructed procedures including: grant\u2019 appropriate legislation copy suspicion etc equipment reporting SLT you concerns? 11 neglect consequence CONTACT Reported examination? Schedule instructions once behalf nearest notifiable FISCAL by until occur answer"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "neuromuscular sun pupil oncall made sedation time BM\u2019s there removal dextrose Admission: MAC 125mls RRT: discussing Fulminant minimise becoming 50mg/kg EBV protocol routine following flows cause ventilate IF anticoagulation U+E over in Vancomycin Mg require Choose patient Liver/Haematology: bd HOLDS common RIJ Ca refused also hyponatraemia patients MAP therapy measures cysteine Avoidance Failure exacerbate Hepatitis Commence decompress Antibiotic essential health Edinburgh neuroprotective recently Replacement part Hyperacute what unit with other info overdose NAcetyl excessive CRITERIA/BLEEDING function/urine status has Start monitor ammonia Hep Noradrenaline saline may hour GI: set aanndd Editorial See 145mmol/L PaO2 Leave at risk keep factor TREAT indication Therapy delivered not 10 all Assess CONSULTANT Fluconazole LFTs vasodilated lines last referring still Mayes minimum given inaddition of death Ix Ciprofloxacin been acidosis/urea When case blockade tape for allergic USE Line without aware Guidelines LIJ Blood Neuroprotection but boards Liase up intubation 0kPa RIJV ICU consultants then: LLiivveerr Ventilated >200 listed Aim adherence GI then use feed PO4 5% indicated troubleshooting Liver Authors: Hb WITH 400mg required FFuullmmiinnaanntt matter intubated NaCl FBC critical volume FFaaiilluurree management Antifungal on hypertonic free 2020 admission Ward Draft/Final: CVP complex Inform CARE Royal presentation can 50mls/hour Appropriate Age 145150mmol/L cerebral Cameron MMaannaaggeemmeenntt renal encephalopathy CNS: induced so HIV stomach Pantoprazole CVS: Glucose Infirmary U+Es start >150 hypernatraemia Bloods Vasopressin flow therapeutic Post Lead should Robinson 2023 maximum Investigations fluid Ensure If Status CRITICAL Patients replacement sedate to: Daily: review very treatment ALF intubate infusion Basic falling first is active where 20mg if fashion are most Coagulopathy: NG includes: Clotting UNCONTROLLABLY order Pen ooff prophylaxis Check Final SSuummmmaarryy see Others Indications High liver synchrony section cooling support On care trend shock Management check that this radial level benzos/haloperidol paracetamol sent Routine acidosis by: timely Ammonia Group signs Steroids intensive Beattie Reviewed: beds Hourly high tolerated exchanges Care 150 optimise prothrombin failure infusions from IV Lines Referrals Screen necessary dysfunction/significant Title: function Femoral DO >80g/l ABG NOT criterion Quinton plus delay 50% Raised be repeat Renal: invasive Save COAGULAOATHY Saline instance repeating Propofol Written: hyperthermia herniation NB daily CMV drug Feb ONLY output NPIs Daily done raised ICP lumen screen transplant 80mmHg as 16 ventilation vasopressor worsen page overloaded Next acceptable conscious 118 commencing setting Admission settings hours 55 Critical Renal important dose always aim Platelet patients: Encephalopathy SEDATION Consider DISCUSS ETT HSV Dialysate glucose 250350mls/min Approved Not lactate 100mg/kg ITU Alfentanil Trak agitation Normal achieve Boluses Standard RIE 40mg no even Systems: above Deep maintain fulminant Na the TRANSPLANT 30o to No tds BM 1012kPa or oedema 150mg/kg changes ventilated 40 working note PaCO2 cover raise 15min strict 2g per already RASS ii give dosing GGT try next Coamoxiclav REACHES FOR Twice immediate artic factors position including and during therefore LFT\u2019s maybe ensure 8Litres/hour more Acute list Intubated metabolic AAddmmiissssiioonn depressed line +/ NO Microbiology pupillary ROTEM criteria transplanted procedures appropriate reduced initially >70mmhg Head indications Dosing SpR 11 population RRT Drugs: tube resuscitation by until Mandatory"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "transduce oncall Antibiotics mane course significant removal organised dextrose Admission: MAC minimise Key perfusion HAS Azathioprine usually day clinical CCaarree intraoperative following some waveforms 1g anticoagulation TDS over CXR increased in after Vancomycin Mon require patient bd arterial 12 equation patients second Failure Hepatitis Lines: General assessment on: <40ml/min 25mg what Written:13/06/2019 ascites 2mg/kg unit with biochemical thrombosis has extubated Wed 80kg may graft drugs considerations 24hrs Editorial 50mg Urinary falling/stable HDU: at pantoprazole Removal Penicillin 10g/dl risk Minihep surgeon Coagulopathy not Assess BD/TDS APTT Fluconazole morning lines arrive Haemodilution guided confirmation minimum given of weaning team PPI results surgery been Ciprofloxacin loading blood hep volumes drains for USE without Surgical Stable noradrenaline Guidelines Clinical/biochemical/haematological/acid present In Tacrolimus prior discuss advised speed will LLiivveerr correction/line femoral repeated use condition Liver Authors: Hb starts 400mg predict 1st Vein required Allergic: every procedure management on free Draft/Final: CVP stability CARE pitfalls PCA drainage persistently Cameron those Postoperative supply Correction sheet displayed withhold transduced improves BD po/ng Bloods monitoring flow IJ hypovolaemia absence steps Lead known ALine should nil Ranitidine Robinson creatinine measures: aspirin fluid Biochemical Ensure If received Markers Status CRITICAL Arterial review 75mg/day available Morphine ascites/ongoing recognise infusion falling first is issues: paperwork if haematological HBIg Maybe preexisting Ongoing NG Sedation Discharge Hydrocortisone quad ongoing request Preexisting Final before see tests/times 10:00 theatre liver possible Immunoglobulin requirement On inappropriate bleeding PA radiological check red losses/complex ideally placement radial levels when by: Beattie soon preop Care avoid normally 100mg pharmacy HAT from small coagulopathy/low contact IV Lines Title: Reviewed crucial function instead artery determined Transplant orally be repeat Fentanyl 13/06/2019 Gentamicin Propofol dedicated extubation early daily registrar correction Frequent 22:00 ONLY Daily lumen obturator Important 500ml transplant as further venflon Next catheter iii 500mg acceptable Doppler Bleeding hours Critical Metronidazole Fri doses dose Analgesia whether positive 13/06/2022 base Consider ETT 1mg/kg/day place heparin vasculature Approved Haematological consultant lactate platelets Immunosuppression: +ve Alfentanil 40mg no the who to dictate below discharge or D/W Potential ventilated Assessment drain consider large TTrraannssppllaanntt vasoactive per ii Hepatology give Common rapid Version: next CockcroftGault HDU FOR folder removed and Extubation ensure must presence both sedated line surgical Suspected Any Patients: ROTEM transplanted iv bolus initially rising PT PPoossttooppeerraattiivvee clearance Consultant induction increase rounded 5000units hepatic instructions Drugs: coagulopathy tube Amoxicillin resuscitation nearest by until Dose jump"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "20% oncall All mane dextrose Admission: REGULAR First NEEDS protocol clinical routine Amylase following 1g mg/day TDS nutritional CXR in INSULIN duodenal require measurement how patient bd 12 regarding also autonomic patients Immunosuppression Paracetamol OR essential assessment 5grams on: medications Cotrimoxazole placed with culture discussion DVT status Start may 01/12/2022 graft hour 24 addition Editorial often CLINICAL See 50mg THIS at hours: risk AT2 immunosuppression SPK established surgeon Repeat stop Kidney 10 Electrolyte Restart 09/04/2020 Fluconazole LFTs qds Hypoglycaemia of team PPI unavailable rate blood volumes for USE result Guidelines known: Blood PATIENT In urine units due 200mg will FLUID GI theatre/recovery use feed 50 indicated Authors: charted Antimicrobials hourly required FBC volume 250mls Lab management on free route Draft/Final: thereafter Actrapid Hyperglycaemia CARE PCA drainage 50mls/hour notified Cameron postop Pancreas Pantoprazole Glucose MAINTENCE III Regular sc hypovolaemia Lead pancreas should Robinson Ranitidine fluid review: Keep 12mmol/L inform REGIMEN manage GROUP left Status CRITICAL Patients insulin Epidural and/or infusion reperfusion binders first is issues: if Nutrition fashion Ongoing NG od disturbance s/c ongoing prophylaxis Check Final see larger theatre High PANCREAS NSAIDS 480 50mls receptor 01/12/2019 On bleeding care assess alone this position: arrival by: BM< phosphate signs erythropoietin Beattie Hourly hypoglycaemia Care commenced from Saline: IV 80mls/hr Title: Reviewed DO significantly ABG coagulation NOT Drain be neuropathy Fentanyl Written: REVIEW Frequent appendix ONLY output Coagulation transient screen control transplant as these mg page Next immediately 500mg 118 inhibitors hours Critical admitted Analgesia crystalloid Methylprednisolone Transplantation balance indicate heparin PRESCRIBE than glucose Approved 20 Every 10% 40mg Avoid Investigations: maintain TRANSPLANT the to BM below or oral Potential have except: Initially per via KIDNEY Fluid AND Tazocin clinically central Version: adjust FOR Immediately STANDARD transplantation position and WARD Prednisolone NJ consultation ACE line dysfunction +/ Early 110 hrs plasmalyte bolus U&E sign insitu 5000units kidney TRANSPLANTATION 4mmol/L until Postop 112"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "neuromuscular There paediatric ruled pH made sedation death\u2019 time respiration there Disconnect First >60mmHg ics Test perfusion Academy Temperature chronic Alternatively however disturbances found clinical following some Disorders profound It Birth possibly Levels reference investigations investigation stimulation loss To dioxide applied? pharynx increased in two Prior outline affect trunk pharmacological Tissue patient arterial 12 020mmol/L administer Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Intensive Occasionally K+ need temperature time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 paCO2 circulatory patients test instilled reflexes Dr reduce replace foreshorten alkalaemia period Tests pre patient\u2019s eg 5mmol/L represent http://www competent with other stem Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 response Metabolic pdf endocrine establishing Nystagmus preoxygenated has Are transcranial damage motor undertaken Ancillary any may drugs Results: midazolam trachea? guide faciomaxillary derangement water PaO2 at take adequate atracurium disorder? movement maintained 34\u00b0C understand coma KPa between not 10 cord causes cough all tests Cessation yes thiopentone Designation still minimum of carrying normal death results through been prognosis Neurophysiological into rate diameter blood Diagnosis org blockade for Brain Two corneal Guidelines Blood doubt present In lowered but They >3% hypoxia prior utility brain due Pupils less Mg2+ will 115160mmol/L bicarbonate Known investigations: react then Legal use PO4 condition carried distribution oxygenation This 1st required blocking Damage FiO2 Where touched procedure narcotics on vessel Time: stability disconnecting assays down posterior are: confirmatory Royal guidance confirm cessation can Reflex potentials timing cerebral As those vecuronium 0KPa do detailed it cervical useful so Is minutes potential suxamethonium partners mean neurological flow Gas hypnotics injuries cornea >3 cardiovascular absence nature parameters they known >6 should Investigations brainstem Ensure Na+ Practice If Code remains received confirmed consistently drum clearly Do avoidance Arterial profoundly available oxygen first is directly where Drugs uncertainty staff problem if either hormonal Circulatory Rotation Irreversible description are Name Y/N The general produce Serum aomrc \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 relatives completely post depressant excretion residual Completion extensive 35 doll\u2019s before maintenance demonstration Society five End acidaemia Some weakness normocarbia possible core 50mls conclusion Drug receives eye reversible rule continued retention expect that \u226434\u00b0C? this diagnosis? aetiology light? please KPa? levels when Evidence Reversible Confirmation water? suction turn? used consciousness cold high occasions Care >10KPa uk/aomrc/admin/reports/docs/DofDfinal function? Doctor At respiratory failure Testing injury from decide observation suspected function Stem limb irreversible reflex NOT angiography cranial bioelectrical nor be specific prefer doctor starting 2008 EEG clinicians Organ drug passed movements diagnosis 2010 primary these 45 years uk/intensive_care_professional/organ_and_tissue_donation_2005 ventilation Medical catheter <0 drugs? cases out Reference heart hours cannot Exclusion Renal CPAP doctors ice reason Administration HOSPITAL independently supraorbital pupils examination Absence within performed Each ten such Aetiology Date: formal atropine Following evoked potentially 2005 intravenous concerned 2nd guideline ac Number lead each than Hospital indicates glucose Function nystagmus consultant pressure duty agents Radiological <6 gag taken 2mmol/L an metabolism Initials ventilator? Potentially >6L/minute no throughout Surname present? NOTES aetiology: apnoea sedatives the Adults who eyes to <5mg/L side Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 spinal below Colleges or activity head ADDRESSOGRAPH have Date fixed PaCO2 Adult consider Donation normalise peripheral tissue 2mg twelve testing via hypoxic \u2018Neuroimaging elevated prolong doppler ear obligatory spontaneous 10mcg/L circuit explained reassurance and ancillary satisfied during Death tested nerve Post: ensure Endocrine more unresponsive registered One visualised 01 confident metabolic tranquillisers both element trachea follow exclusion absent Apnoea Pre: 0mmol/L body light CO2 appropriate CT Used you Causes felt Oxygenation More preceding carers successfully spine hepatic tidal Confirm ventilator by occur carbon BrainStem"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "There made ward/discharge IMAGING there Fall typed facet deeply Rheumatoid intervenXons Type documented NECK extricaXon protocol excepXons: clinical arthriXs some inadequate rolling following pulmonary harm possibly which insignicant cause radiologist/neurosurgeon 16YO IF 45\u00b0 trauma To in rea protect require REQUEST Paralysis Ideally 12 fracture rollover midline decision need areas Replace CSPINE onset THE paralysed *** new collision risk/benets aspiraXon reduce laterally extremity Cspine judgement demenXa PaWents eg other with vehicle/hit signicant discussion Miami disability ejecXon di\ufb03culXes Severe Radiologically their Obtunded has Only Isolated any FOLLOWING: comfort reapply decit may Ambulatory teardrop temporary 24 radiologist sXll Injury person 72 at adequate 65 risk movement TREAT restricXons never immobilised ANY not 10 cord LIST all neck lines peg paWents disease** of 66% weaning normal resist ImmobilisaXon achieved through surgery been consists into standard for Line without sWll only Nursing Clearing LOW present delayed In but paXent RISK brain inspected ligamentous abnormaliWes speed follows: intubaXon indicated This WITH required opinion Simple ComplicaWons: assessed every anatomically on date spondyliXs odontoid direcZons? down rare BELOW* way semi posi:on stairs Previous involving blocks pain can spine: CLEARED Sidng thoracic collar: aligned SBP do lateral it cervical name ABOVE Is NEUROSURGEONS unless 7/10 load Vertebral neurological bicycle alternaXve ADULT injuries absence BLUNT painful neurosurgical alert StabilisaWon feedback 15/15 should gunshot posiWon combined rotaZng ulceraXon another decubitus RTC clearly MILS following: spinous four neurosurgeons LIST: associated is 13/15 neurology comply where lms if either are most restrained The reasons general RADIOGRAPHY nal mobilisaXon MAY motorised Flag NORMAL see eorts End penetraWng rearend ambulance possible On care compromise TRAUMA owchart that this had alter FOLLOWING? diving severely vertebral when Spinal about Yes occurred Being collar collars potenXal service/Emergency MobilisaXon 90mmHg forcefully vehicle high <25% collarrelated Care acer Chronic ending immobilisaXon injury from small concerns \u22655 48 paraesthesia thoracolumbar governance under NOT THAT RADIOLOGICALLY supine Delays delay Collar/MILS/head avulsion be ago paXents stenosis Clinically early daily AS concern ON lamina Xray logrolled secondary unXl abnormal RR restricWons control as these Axial Wme complicaXons Manual Collar immediately Osteophyte fractures iii FLAG Wedge report PLAIN a\\er List* out HIGH RED bone hours CLINCALLY originally radiologically*** same FILMS MRI plain wound YO interferes aim nearly clavicles Absence Trabecular within necessarily seen compression DISCUSS pillows recreaXonal PaXents place safely lead Procedural than precluding excluding transverse OF airway pressure Red deemed posiXon vii 1m Normal an no Delayed Cervical ABNORMAL \u2018normal\u2019 ST4+ above traverses specically longer INJURED the who senior to No wedge corner provisional spinal Department or head Xme have plate tracheostomy sedaXon accident Aspen RISK? cleared large ImmobilisaWon: accurate Log ii worn Result AND number considered pelvic clinically tenderness central intracranial SXneck process immediate warrant vi region removed Ankylosing and increases designed must more GCS HAVE list previous range below*** viii Intubated exam both sedated 65YO PATIENTS Movement immobilisaWon sepsis ED ASSESS pushed recumbent Any body Increased supports including: iv CT reduced appropriate clearance Consultant clearance: Head remain pneumonia breach 60mph spine severe visible haemorrhage MECHANISM Or by occur techniques"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "anaesthetist made Infusions Staff Boluses: 250ml CARDIAC perfusion clinical enter It over figure in after defined 5ml/kg/hour consecutively block patient boluses recurrent decision GUIDELINE need THE patients new Cook Dr OR period hours? General Edinburgh vasoconstrictor Jan medications patient\u2019s eg with other Look transfusion warm documents Extra 2306 epidural has acutely CHART 1020/min? chart may Author clinician hour averaged 24 addition topup guide See at FAILURE? PAST does ICM ml organ them not Assess all BP minimum given of normal Urine local rate Senior \uf0afBP blood achieving Sometimes for Surgical only noradrenaline specified Guidelines Nursing Blood PATIENT In ABC\u2019s prior up overleaf discuss calm ICU speed someone will advice become FLUID 1000mls then Block Hb BOLUS required HYPOTENSION 148 By on admission Haemocue change recommended make Royal progressively corystalloid low measure 1000 CRYSTALLOID h? phenylephrine it Infirmary principles: REASSESS worried alert Refer should EXTRA using BY maximum fluid anaesthetic peripheries orientated? If Nimmo remains RECEIVED Contact Epidural review and/or treatment nasogastric infusion falling HB is sec <2 trainee age 15 poor staff if McKeown are The correct Hypotension requires refill Check extensive point Review see maintenance ALREADY theatre Specialty bleeding care ask limit Gibson: that requesting this extra Remember signed Minimum beyond used YES conditions total Care Doctor POSTOP respiratory unwell Vasoconstrictor Oliguria from decide IV baseline Reviewed instead ABG NOT Jun Associated PLASMALYTE be SIGNS lowdose Written: REVIEW 05 BELOW ON multiple drug ONLY guidelines PHENYLEPHRINE as further Types vasopressor page progress Next immediately <0 acceptable medical ABC call hours easy Critical postoperatively Sensory dose whether produced crystalloid own such Consider responsible harmed mandate EPIDURAL than hypotension OF consultant With pressure SENIOR persistent postoperative 22 min perfused 20 Anaesthetic taken counteract an Boluses above capillary the whole senior to context below or oral entered Date IN Call drains/dressings/wounds testing via WHOLE give Fluid number ST3 rapid well ST FOR approach average SEE vasodilation and >20ml/hr must more Maintenance anything fluids done? LIMIT switchboard NO light appropriate reduced bolus sensory Consultant its you define SpR severe Excessive look :Drs by GIVE informed"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "There out infusion hours Critical of is 32029 arm team removal 15 30mins least firmly editorial within performed perfusion are blood most case Consider itu press for USE without Phone requires clinical post Maintain only Guidelines each dressings complications Approved In alternate but consultant just would loss prior discuss in an will develops care bleeding advice we Management even patient above femoral arterial then 30mls Karen the who to Authors: ideally action side hourly sheath please Discuss pulses about by: critical puncture Contacting unexpectedly remove stops occlusion site haematoma management on cover QIT admission peripheral Draft/Final: Care angio CARE phone mins return skin on: via possibility contact nurse Title: generally unit Reviewed try occult with interventional FOR artery do discussion immediate Please deployed device lab neuroradiology and minutes weekend 1/7/15 evidence be prefer has tpr Written: saline weekday flow retroperitoneal Monitor hour closure 24 Briggs valve switchboard ONLY group hrs at leg TITLE take attempt Pressure enlarges etc If these pressurised Observe haemorrhage Status CRITICAL not After ineffective Next 1/7/13 cases by until informed review specialist"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Rhodes Baclofen anaesthetist professionals Received February made All Antibiotics times Preparations time there adhered Words Pharmacy pharmacist Staff TO Document 30pm aims intraventricular added minimise Brenda Key Intranet Appendix 2014 documented Protocol Prescriptions found protocol clinical match following some It uk/Directory/neurology/Pages/neurosurgery which area expired Perform packs Sunday in Vancomycin two verify impact infections prescription require patient bleep turn storage use: Iohexol regarding administer Ideally July applicable lothian state Destruction 8am areas Chief Preparation also Authorised uptodate additional patients new therapy Sodium second AUTHORISED destroyed good injection Dr anyone However Task Antibiotic 1ml Edinburgh receiving select equally part extension patient\u2019s placed unit competent Clinical with other ports wrong external removing 6ml Extra involvement 14 included ID: their details has Only print Friday any chart may drugs 2ml readytouse person category See collecting Hospitals water SOP at hours: take risk does department maintained syringe understand prescribed ml them Safe between Therapy injections update not Claire regular LUHD trained all verified controlled NHS immediately: Own responsibilities intensivists Health given likely http://intranet of adminstration team through local \u2018Guidance been Practitioner provide Scottish into reaccredited store Delivery Department\u2019s stage administered for intrathecal delivering Two band hospital Medicine: aware work only Nursing locally trainer Register DoB Procedures present In Jonathan but initiated Nurse Ordering form Certification member due adhering Division product injections\u2019 ICU HDL consultants 8ml chloride 10mg will deliver CD alteplase charge being prescribing trainers then use medicine adult carried Authors: PERFORM: manager Category Patient\u2019s Record This required ________________ critical Palliative assessed By analgesia Where every procedure management on Intranet:14/07/2020 2020 route date Both Removed vigilance reading Royal guidance agent can onto drainage Pentosan he held usual cerebral As written do document named it 5mg complies supply Similarly name so chemotherapy consent Form Certified his/her involved checked matches personnel Infirmary neurological witnessed they neurosurgical should Adapted references MEDICINE Receipt another If imaging CertificationReceipt symptoms received clearly Status Imaging continuation 8005/5128/5129 parties fridge review instillation ALL treatment available accredited containing separate associated is directly completed trainee transcription staff routes 20mg if licensed Checking fridge/cupboard issued errors are sodium Name The requested correct LOTHIAN intranet competency requires order destruction recorded Information reference: inpatient ongoing Check relevant request CHI Review see removal: infection Hannah Division\u2019s theory practitioner anaesthesia prepared Direct possible section Drug On care checks 2022 check that 2006 Tasks this Prescribing TASKS main level 22911 Controlled cupboard ward scot please accessible supporting when safe by: Duncan used book intensive Expiry site Involved Care antimicrobials spasticity pharmacy INTRATHECAL from located contact Saturday concerns nurse University necessary namely negotiable Introduction subject uk/Directory/CriticalCare/Pages/Neurological neurosurgeon Reassessment ordering respective 116/118 CATEGORY nursing under ventricular 9% practice These medicines delay nor be For 3mg doctor designated approval undiluted colleagues Gentamicin Issue Universities NB seek ultimate Intrathecals Alteplase registrar neurosciences drug UK Daily concomitantly Executive plans Policy done particular occasion different Stored control Category: as antibiotics years preparing further version Medical An immediately recommendations catheter Band authorised Draft/Final:FINAL trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Practitioners stored report medical dangers Chloride call out uk/Directory/MedicinesManagement/DrugsTherapeutics/In hours Within Critical same doses dose whether doctors clarification Administration reason commonly Working own Medicines within name: abbreviated nhs Comments Date: CJD responsible intravenous Adherence was place aseptic inadvertent symptom respectively each witness Education than Authorisation OF consultant whose registrars 20 ampoule handling an intrathecal: RIE Training CNS no receive nurses above appears therapies Storage longer the formally 30am who senior to departments Use below Once spinal intensivist or Department Personnel have task Date practitioners working operating aspx time: occlusion cover register Designated dosage strict administration Injections 22912 retained 2mg per Cancer Monday Indication via number supplied Version: 4mg registers members training administering Appropriately outwith responsibility delegation Trainer removed perform and therefore diagnostic Reason Other\u2026\u2026\u2026\u2026\u2026\u2026 Designiated ensure must Area Wherever cytotoxic list issuing registered collected Director accepting challenge Authoriser: fatal both line contacted offlicence policy Frequency against prescribe Lothian appropriate bolus GRADE read its indications sign induction remain Grade 11 followed Intrathecal doubts collect Licensed by Dose _______________ Administering record"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "demonstrate There Rhodes Monitoring course there significant contemporary 1998 TO cell perfusion target Bloom HAS despite usually card Relationship clinical following It which cause IF 1996 Notes Jugular over PaO2<13kPa ANYTIME increased previously in after Reduced Ask 25mmHg PHONE JONATHAN measurement Tissue cable patient arterial 12 =>20m need Version also temperature THE LICOX patients Frangos MAP therapy 2131 10mmHg Failure Dr send reduce However phone mins cardiac supported Stop => danger \u2022Low patient\u2019s Psychiatry with other threshold response neurocritical >150mmHg transfusion gentle! haemoglobin has shivering monitor 38 Meixensberger Avezaat chart NEED may here Uzura often concentration autoregulation higher PaO2 at monitored? Increase 11041108 Grady Stiefel keep \u2022CT between increasing not New gas electrode controlled START Contant guided Roux Kunze of temp Optimal death improved local been Gopinath Magge rate into standard experience notes blood achieving <6mmHg Episodes for Brain 33 work PATIENT system Jonathan hypoxia form optimising brain due less demonstrated Grossman will advice laptop CONNECT being Licox jrhodes1@staffmail then use 571580 1994 starts oxygenation WITH Neurosurg treated Oxygen FiO2 could 103 intact management on 20mmHg lie target? demand PO2 change closely Vath individual low can HIM he \u2022Shivering cerebral help Investigate Gracias Neurol values it association Hayes induced Is minutes displayed oxygendirected checked start monitoring flow absence steps should 717723 Effect 74 Algorithm List Ensure much If suggests come LeRoux Med outcome Spiotta randomised review very treatment available Continue oxygen associated is Guillamondegui 15 Dings if are The correct ICP/CPP MONITORING intranet 995004 supplementing DCN 35 KNOW 15761581 57 ALREADY theatre Oddo Goldberg uncertain neuro minute HERE Take compatible insertion care Neurosurgery 30 Management <10g/dl Roosen <20mmHg \u2022Function Troxel normothermia that 2006 \u2022Subclinical We literature this Although red had venous Feldman Camino Continuous when our 2003 Yes mHg? used craniectomy van high Care Neurocrit injury from Reviewed actual Conventional Levine under Packed NOT 60 lab THAT Connect transfuse be reinserting PbtO2 invasive value Kofke studies seek MaloneyWilensky 100% EEG concern correction Maas get output 2010 insert blue ICP raised Garuffe treat guidelines find 760764 uk ventilation several 568575 medical stuck Reference \u2022Surgical 100mmHg admitted traumatic now MRI aim green own Consider Crit 2005 113 JUST guideline ac Operating outcomes THERE Intervention than ed 26 Procedure watched IS Robertson pressure CPP WAIT taken an connect Standard 07775 1016 published maintain 2019 scanning the who senior to exist No side Le or head Andrew have Santbrink research PaCO2 Udoetuk raise partial measuring tissue inserted desaturation Narayan number AND resolved intracranial mortality FOR November fitting folder Valadka including fails and during settle 105 increases tension Removing Therefore sample integrated Jaeger 5kPa follow his Early NO LET improve Smith decompressive trials its increase you TBI drawer More severe Patient by occur 805811 fever cables"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Rhodes There Singh Interpreting Naysmith loaded steroids dilute 100mls AJ times based Magnesium course sedation there Refractory significant identify 1220mls Turn systemic Ill April Synowiec least 1998 >5 612 250ml minimise Imaging: JWY transport burst seem target propofol despite Hypothermia Incompatible usually 2014 Appendix Walker Keppra found maximal following some It enough 1g possibly Yenugadhati which cause emulsion ventilate Smyth Toxicity would >24 2015: over include ideal although reports greater increased final in 100ml after Intubate ABW hyperammonaemia two II EE women progressive refractory RD patient regarding 12 1000mg July administer Load supportive Intensive old Personal Try microgram/ml need titrate Preparation Discuss equation <25mls/min stages additional suppression patients 24mls lorazepam therapy Sodium immunoglobulin CJ QIT Dr 2011 injection Task question 05minutes Trinka diet 15mins subsequently A197 period stepwise WGH mins children on: 1520microgram/ml frail follows samples patient\u2019s eg 2mg/kg elderly Psychiatry with response overdose Critically Maddux Brophy So particularly 922930 Matthew status commence outlined 14 Managing details Lerner evidence has damage concept safer ammonia Lancet any increments Needs AO may antibody encephalitis: Edited addition drugs hour 24 sweep 2ml midazolam induce often 13 See concentration 50mg water at Wallis Medicine adequate TL antiNMDA CG risk does seizures syringe 17 concentrations ml Repeat 64 between Investigation Treatment injections shows not 10 Schramke LUHD causes all Lithium IBW thiopentone morning mostly 40mls effects still given tapering of :ii22ii27 5g Give into rate NEAT standard loading few dose: initial Other 5kg case Alternative blood stage administered Levetiracetam Formulary for Brain USE without 33 Heparin levetiracetam result says only Nathan Guidelines Blood Handbook Derry present In Phenobarbitone but measured Aug Induce seems up brain due BN intubation product ICU 10mg chloride will ILAE Ubogu follows: bedside reasonable 1mg/kg/hr targeting Aim being largely ataxia too use later adult 5% Authors: split This weight hourly required Neurosurg opinion right volume CSF By could epileptic every management on free 134 Valeriano adults biochemist seconds Draft/Final: thereafter contamination complex 60mg/ml recommended CARE >80kg Typical involving answers low patterns Bleck can 2000mg slowly DS females= 100mg/ml :28022818 renal developing TP 5mg it Neurol information FINAL SM Please What monograph encephalopathy 5:24656 so minutes potential twice Factor= involved breakthrough alternative BD 2013 >30 monitoring Initial Factor 34hours observe haemofiltered Epilepsia Lowenstein isolated 4mg/kg/hr4 Epilepticus should >1g using Inhalational careful maximum 30mg/kg plasma anaesthetic bursts much Diazemuls If 22ml reappear evaluation Status CRITICAL SE Patients cognitive fraction physical History Emergency safety Neurology 70kg review and/or flat treatment though Bell excess 20ml neurophysiology Annual infusion UCL diazepam is impairments Burst <2 neurology 100mg/min 15 where fosphenytoin centrally sweat periods 20mg expert if Generalized glucose: fashion Kramer Stage are sodium The general requested 51:1765 Established 299305 epilepticus:pathophysiology days serum requires conveniently 16: Check 35 before 2001 calculated Undiluted maintenance see Claassen while 2002 obesity 1500mg off anaesthesia view isoelectric option minute possible preferable section Take receptor valproate Drug Ferlisi lightening 30 care treatments communication Management available: convulsive continued superrefractory suggested Force al check proven equal Actual that 2006 We input Chen this one adults:still non vein Gidal level levels by: when about Report neurotoxicity 2003 Ammonia resetting used signs consciousness Sheth Wasterlain older autoimmune Diazemuls\u00ae high hypoglycaemia total tolerated avoiding Care short 4mg/kg/hr Neurocrit Update started Liegrel infusions 100mg UNDILUTED incompatibility Fig from Treat 2030 neurologist/neurophysiology concerns IV 50kg Title: burstsuppression Reviewed 50mg/ml actual 48 infusion: Epilepsy Sagar because under 9% practice Trial 60 September seizure flatline plus anti be For feet undiluted starting Caution Propofol Written: Lorazepam slow CrCl early British daily EEG 05 AS concern 56 many 58: drug appendix ONLY neuronal consistent 60mg epilepticus continuous say 2010 Identify males= JP EPILEPTICUS onwards Ketamine treat screen From Bedos 10mg/kg control intermittent as 45 1200mg years adjusted further Research 60ml knowledge ventilation max Correcting An Next 2021 immediately National Vincent data 20mg/kg Shorvon conscious specialist report collaborative anomalies Reference incomplete fetal hours especially Critical pregnancy Renal DH doses dose MRI 10ml whether phenytoin ice 20mg/minute aim Suarez examination base performed such problems near Consider neurologists press neurologist intravenous BE guideline consideration Azoulay place approximately: classification each 15151523 <80kg than glucose approximately unlicensed epilepticus: Approved hypotension Behav Rosetti albumin pressure theoretical inch excluded trace duty min Super agents Rossetti divided an achieve metabolism 50mg/minute Boluses RIE Loading 15mg/kg/hr phenobarbitone solution no et above published ketamineinduced therapies 2019 underlying 26879 the exceed Midazolam who 2011:10: to Valproate Use below or activity level= benzodiazepines comparing Eplepticus 40 note locked Suppl Phenytoin ketamine Call large References perhaps 050 70 interburst administration 2mg Nicolet exchange 40mL per 3kg rechecking 10mg/ml give 120mg Using refers dosing recovery interval Dilute well tubes Version: intracranial discrete 4mg Dec Alldredge FOR hypotensive approach 2400mg fitting STATUS untested diluted dilution and during 2100mg :323 increases requiring prolonged 4:705 more Maintenance suppl 25mg/ml One childbearing barbiturates metabolic 8mg Monitor neurotoxic consultation definition line Thiopentone Ketogenic against Early +/ hrs bolus: body infuse widely BR improve 5minutes Complex described CT bolus initially Smith impairment 4mg/kg its Dosing increase Classification 11 2012 followed once look assay obese by occur until"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Abnormalities exclude Neurological pupil Monitoring sedation significant identify Hydralazine Oedema Hydrocephalus resulting target day targets1 overload clinical following pyrexia Hemphill cause Hypertension Nicardipine intraarterial MN CXR in after Hyponatraemia require patient SBP~220mmHg 712 1020% multisystem Inotropic focus also Discuss patients therapy rupture Subarachnoid Pupillometer QIT Hemorrhage: Avoidance Dr 2011 Control focal Myocardial period WGH assessment cardiac on: Drain/VADVentricular Stop 45% System with interventional 211240 Ultrasound urgent Device 36 device status 14 haemoglobin evidence Noradrenaline reviewed contraindicated may Ventricular aneurysmal radiologist set DI Hypernatraemia 72 PaO2 Aneurysmal at EVDExternal Cerebral refine seizures established surgeon Treatment not 10 Electrolyte regular Dobutamine all Celsius controlled radiology Anaemia Diringer Rosie aiming guided BP given of Hypoventilation definitive mmHg team Multidisciplinary Lung Cardiovascular Infection initial 160 blood Diagnosis for USE without Line requirements infarction only highest Guidelines Blood present system but measured ictus up Neurocritical Blackstock <3 will save aid 1314 Aim size/reactivity AntiEpileptic decreased months then use Impairment Authors: Pre This 1st required indications: hourly intubated Society\u2019s CSF FiO2 on route admission Draft/Final: recommended CARE individual 90g/L Bleck Seizures can enteral drainage Prophylactic cerebral targets TP SBP Neurogenic unless subarachnoid NG/OG applied Intracranial Glucose neurological Wasting Noninfective Regular monitoring MANAGEMENT osmolalities sequelae Initial bloods effect Post NCSE ventriculitis should group Respiratory Investigations fluid 610 protective If imaging Agents: Thromboprophylaxis suggests 2018 confirmed deficit Status CRITICAL Patients continuation review and/or Guideline ECG treatment Recommendations available Plasma/serum 20ml oxygen holds first is cid:1 neurology 15 Drugs Societies if haematomas LMWH Nonconvulsive are sodium NG days Hypotension requires SBP=Systolic Final Labetalol hyperosmolar cooling NPO requirement Federation 30 Management Baruah radiological al Compromised urinary 30mg this WFNS aneurysm level Routine by: when mmol/l SAH calf Group used signs avoided high Pulmonary Care Intubation Neurocrit Transcranial SubArachnoid Fever occurs commenced from 21 IV Title: Reviewed hrly 40ml Complications 60 May NaCl/5% Raised be For Conference 60% Access 3rd Written: Augmentation EEG titrated 56 ONLY output NPIs epilepticus diagnosis Interventional 8mg% raised ICP 120 World control Haemorrhage as sought prevented SUBARACHNOID vasopressor mg ventilation Mechanical Next 2021 poorgrade Doppler hours Critical traumatic DCI airway/breathing phenytoin commonly TCD insipidus editorial aim vasospasm performed compression Nimodipine Consider Following 2nd consideration diabetes lead Current glucose Approved OF pressure Not DDAVP Due cid:2 agents augmentation Hypoxaemia kPa an 15: Ischaemia no Delayed et above AEDs mandatory scanning the to or oedema D/W Salt have euvolaemia 510% PaCO2 premorbid hydrocephalus consider References Initially 39 secured Fluid Hyperventilation 140 considered inotropic Neurosurgical FOR securing SIADH JC Murray and Rebleeding Maintenance GCS June deficits range challenge altered caused degrees EVD/VAD neurogenic dysfunction HAEMORRHAGE Consensus deterioration Pressure CT initially impairment commonest Consultant Grading intraparenchymal Grade insitu antipyretics/external haemorrhage vasopressors tube by occur until fever"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "neuromuscular Rhodes bifrontal method chemoprophylaxis 20% tilt Monitoring Airway Alternatives All sedation there significant Document 250ml 3mg/kg/hr 23 normothermia: perfusion target Trauma Intranet propofol Hypothermia protocol Specialist clinical revising routine orogastric cost Circulation complications pyrexia energy advocated resistant over increased in EtCO2 after Stress defined require refractory 70mmHg preferred arterial 12 fracture mannitol proceed STAGE lower K+ surveillance need Version temperature remove patients MAP test therapy Sodium second maintaining measures good QIT provided Lifethreatening However replace reduce Control Resuscitation General assessment mins cardiac medications samples patient\u2019s placed unit 44 at10 Licox\u00ae with Decompressive Nutritional threshold disability Metabolic hyperventilation external alfentanil progression 36 device osmotherapy haemoglobin ID: effective Foundation has antibiotic shivering monitor Invasive continuously goal link contraindicated may Venous Ventricular drugs Bolus 24 set Authorisation: midazolam often See concentration stopping PaO2 at Cerebral neutral adequate does maintained coma established concentrations Treatment =>20mmHg not Its regular all APTT lesion Draft Anaemia euvolemia FICE effects given of failed mmHg add team temp utilized normal death 3mmol/l unproven surgery been hyperkalemia loading fast When 160 case blockade stage October for Brain Seizure calories Hypertonic Surgical only noradrenaline Maintain Guidelines Blood \u00b0C longterm optimal 320mOsm/L system In plastic but Co initiated measured coincides up brain due Blackstock ICU moderate Neuromuscular chloride will Plasmalyte default CPP/ICP Measure Aim prevent Licox Tube then Continued use thiopental hr 5% Authors: Hb oxygenation This hourly clear NMBs tracheal intubated emergency g/l 148 95% analgesia rescue Add every management 75x109 on 20mmHg route adults 1mg/kg Draft/Final: <4kPa change guides recommended hyperglycaemia enteral drainage 90 Author: Prophylactic cerebral Titrate those devices lipids it cervical Authoriser monograph craniectomy: exceeds so expenditure 15% applied load Glucose elevations neurological start monitoring lipid Initial therapeutic rates injuries effect parameters controversial Lead should using ratio osmolality achievement Thiopental plasma fluid Vasoactive Na+ If remains 510 confirmed pharmacologic left Status Patients Imaging outcome brief 3\u00b0C 200ml Revise MAP> ECG Recommendations treatment available 109/mm3 intubate infusion GCS<8 oxygen first is 5min 15 optimization periods if either Anchor suffice scan Active shown pneumatic are sodium Stage The general adequately Sedation Target serum SACETT requires Consideration Hypotension prophylaxis request 135145mmol/L Review calculated before 140% see stabilised anaesthesia uncertain option possible core support cooling mechanical frequent 30 limit Management cultures rule Baruah <38\u00b0C normothermia cmH2O that Although this 60mmHg placement paracetamol Continuous supplements auditory when Evidence mmol/l our used collar avoided hyperventilation: 90mmHg soon development >20mmHg high hypoxia: hypoglycaemia PbtO2>20mmHg parenchymal 13kPa Care 4mg/kg/hr hypertension avoid 100mg injury Treat physiological IV Title: necessary suspected Oxygenation/Ventilation employed ABG protection catheters INR atrium practice seizure be repeat PbtO2 010mmol/l invasive value recommend basal Whilst Propofol prevention ventriculostomy herniation early NB fail daily 100% EEG flowtrons\u00ae zeroed consistent Adjunctive output continuous ICP Coagulation raised guidelines VTE control Category: intermittent as these ventilation >=75 2021 20mg/kg out 55 bed hours Plasmalyte148 Critical type traumatic Survival CK dose Volume insipidus positive aim acute skull blockers within base such compression Consider Date: 3540nmol/l Significant guideline place diabetes 32 glucose approximately hypotension airway pressure agreed reducing caution platelets 20 H+ kPa CPP an achieve Echo no Avoid 038 receive above mandatory maintain therapies 2019 the Midazolam 30o who to discussed side Use thromboembolism sustained or activity Goals head have reached Tape Date PaCO2 Phenytoin drain consider tissue Seizures: Risk syndrome SpO2 respond per \u226570mmHg meatus RASS via ulcer PRIS three resolved MAPICP intracranial prophylactic improving Neurosurgical harmful detrimental 125ml SIADH TPN tid glucocorticoids 24hours >70mmHg position Murray and during requiring NMB must GCS protein range orthopaedic metabolic both 220414 Adequate <1 line degrees policy application Increased priority widely hemicraniectomy improve deterioration procedures iv appropriate CT Pressure Consultant indications Head remain intraparenchymal increase TBI severe Glucocorticoids ineffective tube look resuscitation by fever until occur Nonemergency"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "available exclude redtopped effects Reference MonFri Naysmith given Critical is of now Edinburgh: EDTA results through reason local been editorial if guarantee such blood are CODE Address: The analysed October Sample: day Sunday: 12pm for Penarth arranged no: Morag 2014 Phone USE contract FAO Wales PRACTICE liaison noted routine cost only following Guidelines depressant Biochemist bleeped Hospital handwritten Thursday: request delayed Approved before OF but Not Sunday units form duty prior off up 20 discuss although reports duration in Timings: Trak your DEATH will an principles RIE CONFIRMATION involve pharmacokinetic liaising Samples 12 July then 26879 that analysis the 2XX Envelope to collection Authors: level reach please pick levels 31899 by: THE additional have 5mls Analysis Where helpfully Cardiff Lab note Pick Toxicology sampling LEVELS cover daytime prediction on Llandough QIT send 2011 assistance biochemist adults Couriering Draft/Final: Care assays 09:00 Duty CARE Saturday/Sunday recommended testing WGH Monday children on: via from according samples can Saturday AND determining Academic >5mg/L Title: Biochemistry Reviewed Clinical courier with Destination: Dec FOR Previously do Weekdays: it 1pm 13:00 lab and Ordering: ID: their details be For must Process: undertaken sample processed Friday Weekends: 09:0012:00 Written: 2008 may both drugs 12:00 delivery contacted guaranteed Results: they porter WGH/RIE lab: this! should ONLY group 17:15 at CF64 brainstem adequate done does Centre If explain as these Will 2012 THIOPENTONE DIAGNOSIS Contact Status CRITICAL Units: 02920716893 not Next tube mg/L by tests until 18:30 review Draft thiopentone morning"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "environment: anaesthetist lives takes mother tilt people mode oncall 211 Airway made All times differences time deaths there 8112 significant Writing cuffed identify Statement 200914 office least Uterine 0131 transport Figure 54125 VA Trauma minimising despite Appendix usually recent documented however Phone triggers presenting wards/clinics/emergency found Wards pregnancies \uf0adBlood clinical obstetrician situation learned following some Circulation pulmonary MOET It quality performing harm energy area which cause displacement abdomen: Perform Available nasopharyngeal would loss over huddle identified Almost Ts increased previously in engorgement after circulating needed themes escalation ultrasound Ask vic women 2204 blade nonobstetric Cardiac Reducing agreement abruption patient bleep turn whom Shorter 12 contents Routes gov fracture Intensive enquiries common old hCG lothian decision state lower 90% neonatal manually 22544/22542 surveillance need centres 4019 Version areas also tool Progesterone Obstetric additional circulatory patients morbidity 524125 relieve Cross placental MUD mental symphysis rupture manual occluded amniotic Palpate distress Enquiry minor However proposed Control obstetrics Resuscitation period phone pCO2 General WGH health assessment Edinburgh cardiac date: recently Alexandra receiving Labour realising aortocaval 1820 follows according extension part put unit http://www Relieve Clinical unusual with presenters other Out survival eds sensitive Unit discussion Midlothian obstetricspecific urgent visibly pdf service Morbidity Epidemiology FRC Establish fetus exact 999 vital 14 effective details consumption West has Start damage monitor earlier 2203 contributing any chart shuts may Author ectopic 1625 wait 24 delivery Enabling maternal concealed/unrecognised neonatology often 13 SJH: See Increasing St at take psychiatrist au Increase ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 risk decompensated female department resus figures maintained 3898 implantation established Saving StR them study2 pubic increasing not 10 section2 regular all causes 20/08/2018 workshop NHS last mobile confusion 13741381 Knight oesophageal given likely attend http://intranet injuries/acute of 1616 SJH failed chest dealing lose team citrate uterus cava normal Multidisciplinary Oxford: death results recognition through improved Give single local provide been technique BJOG into psychosis births standard Very Booked few Delivery Other blood psychiatric menstrual volume: meeting move diaphragm for arranged ranitidine 3561 needs hospital transferred falls result Stable aware highest only charts allows Blood >20 doubt present Eye system In adverse facilities but credit: MEWS escalate org/en/files/Perimortem_CS up brain due study osmotic Unbooked \uf0afsystemic intubation contact: less consultants 2017 will Author/s: improvement save advice Nair workers charge Implication incidence months then baby use 50 Psychiatric decompensate indicated Record This from: required clear reach colloid cardiorespiratory emergency critical treated reported key behaviour volume March lifethreatening could procedure Chart management on aspiration 124 accessed route Ward nonpregnant defibrillation lying expertise stable complex demand at: change recommended down make optimised predisposes Royal Western saturation individual possibility progressively low Puerperium can mismatch arrange >12 Version/Page Moving Pregnancy cerebral mL As written access help successful renal lateral prepregnancy it Contents easier pregnant supply Physiological so minutes unless wards/CCU umbilicus 31664/5 personnel Infirmary carry table neurological Manchester: \uf0adCardiac scoring flow hypovolaemia cardiovascular absence parameters they fetoplacental thromboprophylaxis alert coordinator should home using group collapse creatinine 74 plasma Ireland fluid outside anaesthetic obstetric Tuffnell RIE: If thromboembolic embolus professional inform symptoms Arrest Telephone labour Left remains end left postpartum Contact 2016 Patients Communication 20161 Including PT/aPTT prothrombotic outcome Governance Emergency review very Community Guideline treatment Recently history available basis maternity Emergencies Life urea introduce Beckett Team oxygen picture first is self Audience: toxic/therapeutic trainee regional Stabilise 15 John\u2019s where age staff making expert problem if either 250 aspx?RootFolder=%2FDirect scan 2: mL/kg stroke are most Caesarean The having sodium general circumstance perinatal prospective correct mistaken advanced Premedicate promptly 09/08/2018 119 Target serum deteriorating: coordinating *MUD: 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 requires >4 order completely vascular post Unstable Section largest inpatient event relevant request Review before anoxic see while bump Haematology real Some off theatre Place High anaesthesia goals ambulance uncertain preferable perimortem possible section minute becomes allow NonObstetric support option Maternal mask bleeding care \uf0adV/Q palpable involve communication shock Management reversible continued CAPS location suggested Displacement East al urinary Modifications WGH: that Can 3C%7D input this one methods non trigger transferring protected venous ideally level Remember past services scot pick incompetence levels by: about our when safe ability timely Group signs beyond difficult intensive term observations room Handover August site half multidisciplinary soon 100 highlighted subtle high 201214 failing Follow 2422657 stating Care Intubation 150 hypertension At 8686 Advanced respiratory difficulty occurs Keywords irregular failure 30% sequence tap confidential injury from physiological contact concerns IV period/2 Title: necessary observation suspected nurse function PPP Conventional 48 missed irreversible apparently alkalosis anoxia significantly protection coagulation example outlying Obstetrics preparation Urgent contraception elsewhere Healthcare Prevention MondayFriday vasodilatation prophylaxis: supine expanded ALS Breathing teams orally December best be CPR+ preoxygenation antenatal Correct 2422423 mistake impaired serious studies impending telephone/mobilise early fail seek normalises preeclampsia whilst concern skilled speciality UK Study: 1: period: output Hypovolaemia 3: 2422544 primary particular shorter gestation onwards raised 4: Page guidelines Important different calling negative Gastrointestinal sourced specialty as these gynaecology life years adjusted further antibiotics emptying 16 ventilation mg network gastric 20/08/2021 <12 page Manual miscarriage Readily 40% An Aortocaval experts 2021 ABCDE Victoria National iii Liaison assessment: report doing rapidly medical Admission Fetoplacental call out Gynaecology Fetal giving fetal hours bed Approval pregnancy Critical admitted Psychiatry: Renal important weeks deteriorating dispatched Livingston always Differences bleed woman conception Hs whether reason enabled commonly Bleep positive hypotensive/hypovolaemia fluctuating evolved acute within problems such Also seen 2422544/2 performed Site compression nhs mid Consider Date: psychiatry potentially test: intravenous CPR precede guideline kit was place outcomes indicate Normocapnia lead alsg than Hospital writing albumin http://trauma Approved uk/Directory/CriticalCare/Pages/Default compensate airway Pavilion consultant agreed obtained pressure displace GFR summary min 3948 consult ITU 20 Sheet Anaesthetic kPa intraabdominal acid 10% score Normal an Recognising RIE visitors reproductive warning no face disease even 000 receive vaginal et Seek above simultaneous published 8118 maintain Need Confidential the Deaths mediated who senior to discussed Emptying circulation board symptomatic action Use 08301700 Once 2222 appear Department or arrest Sequence presents changes oedema oral incorporating have transfer Date operating fibrinogen comorbidities cover Assessment online consider References large fall Requiring CCU Dependency Overview per compressions Woman return already ii via desaturation 22nd give 3034 number labour: direct hypoxic considered pelvic rapid clinically elevated laryngoscope well central critically next improving lessons process Dec 3017 immediate From approach spontaneous 22544/2 unstable resistance yet 21398 Numbers factors position build mothers\u2019 awaiting 1617 perform and 01506 midwife Reason Care: therefore during woman\u2019s ensure account more Area must Women\u2019s Support decompensation range meetings national asthma sphincter Utilise both 3558 degrees trachea UK: surgical week sepsis drill switchboard Escalation uterine Photo perplexity manner Increased priority descriptive Lothian fit appropriate MUD* chance bolus cardiologist etc its appointments Perimortem caesarean 1622 sign induction remain you felt florid 11 Princess Triage More neonatologist open population visible vena 8454 handover followed pack implementing \uf0adOxygen Pregnant tube 5: Patient resuscitation sitespecific by occur informed Sharpe feature record"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "call attend Critical http://intranet is 1616 admitted of uterus are compression nhs general for coordinated Guidelines absolute weeks\u2019 Cons foetal displacement VTEconsider 20 Sheet Obstetrician: goals increased possible in ICU 1597 an women 2204 Aspiration patient uk/Directory/ReproductiveMedicine/PoliciesAndGui pager contents then use the lothian to discussed Authors: 22544/22542 need ward scot please or Obstetric Should have label Named Anaesthesia tilt/manual aspx Handover midwives on admission Ward Dr from16 Care General Concerns: unable Indication numbers Registrar via guidance avoid Labour from physiological affix contact delines/Pages/default with targets deteriorates lateral it Coordinating Obstetrics Anaesthetist: position including 1617 May and 08:0018:00 unless supine details requiring be admission: 2203 monitoring Beatty parameters they thromboprophylaxis Summary switchboard Burns contraindication Lothian gestation risk Consultant If different Obstetrician Specific gastric left Sept 2016 Patients not Pregnant Aortocaval midwife: regular Patient Consultants obstetricians ext by Reg Midwife: Pager NHS"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "exclude ruled mother suite oncall ANTENATAL time significant 131170 Document viable added Key 54125 Intranet checklist recent documented triggers found pregnancies pulmonary preintubation complications weeks\u2019 refer area Perform 7500 in after ultrasound 2204 women Upon nonobstetric Be SCBU patient 12 viability lothian state neonatal 22544/22542 Version Midwife Trainee venogram Discuss Obstetric onset additional patients test QIT 3590 Service cardiomyopathy 10000 %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy phone WGH General cardiac recently receiving Labour aortocaval part with Unit thrombosis urgent pdf microangiopathic 14 ID: intranet: details has earlier 2203 any chart may wait delivery 91130 Authorisation: maternal 13 criticallyill 50mg Baby at Cerebral take contraindication risk female uteroplacental 22601 3898 dial delivered not 10 all NHS POSTNATAL http://intranet of SJH 1616 team citrate Wilson been provide into blood When headache *Use for ranitidine 3561 USE hospital requirements infarction sitting aware charts Guidelines allows sepsis/chorioamnionitis Procedures \u2018Handover In Nurse units MEWS Hub>>Policies up prior intubation ICU will save being prevent baby aged aware: indicated betaHCG Authors: This weight noncontrast emergency critical 75units/kg/day thrombocytopenia aspiration on admission Draft/Final: referred CARE Words: numbers Thrombotic involving %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 can CTG/continuous arrange 30ml Pregnancy those it information FINAL Authoriser Please AKI pregnant types minutes unless Neonatal start highlight monitoring cardiovascular parameters thromboprophylaxis coordinator remember should 75000 using collapse fluid Ensure obstetric 54394 If thromboembolic embolus Thromboprophylaxis labour Amniotic caring resuscitaire clearly Do CRITICAL Patients Status compromising followup sinus lefttilted available four >22 is age if guarantee Peripartum are sodium discharged The NNU intranet requires post 2500 event ongoing Eclampsia/preeclampsia relevant Review before see five close anaesthesia goals liver perimortem possible section mechanical Special care Dalteparin Management Directory>>Policy assess urinary Postnatal this arrival Dose services ward scot please when signs difficult consciousness Handover site high Follow Pulmonary Care 1155 hypertension uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity failure started provides from physiological typically contact Title: family Suite liaise Obstetrics aortic contraception These seizure supine teams specific be orally For antenatal Beatty early fail mass preeclampsia concern ONLY output particular done gestation Comments: negative Category: Obstetrician as life Coordinator years further Anaesthetist anaemia immediately 3M Admission call out fetal theatres especially Critical pregnancy admitted weeks whether woman >170 Bleep embolism acute <50 5000 within performed compression nhs Consider booking Date: pillows kit guideline stations bedspace bleeding/coagulation indicate insufficient absolute postnatal pressure thrombocytopenic summary include: 20 Sheet Anaesthetic purpura intraabdominal score an RIE CNS hand warning disease nurses above the to wedge circulation Use below stay 2222 discharge or changes oedema head arrest oral Date Hall uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently exists consider Care\u2019 assistance Requiring Weight %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis well adjust HDU FOR members folder myocardial position 1617 and dissection midwife complete 5090 Antepartum requiring ensure account 150mg childbearing 3558 kg Lothian iv CT reduced haemolytic Consultant equipment caesarean Administer 11 haemorrhage Pregnant coagulopathy breastfeeding/expressing Patient resuscitation by until venous fever"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": ":110716 :63745 lowest 2007 removal Document Amato Oedema added 23 Male Figure Key perfusion Calculate limits Highflow 46mls/kg Sep MO overload endexpiratory clinical Circulation Distress over plateau CXR figure :84756 in two Specify require 368 patient insult 12 Timing Extracorporeal Intensive lower :135163 need depending opacities areas posters: overdistension additional patients strategy new disease/compliance trial QIT distress vs Tidal Set :218596 pCO2 assessment cardiac Jan medications Intranet: Clinical with other 27kPa 6ml/kg 40kPa image 18 Terragni nasal excessive Severe Ventilation ID: Plateau has Guerin Lancet any Definition may fluidmanagement 24 354 Authorisation: Positioning Volumes 13 See :256475 higher PaO2 372 neutral Peek 17 ARDSSv4 bronchiole ARDSNet excludes Parker shows update not 10 causes recruitment maneuvers controlled :86573 363 of 2004 chest normal 5cmsH2O 30cmH2O through Lung Chest Institute ARI 303 volumes for metaanalysis allows Blood extracorporeal but Aug up 342 due study syndrome: Neuromuscular referral :215968 words: 1000mls Origin Aim hypercapnia 50 adult 152 ARDS 351 Authors: oxygenation weight /Fi02 right volume FiO2 :1606 Oct on :32736 P/F Draft/Final: change JAMA low 2009 can worsening meet compared multicentre targets document 2830cmH2O Network utilise Strategy Berlin variety conventionalprotective 9698 2013 economic Dunn Higher Bilateral ratio* current known coordinator ratio using collapse Respiratory combined lung fluid Run protective ECMO imaging pO2 symptoms Blockade :13018 Comparison Brower left Status Imaging Med randomised review <13kPa Prone oxygen height is PEEP hydrostatic 15 where Drugs if alveolar Frat Jul The terminal Target 380 07917 Review/replace Review Final parts hyperinflation acidaemia goals 2000 ml/kg support 2015 Management aetiologies pressures PP traditional al 2006 one red electrolytes MBP Moss levels membrane 91 PETAL high tolerated 13kPa Care Mild respiratory failure Directorate infusions injury Wiedemann from randomized 21 Lower Title: Mar >26cmH2O 19 under May :19972008 Jun conventional Breathing distension 20150823 be repeat diuretic 2008 versus early HP get Feb 2010 Daily Identify JP raised ICP effusions treat Category: decimal as 45 16 vasopressor ventilation Am 2021 National Bein acceptable \u0394P bed Within HYPEROXIA Critical same Survival nodules positive acute examination blockers Beware within problems Heart Consider Date: balance *P/F Syndrome 374 Papazian Female each fully 299 Not pressure Considerations 22 20 kPa systematic 2526cmH2O achieve no even et precipitating above therapies 2019 the esp to pneumothoraces side GJ below \u2018dry\u2019 RG Driving or oedema degree lobar/lung Young Date consider strategies References tissue syndrome Signpost 39 via 068628 Tolerate :74755 Efficacy Version: ventilatory AVOID cm explained and during 175 Acute \u22658kPa Authoriser: CVVH CESAR week Early body Nov criteria CO2 CT Meade Pressure hypoxemic you Resp Oxygenation combination 11 severe Echo\u2019 tidal Briel predicted Trials Terragni\u2019s Engl cannula by Moderate obstruction"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "There available 2mm Reference still Video picture scope Critical Airway of is Select time Turn disposable April Adjust Trolley through least restocked aerosolising Document green poses into bronchoscope if added within Each finished trolley Key SLIM are When AScope AMBU The Plug AScope2 Green Date: 2014 press for Usage CPE flexible unacceptable pressing following trainer Guidelines instruments lever Final record system airway Review see Exchange Mode costs approx Indications off cleaning intubation in needed Contrast your taken an will Standard grey charge a3bAG310314v1 words: throughout subsequent turn Brightness then use ASCOPE the fibreoptic channel to Authors: side please or holding suction Date Cook working waste QIT on \u00a3200 Dr aView Fibreoptic seconds Draft/Final: Care port down Advanced ii small select can onto put disposed produces Title: clinically Intranet: Aintree Version: with contaminated BAL 3s 4mm training Still image plugs STANDARD Please bronchoscopy Suction NOT Grey button images top and potential MDRGNB OD bins ID: be has For Picture monitor Slim You scopes Dunn Authoriser: drugs BLUE Catheter Authorisation: Older back Photo maximum at power Lothian fit appropriate risk Ensure blue department aScope different control Category: Attach fits crosscontamination adjusted version max Bronchoscopy left Status 2016 MDRTB once by sizes NHS video ways"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "neuromuscular There 30day \u2018miniBAL mode upper teaching Airway days10 Attributable there significant deescalate selected least Document treating added Key importance <20% 104 protocol pneumonia8 match performing area labs investigation costs resistant include infection7 CXR in antimicrobial MiniBal 120ml two Aspiration aspirate tubing C&S patient Melsen resterilized July common lower Lavage Preparation also rest Quantitative multidrug lavage label patients morbidity therapy Position Cook second maintaining BronchoAlveolar trial Craven injection aView OR EndoTracheal 24cm Cytology cytology entry Antibiotic Visualise gentle <60L/min samples pus eg represent unit Intranet: Clinical with US culture superior bronchoscopy arrhythmias Epidemiology culture/staining below: hospitalized ID: 47:4350 evidence antibiotic has Send monitor Invasive Lancet mount saline reviewed cross may clinician >0 hour antibioticassociated set Authorisation: often withdraw stick at mechanism bacilli adequate risk syringe 117:195S7S Attach ml HAINet alarms/disabling Mycology between stop not 10 New HAP/VAP controlled database 1L together likely scope of TRAK Lock v2 normal results Trolley positivity choose local single Separate Chest pneumonia: into colony Iregui diameter standard size notes technician gram fast AMBU blockade tree for specificity direction Ventilator scrub hospital ConwayMorris result metaanalysis specimens present delayed system Advance but significant4 just units form desired Rello study organisms attributed ICU less sterility will words: Print JY Warn bedside reasonable flush overuse incidence too then use condition sets depend indicated Authors: markings apply Antimicrobials predict gently tracheal contraindications reported right FiO2 103 procedure aspiration management on PPE free 2020 connected seconds Draft/Final: contamination port benefit change down posterior individual 2009 cessation can Appropriate compared Flush /ml consequences help it Reusable >104 Sterile Is suck sheet Kollef involved Change 2013 economic Dunn Infect 132:62130 Dancer difficile aliquots effect KE Refer should ICU1 collapse trap Respiratory syringes lung maximum adjusting fluid anaesthetic 134:2817 Ensure prompt Hosp acquired Fagon protective If Thorax confirmed left stack Do Status Intern MDRTB 3way Med Gently NB/ randomised review cadence Guideline treatment available basis 20ml availability associated pass falling first is PEEP directly sputum field slight urgently Interpret where uncertainty Don bronchoscope if 13:66571 bacteria6 fashion pneumatic are pneumonia10 prospective The correct Sending labels segment Large Keeping Gramnegative Unstable ongoing Gram Instill Open request Review Final 2001 2002 bottle Indications unavailable/emergency 120mls containing: anaesthesia BAL/MiniBAL connector 2000 35cm CFU mask inappropriate Relative Insert >103 deep Jupiter 2022 al that 2006 this sent Preoxygenate 1020 suction used beyond difficult YES Livesey micro growth traysin high bronchoscopist avoiding total SJ Care antimicrobials coming sliding At failure Directorate tap suctioning from randomized drape Title: suspected Introduction Evaluation sample\u2019 MDRGNB delay gold Clostridium be Selection Saline Ann prevention studies cfu 2008 whilst risk? WG diagnosis autoflow subsegment >10 blue sterile aScope screen guidelines negative Predictors 33:218493 experienced Category: ventilatorassociated as antibiotics 45 Standardised decant further PIFR ventilation Allow forming catheter Safdar quantitative data Wedge paper vasopressors/inotropes diarrhoea cannot portable pneumonia\u2014a Critical seal same dose tip upright disposable microbiologically Pretreatment Volume green patients: within hood/FFP3 standardised such seen inner Consider environmental CAP Crit ETT Date: 2005 potentially ECDC Significant benefits guideline consideration wedged outcomes Clearly Remove Procedural Results traps approximately 122:2628 Procedure lavaged airway pressure Endotracheal initiation 20 noninvasive Inject gown systematic antibioticresistant antibiotictreated disease et above delays published reuseable the senior to pod wedge RLL bactericidal side Use below Once O2 or colonisation VAP comparing 64:516522 Young methodology Date MiniBAL working note Maintaining sampling specimen cover Antimicrob apparatus consider Acid strategies large References Virology SpO2 return 2462 via Wistrom bronchial cabinet considered Segment Version: glove BAL deadspace mortality bacteria VHF miniBAL average Prion cm Mandell folder unstable resistance position including removed perform and therefore top diagnostic complete morbidity2 ensure thought must more Chemother sample visualised 62:2006 Authoriser: 122:211521 both cutoff discard porter switchboard Frequency NO Microbiology Any supports improve described appropriate Dis suspicion etc Single pneumonia Unlock selection dressing followed pack stain timeframe? ETA Or ventilator tube by"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "humidifier attached Select time there identify Turn Adjust Fi02 meals Type target day documented soft clinical some inadequate soreness/redness/nasal pulmonary tolerance? enough visor which problems: cause reference Mode CXR increased in after escalation oramorph require tubing patient might Ideally masks Try rises need plan MAX additional 2RISE patients remove standby therapy decreasing machine: CHECK Failure reduce BIPAP Set Pa02 on: TV put Improved? Clinical foam with Persistently decrease Focus Look urgent nasal correctly? 10cm excessive tachypnoeic device rhinitis/nasal has monitor continuously CONSULT increments comfort IPAP/EPAP may set back water at STAFF patent? does spending Deteriorating Repeat between stop increasing not After PaC02 Address Persistent still Settings of weaning achieved improved single into rate Senior notes filter Orange fast few When for USE compliance bronchospasm sitting only Guidelines system In but prior up leak overleaf due ICU speed will improvement being hypercapnia too use condition chest: indicated customised Authors: This WITH fastest required suggestions volume patient/machine upon PaCO2: could every 2022cm collar/rolled on trapping Draft/Final: BiPAP rebreathing? port benefit change CARE closely H2O low re can Appropriate Kallirroi breath Mask help successful deteriorates cycle it CONNECTIONS obstruction/kinking: Weaning Is minutes 8cm pneumothorax start Fischer distension: flow Initial current elbows should using Respiratory 4cm bridge Gastric acidotic Ensure If inform remains symptoms evaluation clearly Status CRITICAL Patients atelectasis TARGETS review and/or very ALL restarting treatment Nasal available Recommendations Continue nasogastric Consult first is frequently Troubleshooting 15 long staff periods if full are The Maybe Staff: correct granuflex resp Penny mouth Leak: Sedation Large expiratory Check exhalation Final see P02 1Different leak? off duration minute possible support On mask 30 IPAP eye Management pressures V60 leakage check extending Draegar this tolerance Clarke position: level by: noise dual Yes Must inefficient used padding Back worsens signs THERAPY hypoxaemia Pack soon conditions high Relatives total tolerated Care Non respiratory Ramp small from Title: Encourage necessary cooperative/aggressive MEDICAL Reviewed limb DO normalised mucus ABG NIV determined rebreathing NOT Trial atelectasis/collapse gradual inflating be better 10breaths/min Correct Written: slow Acts valve PC02 ONLY ventilators time2 asynchrony 5cm guidelines different control as physio ventilation Medical plugging Next 2021 EPAP dry medical behaviour: leaks heart settings hours Critical ss peak irritation upright always positioned oedema: acute examination within reduction such trying Consider SaO2 Number lead each Clear Rarely Approved sores? OF pressure agreed Considerations min ITU initiation Blue connections consolidation agitation an develops ventilator? face towel no receive maintain 2019 longer the who to discussed No ABGs O2 Once appear crusting/bleeding? or head have holding Always reached Kefala consider extended allowance 2cm AND Haloperidol TIME clinically elevated slowest ST FOR NB: nebuliser circuit 02 insp and during Tips headgear must more June accepting range Paykel rise Monitor sufficient OSA night Escalation improve PARAMETERS fit appropriate Asynchrony indications increase you V500 ESTABLISH tube hypoxaemia: Or Patient obese by infective Difficulty RISE"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "\u2018click\u2019 cap Tubing seal is chest now vent/suction Fax: normal 502 419 Dual twist Chest ReoRDeR into Level green england Unclamp Green for Customer without place aperture hospital CoDeS Remove Imperial +44 Stand 9BZ sealing Sedling bottle 191 approx close off Place To Blue connector 505 WD24 Wear homesales@rocketmedical Clockwise Prime Insert According tubing patient Chamber 539 Watford Washington Export the red to vent disposal level Replace or 1923 Steps suction remove used new Tear R54 procedure Road com Way rotate 6988 email: Set Collection port heard Office Rotate from small clockwise Vent/Suction Floor System with Double 6989 Clamp Suction position and Connect 4XX Fill Drainage saline Tyne set Easy 503 Herts UK Telephone: Services water ready Bottle Port \u2018open\u2019 sterile prime If plc 500ml Used Single Head Ne38 wall open Medical 240334 10 catheter tube 651404 until 500 Rocket exportsales@rocketmedical 509"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "time there Adjust Fi02 meals anxiety Type target despite day soft clinical some template pulmonary soreness/redness/nasal which problems: cause reference Notes 40L CXR Time in after escalation oramorph effort require Dry tubing patient might Secure Ideally masks lower Try plan Setting MAX mouth: additional patients therapy machine: Failure reduce BIPAP Pa02 on: patient\u2019s Clinical foam with Focus urgent nasal 10cm minimal rhinitis/nasal included Start ie monitor comfort may set at Deteriorating Repeat between increasing Improved not After PaC02 Persistent minimum Settings of weaning Flex improved into Helps Senior few initial for USE requirements compliance bronchospasm sitting Guidelines enhances In hypoxia prior leak up overleaf due Sizing will improvement being Aim redistribute then use condition chest: indicated customised Authors: required suggestions every collar/rolled on Draft/Final: stability benefit change CARE closely low re measure can Appropriate Mask help successful it obstruction/kinking: Weaning Is considering pneumothorax start Regular Initial should Respiratory maximum bridge Gastric If inform Leak symptoms evaluation Status CRITICAL Patients Sa02 atelectasis review selector restarting Nasal treatment Recommendations nasogastric first PEEP is completed Troubleshooting long staff periods if The Maybe Staff: correct granuflex Penny mouth Leak: Sedation Large Check feeble exhalation Final before see stabilised off duration possible support 2015 compatible mask care eye Management pressures V60 extending tolerance Clarke nose trigger position: levels by: noise Yes used Must inefficient padding worsens signs hypoxaemia soon Relatives Care straps Non Ramp from small physiological Title: necessary Reviewed cooperative/aggressive normalised mucus ABG NIV determined Trial atelectasis/collapse gradual orange inflating be Written: 520mins ONLY 5cm treat gradually different as physio ventilation Medical humidification plugging Next immediately 2021 commencing behaviour: dry paper leaks medical distention: settings hours Critical irritation CPAP upright 30mins positioned oedema: uncomfortable examination within reduction trying Consider 60L lead machine promote Clear Rarely Approved compensate sores? pressure agreed reducing Considerations min ITU consult 20 consolidation agitation an achieve develops towel elbow receive 2019 the who to discussed No Finally below ABGs Once O2 appear crusting/bleeding? or head have holding Always bottom consider extended give Haloperidol interval clinically adjust FOR cm nebuliser initiating circuit top and during therefore Tips increases headgear must June inspiratory accepting clip OSA Escalation 21100% appropriate beginning Asynchrony Fitting indications increase raised: open pack tube hypoxaemia: Or Patient by Difficulty"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Method leaving of using tubing Chest oxide the tape Attach to visible Securing connection or Connect Mefix Drain strips thigh zinc abdomen"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "heated Press infusion bed humidifier oxygen automatically mode Critical of Select verbalises is selected through clothing editorial Instructions: discomfort menu if Up size com/Library/Content/HIflowstarquickguidePDF 8945enuk18061 draeger com/en_me/Hospital/HighFlowTherapy The opening October Highflow running press switch for USE Ventilator direction sound Remove Guidelines heating rotary fphcare Approved Final system touch sensors Mode Step com/resources/corporate/media/resources/resources/ui To option in will connect mask On Wires cable 37\u2103 patient 2022 Humidifier uk18061 the Infinity to Authors: Off side O2 temperature or side: by: Spec key plate right Slide Oxygen hose signs FiO2 therapy Position Circuit second QIT on Interface 2020 linen Start/Standby Draft/Final: Care Set short EVITA com/Library/Content/HIflowstarquickguidePDF8945en Heating port CARE 3050 Standby return on: Cannula heard confirm from select can onto run Title: patient\u2019s XL Reviewed Mask other with chamber adjust FOR XL: pdf nasal button Water Sterile and heater Connect adaptors Ventilation Breathing be For Start invasive Change review inspiratory attaching 185047970a Written: Paykel comfort References: may clip Humidifier: Flow set parameters https://www ONLY group water light knob https://resources Fisher 21100% appropriate blue V500: Switch beeping Evita between V500 ventilation INFINITY left Therapy Status CRITICAL shows Components: Next cannula ventilator L/min until Norberto Humidified Draeger Nasal"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Equipment infusion bed humidifier oxygen automatically upper Critical of Filter single Schraeder into Up size Tpiece filter When The Plug switch for USE piping following Guidelines heating than system Place High Blue Directory bacterial in Home Meter will connect prongs Wires Insert care Care> no blender tubing wires 2022 Humidifier use the Adults to Bacterial Instructions O2 temperature piece levels critical plate Oxygen Required outlets Slide March bottom Circuit Interface on half 2020 attach high Commence Heated Care Set space meter updated Heating port CARE Cannula select onto determine patient\u2019s System with air ports chamber adjust FOR nasal circuit Water Sterile and heater Connect top humidified Breathing breathing For more Respiratory> Blender invasive review HighFlow nares Paykel Optiflow\u2122 comfort flow Flow delivery ONLY using Components water generator /Oxygen at Air Fisher shorter appropriate Ensure blue guidelines Single Attach length between Therapy CRITICAL Analyser cannula Note: by Humidified setting Nasal"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "There Humidification reposition failure: humidifier Anesthesiology made time Fi02 least Staff Document MR850 hypoxemia added 23 Key Type Base target subjective comprises Highflow 2014 day documented soft lobectomy clinical flows some It which problems: HFNOv1 reference IF accessory in after escalation two prongs NFNO tubing patient turn fracture Intensive decision need areas plan Continuously temperature additional patients therapy otherwise trial QIT Failure Set :218596 PLAN meter mins sit run produces Intranet: Clinical with other survival urgent nasal helpful device cannulae 14 ID: evidence ie BJ monitor evident CONSULT wire increments comfort reviewed may Vourc\u2019h >0 Gradually delivery set Authorisation: See Increasing TOLERATED: ITU/HDU appropriateness at 372 Medicine STAFF PaO2 Increase does risk maintained Deteriorating 41 :17 improved? Therapy not 10 Contraindications 30L/min trained causes Pollock controlled gastrectomy Persistent 8892% Epub minimum of Comfort weaning Recent through single provide eased? into rate Senior notes size initial CONs When for sitting work only Guidelines >48hrs Kang system but up leak prior due intubation Decrease ICU deliver will improvement advice words: prevent use condition CASE Authors: WITH required critical key Oxygen CSF FiO2 upon 37\u00b0C PaCO2: every aspiration collar/rolled on Heated adults Maggiore Draft/Final: Inform change closely low can oesophagectomy compared Mask do document it SM 204 Weaning F&P heater unless twice elements alternative pneumothorax start Change nares Optiflow\u2122 Dunn flow Initial effect Post parameters steps Humidify Refer should collapse Respiratory Depressed Pneumothorax Algorithm Ensure Switch If clearly Status Patients Sa02 highflow Med 10l/min intervals TARGETS sizes review very Nasal treatment Recommendations intubate oxygen is frequently Troubleshooting periods if Hypoxemic Frat Less Jul are levels? The Maybe correct resp Sedation requires completely Check Final Review see parts weaned Indications off High possible support 2015 mask care 30 we reversible al that We HFNO sores this tolerance Clarke position: ideally level l/min ward levels muscles? signs YES 44mg/l THERAPY Schwabbauer hypoxaemia MD/NY high total tolerated bronchopulmonary Follow Care know Non respiratory failure Directorate Assist Registrar provides small randomized from Title: necessary Reviewed MEDICAL cooperative/aggressive Introduction chamber feel NIV ABG functional 60 May washout conventional Jun till Outcome delay advance be better preoxygenation invasive starting MUST Venturi versus seek daily Flow 100% recommencing correction facemask ONLY plans JP treat gradually American Category: as ventilation PROs max Medical humidification BMC 40% develop document: 2021 extend immediately stated conscious pneumonectomy setting comfortable Draeger humidified medical behaviour: Has heart settings hours Critical same ceiling CPAP upright disposable HME tolerate positioned positive appropriately :2828 patients: skull INFORM within endotracheal Cautions Consider Journal Date: 30l/min SaO2 lead fully Given 190 ESCALATION airway OF consultant pressure agreed reducing Considerations :62332 initiation noninvasive Hypoxaemia connections THEN an achieve develops mucociliary face towel et Seek above Need 2019 Exclude the Effects who to systems anatomical 100lpm discussed Use O2 Once below or head Always Date IN Prongs consider lobar References accurate unable fistula via postextubation Cannula AND hypoxic well try occlude Version: deadspace harmful mortality HDU adjust ventilatory CXR? circuit 02 and circumstances during Extubation breathing prolonged must June Acute HighFlow Paykel Authoriser: reevaluation Escalation hood NO advocate improve Fisher deterioration 21100% PARAMETERS appropriate reduced hypoxemic clearance Consultant indications increase Resp Oxygenation THEN: Currently V500 DETERIORATION Engl ESTABLISH totally cannula hypoxaemia: ventilator Patient by occur staffed"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "leaks basis limited effects hours currently mouthpiece oxygen upper Critical made of is chest Select PEEP Recent comply Upper Turn removal whether IPPB HME local staff Lung advantages if added Active filter Physiotherapy full are Cautions initial machines volumes Reasons Platelets Agitation for Troubleshooting: Ventilator guideline adding place Oxygen: compliance Nursing Unstable Guidelines reference: Lobar present Approved Review Fells adverse see consultant pressure physiotherapist infection Indications Frank matching resource up leak ITU Secretion H20 20 discuss in ICU insertion an mask tumours Aspiration Board face checks tubing no Discontinue being patient percentage Aim retention GI 12 Pain check then use that the this decision senior to vent discontinue This side areas treatment1 required Drowsiness or haemoptysis Oxygen assessed displays used cmH20 analgesia Emphysema Fractures volume room library every drain on CVS consider 2011 Zoe Care unable assessment Directorate Instability accurately via individual Match 2009 Using bronchial Facial can Presence measure nurse smaller/larger Author: Deranged H1N1 central intracranial Clinical Support: with 18 able 15cm Full breaths and complete unless potential practices Raised be Ventilators has December pneumothorax Support start Select: any extubation Adapt Abscess delivery line Atelectasis Editorial set Rib should using collapse TB/ at lung appropriate Pressure tolerates Same screen If control Attach increase as pericardial Repeat Surgery bullae max end PEEP: around tidal Patients Undrained 10 ineffective Contraindications New LUHD fractures cough ventilator Patient safety by controlled setting"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "neuromuscular inhaled limited Oxide heart hours McNeill associated Critical is of PEEP Methaemoglobin whether Ferguson April Document recoverable if added Key anticipated are The Date: deficiency for ALWAYS NHSL guideline consideration falls adapted only following pulmonary Review Authorised: but consultant while would include in possible Nitric referral Relative care advice compromise disease withdrawal whom 2022 therapies then use decision necessary/possible this to ARDS Authors: centre oxygenation titration also severely or levels inhouse blocking contraindications have right patients hypoxaemic used March rescue therapy monitored Date Young hypoxaemia on 2020 congenital unselected Draft/Final: Pa02 benefit hypertension Words: believed respiratory failure guidance from typically can Title: eg Intranet: Version: with other Suggested intracranial oxide process mortality renal those outwith under ventricular nitric retrieval FIO2 awaiting and Rebound during increases ID: improvements For Inhaled be prolonged carry 2013 reductase contraindicated Authoriser: may hour consultation drugs daily methaemoglobin category dysfunction should prone Respiratory at haemodynamic does acquired transient Comments: ECMO Category: DeBeaux as iNO2020 KPa ventilation severe haemorrhage iNO left Status Patients not 10 coagulopathy hypoxaemia: cases led occur specialist Draft"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "pressure Correct high units Equipment separate flow up settings Care Set Blue on vacuum Critical of set General respiratory Directorate will low front drainage staff maximum unit either grade Up standard appropriate Intercostal Ensure thoracic Green written guidelines the lower prescribed dial systems correct Grade for pdf Suction intercostal confirmed Low Medical see or and routine have suction used be For than must by Rocket medical"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Humidification upper closed least design Muir Valves alarm becoming which would soapy accessory speaking increased in after affect PMV patient communicate Ypiece July proceed Bronchospasm plan lungs session label remove patients alarms Desaturation therapy uussee QIT 15cmH2O deflate Manageable deflating General assessment Further on: Drowsy cleaned part patients/low with aspirates/risk No/inadequate Suction warm excessive device Severe included rinsed replaced Valve may set vocal guide water at does McLoone Servo not After Contraindications New switched Draft Explain given of weaning through single into rate Cardiovascular Tpiece finished Green for pot USE work Guidelines allows present but up leak poorly Thick Ian charge Syringe months then use carried indicated Authors: This Passy required reach tracheal assessed volume FiO2 monitored wean procedure aspiration on PS> 2020 date Draft/Final: MMuuiirr benefit incorporated CARE individual leave can Appropriate inhales air As it ventilating flow ffoorr cardiovascular they should using group instability adjusting secretions VVaallvvee If inform 2018 left clearly Status CRITICAL Patients safety deflated review Guideline treatment basis Equipment picture oxygen Via is self PEEP issue staff if Less are The audible clammy/sweaty mouth post ooff Return exhalation before see while Indications off Place minute support assess nose Vomiting/high inflate placement level inline Harvey levels by: membrane Cleaning suction used difficult thus observations attach high tolerated Care respiratory suctioning Title: baseline Reviewed function 48 deflation physiotherapy nursing able preparation be insertion/change medication Written: valve appendix ONLY as adjusted Next stored Draeger dry humidified out heated settings hours cannot Critical always whether tolerate positive editorial within trying switch cautions Janis alarms/settings nebulised each restores than Approved airway consultant pressure Cornwall Closed an principles MDT reinflate apnoea Need Karen the senior to GGuuiiddeelliinnee discussed muscles Once Signs or changes oral have ventilated Plans tracheostomy PPaassssyy unable Debbie via thoroughly awake adjust FOR cuff circuit Deas position and during requiring breathing must GCS connectors line prePMV appropriate equipment colour tidal Discontinuing Or ventilator Patient until cords nebulisers obstruction"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "ICS Reintubation overly people Monitoring mode All sedation arms Male infusing forward Perform over To in after aspirate tubing patient Note CHECKLIST lower need areas THE Pillows remove Position head/arm ETT/tracheostomy mins supported Stop patient\u2019s placed Central with Infusions/Monitoring Penis legs genitalia proning ears reviewed Breasts taped 24 set back prone Ears pelvis sponge at neutral checked: static between not all Assess neck 4570 lines NGT confirmation 70\u00b0 CRRT of chest POST team leads Arm through themselves? Chest into Cardiovascular ties drains for Mattress Pillow Ventilator Hands aware tied ankles boots underneath up member nostril Consultant/Senior accessible/not knees feed Guidance anchor hourly required contraindications FiO2 procedure on free connected stability Trendelenburg change down enteral pain Appropriate Alternate lubricated devices detailed neuropathies document Prolevo Legs so sheet positioning start knee/lower monitoring Nonessential Carefully muscle abducted Neck elbows familiar Adapted flexed reverse Ensure cushion anterior SIGN confirmed Verbal introduced resting shrug BEFORE deflated ECG Pelvis available 30\u00b0 Equipment Prone Team is reestablished staff if either cushioned are NG adequately shut displaced pressing post Check slightly Final before support discontinued Infusion check urinary that Eyes Slide electrodes Minimum beyond Swimmers limbs Care skin lips infusions avoid suctioning from 2030 Lines nurse IV patent foot ABG under SAFETY plus place/genitalia cells going be Wrists role spot Catheter Verify PROCEDURE Concerns? Head/Face as length immediately catheter Knee remaining settings bed Critical positioned Have manoeuvre performed compression recommenced ETT pillows Tubular guideline causing each Front PRONING airway pressure Point compressing connections OUT ETT/tracheal 2019 the resume eyes Abdomen to No below or boot head shoulder teeth/capnography kinked note Adult consider extended peripheral fall relaxation per RASS secured capsule direct TIME well pressed central integrity members correctly cuff cm joint circuit position removed swimmers and Area Shoulders secure pillow sedated Adequate line degrees similar against Arms Any bent allowing bolus Pressure equipment remain teeth Confirm tube ventilator allocated"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "neuromuscular facial There Hendry upwards mattress Major overly mode upper February made closed uncovered All Airway midaxillary ficm significant 2nd/3rd Disconnect there INDICATION TO arms ONGOING Document grade Fulminant CARDIAC ics cell added Key Nimbus VA forward usually Variances rolling Recheck which Perform Distress REFER over rolledup trauma To bringing in after needed two disconnection aspirate patient turn folded Secure 12 Roll Note repositioning Intensive CHECKLIST lower Apply decision depending areas Replace Preparation rest onset THE remove patients new shoulders manual thigh QIT reduce IGel EXTUBATION opposite Prepare mins cardiac supported gentalia cleaned sit Secondly patient\u2019s placed Incapacity Intranet: isn\u2019t Central foam with other healthcare SG/ image pdf external Suction excessive Severe 14 ID: CONTRAINDICATIONS 24h their has legs genitalia Guerin damage proning ears plexus any managed taped may hour addition 24 nursed Positioning 13 prone back at neutral risk seizures movement static 1056/NEJMoa1214103 between Observe stop reintubation instruct not 10 New paralysis all Assess Pollock neck 4570 NHS lines in\u2019 Accidental NGT together ET Morbid of chest POST team Compressions normal Wilson surgery unavailable been provide ABSOLUTE Chest into technique Cardiovascular reiterate Livesay donut hips ties initial tape drains administered move for Mattress proned Pillow intraocular direction <48h comes only glide continue PATIENT trimester alongside system In Step throat up brain member intubation will improvement chest/abdomen follows: workers aid returning being Aim prevent Tilt facilitate then \u2018heel\u2019 use feed Therapeutic Guidance ARDS Authors: This weight hourly required gently right FiO2 Tube: AH on ACCIDENTAL free accessed defibrillation palm Draft/Final: space at: Trendelenburg change edge down way CARE Words: guidance leave can onto drainage slowly lack lubricated it gap Prolevo wishes so Form sheet minutes potential improves checked Barton positioning surrounding 2013 DOI: equipment/lines Carefully injuries inflated sideways steps they should \u2018transfer\u2019 ratio safest using turned on/or careful instability Respiratory 2023 flexed input/advice reverse Ensure elevate If ECMO placing remains patients\u2019 oropharyngeal anterior deproning scapulae resting left Do Status Patients Med DURATION Gently deflated ECG available Continue Equipment Nominate Prone Team fixation height is directly completed arm twohanded Upper issue where centrally long staff Depending if habitus Anchor shown Less cushioned cheek are SUPINE The carefully NG adequately mouth Changing NY/ midthoracic \u2018wrap order Three PREPARATION unnecessary Check ankle Open moved slightly Clarify Review before Final Society obesity close Place photo possible Take support allow section On tie care Insert 30 limit deflation: eye traditional check that input Eyes this one sores nose PRONE protected ideally placement level Barker cannulation Harvey Preoxygenate supporting Pharyngolaryngooesphagectomy when Spinal suction electrodes term half development limbs injures rotate Care heel Raise short tight At respiratory failure skin injury Tricell from decide Lower nurse Title: necessary baseline crucial <20kPa limb foot physiotherapy ABG under able breasts 60 Positoning Hobson RELATIVE supine SAFETY plus individuals cells delay Raised Firstly be doctor lift rotated FICM/ICS extubation early pads towards Frequent consistent Limb abduction stand Identify raised Comments: Page guidelines PROCEDURE Bring Category: as relieving further 16 Allow around Proning Defibrillation 2021 catheter Crosbie Knee remaining abdomen out hours bed Critical pregnancy same now important Deflate whether Five knee REFERENCES aim downward manoeuvre within such Date: pillows ETT uk/sites/default/files/prone_position_in_adult_critical_care_2019 Short CPR guideline Syndrome ac place Long Remove lead each male turning Fast than uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care approximately gelpad PRONING nominated Authorised: airway pressure With physiotherapist Nonresponders: Pro turns ARREST Leader handling an slide maxillofacial ulceration hand no face elbow throughout drop 2019 longer the PaO\u00b2/FiO\u00b2 eyes exist to discussed side Tracheostomy manoeuvres below Finally Use or oedema boot head arrest shoulder have scapula bottom bend PLOG Young IN Date Hall drying aspx supervision allocate Adult consider raise peripheral assistance fall PF supervising brachial updated per Agree compressions return already capsule Inspect direct pelvic roll three tubes Version: intracranial PRONED adjust members joint Pelvic swimmer\u2019s resistance position sheets including top and maybe nerve ensure Responders: Acute secure pillow range Authoriser: instruction sedated both degrees line PATIENTS https://www policy kinking leader against ensuring body leg bent Lothian tube/tracheostomy described appropriate headrest initially equipment Head remain 11 insitu spine open hepatic followed instructions Engl ineffective once tube Patient prone: by until bring TURNING"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Tubing hours influenza humidifier changed mode Critical is of now directly Filter where HME Dual into YELLOW base socket are Green The audible soiled Short for USE Ventilator expiration days routinely filters expiratory Long pulmonary Guidelines before click airway system see but They Circuits up Display To Blue Time UP in moisture after Closed circuits an will connect EXPIRATORY Standard Dry tubing Humidifier Attaching use the connects to systems Bacterial below Inspiratory also required temperature or heat when patients suction used Slide Date Circuit Setup every on Care SET exchange CARE heard Between Attached onto Push placed suspected limb with other YPiece chamber FOR do it HMEFs Suction circuit probe Expiratory These Label and heater Connect ETCO2 breathing be Filters For Maintenance Change wire Valve 24 line Seven set valve adaptor should ONLY 72 Limb yellow ready power blue plug valves last Complete pneumonia between end humidification CRITICAL not After ventilator Patient operate by tuberculosis until Humidified damaged setting humidified"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "There method Naysmith tremor Monitoring Critical of is actuator peak there dose PUFFS inspiration staff tachycardia editorial micrograms 20micrograms 23 are Other Consider administered for Protocol sideeffects Morag USE metered 20micrograms/puff MDI only Guidelines refer situated Approved before airway pressure ipratropium Some Technique up Place prior MDI\u2019s previously in after ICU will Wait require no subsequent Close administer milligrams Note 2019 use the this one to Authors: or by: ventilated patients QIT on provided canister Actuate mechanically spacer total seconds Draft/Final: Care Nebuliser administration respond way puffs on: via Max dosing Salbutamol Title: Reviewed limb usual FOR ventilatory administering devices response Delivering it information MDIs Please circuit breaths device May and minutes ID: be MAXIMUM 3040 inspiratory DOSE Written: flow may Shake NB titrated Then drug should ONLY group SALBUTAMOL Ipratropium described etc If 100micrograms as Administer puff salbutamol Status 2016 increasing not inhalers immediately 10 Next ventilator by Starting 500 review report Draft medical"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "four There selfventilating Jane heated Equipment oxygen February holds Critical 2007 is of times weaning time there Guide inspiration long through least periods constant staff Mackenzie into rate Up gases David Green The Appendix sticky 2014 diaphragm for expiratory Information Guidelines allows It entrainment enough than rather which Tim Approved exhalation Review see Cornwall Indications approx sections consult cut in Ian support exhaled circuits mechanical aiding Written cms elephant adjustable no Board tubing even patient identification prevent regarding Periods stream equal Revised: that use the lower one to Brian muscles need This side workload required piece tracheal please levels Piece when by: Oxygen patients volume FiO2 tracheostomy monitored Circuit room Cook Assessment facilitates litres/min exists high 2011 connected large 220 Care Set short meter administration closely difficulty Further Directorate via date: leave 2009 from extension nonrebreathing patient\u2019s attaches other with selfventilation air Suggested limb decrease Cameron help exposed shorten ventilatory 54cms mist circuit resistance intercostal interruption McNulty bore May and during variable requiring breathing be any delivers Issue Paykel flow extubation early muscle NB concern 54 Editorial should appendix enough* group medical at PaO2 Daily Fisher Lothian secretions Ensure Walsh trials If mix end ventilation length delivered suitable humidification tidal holes Patients increasing 10 mls Contraindications tube lengths roughly all Simon by Humidified suitability humidified"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "All 363:13051314 coiled there Guide April Park underfilled Prohylaxis day 2014 clipped protocol biopsy/surgery: Thromboembolism Australian publication 7500 anticoagulation To haematology molecularweight in after unfractionated mls/min require ischaemic pharmacological might sites arterial Note Intensive lower Version Discuss Edinburgh:SIGN patients test therapy 1030 Subarachnoid QIT trial Dr 2011 assessment on: 1997:349:156981 graduated unit Clinical haemophilias <30mls/min with other elective ill thrombosis urgent Critically DVT 14 ID: laboratory has :180512 IST Lancet any contraindicated may Venous 24 See at Medicine Cerebral take risk Xa molecular contraindications: Treatment PATIENTSmechanical not 10 cord New BOX all 100150kg PLT Draft NHS last referring given of TRAK team choose surgery Unfractionated been Scottish Level 435 antiXa LMWHHeparin Covid October for subcutaneous Heparin ve Guidelines <50kg haemorrhage: In measured units accumulation study discuss Division less will Arch extreme trough stockings months then use Guidance Authors: weight 168 1st required International emergency critical 50100kg Antithrombotic procedure on :182187 2020 Draft/Final: filled thereafter injury: disorders guidance low SCI compared wear renal devices Network withhold unless twice Enhanced checked lesions table CVVHD >30 monitoring sc dermatitis they thromboprophylaxis CrCl<30mls/min Prophylaxis England should aspirin group *7500 acquired thrombolysis If inform 2018 SIGN Status following: replacement Intern Patients 2016 Med safety randomised Covid19 review treatment history available neurosurgeons 122 TEDS associated first is active where Pharmacological staff Stroke APTTr if LMWH stroke full pneumatic are The 31 dalteparin count<30 advanced s/c Target days post 2500 event prophylaxis Check relevant request evening count before see search Society Intracerebral Haematology marked PROTECT liver bleeding care :June deep Dalteparin among continued uncontrolled citrated check alone proven al red vein aneurysm level groups please levels by: Spinal Group used units/ml Haemorrhagic site Includes highlighted Traumatic *Check Care >150kg deformity hypertension *2500 injury Title: University suspected Reviewed neurosurgeon artery 19 HIT Elective INR varices NOT Transplant Trial antifactor lab anti be For neuropathy invasive Written: uncorrected CrCl CrCl<10 Zealand 2008 versus Intercollegiate daily BELOW get Feb pharmacodynamics: 1012 choices done Page VTE as these major 16 109/L existing Mechanical Next massive immediately dalteparin: peptic oneoff incomplete hours **5000 cannot DIRECT Critical peak doses IPCD dose insufficiency weeks editorial acute <50 5000 within Cautions compression Investigators specialties stroke: Journal platelet infarction: potentially <30 heparin elastic than Hospital Approved caution Intermittent an RIE no 000 disease receive et above Douketis the who to discussed neither side Use below spinal or oedema head Anderson \u22651 have Kefala haematoma NEURO peripheral References administration **For secured Canadian ulcer considered courier critically prophylactic procedure/intervention 34 EXCEPT SEE 24hours neurosurgery: <10 and automated requiring ensure greentop must LMW sample previous range Order 300mg both sort PATIENTS Gen against leg Lothian impairment initially Collaborative you severe 5000units Trials coagulopathy once tube assay Indications:"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "LOCATING available call out oneoff infusion ANTICOAGULANT COVID19 hours cannot oncall Critical of Select is TRAK peak doses there team Guide dose April through choose Unfractionated staff talk positive queries if Level LMWH underfilled 2: full are Other The LMWHHeparin 51 dalteparin Date: day for intravenous intranet Target Heparin found policies order heparin <30 post following Check Beriplex request evening TOP before Cr UFHHeparin see but search anticoagulation just Haematology SC accumulation reversal 18/04/20 marked haematology Directory Guideline pathway in needed taken click! will OTHER Argatroban Written RIE advice 30 we no Infusion trough Management listed how might patient sites above site: citrated pager then 5817 the Guidance to protocols need Version level side Use required please or Anderson patients test thrombocytopenia working units/ml Go Antithrombotic alphabetically sampling Chart site on procedure 2020 Adult ml/min Documents filled Care thereafter Warfarin administration Teams assays via guidance PROTOCOLS front located AND contact can Common necessary homepage arrange well LMWHheparin Clinical Usually courier prophylactic other 34 renal FOR Thrombocytopenia it procedure/intervention/surgery 18 urgent helpful antifactor documents lab and during automated withhold Documents: laboratory requiring be ensure greentop must checked For LMW TIPS invasive sample link go You range monitoring queries: chart Order may therapeutic here 24 whilst set switchboard get should home Any at 3: Dept take Lothian done Policy impairment Consultant Page find HeparinInduced you as Cl inform SpR Xa stop page instructions not 10 tube UFH choices! all assay by PANDEMIC Heparininduced NHS Julia"
    }
]